assays_variant_id,assays_cell_id,assays_assay_subcellular_fraction,assays_assay_type,assays_assay_tax_id,assays_confidence_score,assays_assay_category,assays_src_id,assays_assay_id,assays_assay_strain,assays_doc_id,assays_src_assay_id,assays_assay_cell_type,assays_bao_format,assays_chembl_id,assays_description,assays_assay_test_type,assays_relationship_type,assays_tissue_id,assays_assay_tissue,assays_tid,assays_assay_organism,assays_curated_by
,,,A,10116.0,1,,1,7524,,9866,,,BAO_0000218,CHEMBL618647,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7525,,9866,,,BAO_0000218,CHEMBL618648,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7526,,9866,,,BAO_0000218,CHEMBL618649,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7527,,9866,,,BAO_0000218,CHEMBL618650,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7528,,9866,,,BAO_0000218,CHEMBL618651,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7529,,9866,,,BAO_0000218,CHEMBL876497,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7530,,9866,,,BAO_0000218,CHEMBL618652,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7531,,9866,,,BAO_0000218,CHEMBL618653,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7532,,9866,,,BAO_0000218,CHEMBL618654,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7533,,6351,,,BAO_0000218,CHEMBL618655,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7534,,1465,,,BAO_0000218,CHEMBL618656,Compound was tested for solubility in water,,N,,,50597,Rattus norvegicus,Intermediate
,,,P,,0,,1,7535,,5182,,,BAO_0000100,CHEMBL618657,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,U,,,22229,,Intermediate
,,,A,10116.0,1,,1,7536,,17847,,,BAO_0000218,CHEMBL618658,Solubility was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7537,,15339,,,BAO_0000218,CHEMBL618659,solubility in water (ug/mL) at 37 degree C.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7538,,5202,,,BAO_0000218,CHEMBL618660,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7539,,1088,,,BAO_0000218,CHEMBL618661,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7540,,3169,,,BAO_0000218,CHEMBL873807,Half life in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7541,,5353,,,BAO_0000218,CHEMBL618662,Half life in Dawley rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7542,,2864,,,BAO_0000218,CHEMBL618663,Half life period after 3 mg/kg iv administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7543,,2864,,,BAO_0000218,CHEMBL618664,Half life period after 3 mg/kg iv administration in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7544,,2864,,,BAO_0000218,CHEMBL618665,Half life period after 3 mg/kg iv administration in the rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7545,,6362,,,BAO_0000218,CHEMBL876498,Half life period in female Sprague-Dawley rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7546,,6249,,,BAO_0000218,CHEMBL618666,Half life period in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7547,,3169,,,BAO_0000218,CHEMBL620440,Half-life in rats was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7548,,3169,,,BAO_0000218,CHEMBL620441,Half-life in rats with metabolic oxidation,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7549,,3169,,,BAO_0000218,CHEMBL620442,Half-life in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7550,,17260,,,BAO_0000218,CHEMBL620443,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7551,,17260,,,BAO_0000218,CHEMBL620444,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7552,,17260,,,BAO_0000218,CHEMBL620445,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7553,,17260,,,BAO_0000218,CHEMBL620446,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7554,,2879,,,BAO_0000218,CHEMBL620447,Biological half-life measured in plasma of rat,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7555,,2879,,,BAO_0000218,CHEMBL621129,Biological half-life measured in plasma of rat; 22-25,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7556,,2879,,,BAO_0000218,CHEMBL621130,Biological half-life measured in plasma of rat; 9-16,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7557,,3184,,,BAO_0000218,CHEMBL873808,Compound was evaluated for its half life when administered intravenously in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7558,,4891,,,BAO_0000218,CHEMBL876598,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7559,,429,,,BAO_0000218,CHEMBL621131,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7560,,5656,,,BAO_0000218,CHEMBL621132,Half life (T1/2) after oral administration in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7561,,4413,,,BAO_0000218,CHEMBL621133,Half life of compound after iv administration of 20 mg/kg dose in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7562,,3598,,,BAO_0000218,CHEMBL621312,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Expert
,,,A,10116.0,1,,1,7563,,17267,,,BAO_0000218,CHEMBL621313,Half life of compound was determined in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7564,,4727,,,BAO_0000218,CHEMBL621314,Half life of compound was determined in rat blood,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7565,,17651,,,BAO_0000218,CHEMBL621315,Half life at 1 mg/kg was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7566,,17651,,,BAO_0000218,CHEMBL621316,Half life at 10 mg/kg was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7567,,401,,,BAO_0000218,CHEMBL621317,Half life in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7568,,4942,,,BAO_0000218,CHEMBL621318,Half life in rats in hours,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7569,,17735,,,BAO_0000218,CHEMBL621319,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7570,,6056,,,BAO_0000218,CHEMBL621377,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7571,,5213,,,BAO_0000218,CHEMBL621378,Half life was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7572,,6616,,,BAO_0000218,CHEMBL876599,Half life after i.v. administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7573,,5937,,,BAO_0000218,CHEMBL621379,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7574,,5819,,,BAO_0000218,CHEMBL621380,Half life in rat plasma,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7575,,5819,,,BAO_0000218,CHEMBL621381,Half life in rat plasma; Not detected,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7576,,6803,,,BAO_0000218,CHEMBL618515,Half life in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7577,,17804,,,BAO_0000218,CHEMBL618516,Half life period of compound was determined after peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7578,,17804,,,BAO_0000218,CHEMBL618517,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7579,,5948,,,BAO_0000218,CHEMBL618518,Half life period in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7580,,1916,,,BAO_0000218,CHEMBL618519,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7581,,1916,,,BAO_0000218,CHEMBL618698,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7582,,1916,,,BAO_0000218,CHEMBL618862,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7583,,4890,,,BAO_0000218,CHEMBL618863,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7584,,17764,,,BAO_0000218,CHEMBL618864,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7585,,4727,,,BAO_0000218,CHEMBL618865,Half life time in rat the dose of 2 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7586,,17509,,,BAO_0000218,CHEMBL618866,Half-life 24 hr after 10 mg/kg iv administration in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7587,,17509,,,BAO_0000218,CHEMBL618867,Half-life 24 hr after 2 mg/kg iv administration in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7588,,6597,,,BAO_0000218,CHEMBL875828,Half-life consistent with the observed metabolic steady state in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7589,,17735,,,BAO_0000218,CHEMBL618868,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7590,,6597,,,BAO_0000218,CHEMBL618869,Half-life for oxidative metabolic stability was determined using male human,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7591,,17670,,,BAO_0000218,CHEMBL618870,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7592,,1696,,,BAO_0000218,CHEMBL618871,Half-life in rat plasma,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7593,,1742,,,BAO_0000218,CHEMBL618872,Half-life in rat plasma was determined,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7594,,17800,,,BAO_0000218,CHEMBL873816,Half-life in rats was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,7595,,12923,,,BAO_0000218,CHEMBL618873,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,U,,,22224,,Autocuration
,,,A,,0,,1,7596,,11954,,,BAO_0000019,CHEMBL621602,Area under curve after oral dose of 0.1 mg//kg,,U,,,22224,,Autocuration
,,,A,,0,,1,7597,,11954,,,BAO_0000218,CHEMBL621603,Area under curve after oral dose of 0.3 mg/kg,,U,,,22224,,Autocuration
,,,A,,0,,1,7598,,11954,,,BAO_0000218,CHEMBL621604,Area under curve after oral dose of 1 mg/kg,,U,,,22224,,Autocuration
,,,A,,0,,1,7599,,11954,,,BAO_0000218,CHEMBL621605,Area under curve after oral dose of 10 mg/kg,,U,,,22224,,Autocuration
,,,A,,0,,1,7600,,11954,,,BAO_0000218,CHEMBL621606,Area under curve after oral dose of 23.4 mg/kg,,U,,,22224,,Autocuration
,,,A,,0,,1,7601,,11954,,,BAO_0000218,CHEMBL621607,Area under curve after oral dose of 3 mg/kg,,U,,,22224,,Autocuration
,,,A,,0,,1,7602,,11954,,,BAO_0000218,CHEMBL621608,Area under curve after oral dose of 3.87 mg/kg,,U,,,22224,,Autocuration
,,,A,,0,,1,7603,,5237,,,BAO_0000019,CHEMBL621609,Area under curve was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,7604,,4026,,,BAO_0000218,CHEMBL621610,Area under curve at a dose of 10 mg/kg,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,7605,,5237,,,BAO_0000218,CHEMBL621611,Area under curve was determined; ND=No data,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7606,,14793,,,BAO_0000218,CHEMBL621612,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7607,,14793,,,BAO_0000218,CHEMBL622308,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7608,,14793,,,BAO_0000218,CHEMBL622309,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7609,,14793,,,BAO_0000218,CHEMBL622310,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7610,,14793,,,BAO_0000218,CHEMBL622311,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7611,,14793,,,BAO_0000218,CHEMBL622312,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7612,,14793,,,BAO_0000218,CHEMBL622931,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7613,,14793,,,BAO_0000218,CHEMBL622932,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7614,,14793,,,BAO_0000218,CHEMBL622736,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7615,,14793,,,BAO_0000218,CHEMBL622737,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7616,,14793,,,BAO_0000218,CHEMBL622738,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7617,,14793,,,BAO_0000218,CHEMBL622739,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7618,,14793,,,BAO_0000218,CHEMBL622740,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7619,,14793,,,BAO_0000218,CHEMBL622741,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7620,,14793,,,BAO_0000218,CHEMBL622742,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7621,,14793,,,BAO_0000218,CHEMBL622743,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,7622,,11637,,,BAO_0000218,CHEMBL622744,AUC in mice,,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,,0,,1,7623,,11149,,,BAO_0000019,CHEMBL624134,Area under curve was measured from the graph obtained from concentration Vs time,,U,,,22224,,Autocuration
,,,A,,0,,1,7624,,10016,,,BAO_0000019,CHEMBL624135,Area under curve value of compound per hour after oral administration,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,7625,,17796,,,BAO_0000218,CHEMBL624136,Area under curve was determined after oral administration in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7626,,17796,,,BAO_0000218,CHEMBL624137,Area under curve was determined after oral administration in rats; No data,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7627,,17796,,,BAO_0000218,CHEMBL624320,Area under curve was determined after oral administration in rats;No data,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,7628,,12923,,,BAO_0000218,CHEMBL624321,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,7629,,15372,,,BAO_0000218,CHEMBL624322,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7630,,15372,,,BAO_0000218,CHEMBL624323,Area under curve was determined for the compound after iv dose of 5.06 in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7631,,15372,,,BAO_0000218,CHEMBL624324,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7632,,15372,,,BAO_0000218,CHEMBL624325,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7633,,15372,,,BAO_0000218,CHEMBL624326,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7634,,15372,,,BAO_0000218,CHEMBL624327,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7635,,15372,,,BAO_0000218,CHEMBL624328,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,7636,,14169,,,BAO_0000218,CHEMBL627848,Area under curve was determined in Dogs after peroral administration,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,7637,,14169,,,BAO_0000218,CHEMBL627849,Area under curve was determined in Rats after peroral administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7638,,14258,,,BAO_0000218,CHEMBL627850,Area under curve was determined in carotid blood of rat when administered intradermally,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7639,,14258,,,BAO_0000218,CHEMBL627851,Area under curve was determined in portal blood of rat when administered intradermally,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,7640,,15011,,,BAO_0000218,CHEMBL627852,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,7641,,15011,,,BAO_0000218,CHEMBL627853,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,7642,,15011,,,BAO_0000218,CHEMBL627854,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,7643,,15011,,,BAO_0000218,CHEMBL627855,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,7644,,15011,,,BAO_0000218,CHEMBL627856,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,7645,,15011,,,BAO_0000218,CHEMBL875339,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,7646,,15011,,,BAO_0000218,CHEMBL627857,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,7647,,11195,,,BAO_0000218,CHEMBL627858,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7648,,10130,,,BAO_0000218,CHEMBL627859,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7649,,10130,,,BAO_0000218,CHEMBL627860,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7650,,10130,,,BAO_0000218,CHEMBL627019,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7651,,10130,,,BAO_0000218,CHEMBL627020,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7652,,10130,,,BAO_0000218,CHEMBL627021,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7653,,10130,,,BAO_0000218,CHEMBL627022,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7654,,10130,,,BAO_0000218,CHEMBL627023,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7655,,10130,,,BAO_0000218,CHEMBL627024,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7656,,10130,,,BAO_0000218,CHEMBL627025,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7657,,10130,,,BAO_0000218,CHEMBL627026,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7658,,10130,,,BAO_0000218,CHEMBL627027,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7659,,10130,,,BAO_0000218,CHEMBL627028,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7660,,10130,,,BAO_0000218,CHEMBL627029,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7661,,10130,,,BAO_0000218,CHEMBL627030,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7662,,10130,,,BAO_0000218,CHEMBL627031,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7663,,10130,,,BAO_0000218,CHEMBL627032,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7664,,10130,,,BAO_0000218,CHEMBL627033,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7665,,10130,,,BAO_0000218,CHEMBL627034,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7666,,10130,,,BAO_0000218,CHEMBL627035,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7667,,10130,,,BAO_0000218,CHEMBL627036,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7668,,10130,,,BAO_0000218,CHEMBL875340,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7669,,10130,,,BAO_0000218,CHEMBL627037,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7670,,10130,,,BAO_0000218,CHEMBL627038,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7671,,10130,,,BAO_0000218,CHEMBL627039,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7672,,10130,,,BAO_0000218,CHEMBL627040,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7673,,10130,,,BAO_0000218,CHEMBL624663,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7674,,10130,,,BAO_0000218,CHEMBL625963,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7675,,10130,,,BAO_0000218,CHEMBL876799,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7676,,10130,,,BAO_0000218,CHEMBL626133,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7677,,10130,,,BAO_0000218,CHEMBL626134,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7678,,6295,,,BAO_0000218,CHEMBL626135,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7679,,6296,,,BAO_0000218,CHEMBL626136,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7680,,6296,,,BAO_0000218,CHEMBL626137,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7681,,6295,,,BAO_0000218,CHEMBL626138,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7682,,6296,,,BAO_0000218,CHEMBL626139,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7683,,17260,,,BAO_0000218,CHEMBL626140,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7684,,17260,,,BAO_0000218,CHEMBL626141,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7685,,17686,,,BAO_0000218,CHEMBL626142,C24h in rat p.o. at 20 mg/kg concentration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7686,,9866,,,BAO_0000218,CHEMBL627930,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7687,,9866,,,BAO_0000218,CHEMBL627931,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7688,,9866,,,BAO_0000218,CHEMBL627932,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7689,,9866,,,BAO_0000218,CHEMBL627933,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7690,,9866,,,BAO_0000218,CHEMBL627934,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7691,,9866,,,BAO_0000218,CHEMBL627935,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7692,,9866,,,BAO_0000218,CHEMBL627936,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7693,,9866,,,BAO_0000218,CHEMBL627937,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7694,,9866,,,BAO_0000218,CHEMBL627938,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7695,,9866,,,BAO_0000218,CHEMBL627939,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7696,,9866,,,BAO_0000218,CHEMBL627940,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7697,,9866,,,BAO_0000218,CHEMBL627941,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7698,,9866,,,BAO_0000218,CHEMBL876800,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7699,,9866,,,BAO_0000218,CHEMBL627942,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7700,,9866,,,BAO_0000218,CHEMBL627943,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7701,,9866,,,BAO_0000218,CHEMBL627944,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7702,,9866,,,BAO_0000218,CHEMBL627945,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7703,,9866,,,BAO_0000218,CHEMBL628584,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7704,,9866,,,BAO_0000218,CHEMBL628585,Biodistribution in rat blood in the presence of GdDTPA at 15 min,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7705,,9866,,,BAO_0000218,CHEMBL628586,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7706,,9866,,,BAO_0000218,CHEMBL628587,Biodistribution in rat blood in the presence of GdDTPA at 30 min,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7707,,9866,,,BAO_0000218,CHEMBL628588,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7708,,9866,,,BAO_0000218,CHEMBL628589,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7709,,9866,,,BAO_0000218,CHEMBL625304,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7710,,9866,,,BAO_0000218,CHEMBL625305,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7711,,9866,,,BAO_0000218,CHEMBL625306,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7712,,9866,,,BAO_0000218,CHEMBL625307,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7713,,9866,,,BAO_0000218,CHEMBL625308,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7714,,9866,,,BAO_0000218,CHEMBL627740,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7715,,9866,,,BAO_0000218,CHEMBL627741,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7716,,9866,,,BAO_0000218,CHEMBL627742,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7717,,9866,,,BAO_0000218,CHEMBL627743,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7718,,9866,,,BAO_0000218,CHEMBL627744,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7719,,9866,,,BAO_0000218,CHEMBL627745,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7720,,9866,,,BAO_0000218,CHEMBL627746,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7721,,9866,,,BAO_0000218,CHEMBL627747,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7722,,9866,,,BAO_0000218,CHEMBL876810,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7723,,9866,,,BAO_0000218,CHEMBL627748,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7724,,9866,,,BAO_0000218,CHEMBL627749,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7725,,9866,,,BAO_0000218,CHEMBL627750,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7726,,9866,,,BAO_0000218,CHEMBL618728,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7727,,9866,,,BAO_0000218,CHEMBL618729,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7728,,9866,,,BAO_0000218,CHEMBL618730,Biodistribution in rat bone in the presence of GdDTPA at 15 min,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7729,,9866,,,BAO_0000218,CHEMBL618731,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7730,,9866,,,BAO_0000218,CHEMBL618732,Biodistribution in rat bone in the presence of GdDTPA at 30 min,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7731,,9866,,,BAO_0000218,CHEMBL618733,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7732,,9866,,,BAO_0000218,CHEMBL618734,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7733,,9866,,,BAO_0000218,CHEMBL618735,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7734,,9866,,,BAO_0000218,CHEMBL876602,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7735,,9866,,,BAO_0000218,CHEMBL618736,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7736,,9866,,,BAO_0000218,CHEMBL618737,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7737,,9866,,,BAO_0000218,CHEMBL618738,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7738,,9866,,,BAO_0000218,CHEMBL618739,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7739,,9866,,,BAO_0000218,CHEMBL618740,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7740,,9866,,,BAO_0000218,CHEMBL618741,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7741,,9866,,,BAO_0000218,CHEMBL618742,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7742,,9866,,,BAO_0000218,CHEMBL618743,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7743,,17752,,,BAO_0000218,CHEMBL618744,Half-life from rat plasma at a single oral dose of 25 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7744,,5610,,,BAO_0000218,CHEMBL618745,Half-life in male rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7745,,5939,,,BAO_0000218,CHEMBL620479,Half-life in rat after peroral administration at 10 mg/kg concentration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7746,,5939,,,BAO_0000218,CHEMBL620480,Half-life in rat after peroral administration at 5 mg/kg concentration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7747,,17771,,,BAO_0000218,CHEMBL620481,Half-life in rat at a dose of 3 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7748,,1974,,,BAO_0000218,CHEMBL620482,Half-life was evaluated in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7749,,4239,,,BAO_0000218,CHEMBL876603,Half-life was measured in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7750,,6681,,,BAO_0000218,CHEMBL620483,Half-life period for the compound was determined in rats at 50 mg/kg dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7751,,17752,,,BAO_0000218,CHEMBL620484,Half-life period in rats after intravenous administration at 5 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7752,,6046,,,BAO_0000218,CHEMBL620485,Half-life period in rat at 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7753,,6685,,,BAO_0000218,CHEMBL620486,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7754,,6685,,,BAO_0000218,CHEMBL620487,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7755,,6685,,,BAO_0000218,CHEMBL620488,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7756,,4727,,,BAO_0000218,CHEMBL620489,Half-life time in rat the dose of 2 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7757,,1088,,,BAO_0000218,CHEMBL620490,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7758,,5610,,,BAO_0000218,CHEMBL620491,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7759,,3032,,,BAO_0000218,CHEMBL876604,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7760,,5199,,,BAO_0000218,CHEMBL620492,Oral half life was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7761,,14941,,,BAO_0000218,CHEMBL620493,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7762,,4408,,,BAO_0000218,CHEMBL620494,Pharmacokinetic property (t1/2) in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7763,,2552,,,BAO_0000218,CHEMBL620495,Plasma elimination half-life was determined,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7764,,5199,,,BAO_0000218,CHEMBL620496,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7765,,15662,,,BAO_0000218,CHEMBL620497,Plasma half life was observed after intravenous administration in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7766,,1465,,,BAO_0000218,CHEMBL620498,Plasma half-life was determined,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7767,,1446,,,BAO_0000218,CHEMBL620499,Plasma half-life following oral administration in Fisher rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7768,,6824,,,BAO_0000218,CHEMBL620500,Plasma half-life in rat,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7769,,17533,,,BAO_0000218,CHEMBL873809,Plasmatic Half-life after intravenous administration to rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7770,,5979,,,BAO_0000218,CHEMBL620501,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7771,,4689,,,BAO_0000218,CHEMBL620502,Terminal half life after intravenous administration (1 mg/kg) in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7772,,4689,,,BAO_0000218,CHEMBL620503,Terminal half life in Rat at a oral dose of 5 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7773,,2463,,,BAO_0000218,CHEMBL620504,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7774,,4883,,,BAO_0000218,CHEMBL876605,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7775,,4883,,,BAO_0000218,CHEMBL620505,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7776,,15662,,,BAO_0000218,CHEMBL873811,plasma half life was observed after intravenous administration in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7777,,3598,,,BAO_0000218,CHEMBL624016,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Expert
,,,A,10116.0,1,,1,7778,,4576,,,BAO_0000218,CHEMBL624017,Half life of compound determined in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7779,,4576,,,BAO_0000218,CHEMBL624018,Mean residence time determined in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7780,,4576,,,BAO_0000218,CHEMBL624019,Plasma half life determined in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7781,,4910,,,BAO_0000218,CHEMBL624020,Compound was evaluated for Tmax in brain after intravenous administration in male rats,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7782,,4891,,,BAO_0000218,CHEMBL624201,Compound was evaluated for pharmacokinetic parameter maximum time period,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7783,,429,,,BAO_0000218,CHEMBL872528,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7784,,5974,,,BAO_0000218,CHEMBL624202,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7785,,5974,,,BAO_0000218,CHEMBL624203,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7786,,5974,,,BAO_0000218,CHEMBL624350,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7787,,5974,,,BAO_0000218,CHEMBL621320,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7788,,17582,,,BAO_0000218,CHEMBL621321,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7789,,4026,,,BAO_0000218,CHEMBL621322,Maximum time (Tmax) required to reach Cmax in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7790,,4890,,,BAO_0000218,CHEMBL621323,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7791,,6571,,,BAO_0000218,CHEMBL621324,Maximum time of clearance of compound in rats after peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7792,,4727,,,BAO_0000218,CHEMBL621325,Maximum time at the dose of 2 mg/kg in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7793,,17651,,,BAO_0000218,CHEMBL875837,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7794,,17651,,,BAO_0000218,CHEMBL621326,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7795,,14465,,,BAO_0000218,CHEMBL621327,Tmax in Guinea pig (PO dose),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7796,,14941,,,BAO_0000218,CHEMBL621328,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7797,,5960,,,BAO_0000218,CHEMBL621329,Pharmacokinetic parameter (Tmax) in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7798,,5022,,,BAO_0000218,CHEMBL621330,Pharmacokinetic parameter (Tmax) was estimated,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7799,,4408,,,BAO_0000218,CHEMBL621331,Pharmacokinetic property (Tmax) in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7800,,5983,,,BAO_0000218,CHEMBL621332,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7801,,4689,,,BAO_0000218,CHEMBL621333,T max in Rat at a oral dose of 5 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7802,,2792,,,BAO_0000218,CHEMBL621334,T max was determined at 10 mg/kg po dose in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,7803,,15011,,,BAO_0000218,CHEMBL621335,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,N,,,50594,Mus musculus,Intermediate
,,,A,9615.0,1,,1,7804,,14180,,,BAO_0000218,CHEMBL621336,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,7805,,14180,,,BAO_0000218,CHEMBL621337,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,7806,,14599,,,BAO_0000218,CHEMBL621338,Area under curve was measured after i.v. administration into Beagle dog.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,7807,,14599,,,BAO_0000218,CHEMBL875838,Area under curve was measured after iv administration into Beagle dog,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,7808,,14599,,,BAO_0000218,CHEMBL621339,Area under curve was measured after po administration into Beagle dog,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,7809,,14599,,,BAO_0000218,CHEMBL621340,Area under curve was measured after po administration into Beagle dog.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,7810,,15675,,,BAO_0000218,CHEMBL621341,Area under curve was measured at peroral dose of 3 mg/kg,,U,,,22224,,Autocuration
,,,A,,0,,1,7811,,12706,,,BAO_0000019,CHEMBL621342,Area under curve was measured by using concentration Vs time,,U,,,22224,,Autocuration
,,,A,,0,,1,7812,,12706,,,BAO_0000019,CHEMBL621343,Area under curve was measured by using concentration Vs time; not tested,,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,7813,,9750,,,BAO_0000218,CHEMBL621344,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,7814,,9750,,,BAO_0000218,CHEMBL621345,Area under curve(AUC) was measured in mice after oral administration.,,N,,,50594,Mus musculus,Intermediate
,,,A,,0,,1,7815,,14691,,,BAO_0000019,CHEMBL621346,Area under curve(AUC) value of the compound,,U,,,22224,,Autocuration
,,,A,,0,,1,7816,,14691,,,BAO_0000218,CHEMBL621347,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,7817,,14691,,,BAO_0000218,CHEMBL621348,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,7818,,2939,,,BAO_0000019,CHEMBL621349,Area under curve(carotid artery) was determined by the availability in blood,,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,7819,,2939,,,BAO_0000019,CHEMBL621350,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,7820,,2939,,,BAO_0000019,CHEMBL875839,Area under curve(carotid artery) was determined by the availability in blood; No data,,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,7821,,2939,,,BAO_0000019,CHEMBL620211,Area under curve(portal vein) was determined by the availability in blood,,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,7822,,2939,,,BAO_0000019,CHEMBL620212,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,7823,,2939,,,BAO_0000019,CHEMBL620213,Area under curve(portal vein) was determined by the availability in blood; No data,,U,178.0,Blood,22224,,Autocuration
,,,A,9544.0,1,,1,7824,,9552,,,BAO_0000218,CHEMBL620214,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,N,1969.0,Plasma,50797,Macaca mulatta,Intermediate
,,,A,9544.0,1,,1,7825,,9552,,,BAO_0000218,CHEMBL620215,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,N,1969.0,Plasma,50797,Macaca mulatta,Intermediate
,,,A,9544.0,1,,1,7826,,9552,,,BAO_0000218,CHEMBL620216,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,N,1969.0,Plasma,50797,Macaca mulatta,Intermediate
,,,A,9615.0,1,,1,7827,,9552,,,BAO_0000218,CHEMBL620888,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,7828,,9552,,,BAO_0000218,CHEMBL620889,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,7829,,9552,,,BAO_0000019,CHEMBL620890,Area under plasma concentration vs time curve observed in rats for 0-3 h,,U,1969.0,Plasma,22224,,Autocuration
,,,A,10116.0,1,,1,7830,,11911,,,BAO_0000218,CHEMBL620891,Area under plasma time curve determined in male rat,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,7831,,16618,,,BAO_0000019,CHEMBL620892,Area under the MAP curve measured over 5 min.,,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,7832,,14387,,,BAO_0000218,CHEMBL621079,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,7833,,14387,,,BAO_0000218,CHEMBL621080,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,N,,,50594,Mus musculus,Intermediate
,,,A,9615.0,1,,1,7834,,12836,,,BAO_0000218,CHEMBL621081,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10026.0,1,,1,7835,,12836,,,BAO_0000218,CHEMBL621082,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,N,,,100712,Cricetinae,Intermediate
,,,A,10116.0,1,,1,7836,,12836,,,BAO_0000218,CHEMBL621083,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,7837,,14339,,,BAO_0000218,CHEMBL621084,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,7838,,14339,,,BAO_0000218,CHEMBL621085,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,7839,,14339,,,BAO_0000218,CHEMBL621086,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,7840,,10524,,,BAO_0000218,CHEMBL621087,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,7841,,9994,,,BAO_0000218,CHEMBL622607,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,7842,,11325,,,BAO_0000218,CHEMBL622608,Serum AUC in marmosets (IV dose),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,7843,,12536,,,BAO_0000019,CHEMBL624481,Area under the curve after intravenous administration at a dose of 10 umol/kg,,U,,,22224,,Autocuration
,,,A,,0,,1,7844,,12536,,,BAO_0000019,CHEMBL624482,Area under the curve after intravenous administration at a dose of 2 umol/kg,,U,,,22224,,Autocuration
,,,A,,0,,1,7845,,12536,,,BAO_0000019,CHEMBL624483,Area under the curve after intravenous administration at a dose of 4 umol/kg,,U,,,22224,,Autocuration
,,,A,,0,,1,7846,,12536,,,BAO_0000019,CHEMBL624484,Area under the curve after intravenous administration at a dose of 40 umol/kg,,U,,,22224,,Autocuration
,,,A,,0,,1,7847,,12536,,,BAO_0000019,CHEMBL624485,Area under the curve after intravenous administration at a dose of 5 umol/kg,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,7848,,15556,,,BAO_0000218,CHEMBL624486,Area under the curve for fumarate salt was evaluated in F344 Rats.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,7849,,2809,,,BAO_0000019,CHEMBL624487,Area under the curve for the compound was calculated.,,U,,,22224,,Autocuration
,,,A,,0,,1,7850,,9511,,,BAO_0000019,CHEMBL624488,Area under the curve in concentration/ time,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,7851,,12818,,,BAO_0000218,CHEMBL624489,Area under the curve administered intraintestinal in rats.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7852,,12818,,,BAO_0000218,CHEMBL625184,Area under the curve administered intravenously in rats.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,7853,,15118,,,BAO_0000019,CHEMBL625185,Area under the curve during intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,7854,,15118,,,BAO_0000019,CHEMBL875954,Area under the curve during intravenous administration; Not determined,,U,,,22224,,Autocuration
,,,A,,0,,1,7855,,15118,,,BAO_0000019,CHEMBL625186,Area under the curve during systemic administration,,U,,,22224,,Autocuration
,,,A,,0,,1,7856,,15118,,,BAO_0000019,CHEMBL625187,Area under the curve during systemic administration; Not determined,,U,,,22224,,Autocuration
,,,A,,0,,1,7857,,2632,,,BAO_0000019,CHEMBL625188,Area under the curve was calculated for the compound.,,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,7858,,14346,,,BAO_0000218,CHEMBL625189,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,7859,,14346,,,BAO_0000218,CHEMBL625190,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,7860,,14346,,,BAO_0000218,CHEMBL621733,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7861,,14346,,,BAO_0000218,CHEMBL621734,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7862,,11149,,,BAO_0000218,CHEMBL621735,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7863,,17796,,,BAO_0000218,CHEMBL621736,Clearance of the drug was measured in the plasma of rat; No data,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7864,,5247,,,BAO_0000218,CHEMBL621737,The pharmacokinetic parameter plasma clearance in vivo in rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7865,,4727,,,BAO_0000218,CHEMBL621738,Plasma clearance at the dose of 2 mg/kg in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7866,,5654,,,BAO_0000218,CHEMBL622806,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7867,,5654,,,BAO_0000218,CHEMBL623519,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7868,,17260,,,BAO_0000218,CHEMBL623520,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7869,,17065,,,BAO_0000218,CHEMBL623521,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7870,,17671,,,BAO_0000218,CHEMBL623522,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7871,,6672,,,BAO_0000218,CHEMBL623523,Clearance rate in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7872,,6673,,,BAO_0000218,CHEMBL623690,Clearance rate in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7873,,5978,,,BAO_0000218,CHEMBL623691,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7874,,5978,,,BAO_0000218,CHEMBL623692,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7875,,5978,,,BAO_0000218,CHEMBL623693,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7876,,5978,,,BAO_0000218,CHEMBL623694,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7877,,4413,,,BAO_0000218,CHEMBL623695,Clearance of compound after iv administration of 20 mg/kg dose in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7878,,2661,,,BAO_0000218,CHEMBL623696,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7879,,2661,,,BAO_0000218,CHEMBL623697,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9544.0,0,,1,7880,,5005,,,BAO_0000218,CHEMBL623698,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,In vivo,U,1969.0,Plasma,22224,Macaca mulatta,Intermediate
,,,A,10116.0,0,,1,7881,,5005,,,BAO_0000218,CHEMBL623699,Compound was tested for its plasma clearance rate in Sprague Dawley rats,In vivo,U,1969.0,Plasma,22224,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7882,,15765,,,BAO_0000218,CHEMBL623700,Mean (%CV) PK parameters for CL(mL/min/kg).,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7883,,3747,,,BAO_0000218,CHEMBL623701,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7884,,16366,,,BAO_0000218,CHEMBL623702,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7885,,4199,,,BAO_0000218,CHEMBL623703,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7886,,17267,,,BAO_0000218,CHEMBL623704,Plasma clearance in rat was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7887,,6535,,,BAO_0000218,CHEMBL623705,Plasma clearance in rat after administration of 2 mg/kg iv,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7888,,6535,,,BAO_0000218,CHEMBL623706,Plasma clearance in rat after administration of 2 mg/kg iv,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7889,,5041,,,BAO_0000218,CHEMBL623707,Plasma clearance was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7890,,5960,,,BAO_0000218,CHEMBL623708,Plasma clearance in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7891,,5937,,,BAO_0000218,CHEMBL623709,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7892,,5871,,,BAO_0000218,CHEMBL623710,Plasma clearance in rat by iv administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7893,,5874,,,BAO_0000218,CHEMBL623711,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7894,,6504,,,BAO_0000218,CHEMBL623712,Plasma clearance in rat p.o.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7895,,6803,,,BAO_0000218,CHEMBL623713,Plasma clearance in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7896,,5041,,,BAO_0000218,CHEMBL623714,Plasma clearance was determined; ND denotes no data,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7897,,5041,,,BAO_0000218,CHEMBL623715,Plasma clearance was determined; ND denotes not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7898,,1916,,,BAO_0000218,CHEMBL623716,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7899,,5199,,,BAO_0000218,CHEMBL622980,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7900,,16367,,,BAO_0000218,CHEMBL622981,Plasma administration to rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7901,,6362,,,BAO_0000218,CHEMBL622982,Plasma clearance of the compound in female Sprague-Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7902,,15662,,,BAO_0000218,CHEMBL622983,Plasma clearance was observed after intravenous administration in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7903,,6215,,,BAO_0000218,CHEMBL622984,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7904,,1466,,,BAO_0000218,CHEMBL622985,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7905,,15662,,,BAO_0000218,CHEMBL623631,plasma clearance was observed after intravenous administration in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7906,,4723,,,BAO_0000218,CHEMBL623632,In vivo CL/F determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7907,,2792,,,BAO_0000218,CHEMBL623633,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7908,,2792,,,BAO_0000218,CHEMBL623634,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7909,,5213,,,BAO_0000218,CHEMBL623635,Compound was tested for the lower blood clearance in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7910,,4687,,,BAO_0000218,CHEMBL621195,Evaluated for the low clearance in rat (in vivo),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7911,,3371,,,BAO_0000218,CHEMBL621196,Pharmacokinetic property (CLb)of the compound was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7912,,4690,,,BAO_0000218,CHEMBL875287,Rapid clearance after intravenous administration in rat was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7913,,5702,,,BAO_0000218,CHEMBL621197,Clearance measured in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7914,,740,,,BAO_0000218,CHEMBL621198,Compound was evaluated for plasma clearance in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7915,,4853,,,BAO_0000218,CHEMBL621199,Low plasma clearance was calculated in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7916,,5789,,,BAO_0000218,CHEMBL621200,Pharmacokinetic property (Clp) in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7917,,4527,,,BAO_0000218,CHEMBL621201,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7918,,4527,,,BAO_0000218,CHEMBL621202,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7919,,6518,,,BAO_0000218,CHEMBL621203,Plasma clearance after IV dosing at 0.5 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7920,,6518,,,BAO_0000218,CHEMBL621204,Plasma clearance after IV dosing at 1 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7921,,9866,,,BAO_0000218,CHEMBL621205,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7922,,9866,,,BAO_0000218,CHEMBL621206,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7923,,9866,,,BAO_0000218,CHEMBL621207,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7924,,9866,,,BAO_0000218,CHEMBL621208,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7925,,9866,,,BAO_0000218,CHEMBL621209,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7926,,9866,,,BAO_0000218,CHEMBL876484,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7927,,9866,,,BAO_0000218,CHEMBL621210,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7928,,9866,,,BAO_0000218,CHEMBL621211,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7929,,9866,,,BAO_0000218,CHEMBL621212,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7930,,9866,,,BAO_0000218,CHEMBL621213,Biodistribution in rat heart in the presence of GdDTPA at 15 min,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7931,,9866,,,BAO_0000218,CHEMBL621214,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7932,,9866,,,BAO_0000218,CHEMBL621215,Biodistribution in rat heart in the presence of GdDTPA at 30 min,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7933,,9866,,,BAO_0000218,CHEMBL621216,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7934,,9866,,,BAO_0000218,CHEMBL621217,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7935,,9866,,,BAO_0000218,CHEMBL621218,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7936,,9866,,,BAO_0000218,CHEMBL621219,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7937,,9866,,,BAO_0000218,CHEMBL621220,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7938,,9866,,,BAO_0000218,CHEMBL621221,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7939,,9866,,,BAO_0000218,CHEMBL621222,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7940,,9866,,,BAO_0000218,CHEMBL621223,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7941,,9866,,,BAO_0000218,CHEMBL876485,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7942,,9866,,,BAO_0000218,CHEMBL621224,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7943,,9866,,,BAO_0000218,CHEMBL621225,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7944,,9866,,,BAO_0000218,CHEMBL621226,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7945,,9866,,,BAO_0000218,CHEMBL621227,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7946,,9866,,,BAO_0000218,CHEMBL621228,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7947,,9866,,,BAO_0000218,CHEMBL621229,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7948,,9866,,,BAO_0000218,CHEMBL621230,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7949,,9866,,,BAO_0000218,CHEMBL621231,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7950,,9866,,,BAO_0000218,CHEMBL621232,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7951,,9866,,,BAO_0000218,CHEMBL621233,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7952,,9866,,,BAO_0000218,CHEMBL621234,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7953,,9866,,,BAO_0000218,CHEMBL621235,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7954,,9866,,,BAO_0000218,CHEMBL621236,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7955,,9866,,,BAO_0000218,CHEMBL621237,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7956,,9866,,,BAO_0000218,CHEMBL876486,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7957,,9866,,,BAO_0000218,CHEMBL622436,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,In vivo,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7958,,9866,,,BAO_0000218,CHEMBL622437,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,In vivo,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7959,,9866,,,BAO_0000218,CHEMBL622438,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,In vivo,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7960,,9866,,,BAO_0000218,CHEMBL622439,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7961,,9866,,,BAO_0000218,CHEMBL622440,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7962,,9866,,,BAO_0000218,CHEMBL622441,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7963,,9866,,,BAO_0000218,CHEMBL622442,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7964,,9866,,,BAO_0000218,CHEMBL622443,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7965,,9866,,,BAO_0000218,CHEMBL622444,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7966,,9866,,,BAO_0000218,CHEMBL622445,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7967,,9866,,,BAO_0000218,CHEMBL622446,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7968,,9866,,,BAO_0000218,CHEMBL622447,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7969,,9866,,,BAO_0000218,CHEMBL622448,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7970,,9866,,,BAO_0000218,CHEMBL622449,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7971,,9866,,,BAO_0000218,CHEMBL622450,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7972,,9866,,,BAO_0000218,CHEMBL622451,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7973,,9866,,,BAO_0000218,CHEMBL622452,Biodistribution in rat liver in the presence of GdDTPA at 15 min,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7974,,9866,,,BAO_0000218,CHEMBL622453,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7975,,9866,,,BAO_0000218,CHEMBL622454,Biodistribution in rat liver in the presence of GdDTPA at 30 min,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7976,,9866,,,BAO_0000218,CHEMBL622455,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7977,,9866,,,BAO_0000218,CHEMBL876024,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7978,,2792,,,BAO_0000218,CHEMBL622456,T max was determined at 3 mg/kg po dose in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7979,,15078,,,BAO_0000218,CHEMBL622457,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7980,,15078,,,BAO_0000218,CHEMBL622458,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7981,,15022,,,BAO_0000218,CHEMBL622459,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7982,,15022,,,BAO_0000218,CHEMBL873343,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7983,,15022,,,BAO_0000218,CHEMBL622460,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7984,,4576,,,BAO_0000218,CHEMBL622461,Time for maximum plasma concentration determined in rat,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7985,,6681,,,BAO_0000218,CHEMBL622462,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7986,,16365,,,BAO_0000218,CHEMBL622463,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7987,,16365,,,BAO_0000218,CHEMBL622464,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7988,,16365,,,BAO_0000218,CHEMBL622465,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7989,,16365,,,BAO_0000218,CHEMBL622466,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7990,,16365,,,BAO_0000218,CHEMBL622467,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7991,,6824,,,BAO_0000218,CHEMBL622468,Time of maximum plasma concentration in rat,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7992,,6685,,,BAO_0000218,CHEMBL876025,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7993,,6685,,,BAO_0000218,CHEMBL622469,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7994,,6685,,,BAO_0000218,CHEMBL622470,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7995,,15662,,,BAO_0000218,CHEMBL622471,Time required to reach maximum concentration (Cmax) after oral administration in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7996,,1742,,,BAO_0000218,CHEMBL622472,Time required to reach maximum concentration in rat plasma,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7997,,2774,,,BAO_0000218,CHEMBL622473,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7998,,5199,,,BAO_0000218,CHEMBL624282,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,7999,,12873,,,BAO_0000218,CHEMBL624283,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8000,,12873,,,BAO_0000218,CHEMBL624284,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8001,,1916,,,BAO_0000218,CHEMBL624285,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8002,,16367,,,BAO_0000218,CHEMBL624286,Time to reach Cmax after oral administration to rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8003,,16366,,,BAO_0000218,CHEMBL624287,Time to reach Cmax when a dose of 1 mg/kg is administered orally,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8004,,216,,,BAO_0000218,CHEMBL624288,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8005,,6410,,,BAO_0000218,CHEMBL624289,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8006,,6410,,,BAO_0000218,CHEMBL873344,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8007,,6215,,,BAO_0000218,CHEMBL619623,Tmax after peroral administration (10 mg/kg) was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8008,,3598,,,BAO_0000218,CHEMBL621399,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Expert
,,,A,10116.0,1,,1,8009,,4527,,,BAO_0000218,CHEMBL621400,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8010,,17670,,,BAO_0000218,CHEMBL621401,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8011,,1465,,,BAO_0000218,CHEMBL621402,Tmax was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8012,,2552,,,BAO_0000218,CHEMBL621403,Tmax was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8013,,5656,,,BAO_0000218,CHEMBL621121,Tmax after oral administration in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8014,,17764,,,BAO_0000218,CHEMBL872525,Tmax after peroral administration in rats at 2.4 uM/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8015,,5610,,,BAO_0000218,CHEMBL621122,Tmax in male rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8016,,6046,,,BAO_0000218,CHEMBL621123,Tmax in rat at 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8017,,5874,,,BAO_0000218,CHEMBL621124,Tmax in rat by po administration at a dose of 40 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8018,,17596,,,BAO_0000218,CHEMBL621125,Tmax in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8019,,17804,,,BAO_0000218,CHEMBL621126,Tmax was measured in rats after peroral administration at 5 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8020,,1908,,,BAO_0000218,CHEMBL621127,Tmax value after oral dose at a dose of 10 mg/kg in rats.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8021,,2959,,,BAO_0000218,CHEMBL621128,Tmax value after administration of 20 mg/Kg oral dose in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8022,,6757,,,BAO_0000218,CHEMBL618263,Tmax value at a dose of 10 mg/kg in male SD rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8023,,6757,,,BAO_0000218,CHEMBL618264,Tmax value at a dose of 100 mg/kg in male SD rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8024,,6757,,,BAO_0000218,CHEMBL618265,Tmax value at a dose of 50 mg/kg in male SD rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8025,,4186,,,BAO_0000218,CHEMBL618266,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8026,,15662,,,BAO_0000218,CHEMBL618267,time required to reach maximum concentration (Cmax) after oral administration in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8027,,429,,,BAO_0000218,CHEMBL618450,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8028,,429,,,BAO_0000218,CHEMBL618451,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8029,,5546,,,BAO_0000218,CHEMBL618452,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8030,,3173,,,BAO_0000218,CHEMBL618453,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8031,,3173,,,BAO_0000218,CHEMBL618454,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8032,,3173,,,BAO_0000218,CHEMBL618455,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8033,,4257,,,BAO_0000218,CHEMBL618456,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8034,,6011,,,BAO_0000218,CHEMBL618457,Compound distribution in rat tissues was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8035,,5472,,,BAO_0000218,CHEMBL618458,Volume of distribution was evaluated in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8036,,14346,,,BAO_0000218,CHEMBL618459,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8037,,14346,,,BAO_0000218,CHEMBL876733,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,8038,,14346,,,BAO_0000218,CHEMBL618460,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,8039,,14346,,,BAO_0000218,CHEMBL618461,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,8040,,15469,,,BAO_0000019,CHEMBL618462,Area under the curve was determined after oral administration (300 uM/Kg),,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,8041,,14346,,,BAO_0000218,CHEMBL618463,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8042,,14346,,,BAO_0000218,CHEMBL618464,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8043,,14346,,,BAO_0000218,CHEMBL618465,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8044,,14346,,,BAO_0000218,CHEMBL618466,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8045,,14346,,,BAO_0000218,CHEMBL618467,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8046,,15372,,,BAO_0000218,CHEMBL618468,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,8047,,12935,,,BAO_0000218,CHEMBL618469,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,8048,,12935,,,BAO_0000218,CHEMBL618470,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,8049,,14813,,,BAO_0000218,CHEMBL618471,Plasma drug AUC in rat (PO dose),,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,8050,,15792,,,BAO_0000218,CHEMBL618472,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,N,,,50594,Mus musculus,Intermediate
,,,A,,0,,1,8051,,3579,,,BAO_0000218,CHEMBL618473,Area under was determined at a dose of 30 mg/kg,,U,,,22224,,Autocuration
,,,A,9669.0,1,,1,8052,,12487,,,BAO_0000218,CHEMBL621699,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,N,,,50506,Mustela putorius furo,Intermediate
,,,A,10116.0,1,,1,8053,,12487,,,BAO_0000218,CHEMBL621700,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8054,,12487,,,BAO_0000218,CHEMBL621701,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9669.0,1,,1,8055,,12487,,,BAO_0000218,CHEMBL621702,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,N,,,50506,Mustela putorius furo,Intermediate
,,,A,9615.0,1,,1,8056,,12487,,,BAO_0000218,CHEMBL621703,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,8057,,12487,,,BAO_0000218,CHEMBL621704,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,8058,,12902,,,BAO_0000218,CHEMBL624259,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8059,,12902,,,BAO_0000218,CHEMBL624260,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8060,,12902,,,BAO_0000218,CHEMBL624430,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8061,,12902,,,BAO_0000218,CHEMBL624431,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8062,,12902,,,BAO_0000218,CHEMBL624432,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8063,,12902,,,BAO_0000218,CHEMBL624433,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8064,,12902,,,BAO_0000218,CHEMBL624434,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8065,,12902,,,BAO_0000218,CHEMBL624435,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,8066,,12745,,,BAO_0000218,CHEMBL618570,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8067,,12745,,,BAO_0000218,CHEMBL618571,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8068,,12745,,,BAO_0000218,CHEMBL618572,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8069,,12745,,,BAO_0000218,CHEMBL618573,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8070,,12745,,,BAO_0000218,CHEMBL619267,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8071,,12745,,,BAO_0000218,CHEMBL619431,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8072,,12745,,,BAO_0000218,CHEMBL619432,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8073,,12745,,,BAO_0000218,CHEMBL619433,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,N,,,50594,Mus musculus,Intermediate
,,,A,,0,,1,8074,,13298,,,BAO_0000218,CHEMBL619434,AUC in mice after oral dose (50 mg/kg),,U,1969.0,Plasma,22224,,Autocuration
,,,A,10090.0,1,,1,8075,,12226,,,BAO_0000218,CHEMBL619435,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,N,1977.0,Serum,50594,Mus musculus,Intermediate
,,,A,,0,,1,8076,,12634,,,BAO_0000019,CHEMBL619436,AUC (0-4 hr) ug/ml/h,,U,1969.0,Plasma,22224,,Autocuration
,,,A,10116.0,1,,1,8077,,14810,,,BAO_0000218,CHEMBL619437,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,8078,,13889,,,BAO_0000218,CHEMBL619438,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,8079,,10018,,,BAO_0000218,CHEMBL619439,Compound was evaluated for Area under curve in mice,,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,8080,,8758,,,BAO_0000218,CHEMBL619440,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,N,,,50597,Rattus norvegicus,Intermediate
,,,F,,0,,1,8081,,8758,,,BAO_0000218,CHEMBL619441,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,8082,,8758,,,BAO_0000218,CHEMBL619442,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,8083,,2249,,,BAO_0000019,CHEMBL875156,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,U,,,22224,,Autocuration
,,,A,,0,,1,8084,,2249,,,BAO_0000019,CHEMBL619443,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,U,,,22224,,Autocuration
,,,A,,0,,1,8085,,2249,,,BAO_0000019,CHEMBL619444,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,U,,,22224,,Autocuration
,,,A,,0,,1,8086,,2249,,,BAO_0000019,CHEMBL623464,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,8087,,15115,,,BAO_0000218,CHEMBL623465,Compound was evaluated for area under curve when administered through oral route in mouse,,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,8088,,6518,,,BAO_0000218,CHEMBL623466,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8089,,6518,,,BAO_0000218,CHEMBL623467,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8090,,6249,,,BAO_0000218,CHEMBL623468,Plasma clearance in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8091,,2463,,,BAO_0000218,CHEMBL622660,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8092,,4969,,,BAO_0000218,CHEMBL622661,Plasma clearance rate in Sprague-Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,8093,,17720,,,BAO_0000218,CHEMBL622662,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8094,,3457,,,BAO_0000218,CHEMBL622663,Pharmacokinetic property (total body clearance) in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8095,,5983,,,BAO_0000218,CHEMBL622664,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8096,,6295,,,BAO_0000218,CHEMBL622665,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8097,,6296,,,BAO_0000218,CHEMBL622666,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8098,,17686,,,BAO_0000218,CHEMBL621615,Cl in rat i.v. at 2 mg/kg concentration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8099,,17764,,,BAO_0000218,CHEMBL621616,Clearance of compound after intravenous administration in rats at 24 uM/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8100,,5503,,,BAO_0000218,CHEMBL621617,Clearance was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8101,,4368,,,BAO_0000218,CHEMBL621618,Clearance by intravenous administration of 3.4 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8102,,6005,,,BAO_0000218,CHEMBL621619,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8103,,5031,,,BAO_0000218,CHEMBL621620,Clearance rate after i.v. administration in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8104,,4890,,,BAO_0000218,CHEMBL621786,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8105,,5182,,,BAO_0000218,CHEMBL621787,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8106,,5979,,,BAO_0000218,CHEMBL621788,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8107,,5656,,,BAO_0000218,CHEMBL621789,Clearance (Cl) after oral administration in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8108,,17804,,,BAO_0000218,CHEMBL621790,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8109,,4839,,,BAO_0000218,CHEMBL621791,Compound was tested for plasma clearance in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,Microsomes,A,10116.0,1,,1,8110,,5041,,,BAO_0000218,CHEMBL621792,In vitro microsome metabolism clearance in rat was determined,In vitro,N,,,50597,Rattus norvegicus,Intermediate
,,Microsomes,A,10116.0,1,,1,8111,,5041,,,BAO_0000218,CHEMBL621793,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,In vitro,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8112,,5974,,,BAO_0000218,CHEMBL621794,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8113,,5496,,,BAO_0000218,CHEMBL621795,In vivo plasma clearance was determined,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8114,,5739,,,BAO_0000218,CHEMBL621796,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,401.0,,A,10116.0,1,,1,8115,,5676,,Hepatocyte,BAO_0000218,CHEMBL621797,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8116,,4239,,,BAO_0000218,CHEMBL621798,Pharmacokinetic property (Plasma clearance) was measured in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8117,,5676,,,BAO_0000218,CHEMBL621799,Pharmacokinetic property (clearance) in rat i.v.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8118,,1918,,,BAO_0000218,CHEMBL621800,"Plasma Clearance was evaluated in rats, iv",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8119,,17800,,,BAO_0000218,CHEMBL621801,Plasma clearance (in vivo) in rats was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8120,,6056,,,BAO_0000218,CHEMBL621802,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8121,,5496,,,BAO_0000218,CHEMBL618596,Plasma clearance was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8122,,5939,,,BAO_0000218,CHEMBL618597,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8123,,5939,,,BAO_0000218,CHEMBL618598,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8124,,17752,,,BAO_0000218,CHEMBL618599,Plasma clearance in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8125,,4576,,,BAO_0000218,CHEMBL618600,Plasma clearance rate determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8126,,6011,,,BAO_0000218,CHEMBL618601,Plasma clearance was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8127,,5510,,,BAO_0000218,CHEMBL618602,Plasma clearance was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8128,,5948,,,BAO_0000218,CHEMBL618603,Plasma clearance value in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8129,,6125,,,BAO_0000218,CHEMBL618604,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Ex vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8130,,4839,,,BAO_0000218,CHEMBL618605,Clearance in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8131,,17686,,,BAO_0000218,CHEMBL618606,Total body clearance in rat i.v. at 2 mg/kg concentration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8132,,6571,,,BAO_0000218,CHEMBL618607,Clearance of compound in rats after intravenous administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8133,,3364,,,BAO_0000218,CHEMBL618608,Clearance after iv administration to rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8134,,13569,,,BAO_0000218,CHEMBL618609,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8135,,13569,,,BAO_0000218,CHEMBL618610,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8136,,13569,,,BAO_0000218,CHEMBL618611,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8137,,13569,,,BAO_0000218,CHEMBL618612,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8138,,13569,,,BAO_0000218,CHEMBL618613,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8139,,13569,,,BAO_0000218,CHEMBL621076,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8140,,13569,,,BAO_0000218,CHEMBL621077,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8141,,17670,,,BAO_0000218,CHEMBL621078,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8142,,5970,,,BAO_0000218,CHEMBL621251,Clearance in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8143,,6495,,,BAO_0000218,CHEMBL621252,Clearance in rat after oral administration at 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8144,,4590,,,BAO_0000218,CHEMBL621253,Clearance in rat.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8145,,6193,,,BAO_0000218,CHEMBL621254,Clearance rate following an oral dose of 20 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8146,,2832,,,BAO_0000218,CHEMBL621255,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8147,,1052,,,BAO_0000218,CHEMBL621256,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8148,,9866,,,BAO_0000218,CHEMBL621257,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8149,,9866,,,BAO_0000218,CHEMBL621258,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8150,,9866,,,BAO_0000218,CHEMBL621259,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8151,,9866,,,BAO_0000218,CHEMBL621260,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8152,,9866,,,BAO_0000218,CHEMBL876494,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8153,,9866,,,BAO_0000218,CHEMBL621261,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8154,,9866,,,BAO_0000218,CHEMBL621262,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8155,,9866,,,BAO_0000218,CHEMBL621263,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8156,,9866,,,BAO_0000218,CHEMBL621264,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8157,,9866,,,BAO_0000218,CHEMBL621265,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8158,,9866,,,BAO_0000218,CHEMBL621266,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8159,,9866,,,BAO_0000218,CHEMBL621267,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8160,,9866,,,BAO_0000218,CHEMBL621268,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8161,,9866,,,BAO_0000218,CHEMBL621269,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8162,,9866,,,BAO_0000218,CHEMBL621270,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8163,,9866,,,BAO_0000218,CHEMBL621271,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8164,,9866,,,BAO_0000218,CHEMBL621272,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8165,,9866,,,BAO_0000218,CHEMBL621273,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8166,,9866,,,BAO_0000218,CHEMBL621274,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8167,,9866,,,BAO_0000218,CHEMBL876495,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8168,,9866,,,BAO_0000218,CHEMBL621275,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8169,,9866,,,BAO_0000218,CHEMBL621276,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8170,,9866,,,BAO_0000218,CHEMBL621277,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8171,,9866,,,BAO_0000218,CHEMBL621278,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,In vivo,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8172,,9866,,,BAO_0000218,CHEMBL621279,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,In vivo,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8173,,9866,,,BAO_0000218,CHEMBL621280,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),In vivo,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8174,,9866,,,BAO_0000218,CHEMBL621281,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8175,,9866,,,BAO_0000218,CHEMBL621282,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8176,,9866,,,BAO_0000218,CHEMBL621283,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8177,,9866,,,BAO_0000218,CHEMBL621284,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8178,,9866,,,BAO_0000218,CHEMBL621285,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8179,,9866,,,BAO_0000218,CHEMBL621286,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8180,,9866,,,BAO_0000218,CHEMBL623220,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8181,,9866,,,BAO_0000218,CHEMBL623221,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8182,,9866,,,BAO_0000218,CHEMBL876029,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8183,,9866,,,BAO_0000218,CHEMBL623222,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,In vivo,N,945.0,Stomach,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8184,,9866,,,BAO_0000218,CHEMBL623223,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,In vivo,N,945.0,Stomach,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8185,,9866,,,BAO_0000218,CHEMBL621445,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,In vivo,N,945.0,Stomach,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8186,,13950,,,BAO_0000218,CHEMBL621446,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8187,,13950,,,BAO_0000218,CHEMBL621447,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8188,,13950,,,BAO_0000218,CHEMBL619681,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8189,,13950,,,BAO_0000218,CHEMBL619682,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8190,,13950,,,BAO_0000218,CHEMBL619683,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8191,,13950,,,BAO_0000218,CHEMBL619684,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8192,,13950,,,BAO_0000218,CHEMBL619685,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8193,,13950,,,BAO_0000218,CHEMBL619686,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8194,,13950,,,BAO_0000218,CHEMBL619687,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8195,,13950,,,BAO_0000218,CHEMBL619688,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8196,,13950,,,BAO_0000218,CHEMBL619689,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8197,,13950,,,BAO_0000218,CHEMBL619690,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8198,,13950,,,BAO_0000218,CHEMBL619691,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8199,,6062,,,BAO_0000218,CHEMBL619692,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8200,,3598,,,BAO_0000218,CHEMBL619693,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,,,50597,Rattus norvegicus,Expert
,,,A,10116.0,1,,1,8201,,1908,,,BAO_0000218,CHEMBL619694,Vc value after IV dose at a dose of 5 mg/kg in rats.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8202,,17596,,,BAO_0000218,CHEMBL619695,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8203,,4891,,,BAO_0000218,CHEMBL619696,Compound was evaluated for pharmacokinetic parameter volume of distribution,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8204,,740,,,BAO_0000218,CHEMBL619697,Compound was evaluated for volume of distribution in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8205,,16366,,,BAO_0000218,CHEMBL619698,Steady state volume distribution was determined; steady state(ss),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8206,,3364,,,BAO_0000218,CHEMBL619699,Steady state volume of distribution after iv administration to rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8207,,2552,,,BAO_0000218,CHEMBL619700,Steady state volume of distribution dosing at 3 mg/kg iv,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8208,,406,,,BAO_0000218,CHEMBL619701,The compound was evaluated for volume of distribution in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8209,,12500,,,BAO_0000218,CHEMBL619702,The compound was tested for volume of distribution in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8210,,12500,,,BAO_0000218,CHEMBL620335,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8211,,5656,,,BAO_0000218,CHEMBL620336,Volume distribution (VD) after oral administration in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8212,,17671,,,BAO_0000218,CHEMBL620337,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8213,,1094,,,BAO_0000218,CHEMBL620520,Volume distribution in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8214,,5833,,,BAO_0000218,CHEMBL620521,Volume distribution in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8215,,5939,,,BAO_0000218,CHEMBL875825,Volume distribution in rat after peroral administration at 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8216,,5939,,,BAO_0000218,CHEMBL620522,Volume distribution in rat after peroral administration at 5 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8217,,6005,,,BAO_0000218,CHEMBL620523,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8218,,1696,,,BAO_0000218,CHEMBL620524,Volume of distribution in rat.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8219,,6672,,,BAO_0000218,CHEMBL620525,Volume of distribution in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8220,,6673,,,BAO_0000218,CHEMBL620526,Volume of distribution in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8221,,5871,,,BAO_0000218,CHEMBL620527,Volume of distribution in rat by iv administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8222,,6803,,,BAO_0000218,CHEMBL620528,Volume of distribution in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8223,,5199,,,BAO_0000218,CHEMBL620529,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8224,,4727,,,BAO_0000218,CHEMBL620530,Volume distribution at the dose of 2 mg/kg in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8225,,16367,,,BAO_0000218,CHEMBL620531,Steady state volume of distribution was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9544.0,0,,1,8226,,5005,,,BAO_0000218,CHEMBL620532,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,In vivo,U,,,22224,Macaca mulatta,Intermediate
,,,A,10116.0,0,,1,8227,,5005,,,BAO_0000218,CHEMBL620533,Compound was tested for its plasma volume distribution in Sprague Dawley rats,In vivo,U,,,22224,Rattus norvegicus,Intermediate
,,,A,10116.0,0,,1,8228,,5005,,,BAO_0000218,CHEMBL620534,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,In vivo,U,,,22224,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8229,,15765,,,BAO_0000218,CHEMBL620535,Mean (%CV) PK parameters for Vdss(mL/kg).,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8230,,2792,,,BAO_0000218,CHEMBL875826,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8231,,2792,,,BAO_0000218,CHEMBL620536,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8232,,5334,,,BAO_0000218,CHEMBL620537,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8233,,5334,,,BAO_0000218,CHEMBL618526,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8234,,5739,,,BAO_0000218,CHEMBL618527,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8235,,5789,,,BAO_0000218,CHEMBL618528,Pharmacokinetic property (Vdss) in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8236,,4239,,,BAO_0000218,CHEMBL618529,Pharmacokinetic property (vdss) was measured in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8237,,4709,,,BAO_0000218,CHEMBL618530,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8238,,6642,,,BAO_0000218,CHEMBL618531,Volume of distribution in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8239,,5247,,,BAO_0000218,CHEMBL618532,The pharmacokinetic parameter volume of distribution in vivo in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,8240,,17720,,,BAO_0000218,CHEMBL618533,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8241,,17686,,,BAO_0000218,CHEMBL618534,Vdss in rat i.v. at 2 mg/kg concentration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8242,,4689,,,BAO_0000218,CHEMBL618535,Volume distribution after intravenous administration (1 mg/kg) in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8243,,5654,,,BAO_0000218,CHEMBL618536,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8244,,5654,,,BAO_0000218,CHEMBL618537,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8245,,4527,,,BAO_0000218,CHEMBL618538,Volume distribution at a dose of 10 uM/kg in rat was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8246,,4521,,,BAO_0000218,CHEMBL618539,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8247,,6057,,,BAO_0000218,CHEMBL618540,Volume distribution was calculated in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8248,,5510,,,BAO_0000218,CHEMBL618541,Volume distribution was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8249,,2938,,,BAO_0000218,CHEMBL618542,Volume of distribution after intravenous administration was evaluated in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8250,,6679,,,BAO_0000218,CHEMBL622544,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8251,,6685,,,BAO_0000218,CHEMBL622545,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8252,,6685,,,BAO_0000218,CHEMBL622546,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8253,,6685,,,BAO_0000218,CHEMBL622547,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8254,,5145,,,BAO_0000218,CHEMBL622548,Volume of distribution in steady state was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8255,,6467,,,BAO_0000218,CHEMBL622549,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8256,,6467,,,BAO_0000218,CHEMBL622550,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,8257,,15115,,,BAO_0000218,CHEMBL622551,Compound was evaluated for area under curve when administered through oral route to mouse,,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,8258,,8758,,,BAO_0000218,CHEMBL622552,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8259,,8758,,,BAO_0000218,CHEMBL622553,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,N,,,50597,Rattus norvegicus,Intermediate
,,,F,,0,,1,8260,,8267,,,BAO_0000218,CHEMBL622554,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,In vivo,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,8261,,8267,,,BAO_0000218,CHEMBL622555,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10090.0,1,,1,8262,,14239,,,BAO_0000218,CHEMBL622556,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8263,,14239,,,BAO_0000218,CHEMBL622557,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8264,,10754,,,BAO_0000218,CHEMBL622558,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8265,,10754,,,BAO_0000218,CHEMBL622559,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,9615.0,1,,1,8266,,10754,,,BAO_0000218,CHEMBL622560,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,8267,,14681,,,BAO_0000218,CHEMBL622561,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8268,,14681,,,BAO_0000218,CHEMBL622562,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8269,,14681,,,BAO_0000218,CHEMBL622563,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,8270,,13118,,,BAO_0000019,CHEMBL622564,Concentration of compound in Central nervous system,,U,,,22224,,Autocuration
,,,A,,0,,1,8271,,13118,,,BAO_0000019,CHEMBL622565,Concentration of compound in Central nervous system; Not detectable,,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,8272,,13318,,,BAO_0000218,CHEMBL622566,"Concentration of diester in the blood, following oral administration in mice",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8273,,13318,,,BAO_0000218,CHEMBL624515,"Concentration of monoester in the blood, following oral administration in mice",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8274,,13318,,,BAO_0000218,CHEMBL624516,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,N,,,50594,Mus musculus,Intermediate
,,,A,,0,,1,8275,,15692,,,BAO_0000019,CHEMBL624517,Evaluated for Pharmacokinetic property: Area under the curve,,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,8276,,14839,,,BAO_0000218,CHEMBL624518,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,N,,,50594,Mus musculus,Intermediate
,,,A,9541.0,1,,1,8277,,14839,,,BAO_0000218,CHEMBL624519,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,8278,,14839,,,BAO_0000218,CHEMBL624520,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,8279,,14839,,,BAO_0000218,CHEMBL624521,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,8280,,14839,,,BAO_0000218,CHEMBL624522,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,8281,,14839,,,BAO_0000218,CHEMBL624523,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,8282,,14839,,,BAO_0000218,CHEMBL624409,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,8283,,14839,,,BAO_0000218,CHEMBL624410,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,8284,,14839,,,BAO_0000218,CHEMBL624411,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,8285,,14839,,,BAO_0000218,CHEMBL623531,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,8286,,14839,,,BAO_0000218,CHEMBL623532,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,8287,,14839,,,BAO_0000218,CHEMBL623533,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,8288,,14839,,,BAO_0000218,CHEMBL623534,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,N,,,100710,Macaca fascicularis,Intermediate
,,,A,10090.0,1,,1,8289,,14839,,,BAO_0000218,CHEMBL623535,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8290,,14839,,,BAO_0000218,CHEMBL623536,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8291,,14839,,,BAO_0000218,CHEMBL623537,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8292,,14839,,,BAO_0000218,CHEMBL623538,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8293,,14839,,,BAO_0000218,CHEMBL623539,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8294,,14839,,,BAO_0000218,CHEMBL623540,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8295,,14839,,,BAO_0000218,CHEMBL623541,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8296,,14839,,,BAO_0000218,CHEMBL623542,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8297,,14839,,,BAO_0000218,CHEMBL623543,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8298,,14839,,,BAO_0000218,CHEMBL623544,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8299,,14839,,,BAO_0000218,CHEMBL623545,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8300,,14839,,,BAO_0000218,CHEMBL623546,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,8301,,5408,,,BAO_0000218,CHEMBL623547,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8302,,6827,,,BAO_0000218,CHEMBL623548,High i.v. clearance in Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,Microsomes,A,10116.0,1,,1,8303,,17538,,,BAO_0000218,CHEMBL623549,In vitro clearance in rat liver microsomes,In vitro,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,Microsomes,A,10116.0,1,,1,8304,,6331,,,BAO_0000218,CHEMBL623550,Intrinsic clearance in rat liver microsomes was determined,In vitro,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,401.0,,A,10116.0,1,,1,8305,,5948,,Hepatocyte,BAO_0000218,CHEMBL875276,Intrinsic clearance in rat hepatocytes was determined,In vitro,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8306,,4026,,,BAO_0000218,CHEMBL621872,Plasma Clearance was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8307,,6647,,,BAO_0000218,CHEMBL621873,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8308,,1696,,,BAO_0000218,CHEMBL621874,Plasma clearance in rat.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8309,,6597,,,BAO_0000218,CHEMBL621875,Plasma clearance in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8310,,347,,,BAO_0000218,CHEMBL621876,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8311,,16423,,,BAO_0000218,CHEMBL621877,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8312,,2879,,,BAO_0000218,CHEMBL621878,Plasma clearance was measured in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8313,,4883,,,BAO_0000218,CHEMBL621879,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8314,,5328,,,BAO_0000218,CHEMBL621880,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8315,,5160,,,BAO_0000218,CHEMBL621881,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8316,,17582,,,BAO_0000218,CHEMBL621882,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8317,,17651,,,BAO_0000218,CHEMBL875283,Total clearance at 1 mg/kg was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8318,,17651,,,BAO_0000218,CHEMBL621883,Total clearance at 10 mg/kg was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8319,,6596,,,BAO_0000218,CHEMBL621884,Clearance in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8320,,4796,,,BAO_0000218,CHEMBL621885,Plasma clearance rate determined in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8321,,6850,,,BAO_0000218,CHEMBL621886,Clearance of compound in rat was evaluated,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8322,,5932,,,BAO_0000218,CHEMBL621887,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8323,,3371,,,BAO_0000218,CHEMBL621888,Pharmacokinetic property (blood clearance) in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8324,,2083,,,BAO_0000218,CHEMBL621889,Plasma clearance in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8325,,4942,,,BAO_0000218,CHEMBL621890,Plasma clearance in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,Microsomes,A,10116.0,1,,1,8326,,6838,,,BAO_0000218,CHEMBL621891,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,In vitro,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8327,,5353,,,BAO_0000218,CHEMBL621892,Clearance in Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8328,,6641,,,BAO_0000218,CHEMBL621893,Clearance rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8329,,6641,,,BAO_0000218,CHEMBL621894,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8330,,6641,,,BAO_0000218,CHEMBL621895,Clearance rat; Not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8331,,6444,,,BAO_0000218,CHEMBL875284,Clearance rate was determined in rat at a dose of 1 mpk i.v.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8332,,6444,,,BAO_0000218,CHEMBL618699,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8333,,6444,,,BAO_0000218,CHEMBL618700,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8334,,6211,,,BAO_0000218,CHEMBL618701,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8335,,12873,,,BAO_0000218,CHEMBL876600,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8336,,6570,,,BAO_0000218,CHEMBL618702,Clearance of compound in rat after 1 mg/kg i.v. administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8337,,3341,,,BAO_0000218,CHEMBL618703,Compound was evaluated for Hepatic clearance in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8338,,4891,,,BAO_0000218,CHEMBL618704,In vivo clearance after 5 mg/kg dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8339,,1094,,,BAO_0000218,CHEMBL618705,Compound was tested for plasma clearance in rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8340,,2938,,,BAO_0000218,CHEMBL618706,Hepatic clearance after intravenous administration was evaluated in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8341,,17853,,,BAO_0000218,CHEMBL618707,Lower clearance in rat (i.v.) at 0.5 mpk,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8342,,6049,,,BAO_0000218,CHEMBL618708,Pharmacokinetic parameter expressed as plasma clearance in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8343,,5789,,,BAO_0000218,CHEMBL618709,Pharmacokinetic property (Clp) in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8344,,4514,,,BAO_0000218,CHEMBL618710,Plasma clearance in Sprague-Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8345,,6448,,,BAO_0000218,CHEMBL618711,Plasma clearance (Clp) in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8346,,6062,,,BAO_0000218,CHEMBL618712,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8347,,5710,,,BAO_0000218,CHEMBL618713,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8348,,4709,,,BAO_0000218,CHEMBL618714,Plasma clearance after intravenous administration of 1 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8349,,4521,,,BAO_0000218,CHEMBL618715,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8350,,1742,,,BAO_0000218,CHEMBL618716,Plasma clearance in rat was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8351,,6057,,,BAO_0000218,CHEMBL876601,Plasma clearance measured in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8352,,6057,,,BAO_0000218,CHEMBL618717,Plasma clearance was calculated in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8353,,5145,,,BAO_0000218,CHEMBL618718,Plasma clearance in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8354,,5833,,,BAO_0000218,CHEMBL618719,Plasma clearance in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8355,,6453,,,BAO_0000218,CHEMBL618720,Plasma clearance in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8356,,6640,,,BAO_0000218,CHEMBL618721,Plasma clearance in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8357,,6305,,,BAO_0000218,CHEMBL621477,Plasma clearance in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8358,,6642,,,BAO_0000218,CHEMBL621478,Plasma clearance in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8359,,5472,,,BAO_0000218,CHEMBL621479,Plasma clearance was evaluated in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8360,,5472,,,BAO_0000218,CHEMBL621480,Plasma clearance was evaluated in rat; Not tested,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8361,,5144,,,BAO_0000218,CHEMBL621481,Plasma clearance rate was determined for the compound in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8362,,6685,,,BAO_0000218,CHEMBL621482,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8363,,6685,,,BAO_0000218,CHEMBL621483,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8364,,6685,,,BAO_0000218,CHEMBL621484,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8365,,13950,,,BAO_0000218,CHEMBL621485,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8366,,13950,,,BAO_0000218,CHEMBL621486,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8367,,13950,,,BAO_0000218,CHEMBL621487,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8368,,13950,,,BAO_0000218,CHEMBL621488,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8369,,13950,,,BAO_0000218,CHEMBL621489,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8370,,13950,,,BAO_0000218,CHEMBL621490,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8371,,13950,,,BAO_0000218,CHEMBL621491,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8372,,13950,,,BAO_0000218,CHEMBL621492,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8373,,13950,,,BAO_0000218,CHEMBL621493,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8374,,13950,,,BAO_0000218,CHEMBL621494,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8375,,13950,,,BAO_0000218,CHEMBL621495,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8376,,13950,,,BAO_0000218,CHEMBL621496,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8377,,13950,,,BAO_0000218,CHEMBL621497,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8378,,13950,,,BAO_0000218,CHEMBL621498,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8379,,13950,,,BAO_0000218,CHEMBL621499,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8380,,13950,,,BAO_0000218,CHEMBL618634,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8381,,13950,,,BAO_0000218,CHEMBL618635,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8382,,13950,,,BAO_0000218,CHEMBL618636,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8383,,13950,,,BAO_0000218,CHEMBL619737,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8384,,13950,,,BAO_0000218,CHEMBL619738,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8385,,13950,,,BAO_0000218,CHEMBL624329,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8386,,13950,,,BAO_0000218,CHEMBL624330,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8387,,13950,,,BAO_0000218,CHEMBL624331,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8388,,13950,,,BAO_0000218,CHEMBL624332,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8389,,13950,,,BAO_0000218,CHEMBL624333,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8390,,13950,,,BAO_0000218,CHEMBL624334,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8391,,13950,,,BAO_0000218,CHEMBL624335,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8392,,13950,,,BAO_0000218,CHEMBL620016,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8393,,13950,,,BAO_0000218,CHEMBL620169,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8394,,13950,,,BAO_0000218,CHEMBL620170,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8395,,13950,,,BAO_0000218,CHEMBL620171,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8396,,13950,,,BAO_0000218,CHEMBL620172,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8397,,13950,,,BAO_0000218,CHEMBL620173,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,N,945.0,Stomach,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8398,,13950,,,BAO_0000218,CHEMBL620174,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,In vivo,N,945.0,Stomach,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8399,,13950,,,BAO_0000218,CHEMBL620175,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,N,945.0,Stomach,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8400,,13950,,,BAO_0000218,CHEMBL620176,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,N,945.0,Stomach,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8401,,13950,,,BAO_0000218,CHEMBL620177,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,N,945.0,Stomach,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8402,,13950,,,BAO_0000218,CHEMBL620178,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8403,,13950,,,BAO_0000218,CHEMBL620179,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8404,,13950,,,BAO_0000218,CHEMBL620180,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8405,,6570,,,BAO_0000218,CHEMBL620181,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8406,,6571,,,BAO_0000218,CHEMBL620182,Volume of distribution of compound in rats after intravenous administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8407,,6453,,,BAO_0000218,CHEMBL620183,Volume of distribution in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8408,,6444,,,BAO_0000218,CHEMBL620184,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8409,,6444,,,BAO_0000218,CHEMBL620185,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8410,,6444,,,BAO_0000218,CHEMBL620186,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8411,,5353,,,BAO_0000218,CHEMBL620187,Volume of distribution was determined in Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8412,,5334,,,BAO_0000218,CHEMBL620188,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8413,,5334,,,BAO_0000218,CHEMBL620189,Volume of distribution was reported in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8414,,6641,,,BAO_0000218,CHEMBL620190,Volumes of distribution in rat after peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8415,,6641,,,BAO_0000218,CHEMBL620191,Volumes of distribution in rat after po administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8416,,6641,,,BAO_0000218,CHEMBL620192,Volumes of distribution in rat after po administration; Not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8417,,5676,,,BAO_0000218,CHEMBL620193,Pharmacokinetic property (Volume) in rat i.v.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8418,,6410,,,BAO_0000218,CHEMBL620194,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8419,,17670,,,BAO_0000218,CHEMBL876730,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8420,,6495,,,BAO_0000218,CHEMBL620195,Volume distribution in rat after oral administration at 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8421,,5408,,,BAO_0000218,CHEMBL620196,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8422,,4883,,,BAO_0000218,CHEMBL620197,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8423,,6647,,,BAO_0000218,CHEMBL620198,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8424,,6495,,,BAO_0000218,CHEMBL620199,Volume of distribution in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8425,,2661,,,BAO_0000218,CHEMBL620200,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8426,,2661,,,BAO_0000218,CHEMBL620201,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8427,,5974,,,BAO_0000218,CHEMBL620202,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8428,,5974,,,BAO_0000218,CHEMBL620203,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8429,,5974,,,BAO_0000218,CHEMBL620204,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8430,,5974,,,BAO_0000218,CHEMBL620205,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8431,,5960,,,BAO_0000218,CHEMBL624664,Pharmacokinetic parameter (Vss) in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8432,,5676,,,BAO_0000218,CHEMBL624665,Pharmacokinetic property (Volume) in rat i.v.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8433,,5948,,,BAO_0000218,CHEMBL624666,Pharmacokinetic property (Vss) in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8434,,5979,,,BAO_0000218,CHEMBL624667,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8435,,5978,,,BAO_0000218,CHEMBL624668,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8436,,5978,,,BAO_0000218,CHEMBL624669,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8437,,5978,,,BAO_0000218,CHEMBL624670,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8438,,5978,,,BAO_0000218,CHEMBL624671,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8439,,6448,,,BAO_0000218,CHEMBL624672,Steady state volume distribution in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8440,,12873,,,BAO_0000218,CHEMBL624673,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8441,,4576,,,BAO_0000218,CHEMBL624674,Steady state volume of distribution determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8442,,17582,,,BAO_0000218,CHEMBL624675,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8443,,1466,,,BAO_0000218,CHEMBL621728,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8444,,5182,,,BAO_0000218,CHEMBL621729,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8445,,5182,,,BAO_0000218,CHEMBL621730,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8446,,6535,,,BAO_0000218,CHEMBL621731,Volume distribution in rat after administration of 2 mg/kg iv,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8447,,6535,,,BAO_0000218,CHEMBL621732,Volume distribution in rat after administration of 2 mg/kg iv,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8448,,5041,,,BAO_0000218,CHEMBL621908,Volume in steady state distribution value was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8449,,5041,,,BAO_0000218,CHEMBL875347,Volume in steady state distribution value was determined; ND denotes no data,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8450,,5041,,,BAO_0000218,CHEMBL621909,Volume in steady state distribution value was determined; ND denotes not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8451,,17065,,,BAO_0000218,CHEMBL621910,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8452,,6597,,,BAO_0000218,CHEMBL621911,Volume of distribution at steady state was evaluated in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8453,,15662,,,BAO_0000218,CHEMBL621912,Volume of distribution at steady state was observed after intravenous administration in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8454,,6485,,,BAO_0000218,CHEMBL621913,Volume of distribution in steady state was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8455,,17655,,,BAO_0000218,CHEMBL621914,Volume of distribution in steady state was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8456,,6616,,,BAO_0000218,CHEMBL621915,Volume of distribution after i.v. administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8457,,1916,,,BAO_0000218,CHEMBL621916,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,8458,,16438,,,BAO_0000218,CHEMBL621917,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",In vivo,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8459,,16438,,,BAO_0000218,CHEMBL621918,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",In vivo,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8460,,16438,,,BAO_0000218,CHEMBL621919,Biodistribution of compound (oxidized form) in spleen tissue,In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8461,,16438,,,BAO_0000218,CHEMBL621920,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8462,,16438,,,BAO_0000218,CHEMBL621921,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8463,,16438,,,BAO_0000218,CHEMBL622401,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8464,,16438,,,BAO_0000218,CHEMBL875348,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8465,,16438,,,BAO_0000218,CHEMBL622402,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8466,,16438,,,BAO_0000218,CHEMBL622403,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8467,,16438,,,BAO_0000218,CHEMBL622404,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8468,,16438,,,BAO_0000218,CHEMBL622405,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,In vivo,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8469,,16438,,,BAO_0000218,CHEMBL622406,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",In vivo,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8470,,16438,,,BAO_0000218,CHEMBL622407,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8471,,16438,,,BAO_0000218,CHEMBL622408,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,In vivo,N,948.0,Heart,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8472,,16438,,,BAO_0000218,CHEMBL622409,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",In vivo,N,948.0,Heart,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8473,,16438,,,BAO_0000218,CHEMBL622410,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,N,948.0,Heart,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8474,,16438,,,BAO_0000218,CHEMBL622411,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,In vivo,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8475,,16438,,,BAO_0000218,CHEMBL627864,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",In vivo,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8476,,16438,,,BAO_0000218,CHEMBL627865,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8477,,16438,,,BAO_0000218,CHEMBL627866,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,In vivo,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8478,,16438,,,BAO_0000218,CHEMBL627751,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8479,,16438,,,BAO_0000218,CHEMBL627752,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8480,,16438,,,BAO_0000218,CHEMBL627753,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8481,,16438,,,BAO_0000218,CHEMBL627754,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8482,,12467,,,BAO_0000218,CHEMBL627755,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8483,,17208,,,BAO_0000218,CHEMBL627756,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8484,,17208,,,BAO_0000218,CHEMBL627757,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8485,,17208,,,BAO_0000218,CHEMBL627758,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8486,,17208,,,BAO_0000218,CHEMBL627759,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8487,,17208,,,BAO_0000218,CHEMBL627760,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8488,,17208,,,BAO_0000218,CHEMBL627761,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8489,,17208,,,BAO_0000218,CHEMBL876811,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,N,948.0,Heart,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8490,,17208,,,BAO_0000218,CHEMBL627762,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,948.0,Heart,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8491,,17208,,,BAO_0000218,CHEMBL627763,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,N,948.0,Heart,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8492,,17208,,,BAO_0000218,CHEMBL627764,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,948.0,Heart,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8493,,17208,,,BAO_0000218,CHEMBL627765,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,N,948.0,Heart,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8494,,17208,,,BAO_0000218,CHEMBL627766,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,948.0,Heart,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8495,,17208,,,BAO_0000218,CHEMBL627767,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8496,,17208,,,BAO_0000218,CHEMBL627768,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8497,,17208,,,BAO_0000218,CHEMBL628422,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8498,,17208,,,BAO_0000218,CHEMBL628423,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,8499,,5089,,,BAO_0000218,CHEMBL628424,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8500,,5089,,,BAO_0000218,CHEMBL628425,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8501,,4257,,,BAO_0000218,CHEMBL628426,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8502,,6679,,,BAO_0000218,CHEMBL628427,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8503,,5546,,,BAO_0000218,CHEMBL626938,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8504,,6141,,,BAO_0000218,CHEMBL626939,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8505,,5334,,,BAO_0000218,CHEMBL626940,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8506,,5334,,,BAO_0000218,CHEMBL626941,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8507,,5334,,,BAO_0000218,CHEMBL626942,Plasma clearance was reported in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8508,,4689,,,BAO_0000218,CHEMBL876812,Plasma clearance after intravenous administration (1 mg/kg) in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8509,,6848,,,BAO_0000218,CHEMBL626943,Plasma clearance of compound in rats was evaluated,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8510,,6848,,,BAO_0000218,CHEMBL626944,Plasma clearance of compound in rats was evaluated; ND indicates not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8511,,6467,,,BAO_0000218,CHEMBL626945,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8512,,6467,,,BAO_0000218,CHEMBL626946,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8513,,4956,,,BAO_0000218,CHEMBL626856,Plasma clearance rate in Sprague-Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8514,,5529,,,BAO_0000218,CHEMBL626857,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8515,,406,,,BAO_0000218,CHEMBL626858,The compound was evaluated for plasma clearance in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8516,,17655,,,BAO_0000218,CHEMBL627018,Total plasma clearance in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8517,,3293,,,BAO_0000218,CHEMBL625331,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8518,,4075,,,BAO_0000218,CHEMBL625332,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8519,,2792,,,BAO_0000218,CHEMBL877590,C max was determined at 10 mg/kg po dose in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8520,,2792,,,BAO_0000218,CHEMBL625333,C max was determined at 3 mg/kg po dose in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8521,,17594,,,BAO_0000218,CHEMBL625334,Cmax after repeated oral dose of compound at 1 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8522,,17594,,,BAO_0000218,CHEMBL625335,Cmax after single intravenous bolus of 1 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8523,,4762,,,BAO_0000218,CHEMBL625336,Cmax of compound at 5 mg/kg after po administration was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8524,,17509,,,BAO_0000218,CHEMBL625337,Cmax 24 hr after 10 mg/kg oral administration in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8525,,17509,,,BAO_0000218,CHEMBL625338,Cmax 24 hr after 2 mg/kg oral administration in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8526,,1466,,,BAO_0000218,CHEMBL625339,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8527,,6535,,,BAO_0000218,CHEMBL625340,Cmax in rat after administration of 2 mg/kg iv,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8528,,6535,,,BAO_0000218,CHEMBL625341,Cmax in rat after administration of 2 mg/kg iv,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8529,,3169,,,BAO_0000218,CHEMBL622687,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8530,,6515,,,BAO_0000218,CHEMBL622688,Cmax wa determined in rat plasma at 30 mg/kg after po administration,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8531,,11149,,,BAO_0000218,CHEMBL622689,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8532,,11149,,,BAO_0000218,CHEMBL620295,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8533,,17858,,,BAO_0000218,CHEMBL620296,Cmax after 10 mg/kg oral administration in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8534,,6518,,,BAO_0000218,CHEMBL620297,Cmax after IV dosing at 0.5 mg/kg in rat; no data,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8535,,6518,,,BAO_0000218,CHEMBL620298,Cmax after IV dosing at 1 mg/kg in rat; no data,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8536,,4426,,,BAO_0000218,CHEMBL620299,Cmax after oral administration at 20 mpk in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8537,,4426,,,BAO_0000218,CHEMBL620300,Cmax after oral administration at 20 mpk in rats; Not performed.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8538,,4426,,,BAO_0000218,CHEMBL620301,Cmax after oral administration at 20 mpk in rats d; Not performed.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8539,,5656,,,BAO_0000218,CHEMBL620302,Cmax after oral administration in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8540,,6518,,,BAO_0000218,CHEMBL620303,Cmax after oral administration at a dose of 2 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8541,,6518,,,BAO_0000218,CHEMBL620304,Cmax after oral administration at a dose of 4 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8542,,6113,,,BAO_0000218,CHEMBL620305,Cmax in rats after 20 mg/kg oral dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8543,,17764,,,BAO_0000218,CHEMBL620306,Cmax after peroral administration in rats at 2.4 uM/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8544,,4756,,,BAO_0000218,CHEMBL620307,Cmax at the dose of 2 mg/Kg administered perorally in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8545,,4756,,,BAO_0000218,CHEMBL620308,Cmax at the dose of 5 mg/Kg administered perorally in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8546,,6402,,,BAO_0000218,CHEMBL620309,Cmax by administering at 20 mg/kg p.o. in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8547,,5610,,,BAO_0000218,CHEMBL620310,Cmax in male rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8548,,5207,,,BAO_0000218,CHEMBL620311,Cmax in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8549,,6011,,,BAO_0000218,CHEMBL620312,Cmax in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8550,,6504,,,BAO_0000218,CHEMBL620313,Cmax in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8551,,6046,,,BAO_0000218,CHEMBL620314,Cmax in rat at 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8552,,6504,,,BAO_0000218,CHEMBL620315,Cmax in rat at the dose of 1 mg/kg i.v.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8553,,5874,,,BAO_0000218,CHEMBL620316,Cmax in rat by po administration at a dose of 40 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8554,,17686,,,BAO_0000218,CHEMBL620317,Cmax in rat p.o. at 20 mg/kg concentration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8555,,5836,,,BAO_0000218,CHEMBL620318,Cmax in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8556,,17596,,,BAO_0000218,CHEMBL620319,Cmax in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8557,,16423,,,BAO_0000218,CHEMBL620320,Cmax was evaluated after 20 uM/kg of peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8558,,17804,,,BAO_0000218,CHEMBL620321,Cmax was measured in rats after peroral administration at 3 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8559,,1908,,,BAO_0000218,CHEMBL620322,Cmax value after oral dose at a dose of 10 mg/kg in rats.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8560,,13950,,,BAO_0000218,CHEMBL620323,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8561,,13950,,,BAO_0000218,CHEMBL620324,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,1870.0,Frontal cortex,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8562,,13950,,,BAO_0000218,CHEMBL620325,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,1870.0,Frontal cortex,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8563,,13950,,,BAO_0000218,CHEMBL620326,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8564,,13950,,,BAO_0000218,CHEMBL620327,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8565,,13950,,,BAO_0000218,CHEMBL620328,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8566,,13950,,,BAO_0000218,CHEMBL620329,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8567,,13950,,,BAO_0000218,CHEMBL620330,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,1891.0,Midbrain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8568,,13950,,,BAO_0000218,CHEMBL875286,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,1891.0,Midbrain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8569,,13950,,,BAO_0000218,CHEMBL620331,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8570,,13950,,,BAO_0000218,CHEMBL620332,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8571,,13950,,,BAO_0000218,CHEMBL620333,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8572,,13950,,,BAO_0000218,CHEMBL620334,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8573,,16434,,,BAO_0000218,CHEMBL621015,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8574,,16434,,,BAO_0000218,CHEMBL621016,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8575,,16434,,,BAO_0000218,CHEMBL621191,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8576,,16434,,,BAO_0000218,CHEMBL621192,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8577,,16434,,,BAO_0000218,CHEMBL621193,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8578,,16434,,,BAO_0000218,CHEMBL621194,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8579,,16434,,,BAO_0000218,CHEMBL624204,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8580,,16434,,,BAO_0000218,CHEMBL624205,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8581,,16435,,,BAO_0000218,CHEMBL624206,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8582,,16435,,,BAO_0000218,CHEMBL624207,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8583,,16435,,,BAO_0000218,CHEMBL624208,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8584,,16435,,,BAO_0000218,CHEMBL624209,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8585,,16435,,,BAO_0000218,CHEMBL624210,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8586,,16435,,,BAO_0000218,CHEMBL624211,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8587,,16435,,,BAO_0000218,CHEMBL624212,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8588,,16435,,,BAO_0000218,CHEMBL624213,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8589,,16434,,,BAO_0000218,CHEMBL876611,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8590,,16434,,,BAO_0000218,CHEMBL624214,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8591,,16434,,,BAO_0000218,CHEMBL624215,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8592,,16435,,,BAO_0000218,CHEMBL624216,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8593,,16435,,,BAO_0000218,CHEMBL624217,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8594,,16435,,,BAO_0000218,CHEMBL624218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8595,,16435,,,BAO_0000218,CHEMBL624219,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8596,,16435,,,BAO_0000218,CHEMBL624220,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8597,,16435,,,BAO_0000218,CHEMBL624221,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8598,,16434,,,BAO_0000218,CHEMBL624222,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8599,,16434,,,BAO_0000218,CHEMBL624223,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8600,,16434,,,BAO_0000218,CHEMBL624224,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8601,,16434,,,BAO_0000218,CHEMBL624225,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8602,,17764,,,BAO_0000218,CHEMBL622420,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8603,,5031,,,BAO_0000218,CHEMBL622421,Volume of steady state distribution after i.v. administration in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8604,,6215,,,BAO_0000218,CHEMBL622422,Vss after intravenous administration (5.0 mg/kg) was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8605,,17671,,,BAO_0000218,CHEMBL622423,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8606,,17752,,,BAO_0000218,CHEMBL622424,Vss was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8607,,6596,,,BAO_0000218,CHEMBL622425,Vss in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8608,,16423,,,BAO_0000218,CHEMBL876612,Vss was evaluated after 10 uM/kg of intra arterial administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8609,,15662,,,BAO_0000218,CHEMBL622426,volume of distribution at steady state was observed after intravenous administration in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8610,,6062,,,BAO_0000218,CHEMBL622427,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8611,,5874,,,BAO_0000218,CHEMBL622428,Pharmacokinetic (PK) parameter Vz in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8612,,4942,,,BAO_0000218,CHEMBL622429,Volume distribution in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8613,,17796,,,BAO_0000218,CHEMBL622430,Volume of distribution in rat; No data,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8614,,4890,,,BAO_0000218,CHEMBL622431,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8615,,15765,,,BAO_0000218,CHEMBL622432,% absorption predicted from in vitro rat ileum transport studies,,N,2116.0,Ileum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8616,,13569,,,BAO_0000218,CHEMBL622433,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8617,,13569,,,BAO_0000218,CHEMBL622434,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8618,,13569,,,BAO_0000218,CHEMBL622435,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8619,,13569,,,BAO_0000218,CHEMBL618748,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8620,,13569,,,BAO_0000218,CHEMBL618749,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8621,,13569,,,BAO_0000218,CHEMBL618750,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8622,,13569,,,BAO_0000218,CHEMBL618751,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8623,,13569,,,BAO_0000218,CHEMBL618752,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8624,,4576,,,BAO_0000218,CHEMBL618753,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8625,,750,,,BAO_0000218,CHEMBL618754,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8626,,750,,,BAO_0000218,CHEMBL618755,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8627,,4590,,,BAO_0000218,CHEMBL618756,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8628,,1716,,,BAO_0000218,CHEMBL618757,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8629,,1974,,,BAO_0000218,CHEMBL618758,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8630,,4502,,,BAO_0000218,CHEMBL621088,Oral bioavailability in rat (dose 30 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8631,,3371,,,BAO_0000218,CHEMBL621089,Pharmacokinetic property (cLogP) in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,8632,,9099,,,BAO_0000218,CHEMBL621090,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,8633,,9099,,,BAO_0000218,CHEMBL621091,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8634,,4590,,,BAO_0000218,CHEMBL876731,Clearance in rat.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8635,,3184,,,BAO_0000218,CHEMBL621092,Compound was evaluated for its clearance when administered intravenously in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8636,,16456,,,BAO_0000218,CHEMBL621093,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8637,,4199,,,BAO_0000218,CHEMBL621094,Blood: Brain distribution ratio is determined in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8638,,4199,,,BAO_0000218,CHEMBL621095,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8639,,4199,,,BAO_0000218,CHEMBL621096,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8640,,8677,,,BAO_0000218,CHEMBL621097,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,8641,,7449,,,BAO_0000218,CHEMBL621098,Percent dose excreted in 0-48 hours administered ip to male rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8642,,11977,,,BAO_0000218,CHEMBL621099,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8643,,11977,,,BAO_0000218,CHEMBL621100,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8644,,11977,,,BAO_0000218,CHEMBL621101,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8645,,11977,,,BAO_0000218,CHEMBL621102,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8646,,11977,,,BAO_0000218,CHEMBL876732,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8647,,11977,,,BAO_0000218,CHEMBL621103,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8648,,11977,,,BAO_0000218,CHEMBL621104,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8649,,11977,,,BAO_0000218,CHEMBL621105,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8650,,11977,,,BAO_0000218,CHEMBL621106,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8651,,11977,,,BAO_0000218,CHEMBL621107,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8652,,11977,,,BAO_0000218,CHEMBL621108,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8653,,11977,,,BAO_0000218,CHEMBL621109,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,8654,,17208,,,BAO_0000218,CHEMBL621110,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8655,,17208,,,BAO_0000218,CHEMBL621111,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8656,,17208,,,BAO_0000218,CHEMBL622541,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8657,,17208,,,BAO_0000218,CHEMBL622542,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8658,,17208,,,BAO_0000218,CHEMBL622543,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8659,,17208,,,BAO_0000218,CHEMBL624412,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8660,,17208,,,BAO_0000218,CHEMBL624413,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8661,,17208,,,BAO_0000218,CHEMBL624414,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8662,,17208,,,BAO_0000218,CHEMBL624415,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,N,2048.0,Lung,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8663,,17208,,,BAO_0000218,CHEMBL624416,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,2048.0,Lung,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8664,,17208,,,BAO_0000218,CHEMBL624417,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,N,2048.0,Lung,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8665,,17208,,,BAO_0000218,CHEMBL624418,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,2048.0,Lung,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8666,,17208,,,BAO_0000218,CHEMBL624419,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,N,2048.0,Lung,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8667,,17208,,,BAO_0000218,CHEMBL624420,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,2048.0,Lung,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8668,,17208,,,BAO_0000218,CHEMBL624421,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),In vivo,N,2385.0,Muscle tissue,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8669,,17208,,,BAO_0000218,CHEMBL624422,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,2385.0,Muscle tissue,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8670,,17208,,,BAO_0000218,CHEMBL624423,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,N,2385.0,Muscle tissue,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8671,,17208,,,BAO_0000218,CHEMBL625123,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,2385.0,Muscle tissue,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8672,,17208,,,BAO_0000218,CHEMBL625124,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,N,2385.0,Muscle tissue,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8673,,17208,,,BAO_0000218,CHEMBL625125,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,2385.0,Muscle tissue,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8674,,17208,,,BAO_0000218,CHEMBL625126,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,N,14.0,Zone of skin,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8675,,17208,,,BAO_0000218,CHEMBL626947,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,14.0,Zone of skin,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8676,,17208,,,BAO_0000218,CHEMBL626948,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,N,14.0,Zone of skin,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8677,,17208,,,BAO_0000218,CHEMBL626949,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,14.0,Zone of skin,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8678,,17208,,,BAO_0000218,CHEMBL626950,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,N,14.0,Zone of skin,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8679,,17208,,,BAO_0000218,CHEMBL626951,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,14.0,Zone of skin,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8680,,17208,,,BAO_0000218,CHEMBL626952,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8681,,17208,,,BAO_0000218,CHEMBL626953,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8682,,17208,,,BAO_0000218,CHEMBL626954,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8683,,17208,,,BAO_0000218,CHEMBL626955,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8684,,17208,,,BAO_0000218,CHEMBL626956,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8685,,17208,,,BAO_0000218,CHEMBL626957,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8686,,17208,,,BAO_0000218,CHEMBL626958,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8687,,17208,,,BAO_0000218,CHEMBL626959,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8688,,17208,,,BAO_0000218,CHEMBL626960,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8689,,17208,,,BAO_0000218,CHEMBL626961,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8690,,17208,,,BAO_0000218,CHEMBL627589,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8691,,17208,,,BAO_0000218,CHEMBL627590,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8692,,3132,,,BAO_0000218,CHEMBL627591,Time taken for EC90 was determined when tested in mouse,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8693,,3132,,,BAO_0000218,CHEMBL627592,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8694,,16597,,,BAO_0000218,CHEMBL627593,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8695,,5727,,,BAO_0000218,CHEMBL627594,Half life in mice,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8696,,5302,,,BAO_0000218,CHEMBL876813,Half life period in mouse after 10 mg/Kg dose,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8697,,5302,,,BAO_0000218,CHEMBL627595,Half life period in mouse after 10 mg/kg dose,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8698,,6348,,,BAO_0000218,CHEMBL627596,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,8699,,5964,,,BAO_0000218,CHEMBL627597,Cmax value at 5 mg/kg po was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8700,,6078,,,BAO_0000218,CHEMBL627598,Cmax value evaluated in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8701,,5206,,,BAO_0000218,CHEMBL627599,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8702,,2959,,,BAO_0000218,CHEMBL627600,Cmax value after administration of 20 mg/Kg oral dose in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8703,,5964,,,BAO_0000218,CHEMBL627601,Cmax value at 1 mg/kg po in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8704,,5964,,,BAO_0000218,CHEMBL627776,Cmax value at 5 mg/kg po in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8705,,6757,,,BAO_0000218,CHEMBL627777,Cmax value at a dose of 10 mg/kg in male SD rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8706,,6757,,,BAO_0000218,CHEMBL627778,Cmax value at a dose of 100 mg/kg in male SD rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8707,,6757,,,BAO_0000218,CHEMBL627779,Cmax value at a dose of 50 mg/kg in male SD rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8708,,17617,,,BAO_0000218,CHEMBL876814,Cmax value in rats at 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8709,,1445,,,BAO_0000218,CHEMBL627780,Cmax value was evaluated in rats at a dose of 20 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8710,,6082,,,BAO_0000218,CHEMBL627781,Cmax value was determined after peroral administration of 20 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8711,,1446,,,BAO_0000218,CHEMBL627782,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8712,,5407,,,BAO_0000218,CHEMBL627783,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8713,,2690,,,BAO_0000218,CHEMBL627784,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8714,,2661,,,BAO_0000218,CHEMBL627785,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8715,,2661,,,BAO_0000218,CHEMBL627786,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8716,,4891,,,BAO_0000218,CHEMBL627787,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8717,,2807,,,BAO_0000218,CHEMBL627788,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8718,,2807,,,BAO_0000218,CHEMBL626579,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8719,,2807,,,BAO_0000218,CHEMBL626580,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8720,,3634,,,BAO_0000218,CHEMBL876815,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8721,,1881,,,BAO_0000218,CHEMBL626581,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8722,,1881,,,BAO_0000218,CHEMBL626582,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8723,,429,,,BAO_0000218,CHEMBL626583,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8724,,5974,,,BAO_0000218,CHEMBL626205,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8725,,5974,,,BAO_0000218,CHEMBL626206,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8726,,5974,,,BAO_0000218,CHEMBL626207,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8727,,5974,,,BAO_0000218,CHEMBL623882,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8728,,17582,,,BAO_0000218,CHEMBL623883,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8729,,17582,,,BAO_0000218,CHEMBL623884,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8730,,3032,,,BAO_0000218,CHEMBL623885,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8731,,6295,,,BAO_0000218,CHEMBL623886,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8732,,6619,,,BAO_0000218,CHEMBL623887,Maximal concentration in rat was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8733,,6616,,,BAO_0000218,CHEMBL623888,Maximal concentration after i.v. administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8734,,3249,,,BAO_0000218,CHEMBL623889,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8735,,17791,,,BAO_0000218,CHEMBL623890,Maximal plasma concentration in rat after oral administration at 50 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8736,,17791,,,BAO_0000218,CHEMBL623891,Cmax in rat plasma after oral dose (50 mg/Kg),In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8737,,1360,,,BAO_0000218,CHEMBL623892,Maximal plasma concentration was determined.,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8738,,2552,,,BAO_0000218,CHEMBL623893,Maximal plasma drug concentration was determined,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8739,,6571,,,BAO_0000218,CHEMBL877616,Maximal concentration in rats after peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8740,,6570,,,BAO_0000218,CHEMBL623894,Maximum concentration in rat after 2 mg/kg peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8741,,6567,,,BAO_0000218,CHEMBL623895,Maximum concentration in rat plasma after 5 mg/kg oral gavage,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8742,,3031,,,BAO_0000218,CHEMBL623896,Maximum concentration of compound in rat was evaluated.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8743,,3436,,,BAO_0000218,CHEMBL623897,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8744,,3436,,,BAO_0000218,CHEMBL623898,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8745,,2083,,,BAO_0000218,CHEMBL623899,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8746,,3436,,,BAO_0000218,CHEMBL623900,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8747,,4527,,,BAO_0000218,CHEMBL623901,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8748,,1974,,,BAO_0000218,CHEMBL623902,Maximum concentration was evaluated in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8749,,3307,,,BAO_0000218,CHEMBL623903,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,In vivo,N,1359.0,Cerebrospinal fluid,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8750,,3307,,,BAO_0000218,CHEMBL623904,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8751,,1916,,,BAO_0000218,CHEMBL877617,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8752,,1500,,,BAO_0000218,CHEMBL623905,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8753,,1500,,,BAO_0000218,CHEMBL623906,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8754,,4186,,,BAO_0000218,CHEMBL623907,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8755,,16434,,,BAO_0000218,CHEMBL623908,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8756,,16434,,,BAO_0000218,CHEMBL623909,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8757,,16434,,,BAO_0000218,CHEMBL623910,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8758,,16434,,,BAO_0000218,CHEMBL623911,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8759,,16435,,,BAO_0000218,CHEMBL623912,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8760,,16435,,,BAO_0000218,CHEMBL624616,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8761,,16435,,,BAO_0000218,CHEMBL624617,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8762,,16435,,,BAO_0000218,CHEMBL624618,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8763,,16435,,,BAO_0000218,CHEMBL624619,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8764,,16435,,,BAO_0000218,CHEMBL624794,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8765,,16435,,,BAO_0000218,CHEMBL624795,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8766,,16435,,,BAO_0000218,CHEMBL623921,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8767,,16434,,,BAO_0000218,CHEMBL623922,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8768,,16434,,,BAO_0000218,CHEMBL623923,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8769,,16434,,,BAO_0000218,CHEMBL623924,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8770,,16435,,,BAO_0000218,CHEMBL623925,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8771,,16435,,,BAO_0000218,CHEMBL623926,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8772,,16435,,,BAO_0000218,CHEMBL623927,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8773,,16435,,,BAO_0000218,CHEMBL623928,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8774,,16435,,,BAO_0000218,CHEMBL623929,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8775,,16435,,,BAO_0000218,CHEMBL623930,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8776,,16434,,,BAO_0000218,CHEMBL623931,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8777,,16434,,,BAO_0000218,CHEMBL622165,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8778,,16434,,,BAO_0000218,CHEMBL621249,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8779,,16434,,,BAO_0000218,CHEMBL621250,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8780,,16434,,,BAO_0000218,CHEMBL621448,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8781,,16434,,,BAO_0000218,CHEMBL621449,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8782,,16434,,,BAO_0000218,CHEMBL621450,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8783,,16434,,,BAO_0000218,CHEMBL621451,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8784,,16435,,,BAO_0000218,CHEMBL621452,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8785,,16435,,,BAO_0000218,CHEMBL621453,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8786,,16435,,,BAO_0000218,CHEMBL621454,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8787,,16435,,,BAO_0000218,CHEMBL621455,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8788,,16435,,,BAO_0000218,CHEMBL621456,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8789,,16435,,,BAO_0000218,CHEMBL625145,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8790,,16435,,,BAO_0000218,CHEMBL875847,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8791,,16435,,,BAO_0000218,CHEMBL625146,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8792,,16434,,,BAO_0000218,CHEMBL625147,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8793,,16434,,,BAO_0000218,CHEMBL625148,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8794,,16434,,,BAO_0000218,CHEMBL625149,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8795,,16435,,,BAO_0000218,CHEMBL625150,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8796,,16435,,,BAO_0000218,CHEMBL625151,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8797,,16435,,,BAO_0000218,CHEMBL625152,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8798,,16435,,,BAO_0000218,CHEMBL625153,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8799,,16435,,,BAO_0000218,CHEMBL625154,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8800,,16435,,,BAO_0000218,CHEMBL625155,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8801,,11977,,,BAO_0000218,CHEMBL625156,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8802,,11977,,,BAO_0000218,CHEMBL624354,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8803,,11977,,,BAO_0000218,CHEMBL624355,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8804,,11977,,,BAO_0000218,CHEMBL624356,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8805,,11977,,,BAO_0000218,CHEMBL624357,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8806,,11977,,,BAO_0000218,CHEMBL624358,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8807,,11977,,,BAO_0000218,CHEMBL624359,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8808,,11977,,,BAO_0000218,CHEMBL624360,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8809,,11977,,,BAO_0000218,CHEMBL624361,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8810,,11977,,,BAO_0000218,CHEMBL624362,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8811,,11977,,,BAO_0000218,CHEMBL624363,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8812,,11977,,,BAO_0000218,CHEMBL624364,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8813,,11977,,,BAO_0000218,CHEMBL624365,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8814,,11977,,,BAO_0000218,CHEMBL624366,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8815,,11977,,,BAO_0000218,CHEMBL624367,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8816,,11977,,,BAO_0000218,CHEMBL624368,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8817,,11977,,,BAO_0000218,CHEMBL624369,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8818,,11977,,,BAO_0000218,CHEMBL624370,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8819,,11977,,,BAO_0000218,CHEMBL625069,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8820,,11977,,,BAO_0000218,CHEMBL625070,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8821,,11977,,,BAO_0000218,CHEMBL626051,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8822,,11977,,,BAO_0000218,CHEMBL626052,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8823,,11977,,,BAO_0000218,CHEMBL626053,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8824,,11977,,,BAO_0000218,CHEMBL626054,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8825,,11977,,,BAO_0000218,CHEMBL626055,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8826,,11977,,,BAO_0000218,CHEMBL626056,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8827,,11977,,,BAO_0000218,CHEMBL626057,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8828,,11977,,,BAO_0000218,CHEMBL625193,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8829,,11977,,,BAO_0000218,CHEMBL625194,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8830,,11977,,,BAO_0000218,CHEMBL625195,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8831,,11977,,,BAO_0000218,CHEMBL625196,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8832,,11977,,,BAO_0000218,CHEMBL625197,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8833,,11977,,,BAO_0000218,CHEMBL625198,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8834,,11977,,,BAO_0000218,CHEMBL627929,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8835,,11977,,,BAO_0000218,CHEMBL627074,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8836,,11977,,,BAO_0000218,CHEMBL627075,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8837,,11977,,,BAO_0000218,CHEMBL627076,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8838,,11977,,,BAO_0000218,CHEMBL627077,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8839,,11977,,,BAO_0000218,CHEMBL627078,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8840,,11977,,,BAO_0000218,CHEMBL627079,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,8841,,4573,,,BAO_0000218,CHEMBL873824,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8842,,3132,,,BAO_0000218,CHEMBL627080,Half life in mouse plasma was determined at dose 25 mg/kg,In vivo,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8843,,17718,,,BAO_0000218,CHEMBL627081,Half life was determined,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8844,,17728,,,BAO_0000218,CHEMBL627082,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8845,,5961,,,BAO_0000218,CHEMBL627083,Half-life in male mice after 1 mg/kg intravenous dose,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8847,,17731,,,BAO_0000218,CHEMBL627085,Half life in mice plasma,,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8848,,17592,,,BAO_0000218,CHEMBL627086,Half life in mouse,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8849,,3132,,,BAO_0000218,CHEMBL627087,Half life in mouse plasma at dose 25 mg/kg,In vivo,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8850,,17729,,,BAO_0000218,CHEMBL627088,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8851,,17729,,,BAO_0000218,CHEMBL627089,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8852,,17729,,,BAO_0000218,CHEMBL627090,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8853,,3277,,,BAO_0000218,CHEMBL627091,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8854,,3760,,,BAO_0000218,CHEMBL627092,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8855,,3760,,,BAO_0000218,CHEMBL876785,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8856,,2862,,,BAO_0000218,CHEMBL627093,Half-life by iv administration in mouse,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8857,,2862,,,BAO_0000218,CHEMBL627094,Half-life by oral administration in mouse,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8858,,5980,,,BAO_0000218,CHEMBL627095,Half-life in mice,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8859,,6159,,,BAO_0000218,CHEMBL627096,Half-life using mouse brain homogenate,,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8860,,6254,,,BAO_0000218,CHEMBL627097,Half-life was measured in mice,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8861,,6062,,,BAO_0000218,CHEMBL627098,Half-life was measured in mouse after an iv dose of 1 mg/kg,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8862,,1574,,,BAO_0000218,CHEMBL627099,Half-life period was determined in mouse blood,,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8863,,56,,,BAO_0000218,CHEMBL627100,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8864,,993,,,BAO_0000218,CHEMBL627101,Plasma half life in mouse,,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8865,,6652,,,BAO_0000218,CHEMBL627102,Stability of the peptide in the presence of mouse serum,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8866,,17852,,,BAO_0000218,CHEMBL627103,Terminal half life of compound was determined in mouse,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8867,,2675,,,BAO_0000218,CHEMBL627104,Terminal half life was evaluated in mice after intravenous administration,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8868,,2675,,,BAO_0000218,CHEMBL627105,Terminal half life was evaluated in mice after oral administration,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8869,,499,,,BAO_0000218,CHEMBL876786,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8870,,499,,,BAO_0000218,CHEMBL873825,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8871,,499,,,BAO_0000218,CHEMBL627106,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8872,,14239,,,BAO_0000218,CHEMBL626336,half life period is evaluated by administering intravenously at 25 mg/kg in mice,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8873,,5506,,,BAO_0000218,CHEMBL877462,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8874,,5506,,,BAO_0000218,CHEMBL626337,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8875,,17734,,,BAO_0000218,CHEMBL626338,Half life after intraperitoneal administration of 100 mg/kg in mice,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8876,,17728,,,BAO_0000218,CHEMBL626339,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8877,,17728,,,BAO_0000218,CHEMBL626340,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8878,,17728,,,BAO_0000218,CHEMBL625377,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8879,,17728,,,BAO_0000218,CHEMBL625378,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,8880,,17728,,,BAO_0000218,CHEMBL625379,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,In vivo,N,,,50594,Mus musculus,Intermediate
,,Microsomes,A,9823.0,0,,1,8881,,14294,,,BAO_0000251,CHEMBL625380,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),,U,,,22224,Sus scrofa,Autocuration
,,Microsomes,A,9823.0,0,,1,8882,,14294,,,BAO_0000251,CHEMBL625381,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),,U,,,22224,Sus scrofa,Autocuration
,,,A,9823.0,0,,1,8883,,6056,,,BAO_0000019,CHEMBL625382,Stability to porcine renal DHP-I,,U,,,22224,Sus scrofa,Autocuration
,,,A,9823.0,0,,1,8884,,1317,,,BAO_0000218,CHEMBL873828,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,In vivo,U,,,22224,Sus scrofa,Autocuration
,,,A,9823.0,0,,1,8885,,1317,,,BAO_0000218,CHEMBL625383,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,In vivo,U,,,22224,Sus scrofa,Autocuration
,,,A,9823.0,0,,1,8886,,5229,,,BAO_0000019,CHEMBL625384,Half-life of the parent prodrug in porcine esterase solution,,U,,,22224,Sus scrofa,Autocuration
,,,A,9823.0,0,,1,8887,,4231,,,BAO_0000019,CHEMBL625385,"First order rate constant, k was determined in in pig liver Esterase",,U,,,22224,Sus scrofa,Autocuration
,,,A,9823.0,0,,1,8888,,4231,,,BAO_0000221,CHEMBL625386,Half life of the in pig liver Esterase,,U,2107.0,Liver,22224,Sus scrofa,Autocuration
,,,A,9823.0,0,,1,8889,,5318,,,BAO_0000221,CHEMBL623571,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,U,2107.0,Liver,22224,Sus scrofa,Autocuration
,,,A,9823.0,0,,1,8890,,5318,,,BAO_0000221,CHEMBL623572,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,U,2107.0,Liver,22224,Sus scrofa,Autocuration
,,,A,9823.0,0,,1,8891,,5318,,,BAO_0000221,CHEMBL623573,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,U,2107.0,Liver,22224,Sus scrofa,Autocuration
,,,A,9823.0,0,,1,8892,,3305,,,BAO_0000221,CHEMBL623574,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,U,2107.0,Liver,22224,Sus scrofa,Autocuration
,,,A,9823.0,0,,1,8893,,3305,,,BAO_0000221,CHEMBL623575,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,U,2107.0,Liver,22224,Sus scrofa,Autocuration
,,,A,9823.0,0,,1,8894,,2842,,,BAO_0000221,CHEMBL623749,Half-life in the presence of pig liver esterase(PLE) was evaluated.,,U,2107.0,Liver,22224,Sus scrofa,Autocuration
,,,A,9823.0,0,,1,8895,,2842,,,BAO_0000221,CHEMBL623750,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,U,2107.0,Liver,22224,Sus scrofa,Autocuration
,,,A,9823.0,0,,1,8896,,889,,,BAO_0000221,CHEMBL623751,Half-life in vitro in pig liver,In vitro,U,2107.0,Liver,22224,Sus scrofa,Autocuration
,,,A,9823.0,0,,1,8897,,1904,,,BAO_0000221,CHEMBL623752,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,U,2107.0,Liver,22224,Sus scrofa,Autocuration
,,,A,10116.0,1,,1,8898,,4186,,,BAO_0000218,CHEMBL623753,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8899,,2774,,,BAO_0000218,CHEMBL623754,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8900,,1742,,,BAO_0000218,CHEMBL623755,Maximum concentration in rat plasma was determined,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8901,,3169,,,BAO_0000218,CHEMBL623756,Maximum concentration in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8902,,3169,,,BAO_0000218,CHEMBL623757,Maximum concentration in rats at 1-2 hours,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8903,,2081,,,BAO_0000218,CHEMBL623758,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8904,,3307,,,BAO_0000218,CHEMBL623759,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8905,,4727,,,BAO_0000218,CHEMBL623760,Maximum concentration at the dose of 2 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8906,,6597,,,BAO_0000218,CHEMBL623761,Maximum concentration was evaluated in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8907,,16365,,,BAO_0000218,CHEMBL623762,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8908,,16365,,,BAO_0000218,CHEMBL877594,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8909,,16365,,,BAO_0000218,CHEMBL623763,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8910,,16365,,,BAO_0000218,CHEMBL623764,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8911,,16365,,,BAO_0000218,CHEMBL623765,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8912,,2591,,,BAO_0000218,CHEMBL623766,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8913,,2591,,,BAO_0000218,CHEMBL623767,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8914,,2591,,,BAO_0000218,CHEMBL623768,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8915,,5978,,,BAO_0000218,CHEMBL623769,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8916,,5978,,,BAO_0000218,CHEMBL623770,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8917,,5978,,,BAO_0000218,CHEMBL623771,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8918,,5978,,,BAO_0000218,CHEMBL623772,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8919,,5978,,,BAO_0000218,CHEMBL623773,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8920,,5978,,,BAO_0000218,CHEMBL623774,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8921,,5978,,,BAO_0000218,CHEMBL623775,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8922,,14465,,,BAO_0000218,CHEMBL623776,Cmax in rat (PO dose),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8923,,4723,,,BAO_0000218,CHEMBL622191,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8924,,4723,,,BAO_0000218,CHEMBL622192,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8925,,4576,,,BAO_0000218,CHEMBL622193,Maximum plasma concentration determined in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8926,,12873,,,BAO_0000218,CHEMBL622194,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8927,,12873,,,BAO_0000218,CHEMBL622195,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8928,,6824,,,BAO_0000218,CHEMBL622196,Maximum plasma concentration in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8929,,17065,,,BAO_0000218,CHEMBL622197,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8930,,2932,,,BAO_0000218,CHEMBL622198,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8931,,2932,,,BAO_0000218,CHEMBL622199,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8932,,2879,,,BAO_0000218,CHEMBL622200,Maximum plasma concentration of compound was measured in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8933,,2864,,,BAO_0000218,CHEMBL622201,Maximum plasma concentration after 20 mg/kg oral administration in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8934,,16367,,,BAO_0000218,CHEMBL623990,Maximum plasma concentration after oral administration to rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8935,,17717,,,BAO_0000218,CHEMBL623991,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8936,,17717,,,BAO_0000218,CHEMBL623992,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8937,,17717,,,BAO_0000218,CHEMBL623993,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8938,,17717,,,BAO_0000218,CHEMBL623994,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,8939,,17720,,,BAO_0000218,CHEMBL623995,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,8940,,17720,,,BAO_0000218,CHEMBL623996,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,8941,,17720,,,BAO_0000218,CHEMBL623997,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8942,,4516,,,BAO_0000218,CHEMBL623998,Maximum plasma concentration dosed orally in rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8943,,4516,,,BAO_0000218,CHEMBL623999,Maximum plasma concentration dosed orally in rats after 6 hours,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8944,,4516,,,BAO_0000218,CHEMBL624000,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8945,,5199,,,BAO_0000218,CHEMBL624001,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8946,,17538,,,BAO_0000218,CHEMBL624002,Maximum plasma concentration in rat after po administration,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8947,,6685,,,BAO_0000218,CHEMBL624003,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8948,,6685,,,BAO_0000218,CHEMBL624004,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8949,,16434,,,BAO_0000218,CHEMBL624005,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8950,,16434,,,BAO_0000218,CHEMBL624006,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8951,,16434,,,BAO_0000218,CHEMBL624007,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8952,,16434,,,BAO_0000218,CHEMBL624008,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8953,,16434,,,BAO_0000218,CHEMBL624009,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8954,,16434,,,BAO_0000218,CHEMBL874387,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8955,,16434,,,BAO_0000218,CHEMBL624010,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8956,,16434,,,BAO_0000218,CHEMBL624011,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8957,,16435,,,BAO_0000218,CHEMBL624012,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8958,,16435,,,BAO_0000218,CHEMBL624013,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8959,,16435,,,BAO_0000218,CHEMBL624736,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8960,,16435,,,BAO_0000218,CHEMBL624737,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8961,,16434,,,BAO_0000218,CHEMBL624738,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8962,,16434,,,BAO_0000218,CHEMBL624739,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8963,,16434,,,BAO_0000218,CHEMBL624740,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8964,,16435,,,BAO_0000218,CHEMBL624896,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8965,,16435,,,BAO_0000218,CHEMBL624897,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8966,,16435,,,BAO_0000218,CHEMBL624108,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8967,,16435,,,BAO_0000218,CHEMBL624109,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8968,,16435,,,BAO_0000218,CHEMBL624110,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8969,,16435,,,BAO_0000218,CHEMBL624111,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8970,,16435,,,BAO_0000218,CHEMBL624112,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8971,,16435,,,BAO_0000218,CHEMBL624113,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8972,,16435,,,BAO_0000218,CHEMBL619709,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8973,,16435,,,BAO_0000218,CHEMBL619710,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8974,,16434,,,BAO_0000218,CHEMBL619711,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8975,,16434,,,BAO_0000218,CHEMBL619712,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8976,,16434,,,BAO_0000218,CHEMBL619713,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8977,,16434,,,BAO_0000218,CHEMBL619714,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8978,,16434,,,BAO_0000218,CHEMBL619715,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8979,,16434,,,BAO_0000218,CHEMBL619716,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8980,,16434,,,BAO_0000218,CHEMBL619717,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8981,,16434,,,BAO_0000218,CHEMBL619718,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8982,,16435,,,BAO_0000218,CHEMBL619719,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8983,,16435,,,BAO_0000218,CHEMBL875329,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8984,,16435,,,BAO_0000218,CHEMBL619720,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8985,,16435,,,BAO_0000218,CHEMBL619721,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8986,,16435,,,BAO_0000218,CHEMBL619722,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8987,,16435,,,BAO_0000218,CHEMBL619723,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8988,,16435,,,BAO_0000218,CHEMBL619724,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8989,,16435,,,BAO_0000218,CHEMBL619725,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8990,,16434,,,BAO_0000218,CHEMBL619726,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8991,,16434,,,BAO_0000218,CHEMBL619727,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8992,,16434,,,BAO_0000218,CHEMBL619728,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8993,,16435,,,BAO_0000218,CHEMBL619729,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8994,,11977,,,BAO_0000218,CHEMBL619730,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8995,,11977,,,BAO_0000218,CHEMBL619731,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8996,,11977,,,BAO_0000218,CHEMBL619732,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8997,,11977,,,BAO_0000218,CHEMBL619733,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8998,,11977,,,BAO_0000218,CHEMBL619734,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,8999,,11977,,,BAO_0000218,CHEMBL619735,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,14.0,Zone of skin,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9000,,11977,,,BAO_0000218,CHEMBL875330,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,14.0,Zone of skin,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9001,,11977,,,BAO_0000218,CHEMBL628465,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,N,14.0,Zone of skin,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9002,,11977,,,BAO_0000218,CHEMBL628466,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,14.0,Zone of skin,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9003,,11977,,,BAO_0000218,CHEMBL628467,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,14.0,Zone of skin,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9004,,11977,,,BAO_0000218,CHEMBL628468,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9005,,11977,,,BAO_0000218,CHEMBL628469,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9006,,11977,,,BAO_0000218,CHEMBL628470,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9007,,11977,,,BAO_0000218,CHEMBL628471,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9008,,11977,,,BAO_0000218,CHEMBL628472,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9009,,11977,,,BAO_0000218,CHEMBL625191,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9010,,11977,,,BAO_0000218,CHEMBL625192,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9011,,11977,,,BAO_0000218,CHEMBL875337,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9012,,11977,,,BAO_0000218,CHEMBL626341,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9013,,11977,,,BAO_0000218,CHEMBL626342,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9014,,11977,,,BAO_0000218,CHEMBL621943,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9015,,3748,,,BAO_0000218,CHEMBL621944,Half life in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9016,,15765,,,BAO_0000218,CHEMBL621945,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9017,,4871,,,BAO_0000218,CHEMBL621946,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9018,,4871,,,BAO_0000218,CHEMBL621947,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9019,,4872,,,BAO_0000218,CHEMBL621948,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9020,,4872,,,BAO_0000218,CHEMBL621949,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9021,,5413,,,BAO_0000218,CHEMBL621950,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9022,,5413,,,BAO_0000218,CHEMBL621951,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9023,,15272,,,BAO_0000218,CHEMBL621952,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9024,,4689,,,BAO_0000218,CHEMBL621953,Stability (%) in rat liver microsomes,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9025,,6057,,,BAO_0000218,CHEMBL621954,Area under curve was calculated after intravenous administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9026,,6057,,,BAO_0000218,CHEMBL621955,Area under the curve was calculated after iv administration in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9027,,6057,,,BAO_0000218,CHEMBL621956,Area under the curve was calculated in rat after peroral administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9028,,6211,,,BAO_0000218,CHEMBL621957,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9029,,5710,,,BAO_0000218,CHEMBL621958,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9030,,5710,,,BAO_0000218,CHEMBL621959,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9031,,17853,,,BAO_0000218,CHEMBL621960,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9032,,17853,,,BAO_0000218,CHEMBL621961,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9033,,15765,,,BAO_0000218,CHEMBL621962,p value of the compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,9034,,15765,,,BAO_0000218,CHEMBL876787,p value of the compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9035,,15765,,,BAO_0000218,CHEMBL621963,p value of the compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9036,,6175,,,BAO_0000218,CHEMBL622637,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,945.0,Stomach,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9037,,6175,,,BAO_0000218,CHEMBL622638,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,945.0,Stomach,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9038,,6175,,,BAO_0000218,CHEMBL626561,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,945.0,Stomach,50597,Rattus norvegicus,Intermediate
,,,F,9986.0,0,,1,9039,,7991,,,BAO_0000019,CHEMBL626562,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9040,,429,,,BAO_0000218,CHEMBL626563,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9041,,429,,,BAO_0000218,CHEMBL626564,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9042,,6253,,,BAO_0000218,CHEMBL626565,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,In vivo,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9043,,6253,,,BAO_0000218,CHEMBL626566,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,In vivo,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9044,,3615,,,BAO_0000218,CHEMBL626567,Clearance rate in rabbits,In vivo,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9045,,4059,,,BAO_0000218,CHEMBL626568,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,In vivo,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9046,,5124,,,BAO_0000218,CHEMBL626569,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,In vivo,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9047,,5124,,,BAO_0000218,CHEMBL626570,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,In vivo,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9048,,5124,,,BAO_0000218,CHEMBL626571,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,In vivo,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9049,,429,,,BAO_0000218,CHEMBL626572,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,In vivo,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9050,,4059,,,BAO_0000218,CHEMBL626573,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,In vivo,U,1969.0,Plasma,22224,Oryctolagus cuniculus,Autocuration
,,Microsomes,A,9986.0,0,,1,9051,,9659,,,BAO_0000251,CHEMBL626574,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,,U,2107.0,Liver,22224,Oryctolagus cuniculus,Autocuration
,,Microsomes,A,9986.0,0,,1,9052,,9659,,,BAO_0000251,CHEMBL626575,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,,U,2107.0,Liver,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9053,,3639,,,BAO_0000218,CHEMBL626576,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9054,,3639,,,BAO_0000218,CHEMBL626577,Dose at which bioavailability of perorally administered compound was tested in rabbit,,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9055,,3639,,,BAO_0000218,CHEMBL626578,The compound was tested for its bioavailability in rabbit (by oral dosage).,In vivo,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9056,,5124,,,BAO_0000218,CHEMBL625263,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,In vivo,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9057,,5124,,,BAO_0000218,CHEMBL625264,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,In vivo,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9058,,5124,,,BAO_0000218,CHEMBL625265,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,In vivo,U,,,22224,Oryctolagus cuniculus,Autocuration
,,Microsomes,A,9986.0,0,,1,9059,,14294,,,BAO_0000251,CHEMBL625266,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),,U,,,22224,Oryctolagus cuniculus,Autocuration
,,Microsomes,A,9986.0,0,,1,9060,,14294,,,BAO_0000251,CHEMBL876796,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9061,,429,,,BAO_0000218,CHEMBL625267,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,In vivo,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9062,,5124,,,BAO_0000218,CHEMBL625268,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,In vivo,U,1969.0,Plasma,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9063,,5124,,,BAO_0000218,CHEMBL625269,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,In vivo,U,1969.0,Plasma,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9064,,5124,,,BAO_0000218,CHEMBL624689,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,In vivo,U,1969.0,Plasma,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9065,,429,,,BAO_0000218,CHEMBL624690,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,In vivo,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9066,,429,,,BAO_0000218,CHEMBL624691,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,U,1088.0,Urine,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9067,,429,,,BAO_0000218,CHEMBL624692,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,U,1088.0,Urine,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9068,,4059,,,BAO_0000218,CHEMBL624693,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,In vivo,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9069,,4137,,,BAO_0000218,CHEMBL624694,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,In vivo,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9070,,11672,,,BAO_0000221,CHEMBL877596,In vitro Biological half-life in crude homogenate of rabbit renal cortex,In vitro,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9071,,12886,,,BAO_0000019,CHEMBL624695,Time within which only 10% of the drug was degraded,,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9072,,3853,,,BAO_0000221,CHEMBL624696,Half life period in rabbit liver homogenate,,U,2107.0,Liver,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9073,,3615,,,BAO_0000019,CHEMBL624697,Half life value in rabbits,,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9074,,6253,,,BAO_0000218,CHEMBL624698,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,In vivo,U,178.0,Blood,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9075,,6253,,,BAO_0000218,CHEMBL624699,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,In vivo,U,178.0,Blood,22224,Oryctolagus cuniculus,Autocuration
,,,A,9986.0,0,,1,9076,,6077,,,BAO_0000218,CHEMBL624700,Half-life period in rabbits following intravenous administration at 2 mg/kg,In vivo,U,,,22224,Oryctolagus cuniculus,Autocuration
,,,A,10116.0,1,,1,9077,,17617,,,BAO_0000218,CHEMBL622903,AUC 0-8 hr value in rats at 10 mg/kg,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9078,,17594,,,BAO_0000218,CHEMBL622904,AUC after administration at 2000 mg/kg/day in rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9079,,6149,,,BAO_0000218,CHEMBL622905,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9080,,17260,,,BAO_0000218,CHEMBL622906,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9081,,17260,,,BAO_0000218,CHEMBL622907,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9082,,6644,,,BAO_0000218,CHEMBL622908,AUC in rat after oral administration at 10.5 mg/kg dose,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9083,,6644,,,BAO_0000218,CHEMBL622909,AUC in rat after oral administration at 11.2 mg/kg dose,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9084,,6644,,,BAO_0000218,CHEMBL622910,AUC in rat after oral administration at 9.7 mg/kg dose,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9085,,6495,,,BAO_0000218,CHEMBL622911,AUC in rat brain after oral administration at 10 mg/kg,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9086,,6504,,,BAO_0000218,CHEMBL622912,AUC in rat p.o.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9087,,17686,,,BAO_0000218,CHEMBL622913,AUC in rat p.o. at 20 mg/kg concentration,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9088,,6495,,,BAO_0000218,CHEMBL622914,AUC in rat plasma after oral administration at 10 mg/kg,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9089,,216,,,BAO_0000218,CHEMBL622915,AUC in rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9090,,1908,,,BAO_0000218,CHEMBL622916,AUC value after IV dose at a dose of 5 mg/kg in rats.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9091,,1908,,,BAO_0000218,CHEMBL622917,AUC value after oral dose at a dose of 10 mg/kg in rats.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9092,,6685,,,BAO_0000218,CHEMBL622918,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9093,,216,,,BAO_0000218,CHEMBL622919,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9094,,6049,,,BAO_0000218,CHEMBL622920,Maximum plasma concentration was evaluated in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9095,,2463,,,BAO_0000218,CHEMBL622921,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9096,,6679,,,BAO_0000218,CHEMBL622922,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9097,,6681,,,BAO_0000218,CHEMBL622923,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9098,,4890,,,BAO_0000218,CHEMBL877604,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9099,,6410,,,BAO_0000218,CHEMBL622924,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9100,,6410,,,BAO_0000218,CHEMBL622925,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9101,,16366,,,BAO_0000218,CHEMBL622926,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9102,,6227,,,BAO_0000218,CHEMBL623625,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9103,,3598,,,BAO_0000218,CHEMBL623626,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Expert
,,,A,10116.0,1,,1,9104,,1465,,,BAO_0000218,CHEMBL623627,Maximum plasma drug concentration was determined,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9105,,4368,,,BAO_0000218,CHEMBL623628,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9106,,15662,,,BAO_0000218,CHEMBL623629,Mean peak plasma concentration was observed after intravenous administration in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9107,,15662,,,BAO_0000218,CHEMBL623630,Mean peak plasma concentration was observed after oral administration in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9108,,5355,,,BAO_0000218,CHEMBL623804,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9109,,5355,,,BAO_0000218,CHEMBL623805,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9110,,1567,,,BAO_0000218,CHEMBL623806,Peak oral plasma concentration was determined in rats by oral administration,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9111,,4026,,,BAO_0000218,CHEMBL623807,Peak plasma concentration (Cmax) was determined,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9112,,6193,,,BAO_0000218,CHEMBL623808,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9113,,4026,,,BAO_0000218,CHEMBL623809,Peak plasma concentration (Cmax) in rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9114,,6485,,,BAO_0000218,CHEMBL623810,Peak plasma concentration at 1 mg/kg peroral administration,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9115,,17655,,,BAO_0000218,CHEMBL623811,Peak plasma concentration in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9116,,14941,,,BAO_0000218,CHEMBL623812,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9117,,5394,,,BAO_0000218,CHEMBL877605,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9118,,4408,,,BAO_0000218,CHEMBL623813,Pharmacokinetic property (Cmax) in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9119,,5983,,,BAO_0000218,CHEMBL623814,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9120,,4878,,,BAO_0000218,CHEMBL623815,Cmax in rat after 3mg/kg oral dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9121,Sprague-Dawley,5862,,,BAO_0000218,CHEMBL623816,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9122,,4517,,,BAO_0000218,CHEMBL623145,Cmax in rats after 20 mg/kg oral dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9123,,5932,,,BAO_0000218,CHEMBL623146,Cmax in rat plasma after 30mg/kg oral dose,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9124,,5436,,,BAO_0000218,CHEMBL623147,Plasma concentration after oral administration of 100 mg/kg to rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9125,,4910,,,BAO_0000218,CHEMBL623042,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9126,,4950,,,BAO_0000218,CHEMBL623043,Tested for the Cmax in rat at 10 mg/kg per orally,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9127,,15078,,,BAO_0000218,CHEMBL623044,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9128,,15078,,,BAO_0000218,CHEMBL623045,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9129,,3360,,,BAO_0000218,CHEMBL623046,Bioavailability as oral Cmax in rats at 30 mins,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9130,,3360,,,BAO_0000218,CHEMBL623226,Bioavailability as oral Cmax in rats at 6hr,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9131,,15022,,,BAO_0000218,CHEMBL623227,The maximum concentration of compound was measured at the dose of 100 umol/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9132,,15022,,,BAO_0000218,CHEMBL623228,The maximum concentration of compound was measured at the dose of 300 umol/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9133,,15022,,,BAO_0000218,CHEMBL623229,The maximum concentration of compound was measured at the dose of 30 umol/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9134,,5160,,,BAO_0000218,CHEMBL623230,The maximum plasma levels for the compounds were determined by LC-MS.,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9135,,15662,,,BAO_0000218,CHEMBL623231,mean peak plasma concentration was observed after intravenous administration in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9136,,15662,,,BAO_0000218,CHEMBL623232,mean peak plasma concentration was observed after oral administration in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9137,,4709,,,BAO_0000218,CHEMBL623233,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9138,,3535,,,BAO_0000218,CHEMBL623234,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9139,,3535,,,BAO_0000218,CHEMBL623235,Concentration in plasma (portal) following oral dose in rats at 1 hr,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9140,,3535,,,BAO_0000218,CHEMBL623236,Concentration in plasma (portal) following oral dose in rats at 2 hr,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9141,,3535,,,BAO_0000218,CHEMBL623237,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9142,,3535,,,BAO_0000218,CHEMBL623238,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9143,,3535,,,BAO_0000218,CHEMBL623239,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,0,,1,9144,,5005,,,BAO_0000218,CHEMBL623240,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,In vivo,U,1969.0,Plasma,22224,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9145,,6326,,,BAO_0000218,CHEMBL623241,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,N,1898.0,Hypothalamus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9146,,6326,,,BAO_0000218,CHEMBL623242,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,N,1898.0,Hypothalamus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9147,,6326,,,BAO_0000218,CHEMBL874394,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9148,,6326,,,BAO_0000218,CHEMBL623243,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9149,,17411,,,BAO_0000218,CHEMBL623244,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9150,,16435,,,BAO_0000218,CHEMBL623245,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9151,,16435,,,BAO_0000218,CHEMBL623246,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9152,,16435,,,BAO_0000218,CHEMBL623247,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9153,,16435,,,BAO_0000218,CHEMBL623248,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9154,,16435,,,BAO_0000218,CHEMBL623249,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9155,,16434,,,BAO_0000218,CHEMBL625072,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9156,,16434,,,BAO_0000218,CHEMBL625073,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9157,,16434,,,BAO_0000218,CHEMBL625074,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9158,,16434,,,BAO_0000218,CHEMBL625075,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9159,,16434,,,BAO_0000218,CHEMBL625076,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9160,,16434,,,BAO_0000218,CHEMBL625077,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9161,,16434,,,BAO_0000218,CHEMBL625078,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9162,,16434,,,BAO_0000218,CHEMBL874395,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9163,,16435,,,BAO_0000218,CHEMBL625079,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9164,,16435,,,BAO_0000218,CHEMBL625080,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9165,,16435,,,BAO_0000218,CHEMBL625081,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9166,,16435,,,BAO_0000218,CHEMBL625082,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9167,,16435,,,BAO_0000218,CHEMBL625083,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9168,,16435,,,BAO_0000218,CHEMBL625084,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9169,,16435,,,BAO_0000218,CHEMBL625085,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9170,,16435,,,BAO_0000218,CHEMBL625086,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9171,,16434,,,BAO_0000218,CHEMBL625087,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9172,,16434,,,BAO_0000218,CHEMBL625088,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9173,,16434,,,BAO_0000218,CHEMBL622205,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9174,,16435,,,BAO_0000218,CHEMBL622206,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9175,,16435,,,BAO_0000218,CHEMBL622207,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9176,,16435,,,BAO_0000218,CHEMBL622366,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9177,,16435,,,BAO_0000218,CHEMBL622367,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9178,,16435,,,BAO_0000218,CHEMBL875331,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9179,,16435,,,BAO_0000218,CHEMBL622368,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9180,,16434,,,BAO_0000218,CHEMBL622369,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9181,,16434,,,BAO_0000218,CHEMBL622370,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9182,,16434,,,BAO_0000218,CHEMBL622371,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9183,,16434,,,BAO_0000218,CHEMBL622372,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9184,,16434,,,BAO_0000218,CHEMBL622373,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9185,,16434,,,BAO_0000218,CHEMBL622374,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9186,,16434,,,BAO_0000218,CHEMBL622375,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9187,,16434,,,BAO_0000218,CHEMBL622376,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9188,,16435,,,BAO_0000218,CHEMBL622377,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9189,,16435,,,BAO_0000218,CHEMBL622378,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9190,,16435,,,BAO_0000218,CHEMBL622379,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9191,,16435,,,BAO_0000218,CHEMBL622380,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9192,,16435,,,BAO_0000218,CHEMBL622381,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9193,,16435,,,BAO_0000218,CHEMBL622382,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9194,,16434,,,BAO_0000218,CHEMBL622383,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9195,,6175,,,BAO_0000218,CHEMBL875332,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,945.0,Stomach,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9196,,6175,,,BAO_0000218,CHEMBL622384,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,945.0,Stomach,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9197,,6175,,,BAO_0000218,CHEMBL622385,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,945.0,Stomach,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9198,,6175,,,BAO_0000218,CHEMBL622386,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,N,945.0,Stomach,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9199,,10839,,,BAO_0000218,CHEMBL622387,The compound was tested for the plasma binding in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9200,,16459,,,BAO_0000218,CHEMBL622388,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9201,,16459,,,BAO_0000218,CHEMBL622389,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9202,,16459,,,BAO_0000218,CHEMBL622390,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9203,,16459,,,BAO_0000218,CHEMBL622391,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9204,,16459,,,BAO_0000218,CHEMBL622392,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9205,,16459,,,BAO_0000218,CHEMBL622393,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9206,,3278,,,BAO_0000218,CHEMBL622394,Plasma level at 2 hr after administration of the compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9207,,3278,,,BAO_0000218,CHEMBL622395,plasma level at 2 hr after administration of the compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9208,,4684,,,BAO_0000218,CHEMBL622396,Stability in rat serum measured as % recovery at 1 min,,N,1977.0,Serum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9209,,4684,,,BAO_0000218,CHEMBL624894,Stability in rat serum measured as % recovery at 10 min,,N,1977.0,Serum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9210,,4684,,,BAO_0000218,CHEMBL624895,Stability in rat serum measured as % recovery at 10 mins,,N,1977.0,Serum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9211,,4684,,,BAO_0000218,CHEMBL624058,Stability in rat serum measured as % recovery at 2 hr,,N,1977.0,Serum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9212,,4684,,,BAO_0000218,CHEMBL624059,Stability in rat serum measured as % recovery at 3 min,,N,1977.0,Serum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9213,,4684,,,BAO_0000218,CHEMBL624060,Stability in rat serum measured as % recovery at 3 mins,,N,1977.0,Serum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9214,,4684,,,BAO_0000218,CHEMBL624061,Stability in rat serum measured as % recovery at 5 min,,N,1977.0,Serum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9215,,4684,,,BAO_0000218,CHEMBL624062,Stability in rat serum measured as % recovery at 5 mins,,N,1977.0,Serum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9216,,16456,,,BAO_0000218,CHEMBL624063,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9217,,16456,,,BAO_0000218,CHEMBL624064,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9218,,723,,,BAO_0000218,CHEMBL624065,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9219,,723,,,BAO_0000218,CHEMBL624066,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9220,,5160,,,BAO_0000218,CHEMBL877490,Half life tested in mature male rat at a dose of 30 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9221,,4709,,,BAO_0000218,CHEMBL874442,Half life after intravenous administration of 1 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9222,,5633,,,BAO_0000218,CHEMBL626890,Half life period after administration (30 mg/kg) in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9223,,5302,,,BAO_0000218,CHEMBL626891,Half life period in rat after 5 mg/Kg dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9224,,5302,,,BAO_0000218,CHEMBL626892,Half life period in rat after 5 mg/kg dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9225,,17791,,,BAO_0000218,CHEMBL626893,Half life period was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9226,,17791,,,BAO_0000218,CHEMBL626894,Half life period was evaluated in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9227,,17791,,,BAO_0000218,CHEMBL626895,Half life period was evaluated in rat; 0.5-1.0,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9228,,17791,,,BAO_0000218,CHEMBL626896,Half life period was evaluated in rat; 5.9-7.5,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9229,,14512,,,BAO_0000218,CHEMBL626897,Half-life in rat plasma,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9230,,6230,,,BAO_0000218,CHEMBL626898,Half-life time in rat was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9231,,3364,,,BAO_0000218,CHEMBL626899,Terminal half-life after iv administration to rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9232,,6874,,,BAO_0000218,CHEMBL626900,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9233,,857,,,BAO_0000218,CHEMBL626901,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9234,,858,,,BAO_0000218,CHEMBL626902,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9235,,858,,,BAO_0000218,CHEMBL626903,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9236,,5355,,,BAO_0000218,CHEMBL874443,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9237,,5355,,,BAO_0000218,CHEMBL626904,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9238,,6305,,,BAO_0000218,CHEMBL626905,Half life in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9239,,13501,,,BAO_0000218,CHEMBL873830,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9240,,17594,,,BAO_0000218,CHEMBL626906,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9241,,4186,,,BAO_0000218,CHEMBL631076,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9242,,2932,,,BAO_0000218,CHEMBL631077,Biological half-life was measured in plasma of rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9243,,17065,,,BAO_0000218,CHEMBL631078,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9244,,15765,,,BAO_0000218,CHEMBL631079,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9245,,2713,,,BAO_0000218,CHEMBL631080,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9246,,2661,,,BAO_0000218,CHEMBL631081,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9247,,2661,,,BAO_0000218,CHEMBL631239,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9248,,740,,,BAO_0000218,CHEMBL631240,Compound was evaluated for plasma half life in rat,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9249,,6597,,,BAO_0000218,CHEMBL631241,AUC value at a dose of 5 mg/kg (p.o.) in rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9250,,2959,,,BAO_0000218,CHEMBL631242,AUC value after administration of 20 mg/Kg oral dose in rat,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9251,,17594,,,BAO_0000218,CHEMBL631243,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9252,,17596,,,BAO_0000218,CHEMBL874444,AUC0-96 after administration at 50 mg/kg,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9253,,17594,,,BAO_0000218,CHEMBL631244,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9254,,3293,,,BAO_0000218,CHEMBL631245,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9255,,6757,,,BAO_0000218,CHEMBL627162,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9256,,6757,,,BAO_0000218,CHEMBL627163,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9257,,6757,,,BAO_0000218,CHEMBL627164,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9258,,5979,,,BAO_0000218,CHEMBL627165,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9259,,5979,,,BAO_0000218,CHEMBL627166,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9260,,5979,,,BAO_0000218,CHEMBL627167,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9261,,4026,,,BAO_0000218,CHEMBL627822,Area under curve (AUC) at a dose of 30 mg/kg in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9262,,5355,,,BAO_0000218,CHEMBL627823,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9263,,5355,,,BAO_0000218,CHEMBL627824,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9264,,5355,,,BAO_0000218,CHEMBL627825,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9265,,5633,,,BAO_0000218,CHEMBL627826,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9266,,1716,,,BAO_0000218,CHEMBL627827,Area under curve (Pharmacokinetic property) was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9267,,1716,,,BAO_0000218,CHEMBL627828,Area under curve (Pharmacokinetic property) of the compound; Not determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9268,,4689,,,BAO_0000218,CHEMBL627829,Area under curve after intravenous administration (1 mg/kg) in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9269,,4527,,,BAO_0000218,CHEMBL627830,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9270,,4527,,,BAO_0000218,CHEMBL627831,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9271,,15662,,,BAO_0000218,CHEMBL627832,Area under curve in male SD rats was observed after oral administration in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9272,,4413,,,BAO_0000218,CHEMBL627833,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9273,,3598,,,BAO_0000218,CHEMBL627834,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,N,,,50597,Rattus norvegicus,Expert
,,,A,10116.0,1,,1,9274,,3598,,,BAO_0000218,CHEMBL628004,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,N,,,50597,Rattus norvegicus,Expert
,,,A,10116.0,1,,1,9275,,5964,,,BAO_0000218,CHEMBL628005,Area under curve at 5 mg/kg po was determined in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9276,,4689,,,BAO_0000218,CHEMBL628006,Area under curve in Rat at a oral dose of 5 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9277,,4186,,,BAO_0000218,CHEMBL628007,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9278,,5510,,,BAO_0000218,CHEMBL625676,Area under curve was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9279,,17858,,,BAO_0000218,CHEMBL631309,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9280,,17804,,,BAO_0000218,CHEMBL631310,Area under curve after intravenous administration at 3 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9281,,6106,,,BAO_0000218,CHEMBL631311,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9282,,5964,,,BAO_0000218,CHEMBL631312,Area under curve at 4 hr in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9283,,4026,,,BAO_0000218,CHEMBL631313,Area under curve at a dose of 30 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9284,,4756,,,BAO_0000218,CHEMBL631314,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9285,,4756,,,BAO_0000218,CHEMBL631315,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9286,,5862,,,BAO_0000218,CHEMBL631316,Area under curve for a 2-mpk po dose in SD rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9287,,5862,,,BAO_0000218,CHEMBL631317,Area under curve in SD rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9288,,6644,,,BAO_0000218,CHEMBL874471,Area under curve in rat after oral administration at 13 mg/kg dose,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9289,,5871,,,BAO_0000218,CHEMBL631318,Area under curve in rat by po administration at 0-24 hr,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9290,,5919,,,BAO_0000218,CHEMBL631319,Area under curve in rat plasma,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9291,,5939,,,BAO_0000218,CHEMBL631320,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9292,,5939,,,BAO_0000218,CHEMBL631321,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9293,,10,,,BAO_0000218,CHEMBL631322,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9294,,11149,,,BAO_0000218,CHEMBL631323,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9295,,5302,,,BAO_0000218,CHEMBL631324,Area under curve value in rat at a dose of 5 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9296,,17796,,,BAO_0000218,CHEMBL631325,Area under curve was determined after oral administration in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9297,,4890,,,BAO_0000218,CHEMBL631326,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9298,,6011,,,BAO_0000218,CHEMBL631327,Area under curve was determined after peroral administration in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9299,,5375,,,BAO_0000218,CHEMBL631328,Area under curve was determined at a dose 30 mpk administered orally.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9300,,17764,,,BAO_0000218,CHEMBL631329,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9301,,4368,,,BAO_0000218,CHEMBL627217,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9302,,5610,,,BAO_0000218,CHEMBL626352,Area under curve was determined in male rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9303,,5833,,,BAO_0000218,CHEMBL626353,Area under curve was determined in rat after PO administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9304,,4257,,,BAO_0000218,CHEMBL626354,Area under curve was determined in rat after a 3 mg/kg of oral dose,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9305,,5937,,,BAO_0000218,CHEMBL626355,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9306,,5932,,,BAO_0000218,CHEMBL626356,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9307,,5932,,,BAO_0000218,CHEMBL626357,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9308,,17411,,,BAO_0000218,CHEMBL626358,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9309,,17411,,,BAO_0000218,CHEMBL626359,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9310,,17771,,,BAO_0000218,CHEMBL626360,Peak plasma concentration in rat at a dose of 3 mg/kg,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9311,,1628,,,BAO_0000218,CHEMBL626361,Plasma concentration at 2 hr in rats was evaluated.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9312,,1628,,,BAO_0000218,CHEMBL626362,Plasma concentration at 2 hr in rats was evaluated; Not available,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9313,,17411,,,BAO_0000218,CHEMBL626363,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9314,,4910,,,BAO_0000218,CHEMBL626970,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9315,,4910,,,BAO_0000218,CHEMBL626971,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9316,,4910,,,BAO_0000218,CHEMBL626972,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9317,,4910,,,BAO_0000218,CHEMBL626973,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9318,,4910,,,BAO_0000218,CHEMBL626974,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9319,,4910,,,BAO_0000218,CHEMBL874592,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9320,,5510,,,BAO_0000218,CHEMBL626975,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9321,,5510,,,BAO_0000218,CHEMBL626976,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9322,,5510,,,BAO_0000218,CHEMBL626977,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9323,,5510,,,BAO_0000218,CHEMBL626978,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9324,,16427,,,BAO_0000218,CHEMBL626979,PK study was carried to determine the relative absorption ranking in rat.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9325,,4689,,,BAO_0000218,CHEMBL626980,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9326,,11450,,,BAO_0000218,CHEMBL626981,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9327,,11450,,,BAO_0000218,CHEMBL626982,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9328,,11450,,,BAO_0000218,CHEMBL626983,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9329,,11450,,,BAO_0000218,CHEMBL622522,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9330,,11450,,,BAO_0000218,CHEMBL622523,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9331,,11450,,,BAO_0000218,CHEMBL622524,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9332,,11450,,,BAO_0000218,CHEMBL622525,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9333,,11450,,,BAO_0000218,CHEMBL622526,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9334,,11450,,,BAO_0000218,CHEMBL619849,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9335,,11450,,,BAO_0000218,CHEMBL619850,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9336,,11450,,,BAO_0000218,CHEMBL623864,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9337,,11450,,,BAO_0000218,CHEMBL623865,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9338,,11450,,,BAO_0000218,CHEMBL623866,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9339,,11450,,,BAO_0000218,CHEMBL623867,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9340,,11450,,,BAO_0000218,CHEMBL877615,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9341,,11450,,,BAO_0000218,CHEMBL623868,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9342,,11450,,,BAO_0000218,CHEMBL623869,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9343,,11450,,,BAO_0000218,CHEMBL623870,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9344,,16434,,,BAO_0000218,CHEMBL623871,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9345,,16434,,,BAO_0000218,CHEMBL623872,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9346,,16435,,,BAO_0000218,CHEMBL622129,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9347,,16435,,,BAO_0000218,CHEMBL622130,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9348,,16435,,,BAO_0000218,CHEMBL622131,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9349,,16435,,,BAO_0000218,CHEMBL622132,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9350,,16435,,,BAO_0000218,CHEMBL622133,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9351,,16435,,,BAO_0000218,CHEMBL622134,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9352,,16435,,,BAO_0000218,CHEMBL622135,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9353,,16435,,,BAO_0000218,CHEMBL622136,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9354,,16434,,,BAO_0000218,CHEMBL622137,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9355,,16434,,,BAO_0000218,CHEMBL622138,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9356,,16434,,,BAO_0000218,CHEMBL623017,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9357,,16434,,,BAO_0000218,CHEMBL623018,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9358,,16434,,,BAO_0000218,CHEMBL623019,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9359,,16434,,,BAO_0000218,CHEMBL623020,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9360,,16434,,,BAO_0000218,CHEMBL623021,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9361,,16434,,,BAO_0000218,CHEMBL623022,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9362,,16435,,,BAO_0000218,CHEMBL623023,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9363,,16435,,,BAO_0000218,CHEMBL623024,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9364,,16435,,,BAO_0000218,CHEMBL623025,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9365,,16435,,,BAO_0000218,CHEMBL620545,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9366,,16435,,,BAO_0000218,CHEMBL620546,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9367,,16435,,,BAO_0000218,CHEMBL620547,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9368,,16435,,,BAO_0000218,CHEMBL620548,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9369,,16435,,,BAO_0000218,CHEMBL620549,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9370,,16434,,,BAO_0000218,CHEMBL620550,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9371,,16434,,,BAO_0000218,CHEMBL620551,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9372,,16434,,,BAO_0000218,CHEMBL620552,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9373,,16435,,,BAO_0000218,CHEMBL620553,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9374,,16435,,,BAO_0000218,CHEMBL620554,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9375,,16435,,,BAO_0000218,CHEMBL875845,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9376,,16435,,,BAO_0000218,CHEMBL620555,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9377,,16435,,,BAO_0000218,CHEMBL620556,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9378,,16435,,,BAO_0000218,CHEMBL620557,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9379,,16434,,,BAO_0000218,CHEMBL620558,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9380,,16434,,,BAO_0000218,CHEMBL620559,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9381,,16434,,,BAO_0000218,CHEMBL622939,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9382,,16434,,,BAO_0000218,CHEMBL622940,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9383,,16434,,,BAO_0000218,CHEMBL622941,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9384,,16434,,,BAO_0000218,CHEMBL622942,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9385,,16434,,,BAO_0000218,CHEMBL622943,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9386,,16434,,,BAO_0000218,CHEMBL622944,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9387,,16435,,,BAO_0000218,CHEMBL622945,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9388,,16435,,,BAO_0000218,CHEMBL622946,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9389,,3341,,,BAO_0000218,CHEMBL622947,Compound was evaluated for terminal half life in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9390,,3634,,,BAO_0000218,CHEMBL622948,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9391,,3634,,,BAO_0000218,CHEMBL622949,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9392,,4839,,,BAO_0000218,CHEMBL622950,Compound was tested for its half life in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9544.0,0,,1,9393,,5005,,,BAO_0000218,CHEMBL622951,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,In vivo,U,1969.0,Plasma,22224,Macaca mulatta,Intermediate
,,,A,10116.0,0,,1,9394,,5005,,,BAO_0000366,CHEMBL622952,Compound was tested for its plasma half life in Sprague Dawley rats,,U,1969.0,Plasma,22224,Rattus norvegicus,Intermediate
,,,A,10116.0,0,,1,9395,,5005,,,BAO_0000366,CHEMBL622953,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,U,1969.0,Plasma,22224,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9396,,1094,,,BAO_0000218,CHEMBL873818,Compound was tested for plasma half-life period in rat,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9397,,5031,,,BAO_0000218,CHEMBL622954,Elimination half life after i.v. administration of compound in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9398,,6518,,,BAO_0000218,CHEMBL622955,Elimination half-life after IV dosing at 0.5 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9399,,6518,,,BAO_0000218,CHEMBL875229,Elimination half-life after IV dosing at 1 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9400,,6518,,,BAO_0000218,CHEMBL622956,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9401,,6518,,,BAO_0000218,CHEMBL622957,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9402,,5408,,,BAO_0000218,CHEMBL622958,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9403,,5408,,,BAO_0000218,CHEMBL622959,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9404,,5408,,,BAO_0000218,CHEMBL622960,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9405,,5408,,,BAO_0000218,CHEMBL622961,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9406,,4687,,,BAO_0000218,CHEMBL622962,Evaluated for the half life in rat (in vivo),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9407,,6640,,,BAO_0000218,CHEMBL622963,Hafl life in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9408,,6640,,,BAO_0000218,CHEMBL622964,Hafl life rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9409,,6641,,,BAO_0000218,CHEMBL622965,Hafl life rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9410,,6640,,,BAO_0000218,CHEMBL622966,Hafl life rat; Not determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9411,,6641,,,BAO_0000218,CHEMBL622967,Hafl life rat; Not determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9412,,17411,,,BAO_0000218,CHEMBL622968,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9413,,17411,,,BAO_0000218,CHEMBL622969,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9414,,17411,,,BAO_0000218,CHEMBL875327,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9415,,6570,,,BAO_0000218,CHEMBL628638,Half life in rat after 1 mg/kg i.v. administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9416,,6570,,,BAO_0000218,CHEMBL628639,Half life in rat after 2 mg/kg peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9417,,17411,,,BAO_0000218,CHEMBL625840,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9418,,4722,,,BAO_0000218,CHEMBL625841,Half life of 10 mg/kg oral dose determined in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9419,,5978,,,BAO_0000218,CHEMBL625842,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9420,,5978,,,BAO_0000218,CHEMBL625843,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9421,,5978,,,BAO_0000218,CHEMBL625844,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9422,,5978,,,BAO_0000218,CHEMBL873822,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9423,,5978,,,BAO_0000218,CHEMBL625845,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9424,,5978,,,BAO_0000218,CHEMBL627059,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9425,,5978,,,BAO_0000218,CHEMBL627060,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9426,,5978,,,BAO_0000218,CHEMBL627061,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9427,,4762,,,BAO_0000218,CHEMBL627709,Half life of compound at 5 mg/kg after po administration was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9428,,5327,,,BAO_0000218,CHEMBL627710,Half life of compound determined after intravenous administration to rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9429,,4847,,,BAO_0000218,CHEMBL627711,Half life of compound was determined in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9430,,17720,,,BAO_0000218,CHEMBL627712,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9431,,4723,,,BAO_0000218,CHEMBL627713,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9432,,4723,,,BAO_0000218,CHEMBL627714,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9541.0,0,,1,9433,,4256,,,BAO_0000218,CHEMBL627889,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,In vivo,U,,,22224,Macaca fascicularis,Intermediate
,,,A,10116.0,0,,1,9434,,4256,,,BAO_0000218,CHEMBL627890,Half life determined in rat by intravenous administration,In vivo,U,,,22224,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9435,,4722,,,BAO_0000218,CHEMBL627891,Half life determined in rats after iv administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9436,,6535,,,BAO_0000218,CHEMBL627892,Half life in rat plasma after administration of 2 mg/kg iv,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9437,,6535,,,BAO_0000218,CHEMBL627893,Half life in rat plasma after administration of 2 mg/kg iv,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9438,,1435,,,BAO_0000218,CHEMBL627894,Half life in rat plasma was determined,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9439,,1435,,,BAO_0000218,CHEMBL627895,Half life in rat plasma was determined; NA means not applicable,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9440,,5206,,,BAO_0000218,CHEMBL627896,Half life in rat was tested,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9441,,6080,,,BAO_0000218,CHEMBL627897,Half life measured in rat plasma,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9442,,4449,,,BAO_0000218,CHEMBL627898,Half life recorded in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9443,,6057,,,BAO_0000218,CHEMBL627899,Half life was calculated,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9444,,6057,,,BAO_0000218,CHEMBL873823,Half life was calculated in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9445,,3747,,,BAO_0000218,CHEMBL627900,Half life was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9446,,17858,,,BAO_0000218,CHEMBL627901,Half life after 10 mg/kg oral administration in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9447,,16365,,,BAO_0000218,CHEMBL627902,Half life after administering orally a dose of 10 mg/kg to a fasting rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9448,,16365,,,BAO_0000218,CHEMBL627903,Half life after administering orally a dose of 30 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9449,,5031,,,BAO_0000218,CHEMBL627904,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9450,,4722,,,BAO_0000218,CHEMBL627905,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9451,,6078,,,BAO_0000218,CHEMBL627906,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9452,,6078,,,BAO_0000218,CHEMBL627907,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9453,,6078,,,BAO_0000218,CHEMBL876783,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9454,,6078,,,BAO_0000218,CHEMBL627908,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9455,,17065,,,BAO_0000218,CHEMBL627909,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9456,,1353,,,BAO_0000218,CHEMBL627910,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9457,,1353,,,BAO_0000218,CHEMBL627911,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9458,,1353,,,BAO_0000218,CHEMBL627912,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9459,,1353,,,BAO_0000218,CHEMBL627913,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9460,,1353,,,BAO_0000218,CHEMBL627914,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9461,,16423,,,BAO_0000218,CHEMBL627915,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9462,,16423,,,BAO_0000218,CHEMBL627916,Area under the curve was evaluated after 20 uM/kg of peroral administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9463,,6062,,,BAO_0000218,CHEMBL627917,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9464,,6056,,,BAO_0000218,CHEMBL627918,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9465,,5182,,,BAO_0000218,CHEMBL627919,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9466,,6410,,,BAO_0000218,CHEMBL627920,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9467,,6410,,,BAO_0000218,CHEMBL627921,Area under the curve was evaluated at an oral dose of 30 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9468,,4723,,,BAO_0000218,CHEMBL627922,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9469,,4723,,,BAO_0000218,CHEMBL876784,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9470,,4723,,,BAO_0000218,CHEMBL627923,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9471,,4723,,,BAO_0000218,CHEMBL626208,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9472,,4723,,,BAO_0000218,CHEMBL626209,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9473,,4723,,,BAO_0000218,CHEMBL626210,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9474,,2463,,,BAO_0000218,CHEMBL627994,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9475,,4709,,,BAO_0000218,CHEMBL627995,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9476,,4075,,,BAO_0000218,CHEMBL627996,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9477,,5394,,,BAO_0000218,CHEMBL627997,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9478,,2661,,,BAO_0000218,CHEMBL627998,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9479,,2661,,,BAO_0000218,CHEMBL628640,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9480,,2661,,,BAO_0000218,CHEMBL628641,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9481,,2661,,,BAO_0000218,CHEMBL628642,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9482,,17791,,,BAO_0000218,CHEMBL628643,Compound was evaluated for area under the curve expressed as (h*ug/ml),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9483,,2591,,,BAO_0000218,CHEMBL628644,Compound was tested for area under curve in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9484,,6567,,,BAO_0000218,CHEMBL628645,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9485,,6211,,,BAO_0000218,CHEMBL628646,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9486,,5529,,,BAO_0000218,CHEMBL628647,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9487,,5408,,,BAO_0000218,CHEMBL628648,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9488,,5408,,,BAO_0000218,CHEMBL625358,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9489,,5408,,,BAO_0000218,CHEMBL625359,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9490,,5408,,,BAO_0000218,CHEMBL625360,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9491,,429,,,BAO_0000218,CHEMBL625361,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9492,,429,,,BAO_0000218,CHEMBL625362,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9493,,429,,,BAO_0000218,CHEMBL625363,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9494,,4796,,,BAO_0000218,CHEMBL625364,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9495,,5974,,,BAO_0000218,CHEMBL625365,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9496,,5974,,,BAO_0000218,CHEMBL625366,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9497,,5974,,,BAO_0000218,CHEMBL625367,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9498,,11450,,,BAO_0000218,CHEMBL625368,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9499,,11450,,,BAO_0000218,CHEMBL625369,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9500,,11450,,,BAO_0000218,CHEMBL625370,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9501,,11450,,,BAO_0000218,CHEMBL625371,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9502,,11450,,,BAO_0000218,CHEMBL625372,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9503,,11450,,,BAO_0000218,CHEMBL625373,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9504,,11450,,,BAO_0000218,CHEMBL625374,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9505,,11450,,,BAO_0000218,CHEMBL877593,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9506,,11450,,,BAO_0000218,CHEMBL625375,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9507,,11450,,,BAO_0000218,CHEMBL625376,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9508,,11450,,,BAO_0000218,CHEMBL621973,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9509,,11450,,,BAO_0000218,CHEMBL621974,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9510,,11450,,,BAO_0000218,CHEMBL621975,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9511,,11450,,,BAO_0000218,CHEMBL622166,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9512,,11450,,,BAO_0000218,CHEMBL622167,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9513,,11450,,,BAO_0000218,CHEMBL622168,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9514,,11450,,,BAO_0000218,CHEMBL622169,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9515,,11450,,,BAO_0000218,CHEMBL622170,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9516,,11450,,,BAO_0000218,CHEMBL622171,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9517,,11450,,,BAO_0000218,CHEMBL622172,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9518,,11450,,,BAO_0000218,CHEMBL622173,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9519,,11450,,,BAO_0000218,CHEMBL622174,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9520,,11450,,,BAO_0000218,CHEMBL622175,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9521,,11450,,,BAO_0000218,CHEMBL622176,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9522,,11450,,,BAO_0000218,CHEMBL622177,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9523,,11450,,,BAO_0000218,CHEMBL622178,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9524,,11450,,,BAO_0000218,CHEMBL622179,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9525,,11450,,,BAO_0000218,CHEMBL622180,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9526,,16435,,,BAO_0000218,CHEMBL622181,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9527,,16435,,,BAO_0000218,CHEMBL622182,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9528,,16435,,,BAO_0000218,CHEMBL622183,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9529,,16435,,,BAO_0000218,CHEMBL622184,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9530,,16435,,,BAO_0000218,CHEMBL622185,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9531,,16435,,,BAO_0000218,CHEMBL622186,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9532,,16434,,,BAO_0000218,CHEMBL622187,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9533,,16434,,,BAO_0000218,CHEMBL625002,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9534,,16434,,,BAO_0000218,CHEMBL622090,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9535,,16435,,,BAO_0000218,CHEMBL622091,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9536,,16435,,,BAO_0000218,CHEMBL622092,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9537,,16435,,,BAO_0000218,CHEMBL622093,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9538,,16435,,,BAO_0000218,CHEMBL622094,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9539,,16435,,,BAO_0000218,CHEMBL622095,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9540,,16435,,,BAO_0000218,CHEMBL622264,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9541,,16434,,,BAO_0000218,CHEMBL622265,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9542,,16434,,,BAO_0000218,CHEMBL622266,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9543,,16434,,,BAO_0000218,CHEMBL622267,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9544,,16434,,,BAO_0000218,CHEMBL622268,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9545,,16434,,,BAO_0000218,CHEMBL622269,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9546,,16434,,,BAO_0000218,CHEMBL625071,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9547,,16434,,,BAO_0000218,CHEMBL621621,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9548,,16434,,,BAO_0000218,CHEMBL621622,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9549,,16435,,,BAO_0000218,CHEMBL621623,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9550,,16435,,,BAO_0000218,CHEMBL621624,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9551,,16435,,,BAO_0000218,CHEMBL621625,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9552,,16435,,,BAO_0000218,CHEMBL621626,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9553,,16435,,,BAO_0000218,CHEMBL621627,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9554,,16435,,,BAO_0000218,CHEMBL621628,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9555,,16435,,,BAO_0000218,CHEMBL875328,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9556,,16435,,,BAO_0000218,CHEMBL621629,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9557,,16434,,,BAO_0000218,CHEMBL621630,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9558,,16434,,,BAO_0000218,CHEMBL621631,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9559,,16434,,,BAO_0000218,CHEMBL621632,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9560,,16435,,,BAO_0000218,CHEMBL621633,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9561,,16435,,,BAO_0000218,CHEMBL621634,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9562,,16435,,,BAO_0000218,CHEMBL621635,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9563,,16435,,,BAO_0000218,CHEMBL621636,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9564,,16435,,,BAO_0000218,CHEMBL621637,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9565,,16435,,,BAO_0000218,CHEMBL621638,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9566,,16434,,,BAO_0000218,CHEMBL618883,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9567,,16434,,,BAO_0000218,CHEMBL618884,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9568,,16434,,,BAO_0000218,CHEMBL628627,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9569,,16434,,,BAO_0000218,CHEMBL628628,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9570,,16434,,,BAO_0000218,CHEMBL628629,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9571,,16365,,,BAO_0000218,CHEMBL628630,Half life after administering orally a dose of 3 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9572,,16365,,,BAO_0000218,CHEMBL628631,Half life after administering orally a dose of 3 mg/kg to a fasting rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9573,,16365,,,BAO_0000218,CHEMBL628632,Half life after administering intravenously a dose of 1 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9574,,526,,,BAO_0000218,CHEMBL628633,Half life after oral dosing in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9575,,16365,,,BAO_0000218,CHEMBL628634,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9576,,4368,,,BAO_0000218,CHEMBL627789,Half life by intravenous administration of 3.4 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9577,,3371,,,BAO_0000218,CHEMBL627790,Half life in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9578,,6448,,,BAO_0000218,CHEMBL627791,Half life in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9579,,6453,,,BAO_0000218,CHEMBL627792,Half life in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9580,,4353,,,BAO_0000218,CHEMBL627793,Half life in rat after intravenous administration of the compound,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9581,,4353,,,BAO_0000218,CHEMBL627794,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9582,,4353,,,BAO_0000218,CHEMBL627795,Half life in rat after po administration of the compound,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9583,,4353,,,BAO_0000218,CHEMBL627796,Half life in rat after po administration of the compound; ND means Not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9584,,4353,,,BAO_0000218,CHEMBL875335,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9585,,4353,,,BAO_0000218,CHEMBL627797,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9586,,5789,,,BAO_0000218,CHEMBL627798,Half life in rat i.v.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9587,,17686,,,BAO_0000218,CHEMBL627799,Half life in rat i.v. at 2 mg/kg concentration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9588,,6495,,,BAO_0000218,CHEMBL627800,Half life in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9589,,484,,,BAO_0000218,CHEMBL627801,Half life in rats after intravenous administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9590,,6467,,,BAO_0000218,CHEMBL627802,Half life in rats at the dose of 1.0 mpk by i.v. administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9591,,6642,,,BAO_0000218,CHEMBL627803,Half life in rat,,N,,,50597,Rattus norvegicus,Expert
,,,A,10116.0,1,,1,9592,,16367,,,BAO_0000218,CHEMBL873820,Half life was evaluated after intravenous administration to rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9593,,1369,,,BAO_0000218,CHEMBL627804,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9594,,5472,,,BAO_0000218,CHEMBL627805,Half life was evaluated in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9595,,6049,,,BAO_0000218,CHEMBL627806,Half life was evaluated in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9596,,5472,,,BAO_0000218,CHEMBL627107,Half life was evaluated in rat; Not tested,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9597,,16366,,,BAO_0000218,CHEMBL627108,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9598,,11149,,,BAO_0000218,CHEMBL627109,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9599,,11149,,,BAO_0000218,CHEMBL627110,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,9443.0,0,,1,9600,,2891,,,BAO_0000218,CHEMBL627111,Half life was measured in monkey at dose of 10 mg/kg by po administration,In vivo,U,,,22224,Primates,Intermediate
,,,A,9443.0,0,,1,9601,,2891,,,BAO_0000218,CHEMBL627112,Half life was measured in monkey at dose of 10 mg/kg by po administration,In vivo,U,,,22224,Primates,Intermediate
,,,A,10116.0,0,,1,9602,,2891,,,BAO_0000218,CHEMBL627113,Half life was measured in rat at dose of 30 mg/kg by iv administration,In vivo,U,,,22224,Rattus norvegicus,Intermediate
,,,A,10116.0,0,,1,9603,,2891,,,BAO_0000218,CHEMBL627114,Half life was measured in rat at dose of 30 mg/kg by po administration,In vivo,U,,,22224,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9604,,4026,,,BAO_0000218,CHEMBL627115,Half life (t1/2) was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9605,,4527,,,BAO_0000218,CHEMBL627116,Half life period at a dose of 10 uM/kg in rat was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9606,,4527,,,BAO_0000218,CHEMBL627117,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9607,,5503,,,BAO_0000218,CHEMBL627118,Half life period was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9608,,4426,,,BAO_0000218,CHEMBL627119,Half life period after intravenous administration at 20 mpk in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9609,,4426,,,BAO_0000218,CHEMBL627120,Half life period after intravenous administration at 20 mpk in rats; Not performed.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9610,,6109,,,BAO_0000218,CHEMBL626922,Half life period after intravenous administration in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9611,,5654,,,BAO_0000218,CHEMBL626923,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9612,,5654,,,BAO_0000218,CHEMBL626924,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9613,,4755,,,BAO_0000218,CHEMBL626925,Half life period in 80% rat plasma at 37 degree Centigrade,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9614,,5862,,,BAO_0000218,CHEMBL626926,Half life period in SD rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9615,,1515,,,BAO_0000218,CHEMBL626927,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9616,,1515,,,BAO_0000218,CHEMBL626928,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9617,,1515,,,BAO_0000218,CHEMBL626929,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9618,,1515,,,BAO_0000218,CHEMBL626930,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9619,,5960,,,BAO_0000218,CHEMBL626931,Half life period in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9620,,6103,,,BAO_0000218,CHEMBL626932,Half life period in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9621,,6317,,,BAO_0000218,CHEMBL626933,Half life period in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9622,,6644,,,BAO_0000218,CHEMBL873826,Half life period in rat after oral administration at 10.5 mg/kg dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9623,,6644,,,BAO_0000218,CHEMBL626934,Half life period in rat after oral administration at 11.2 mg/kg dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9624,,6644,,,BAO_0000218,CHEMBL626935,Half life period in rat after oral administration at 13 mg/kg dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9625,,6644,,,BAO_0000218,CHEMBL626936,Half life period in rat after oral administration at 9.7 mg/kg dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9626,,5974,,,BAO_0000218,CHEMBL626937,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9627,,6295,,,BAO_0000218,CHEMBL625906,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9628,,6296,,,BAO_0000218,CHEMBL625907,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9629,,16427,,,BAO_0000218,CHEMBL625908,PK study was carried to determine AUC (area under curve) value in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9630,,16367,,,BAO_0000218,CHEMBL625909,Pharmacokinetic parameter AUC after intravenous administration to rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9631,,16367,,,BAO_0000218,CHEMBL625910,Pharmacokinetic parameter AUC after oral administration to rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9632,,16365,,,BAO_0000218,CHEMBL625911,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9633,,16365,,,BAO_0000218,CHEMBL625912,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9634,,16365,,,BAO_0000218,CHEMBL626538,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9635,,16365,,,BAO_0000218,CHEMBL876794,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9636,,16365,,,BAO_0000218,CHEMBL626539,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9637,,16365,,,BAO_0000218,CHEMBL626540,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9638,,5394,,,BAO_0000218,CHEMBL626541,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9639,,5394,,,BAO_0000218,CHEMBL626542,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9640,,2792,,,BAO_0000218,CHEMBL626543,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9641,,2792,,,BAO_0000218,CHEMBL626544,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9642,,2792,,,BAO_0000218,CHEMBL626545,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9643,,2792,,,BAO_0000218,CHEMBL626546,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9644,,5334,,,BAO_0000218,CHEMBL626547,Pharmacokinetic parameter area under curve was reported,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9645,,4408,,,BAO_0000218,CHEMBL626548,Pharmacokinetic property (AUC) in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9646,,5983,,,BAO_0000218,CHEMBL626549,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9647,,4397,,,BAO_0000218,CHEMBL626550,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9648,,4397,,,BAO_0000218,CHEMBL626551,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9649,,5491,,,BAO_0000218,CHEMBL623777,Pharmacokinetic property was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9650,,5491,,,BAO_0000218,CHEMBL623778,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9651,,5491,,,BAO_0000218,CHEMBL623779,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9652,,4199,,,BAO_0000218,CHEMBL623780,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9653,,4199,,,BAO_0000218,CHEMBL622015,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9654,,4199,,,BAO_0000218,CHEMBL622016,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9655,,5173,,,BAO_0000218,CHEMBL622017,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9656,,5173,,,BAO_0000218,CHEMBL622018,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9657,,5173,,,BAO_0000218,CHEMBL622019,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9658,,5173,,,BAO_0000218,CHEMBL622020,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9659,,16366,,,BAO_0000218,CHEMBL622021,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9660,,16366,,,BAO_0000218,CHEMBL622022,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9661,,5327,,,BAO_0000218,CHEMBL622023,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9662,,6681,,,BAO_0000218,CHEMBL622024,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9663,,12873,,,BAO_0000218,CHEMBL622693,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9664,,12873,,,BAO_0000218,CHEMBL622694,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9665,,6685,,,BAO_0000218,CHEMBL622695,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9666,,6685,,,BAO_0000218,CHEMBL622696,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9667,,6685,,,BAO_0000218,CHEMBL622697,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9668,,6619,,,BAO_0000218,CHEMBL622874,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9669,,6619,,,BAO_0000218,CHEMBL622875,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9670,,10363,,,BAO_0000218,CHEMBL622876,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9671,,4796,,,BAO_0000218,CHEMBL622877,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9672,,4910,,,BAO_0000218,CHEMBL622878,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9673,,4910,,,BAO_0000218,CHEMBL622879,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9674,,4839,,,BAO_0000218,CHEMBL877602,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9675,,15078,,,BAO_0000218,CHEMBL622880,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9676,,15078,,,BAO_0000218,CHEMBL622881,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9677,,15078,,,BAO_0000218,CHEMBL622882,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9678,,15078,,,BAO_0000218,CHEMBL622883,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9679,,11450,,,BAO_0000218,CHEMBL622884,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9680,,11450,,,BAO_0000218,CHEMBL622885,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9681,,8151,,,BAO_0000218,CHEMBL622886,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9682,,8151,,,BAO_0000218,CHEMBL622887,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9683,,8151,,,BAO_0000218,CHEMBL622888,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9684,,8677,,,BAO_0000218,CHEMBL622889,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9685,,8677,,,BAO_0000218,CHEMBL622890,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9686,,8677,,,BAO_0000218,CHEMBL622891,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9687,,8677,,,BAO_0000218,CHEMBL877603,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9688,,8677,,,BAO_0000218,CHEMBL622892,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9689,,8677,,,BAO_0000218,CHEMBL622893,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9690,,8677,,,BAO_0000218,CHEMBL622894,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9691,,8677,,,BAO_0000218,CHEMBL622895,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9692,,8677,,,BAO_0000218,CHEMBL622896,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9693,,8677,,,BAO_0000218,CHEMBL622897,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9694,,8677,,,BAO_0000218,CHEMBL622898,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9695,,8677,,,BAO_0000218,CHEMBL622899,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9696,,8677,,,BAO_0000218,CHEMBL622900,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9697,,8677,,,BAO_0000218,CHEMBL624114,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9698,,8677,,,BAO_0000218,CHEMBL624115,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9699,,8677,,,BAO_0000218,CHEMBL624116,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9700,,8677,,,BAO_0000218,CHEMBL624117,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9701,,8677,,,BAO_0000218,CHEMBL624118,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9702,,8677,,,BAO_0000218,CHEMBL624119,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9703,,8677,,,BAO_0000218,CHEMBL624120,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9704,,8677,,,BAO_0000218,CHEMBL624121,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9705,,8677,,,BAO_0000218,CHEMBL624122,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9706,,8677,,,BAO_0000218,CHEMBL624123,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9707,,8677,,,BAO_0000218,CHEMBL624124,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9708,,8677,,,BAO_0000218,CHEMBL624125,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9709,,8677,,,BAO_0000218,CHEMBL624126,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9710,,8677,,,BAO_0000218,CHEMBL624127,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9711,,8677,,,BAO_0000218,CHEMBL624128,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9712,,8677,,,BAO_0000218,CHEMBL624129,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,14.0,Zone of skin,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9713,,8677,,,BAO_0000218,CHEMBL624130,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,14.0,Zone of skin,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9714,,8677,,,BAO_0000218,CHEMBL622340,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,14.0,Zone of skin,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9715,,8677,,,BAO_0000218,CHEMBL622341,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,14.0,Zone of skin,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9716,,8677,,,BAO_0000218,CHEMBL622342,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9717,,8677,,,BAO_0000218,CHEMBL622343,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9718,,8677,,,BAO_0000218,CHEMBL622344,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9719,,8677,,,BAO_0000218,CHEMBL622345,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9720,,8677,,,BAO_0000218,CHEMBL622346,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9721,,8677,,,BAO_0000218,CHEMBL622347,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9722,,8677,,,BAO_0000218,CHEMBL622348,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9723,,8677,,,BAO_0000218,CHEMBL622349,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9724,,16434,,,BAO_0000218,CHEMBL622350,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9725,,16434,,,BAO_0000218,CHEMBL622351,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9726,,16434,,,BAO_0000218,CHEMBL622352,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9727,,16435,,,BAO_0000218,CHEMBL622353,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9728,,16435,,,BAO_0000218,CHEMBL622354,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9729,,16435,,,BAO_0000218,CHEMBL622355,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9730,,16435,,,BAO_0000218,CHEMBL622356,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9731,,16435,,,BAO_0000218,CHEMBL622357,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9732,,16435,,,BAO_0000218,CHEMBL622358,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9733,,16435,,,BAO_0000218,CHEMBL622359,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9734,,16435,,,BAO_0000218,CHEMBL874393,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9735,,16434,,,BAO_0000218,CHEMBL622872,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9736,,16434,,,BAO_0000218,CHEMBL622873,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9737,,16434,,,BAO_0000218,CHEMBL623047,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9738,,16435,,,BAO_0000218,CHEMBL623048,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9739,,16435,,,BAO_0000218,CHEMBL623049,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9740,,16435,,,BAO_0000218,CHEMBL623050,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9741,,16435,,,BAO_0000218,CHEMBL623051,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9742,,16435,,,BAO_0000218,CHEMBL623052,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9743,,16435,,,BAO_0000218,CHEMBL626343,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9744,,16434,,,BAO_0000218,CHEMBL626344,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9745,,16434,,,BAO_0000218,CHEMBL626345,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9746,,16434,,,BAO_0000218,CHEMBL626346,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9747,,16434,,,BAO_0000218,CHEMBL626347,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9748,,16434,,,BAO_0000218,CHEMBL626348,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9749,,16434,,,BAO_0000218,CHEMBL626349,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,9750,,16435,,,BAO_0000218,CHEMBL626350,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9751,,16435,,,BAO_0000218,CHEMBL626351,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9752,,16435,,,BAO_0000218,CHEMBL627650,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,9753,,16435,,,BAO_0000218,CHEMBL627651,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9754,,16435,,,BAO_0000218,CHEMBL627652,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9755,,16435,,,BAO_0000218,CHEMBL627653,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9756,,13091,,,BAO_0000218,CHEMBL627654,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9757,,13091,,,BAO_0000218,CHEMBL627835,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9758,,13091,,,BAO_0000218,CHEMBL627836,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9759,,13091,,,BAO_0000218,CHEMBL627837,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9760,,13091,,,BAO_0000218,CHEMBL627838,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9761,,13091,,,BAO_0000218,CHEMBL875338,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9762,,13091,,,BAO_0000218,CHEMBL627839,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9763,,13091,,,BAO_0000218,CHEMBL627840,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9764,,13091,,,BAO_0000218,CHEMBL627841,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9765,,13091,,,BAO_0000218,CHEMBL627842,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9766,,13091,,,BAO_0000218,CHEMBL627843,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9767,,13091,,,BAO_0000218,CHEMBL627844,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9768,,13091,,,BAO_0000218,CHEMBL627845,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9769,,5874,,,BAO_0000218,CHEMBL627846,Half life period in rat by iv administration at a dose of 3 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9770,,1515,,,BAO_0000218,CHEMBL627847,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9771,,1515,,,BAO_0000218,CHEMBL873821,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9772,,1515,,,BAO_0000218,CHEMBL626079,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9773,,1515,,,BAO_0000218,CHEMBL626080,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9774,,5491,,,BAO_0000218,CHEMBL626081,Half life period was evaluated in rat plasma,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9775,,5491,,,BAO_0000218,CHEMBL875344,Half life period was evaluated in rat plasma; Not tested,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9776,,1918,,,BAO_0000218,CHEMBL626082,Half life period was evaluated in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9777,,1918,,,BAO_0000218,CHEMBL626250,"Half life period was evaluated in rats, iv",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9778,,6113,,,BAO_0000218,CHEMBL626251,Half life period after intravenous administration at 5 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9779,,5546,,,BAO_0000218,CHEMBL626252,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9780,,5553,,,BAO_0000218,CHEMBL626253,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9781,,4188,,,BAO_0000218,CHEMBL626254,Half life stability of compound was evaluated in rat plasma,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9782,,6215,,,BAO_0000218,CHEMBL626255,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9783,,6141,,,BAO_0000218,CHEMBL626256,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9784,,5182,,,BAO_0000218,CHEMBL626257,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9785,,5182,,,BAO_0000218,CHEMBL626258,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9786,,5710,,,BAO_0000218,CHEMBL626259,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9787,,5789,,,BAO_0000218,CHEMBL626260,Half in rat i.v.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9788,,6011,,,BAO_0000218,CHEMBL875345,Half period in rat after intravenous administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9789,,17594,,,BAO_0000218,CHEMBL626261,Half-life after repeated oral dose of compound at 1 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9790,,12357,,,BAO_0000218,CHEMBL626262,Half-life measured in in vitro Cathepsin B assay in rat liver,In vitro,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9791,,5210,,,BAO_0000218,CHEMBL626263,Half-life of compound was determined in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9792,,17596,,,BAO_0000218,CHEMBL625270,Half-life at 10 mg/kg in rat upon intravenous administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9793,,6672,,,BAO_0000218,CHEMBL625271,Half-life determined in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9794,,6673,,,BAO_0000218,CHEMBL625272,Half-life determined in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9795,,4910,,,BAO_0000218,CHEMBL625273,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9796,,3741,,,BAO_0000218,CHEMBL625274,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9797,,17671,,,BAO_0000218,CHEMBL625275,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9798,,4910,,,BAO_0000218,CHEMBL625276,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9799,,17537,,,BAO_0000218,CHEMBL625277,Half-life in rat plasma,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9800,,4965,,,BAO_0000218,CHEMBL625278,Half-life in rat plasma was determined,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9801,,17537,,,BAO_0000218,CHEMBL625279,Half-life in rat plasma; Not tested,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9802,,6124,,,BAO_0000218,CHEMBL625280,Half-life in rat serum,,N,1977.0,Serum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9803,,6124,,,BAO_0000218,CHEMBL876797,Half-life in rat serum; na is not available,,N,1977.0,Serum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9804,,6078,,,BAO_0000218,CHEMBL625281,Half-life was calculated in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9805,,17668,,,BAO_0000218,CHEMBL873827,Half-life was calculated in rat plasma,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9806,,3185,,,BAO_0000218,CHEMBL625282,Half-life was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9807,,4883,,,BAO_0000218,CHEMBL625283,Half-life was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9808,,2959,,,BAO_0000218,CHEMBL625284,Half-life after administration of 20 mg/Kg oral dose in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9809,,4029,,,BAO_0000218,CHEMBL625285,Half-life after administration of 3.2 mg/kg intravenously in male rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9810,,4029,,,BAO_0000218,CHEMBL625286,Half-life after intravenous administration in female rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9811,,4029,,,BAO_0000218,CHEMBL625287,Half-life after intravenous administration in male rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9812,,6180,,,BAO_0000218,CHEMBL625288,Half-life after intravenous dose in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9813,,1557,,,BAO_0000218,CHEMBL625289,Half-life in a rat liver homogenate preparation,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9814,,12500,,,BAO_0000218,CHEMBL625290,Half-life in plasma of rat,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9815,,12500,,,BAO_0000218,CHEMBL876798,Half-life in plasma of rat at dose of 3-10 mgkg,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9816,,5064,,,BAO_0000218,CHEMBL625291,Half-life in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9817,,5145,,,BAO_0000218,CHEMBL625292,Half-life in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9818,,5147,,,BAO_0000218,CHEMBL625293,Half-life in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9819,,5833,,,BAO_0000218,CHEMBL622832,Half-life in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9820,,6596,,,BAO_0000218,CHEMBL622833,Half-life in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9821,,17655,,,BAO_0000218,CHEMBL622834,Half-life in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9822,,6495,,,BAO_0000218,CHEMBL622835,Half-life in rat after oral administration at 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9823,,17538,,,BAO_0000218,CHEMBL622836,Half-life in rat after po administration at a dose of 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9824,,17538,,,BAO_0000218,CHEMBL622837,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9825,,10,,,BAO_0000218,CHEMBL622838,Half-life in rat at 3 mg/kg dose administered intravenously,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9826,,17669,,,BAO_0000218,CHEMBL622839,Half-life in rat brain homogenate,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9827,,17065,,,BAO_0000218,CHEMBL622840,Half-life in rat plasma,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9828,,4333,,,BAO_0000218,CHEMBL622841,Half-life in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9829,,6827,,,BAO_0000218,CHEMBL622842,Half-life in Dawley rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9830,,889,,,BAO_0000218,CHEMBL622843,Half-life in vitro in rat plasma,In vitro,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9831,,889,,,BAO_0000218,CHEMBL622844,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,In vitro,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9832,,3747,,,BAO_0000218,CHEMBL622845,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9833,,15022,,,BAO_0000218,CHEMBL622846,The area under the curve of compound was measured at the dose of 100 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9834,,15022,,,BAO_0000218,CHEMBL622847,The area under the curve of compound was measured at the dose of 300 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9835,,15022,,,BAO_0000218,CHEMBL622848,The area under the curve of compound was measured at the dose of 30 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9836,,3360,,,BAO_0000218,CHEMBL622849,Bioavailability as oral AUC in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9837,,5334,,,BAO_0000218,CHEMBL622850,The plasma concentration versus time curve (AUC) was determined,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9838,,17411,,,BAO_0000218,CHEMBL876807,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9839,,17411,,,BAO_0000218,CHEMBL622851,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9840,,17411,,,BAO_0000218,CHEMBL622852,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9841,,6570,,,BAO_0000218,CHEMBL622853,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9842,,6570,,,BAO_0000218,CHEMBL622854,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9843,,17411,,,BAO_0000218,CHEMBL622855,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9844,,14941,,,BAO_0000218,CHEMBL622856,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9845,,14941,,,BAO_0000218,CHEMBL622857,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9846,,17538,,,BAO_0000218,CHEMBL622858,AUC in rat after po administration at a dose of 10 mg/kg,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9847,,17752,,,BAO_0000218,CHEMBL622859,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9848,,17509,,,BAO_0000218,CHEMBL622860,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9849,,17509,,,BAO_0000218,CHEMBL622861,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9850,,17509,,,BAO_0000218,CHEMBL622862,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9851,,17509,,,BAO_0000218,CHEMBL622863,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9852,,17509,,,BAO_0000218,CHEMBL623817,Area under curve value 6 hr after po administration in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9853,,17717,,,BAO_0000218,CHEMBL623818,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9854,,17717,,,BAO_0000218,CHEMBL623819,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9855,,17717,,,BAO_0000218,CHEMBL623820,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9856,,17717,,,BAO_0000218,CHEMBL623821,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9857,,6642,,,BAO_0000218,CHEMBL623822,AUC normalized for dose (AUCN) in rat,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9858,,6640,,,BAO_0000218,CHEMBL623823,Area under curve in rat after p.o. administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9859,,6641,,,BAO_0000218,CHEMBL623824,Area under curve in rat after p.o. administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9860,,6641,,,BAO_0000218,CHEMBL623825,Area under curve in rat after p.o. administration; Not determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9861,,6641,,,BAO_0000218,CHEMBL622070,Area under curve in rat after peroral administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9862,,3603,,,BAO_0000218,CHEMBL622071,Area under curve (carotid artery) value of the compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9863,,3550,,,BAO_0000218,CHEMBL622072,Bioavailability expressed as the area under curve of rat carotid artery,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9864,,15662,,,BAO_0000218,CHEMBL622073,Area under curve in male SD rats was observed after intravenous administration in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9865,,17720,,,BAO_0000218,CHEMBL622074,Area under curve of the compound was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9866,,5407,,,BAO_0000218,CHEMBL622075,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9867,,17752,,,BAO_0000218,CHEMBL622076,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9868,,17752,,,BAO_0000218,CHEMBL622077,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9869,,3603,,,BAO_0000218,CHEMBL622078,Area under curve (portal vein) value of the compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9870,,3550,,,BAO_0000218,CHEMBL622079,Bioavailability expressed as the area under curve of rat portal vein,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9871,,17655,,,BAO_0000218,CHEMBL622080,Area Under plasma concentration time curve in rat upon peroral administration,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9872,,17582,,,BAO_0000218,CHEMBL877612,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9873,,17582,,,BAO_0000218,CHEMBL622081,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9874,,17791,,,BAO_0000218,CHEMBL622082,Compound was evaluated for oral bioavailability in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9875,,17791,,,BAO_0000218,CHEMBL622083,Compound was evaluated for oral bioavailability in rats after iv administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9876,,17791,,,BAO_0000218,CHEMBL622084,Compound was evaluated for oral bioavailability in rats; 30-80,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9877,,17791,,,BAO_0000218,CHEMBL622085,Compound was evaluated for oral bioavailability in rats; 50-60,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9878,,17791,,,BAO_0000218,CHEMBL622086,Compound was evaluated for oral bioavailability in rats; no data,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9879,,17791,,,BAO_0000218,CHEMBL622087,Compound was evaluated for oral bioavailability in rats; peptide,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9880,,7768,,,BAO_0000218,CHEMBL622088,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9881,,7768,,,BAO_0000218,CHEMBL622089,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9882,,7768,,,BAO_0000218,CHEMBL623685,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9883,,7768,,,BAO_0000218,CHEMBL623686,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9884,,8677,,,BAO_0000218,CHEMBL623687,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,945.0,Stomach,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9885,,8677,,,BAO_0000218,CHEMBL623688,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,945.0,Stomach,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9886,,8677,,,BAO_0000218,CHEMBL623689,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,945.0,Stomach,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9887,,8677,,,BAO_0000218,CHEMBL622485,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,945.0,Stomach,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9888,,8677,,,BAO_0000218,CHEMBL622486,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9889,,8677,,,BAO_0000218,CHEMBL877613,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9890,,8677,,,BAO_0000218,CHEMBL622487,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9891,,8677,,,BAO_0000218,CHEMBL622488,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9892,,8677,,,BAO_0000218,CHEMBL622489,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9893,,6899,,,BAO_0000218,CHEMBL622490,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9894,,6899,,,BAO_0000218,CHEMBL622491,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9895,,6899,,,BAO_0000218,CHEMBL622492,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9896,,6899,,,BAO_0000218,CHEMBL622493,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9897,,6899,,,BAO_0000218,CHEMBL622494,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9898,,8677,,,BAO_0000218,CHEMBL622495,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9899,,6899,,,BAO_0000218,CHEMBL622496,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9900,,6899,,,BAO_0000218,CHEMBL622497,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9901,,2189,,,BAO_0000218,CHEMBL622498,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9902,,2189,,,BAO_0000218,CHEMBL624918,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9903,,2189,,,BAO_0000218,CHEMBL624919,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9904,,10839,,,BAO_0000218,CHEMBL624920,Biodistribution of compound in rat blood after 5 min of administration,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9905,,10839,,,BAO_0000218,CHEMBL624921,Biodistribution of compound in rat blood after 5 min of administration.,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9906,,10839,,,BAO_0000218,CHEMBL624922,Biodistribution of compound in rat brain after 5 min of administration,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9907,,10839,,,BAO_0000218,CHEMBL624923,Biodistribution of compound in rat heart after 5 min of administration,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9908,,10839,,,BAO_0000218,CHEMBL624924,Biodistribution of compound in rat heart after 5 min of administration.,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9909,,10839,,,BAO_0000218,CHEMBL624925,Biodistribution of compound in rat kidney after 5 min of administration,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9910,,10839,,,BAO_0000218,CHEMBL624926,Biodistribution of compound in rat kidney after 5 min of administration.,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9911,,10839,,,BAO_0000218,CHEMBL624927,Biodistribution of compound in rat liver after 5 min of administration,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9912,,10839,,,BAO_0000218,CHEMBL874402,Biodistribution of compound in rat liver after 5 min of administration.,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9913,,10839,,,BAO_0000218,CHEMBL624928,Biodistribution of compound in rat lung after 5 min of administration,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9914,,10839,,,BAO_0000218,CHEMBL624929,Biodistribution of compound in rat lung after 5 min of administration.,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9915,,10839,,,BAO_0000218,CHEMBL624930,Biodistribution of compound in rat muscle after 5 min of administration,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9916,,10839,,,BAO_0000218,CHEMBL624931,Biodistribution of compound in rat muscle after 5 min of administration.,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9917,,4043,,,BAO_0000218,CHEMBL624932,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9918,,4043,,,BAO_0000218,CHEMBL624933,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9919,,4043,,,BAO_0000218,CHEMBL624934,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9920,,4043,,,BAO_0000218,CHEMBL624935,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9921,,4043,,,BAO_0000218,CHEMBL624936,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9922,,4043,,,BAO_0000218,CHEMBL624937,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9923,,4043,,,BAO_0000218,CHEMBL624938,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9924,,4043,,,BAO_0000218,CHEMBL624939,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9925,,4043,,,BAO_0000218,CHEMBL624940,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9926,,4043,,,BAO_0000218,CHEMBL874403,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9927,,1446,,,BAO_0000218,CHEMBL624941,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9928,,9971,,,BAO_0000218,CHEMBL624942,Dose required to lower urine osmolality to 300 mOsm/kg in rat,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9929,,9971,,,BAO_0000218,CHEMBL624943,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9930,,5765,,,BAO_0000218,CHEMBL624944,% Bioavailability after 1 day of the drug administration in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9931,,5765,,,BAO_0000218,CHEMBL624945,% Bioavailability after 4 day of the drug administration in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9932,,4257,,,BAO_0000218,CHEMBL624946,Absolute bioavailability was evaluated in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9933,,13091,,,BAO_0000218,CHEMBL624947,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9934,,13091,,,BAO_0000218,CHEMBL624948,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9935,,13091,,,BAO_0000218,CHEMBL624949,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9936,,13091,,,BAO_0000218,CHEMBL622025,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9937,,13091,,,BAO_0000218,CHEMBL622026,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9938,,13091,,,BAO_0000218,CHEMBL622027,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9939,,13091,,,BAO_0000218,CHEMBL622028,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9940,,13091,,,BAO_0000218,CHEMBL622029,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9941,,13091,,,BAO_0000218,CHEMBL622208,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9942,,13091,,,BAO_0000218,CHEMBL622209,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9943,,13091,,,BAO_0000218,CHEMBL622210,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9944,,13091,,,BAO_0000218,CHEMBL622211,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9945,,13091,,,BAO_0000218,CHEMBL622212,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9946,,13091,,,BAO_0000218,CHEMBL622213,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9947,,13091,,,BAO_0000218,CHEMBL874404,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9948,,13091,,,BAO_0000218,CHEMBL620452,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9949,,13091,,,BAO_0000218,CHEMBL620453,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9950,,13091,,,BAO_0000218,CHEMBL620454,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9951,,13091,,,BAO_0000218,CHEMBL624067,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9952,,13091,,,BAO_0000218,CHEMBL624068,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9953,,13091,,,BAO_0000218,CHEMBL624069,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,N,992.0,Female gonad,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9954,,13091,,,BAO_0000218,CHEMBL624070,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,N,992.0,Female gonad,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9955,,13091,,,BAO_0000218,CHEMBL624071,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,N,992.0,Female gonad,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9956,,13091,,,BAO_0000218,CHEMBL624072,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9957,,13091,,,BAO_0000218,CHEMBL624073,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9958,,13091,,,BAO_0000218,CHEMBL624788,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9959,,13091,,,BAO_0000218,CHEMBL624789,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9960,,13091,,,BAO_0000218,CHEMBL624790,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9961,,13091,,,BAO_0000218,CHEMBL624791,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9962,,13091,,,BAO_0000218,CHEMBL624792,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9963,,13091,,,BAO_0000218,CHEMBL624793,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9964,,13091,,,BAO_0000218,CHEMBL877491,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9965,,13091,,,BAO_0000218,CHEMBL624957,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9966,,13091,,,BAO_0000218,CHEMBL624958,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9967,,13091,,,BAO_0000218,CHEMBL624959,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9968,,11977,,,BAO_0000218,CHEMBL624960,Dissociation constant was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9969,,14941,,,BAO_0000218,CHEMBL624961,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9970,,15078,,,BAO_0000218,CHEMBL624962,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9971,,15078,,,BAO_0000218,CHEMBL624963,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9972,,4755,,,BAO_0000218,CHEMBL624964,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9973,,589,,,BAO_0000218,CHEMBL624965,LogP value was evaluated in the in situ rat gut perfusion assay,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9974,,17582,,,BAO_0000218,CHEMBL624966,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9975,,5031,,,BAO_0000218,CHEMBL624967,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9976,,17764,,,BAO_0000218,CHEMBL624968,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9977,,17720,,,BAO_0000218,CHEMBL624969,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,9978,,2862,,,BAO_0000218,CHEMBL624970,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,N,,,50597,Rattus norvegicus,Expert
,,,A,10116.0,1,,1,9979,,16423,,,BAO_0000218,CHEMBL624971,Half-life was evaluated after 10 uM/kg of intra arterial administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9980,,16423,,,BAO_0000218,CHEMBL624972,Half-life was evaluated after 20 uM/kg of peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9981,,6005,,,BAO_0000218,CHEMBL624973,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9982,,2938,,,BAO_0000218,CHEMBL624974,Half-life was evaluated in plasma of rat,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9983,,6410,,,BAO_0000218,CHEMBL624975,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9984,,6410,,,BAO_0000218,CHEMBL877492,Half-life was evaluated in rats at an oral dose of 30 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9985,,6062,,,BAO_0000218,CHEMBL624976,Half-life was measured in rat after an iv dose of 1 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9986,,6571,,,BAO_0000218,CHEMBL624977,Half-life period of compound in rats after peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9987,,3136,,,BAO_0000218,CHEMBL626848,Half-life period of compound was measured in rat plasma.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9988,,3136,,,BAO_0000218,CHEMBL626849,Half-life period of compound was measured in rat plasma; ND is not determined,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9989,,3136,,,BAO_0000218,CHEMBL626850,Half-life period of compound was measured in rat plasma; not determined,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9990,,4521,,,BAO_0000218,CHEMBL626851,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9991,,5871,,,BAO_0000218,CHEMBL626852,Half-life period in rat by iv administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9992,,6077,,,BAO_0000218,CHEMBL626853,Half-life period in rats following intravenous administration at 2 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9993,,6679,,,BAO_0000218,CHEMBL626854,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9994,,5144,,,BAO_0000218,CHEMBL627486,Half-life period was determined for the compound in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9995,,4498,,,BAO_0000218,CHEMBL627487,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9996,,4498,,,BAO_0000218,CHEMBL627488,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9997,,1908,,,BAO_0000218,CHEMBL627489,Half-life value after IV dose at a dose of 5 mg/kg in rats.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9998,,6211,,,BAO_0000218,CHEMBL627490,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,9999,,5529,,,BAO_0000218,CHEMBL873829,Half-life was determined in rat after intravenous administration (0.5 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10000,,6444,,,BAO_0000218,CHEMBL627655,Half-life was determined in rat at a dose of 1 mpk i.v.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10001,,6444,,,BAO_0000218,CHEMBL625994,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10002,,6444,,,BAO_0000218,CHEMBL625995,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10003,,5207,,,BAO_0000218,CHEMBL625996,Half-life in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10004,,530,,,BAO_0000218,CHEMBL625850,In vitro half life in rat plasma,In vitro,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10005,,1116,,,BAO_0000218,CHEMBL625851,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",In vitro,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10006,,3219,,,BAO_0000218,CHEMBL625852,In vitro half life in rat,In vitro,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10007,,6109,,,BAO_0000218,CHEMBL625853,In vivo half life period after intravenous administration in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10008,,17582,,,BAO_0000218,CHEMBL625854,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10009,,17582,,,BAO_0000218,CHEMBL874450,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10010,,5974,,,BAO_0000218,CHEMBL625855,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10011,,5974,,,BAO_0000218,CHEMBL625856,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10012,,5974,,,BAO_0000218,CHEMBL625857,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10013,,5974,,,BAO_0000218,CHEMBL873831,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10014,,17853,,,BAO_0000218,CHEMBL625858,Longer half-life in rat (i.v.) at 0.5 mpk,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10015,,17853,,,BAO_0000218,CHEMBL625859,Longer half-life in rat (p.o.) at 2.0 mpk,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10016,,3457,,,BAO_0000218,CHEMBL625860,Pharmacokinetic property (half life) in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10017,,2792,,,BAO_0000218,CHEMBL625861,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10018,,2792,,,BAO_0000218,CHEMBL625862,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10019,,2792,,,BAO_0000218,CHEMBL625863,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10020,,2792,,,BAO_0000218,CHEMBL625864,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10021,,5739,,,BAO_0000218,CHEMBL625865,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10022,,15765,,,BAO_0000218,CHEMBL625866,Pharmacokinetic half time was determined intravenously in rats.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10023,,6567,,,BAO_0000218,CHEMBL625867,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10024,,2448,,,BAO_0000218,CHEMBL625868,Plasma half life of hydrolysis of the compound,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10025,,5423,,,BAO_0000218,CHEMBL625869,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10026,,4853,,,BAO_0000218,CHEMBL874451,Plasma half life period was calculated in rat,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10027,,4514,,,BAO_0000218,CHEMBL625870,Plasma half-life in Sprague-Dawley rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10028,,4514,,,BAO_0000218,CHEMBL625871,Plasma half-life in Sprague-Dawley rats; Not determined,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10029,,1500,,,BAO_0000218,CHEMBL625872,Plasma half-life in rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10030,,1500,,,BAO_0000218,CHEMBL625873,Plasma half-life in rats; <MQL,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10031,,5334,,,BAO_0000218,CHEMBL625874,Plasma half-life period (0-8 h) was determined,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10032,,5334,,,BAO_0000218,CHEMBL625875,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10033,,5334,,,BAO_0000218,CHEMBL625876,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10034,,5334,,,BAO_0000218,CHEMBL631258,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10035,,4956,,,BAO_0000218,CHEMBL631259,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10036,,4956,,,BAO_0000218,CHEMBL631260,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10037,,7768,,,BAO_0000218,CHEMBL631261,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10038,,7768,,,BAO_0000218,CHEMBL631262,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10039,,7768,,,BAO_0000218,CHEMBL631263,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10040,,7768,,,BAO_0000218,CHEMBL631264,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10041,,7768,,,BAO_0000218,CHEMBL631265,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10042,,7768,,,BAO_0000218,CHEMBL631266,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10043,,7768,,,BAO_0000218,CHEMBL631267,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10044,,7768,,,BAO_0000218,CHEMBL631268,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10045,,7768,,,BAO_0000218,CHEMBL631269,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10046,,7768,,,BAO_0000218,CHEMBL631270,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10047,,7768,,,BAO_0000218,CHEMBL631271,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10048,,7768,,,BAO_0000218,CHEMBL631272,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10049,,7768,,,BAO_0000218,CHEMBL631273,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10050,,7768,,,BAO_0000218,CHEMBL631274,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10051,,7768,,,BAO_0000218,CHEMBL631275,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10052,,7768,,,BAO_0000218,CHEMBL626984,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10053,,7768,,,BAO_0000218,CHEMBL626985,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10054,,7768,,,BAO_0000218,CHEMBL626986,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10055,,7768,,,BAO_0000218,CHEMBL626987,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10056,,7768,,,BAO_0000218,CHEMBL626988,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10057,,7768,,,BAO_0000218,CHEMBL626989,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10058,,7768,,,BAO_0000218,CHEMBL626990,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10059,,7768,,,BAO_0000218,CHEMBL626991,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10060,,7768,,,BAO_0000218,CHEMBL626992,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10061,,7768,,,BAO_0000218,CHEMBL626993,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10062,,7768,,,BAO_0000218,CHEMBL874593,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10063,,7768,,,BAO_0000218,CHEMBL626994,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10064,,7768,,,BAO_0000218,CHEMBL626995,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10065,,7768,,,BAO_0000218,CHEMBL626190,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10066,,7768,,,BAO_0000218,CHEMBL626191,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10067,,7768,,,BAO_0000218,CHEMBL626364,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10068,,7768,,,BAO_0000218,CHEMBL626365,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10069,,7768,,,BAO_0000218,CHEMBL626366,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10070,,7768,,,BAO_0000218,CHEMBL626367,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10071,,7768,,,BAO_0000218,CHEMBL626368,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10072,,7768,,,BAO_0000218,CHEMBL626369,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10073,,7768,,,BAO_0000218,CHEMBL626370,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10074,,4498,,,BAO_0000218,CHEMBL626371,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10075,,4498,,,BAO_0000218,CHEMBL626372,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10076,,3603,,,BAO_0000218,CHEMBL626373,Bioavailability after a dose of 10 mg/kg p.o.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10077,,6215,,,BAO_0000218,CHEMBL626374,Bioavailability after peroral administration (10 mg/kg) was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10078,,5710,,,BAO_0000218,CHEMBL626375,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10079,,5710,,,BAO_0000218,CHEMBL626376,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10080,,5676,,,BAO_0000218,CHEMBL626377,Bioavailability in rat po was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10081,,17667,,,BAO_0000218,CHEMBL626378,Bioavailability of compound at 10 mg/kg in rat after oral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10082,,17667,,,BAO_0000218,CHEMBL626379,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10083,,6848,,,BAO_0000218,CHEMBL626380,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10084,,6848,,,BAO_0000218,CHEMBL626381,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10085,,17267,,,BAO_0000218,CHEMBL626382,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10086,,6362,,,BAO_0000218,CHEMBL626383,Bioavailability in rat (Sprague-Dawley) (female),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10087,,17671,,,BAO_0000218,CHEMBL874652,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10088,,17671,,,BAO_0000218,CHEMBL626384,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10089,,4333,,,BAO_0000218,CHEMBL626385,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10090,,6077,,,BAO_0000218,CHEMBL626386,Bioavailability in rat at an oral dose of 2 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10091,,3278,,,BAO_0000218,CHEMBL626387,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10092,,5964,,,BAO_0000218,CHEMBL626388,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10093,,4884,,,BAO_0000218,CHEMBL626389,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10094,,4905,,,BAO_0000218,CHEMBL626390,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10095,,4884,,,BAO_0000218,CHEMBL626391,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10096,,6850,,,BAO_0000218,CHEMBL626392,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10097,,2864,,,BAO_0000218,CHEMBL626393,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10098,,5780,,,BAO_0000218,CHEMBL623026,Bioavailability was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10099,,1465,,,BAO_0000218,CHEMBL623027,Bioavailability,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10100,,5199,,,BAO_0000218,CHEMBL623028,Bioavailability,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10101,,5765,,,BAO_0000218,CHEMBL623029,Bioavailability in rat after 1 day dosing,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10102,,5765,,,BAO_0000218,CHEMBL623030,Bioavailability in rat after 4 day dosing,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10103,,6518,,,BAO_0000218,CHEMBL623031,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10104,,6518,,,BAO_0000218,CHEMBL623032,Bioavailability after IV dosing at 1 mg/kg in rat; no data,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10105,,6518,,,BAO_0000218,CHEMBL623033,Bioavailability after oral administration at a dose of 2 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10106,,6518,,,BAO_0000218,CHEMBL623034,Bioavailability after oral administration at a dose of 4 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10107,,2083,,,BAO_0000218,CHEMBL623035,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10108,,17260,,,BAO_0000218,CHEMBL623036,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10109,,4956,,,BAO_0000218,CHEMBL623037,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10110,,4368,,,BAO_0000218,CHEMBL623038,Bioavailability by intravenous administration of 3.4 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10111,,17752,,,BAO_0000218,CHEMBL874385,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10112,,1446,,,BAO_0000218,CHEMBL623039,Bioavailability in rat (Fisher) (fasted),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9443.0,0,,1,10113,,2891,,,BAO_0000218,CHEMBL623040,Bioavailability in monkey after po administration of 10 mg/kg dose,In vivo,U,,,22224,Primates,Intermediate
,,,A,9443.0,0,,1,10114,,2891,,,BAO_0000218,CHEMBL623041,Oral bioavailability in monkey (dose 10 mg/kg),In vivo,U,,,22224,Primates,Intermediate
,,,A,10116.0,1,,1,10115,,6672,,,BAO_0000218,CHEMBL623741,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10116,,6673,,,BAO_0000218,CHEMBL623742,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10117,,17655,,,BAO_0000218,CHEMBL623743,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10118,,17796,,,BAO_0000218,CHEMBL623744,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10119,,17853,,,BAO_0000218,CHEMBL623745,Bioavailability in rat (dose 2.0 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10120,,4521,,,BAO_0000218,CHEMBL623746,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10121,,4940,,,BAO_0000218,CHEMBL623747,Oral bioavailability in rat (dose 5 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,0,,1,10122,,2891,,,BAO_0000218,CHEMBL623748,Bioavailability in rat after po administration of 30 mg/kg dose,In vivo,U,,,22224,Rattus norvegicus,Intermediate
,,,A,10116.0,0,,1,10123,,2891,,,BAO_0000218,CHEMBL623916,Bioavailability in rat after po administration of 30 mg/kg dose,In vivo,U,,,22224,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10124,,4521,,,BAO_0000218,CHEMBL623917,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10125,,17686,,,BAO_0000218,CHEMBL623918,Bioavailability in rat (dose 2 mg/kg i.v.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10126,,17796,,,BAO_0000218,CHEMBL874386,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10127,,17796,,,BAO_0000218,CHEMBL623919,Bioavailability in rat; Only traces detected in rat plasma,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10128,,5064,,,BAO_0000218,CHEMBL623920,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10129,,5147,,,BAO_0000218,CHEMBL623148,Bioavailability upon oral administration of compound,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10130,,1916,,,BAO_0000218,CHEMBL623149,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10131,,6049,,,BAO_0000218,CHEMBL623150,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10132,,1445,,,BAO_0000218,CHEMBL623151,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10133,,1445,,,BAO_0000218,CHEMBL623152,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,10134,,2862,,,BAO_0000218,CHEMBL623153,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,N,,,50597,Rattus norvegicus,Expert
,,,F,10116.0,1,,1,10135,,2862,,,BAO_0000218,CHEMBL623154,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,N,,,50597,Rattus norvegicus,Expert
,,,A,10116.0,1,,1,10136,,4194,,,BAO_0000218,CHEMBL623155,In vitro and metabolic stability was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10137,,4194,,,BAO_0000218,CHEMBL623156,In vitro metabolic stability in rat hepatocytes,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10138,,5486,,,BAO_0000218,CHEMBL623157,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,N,,,50597,Rattus norvegicus,Intermediate
,401.0,,A,10116.0,1,,1,10139,,17582,,Hepatocyte,BAO_0000218,CHEMBL623158,Metabolic rate for compound was observed in rat hepatocytes,In vitro,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10140,,5600,,,BAO_0000218,CHEMBL623159,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10141,,14294,,,BAO_0000218,CHEMBL874390,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10142,,14294,,,BAO_0000218,CHEMBL623160,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10143,,14294,,,BAO_0000218,CHEMBL623161,Metabolism of compound in rat S9 microsomes; Trace,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10144,,17847,,,BAO_0000218,CHEMBL623162,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10145,,11020,,,BAO_0000218,CHEMBL623163,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10146,,11020,,,BAO_0000218,CHEMBL623164,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10147,,11020,,,BAO_0000218,CHEMBL623165,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10148,,11020,,,BAO_0000218,CHEMBL623166,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10149,,11020,,,BAO_0000218,CHEMBL624983,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10150,,11020,,,BAO_0000218,CHEMBL624984,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10151,,11020,,,BAO_0000218,CHEMBL624985,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10152,,11020,,,BAO_0000218,CHEMBL622970,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10153,,11020,,,BAO_0000218,CHEMBL622971,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10154,,11020,,,BAO_0000218,CHEMBL622972,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10155,,11020,,,BAO_0000218,CHEMBL622973,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10156,,11020,,,BAO_0000218,CHEMBL622974,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10157,,11020,,,BAO_0000218,CHEMBL622975,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10158,,11020,,,BAO_0000218,CHEMBL622976,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10159,,11020,,,BAO_0000218,CHEMBL622977,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10160,,11020,,,BAO_0000218,CHEMBL624351,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10161,,11020,,,BAO_0000218,CHEMBL624352,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10162,,11020,,,BAO_0000218,CHEMBL624353,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10163,,11020,,,BAO_0000218,CHEMBL622397,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10164,,11020,,,BAO_0000218,CHEMBL622398,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10165,,11020,,,BAO_0000218,CHEMBL622399,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10166,,11020,,,BAO_0000218,CHEMBL622400,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10167,,11020,,,BAO_0000218,CHEMBL628428,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10168,,11020,,,BAO_0000218,CHEMBL628590,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10169,,11020,,,BAO_0000218,CHEMBL628591,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10170,,11020,,,BAO_0000218,CHEMBL628592,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10171,,11020,,,BAO_0000218,CHEMBL628593,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10172,,11020,,,BAO_0000218,CHEMBL875333,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10173,,11020,,,BAO_0000218,CHEMBL628594,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10174,,4969,,,BAO_0000218,CHEMBL628595,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10175,,6737,,,BAO_0000218,CHEMBL628596,Stability in rat plasma was determined,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10176,,6737,,,BAO_0000218,CHEMBL628597,Stability in rat plasma was determined; ND= no data,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10177,,5089,,,BAO_0000218,CHEMBL628598,Tested for plasma half life period in rat (0-8 hr),,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10178,,5089,,,BAO_0000218,CHEMBL628599,Tested for plasma half life period in rat (0-8 hr); Not determined,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10179,,1466,,,BAO_0000218,CHEMBL628600,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10180,,1466,,,BAO_0000218,CHEMBL628601,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10181,,4950,,,BAO_0000218,CHEMBL628602,Tested for the half life in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10182,,2412,,,BAO_0000218,CHEMBL628603,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,In vitro,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10183,,2412,,,BAO_0000218,CHEMBL628604,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,In vitro,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10184,,2412,,,BAO_0000218,CHEMBL628605,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,In vitro,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10185,,2412,,,BAO_0000218,CHEMBL628606,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,In vitro,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10186,,2412,,,BAO_0000218,CHEMBL628607,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,In vitro,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10187,,15022,,,BAO_0000218,CHEMBL628608,The biological half life the compound was measured at the dose of 100 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10188,,15022,,,BAO_0000218,CHEMBL628609,The biological half life the compound was measured at the dose of 30 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10189,,406,,,BAO_0000218,CHEMBL628610,The compound was evaluated for plasma half life period in rat,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10190,,15078,,,BAO_0000218,CHEMBL873819,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10191,,15078,,,BAO_0000218,CHEMBL628611,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10192,,5247,,,BAO_0000218,CHEMBL628612,The pharmacokinetic parameter half-life period in vivo in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10193,,5041,,,BAO_0000218,CHEMBL628613,"The pharmacokinetic property, Half-life was determined",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10194,,5041,,,BAO_0000218,CHEMBL628614,"The pharmacokinetic property, Half-life in rat in vivo",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10195,,5041,,,BAO_0000218,CHEMBL628615,"The pharmacokinetic property, Half-life was determined; ND denotes no data",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10196,,5041,,,BAO_0000218,CHEMBL628616,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10197,,3918,,,BAO_0000218,CHEMBL627924,The plasma half life period in rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10198,,2906,,,BAO_0000218,CHEMBL627925,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10199,,6467,,,BAO_0000218,CHEMBL627926,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10200,,5510,,,BAO_0000218,CHEMBL627927,t1/2 (apparent elimination)of the compound was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10201,,3788,,,BAO_0000218,CHEMBL627928,t1/2 value in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10202,,17796,,,BAO_0000218,CHEMBL627539,Half life in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10203,,12873,,,BAO_0000218,CHEMBL876790,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10204,,5983,,,BAO_0000218,CHEMBL858186,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10205,,15765,,,BAO_0000218,CHEMBL627540,Half-life period in fasted rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10206,,2661,,,BAO_0000218,CHEMBL627541,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10207,,2661,,,BAO_0000218,CHEMBL627715,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10208,,429,,,BAO_0000218,CHEMBL627716,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10209,,17655,,,BAO_0000218,CHEMBL627717,Maximum time required to achieve Cmax was determined in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10210,,17717,,,BAO_0000218,CHEMBL627718,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10211,,17717,,,BAO_0000218,CHEMBL627719,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10212,,17717,,,BAO_0000218,CHEMBL627720,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10213,,6570,,,BAO_0000218,CHEMBL627721,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10214,,6570,,,BAO_0000218,CHEMBL627722,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10215,,5978,,,BAO_0000218,CHEMBL627723,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10216,,5978,,,BAO_0000218,CHEMBL626058,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10217,,5978,,,BAO_0000218,CHEMBL626059,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10218,,5978,,,BAO_0000218,CHEMBL626060,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10219,,17720,,,BAO_0000218,CHEMBL626061,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10220,,4723,,,BAO_0000218,CHEMBL876791,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10221,,4723,,,BAO_0000218,CHEMBL626062,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10222,,4756,,,BAO_0000218,CHEMBL626063,Tmax at the dose of 2 mg/Kg administered perorally in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10223,,4756,,,BAO_0000218,CHEMBL626064,Tmax at the dose of 5 mg/Kg administered perorally in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10224,,17720,,,BAO_0000218,CHEMBL626065,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10225,,17720,,,BAO_0000218,CHEMBL626066,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10226,,1466,,,BAO_0000218,CHEMBL626067,tmax upon peroral administration of 10.0 mg/Kg dose in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,10227,,7449,,,BAO_0000218,CHEMBL626068,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,10228,,7449,,,BAO_0000218,CHEMBL626069,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,10229,,7449,,,BAO_0000218,CHEMBL626070,Percent total excretion of 3-methoxyacetaminophen glucuronide,,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,10230,,7449,,,BAO_0000218,CHEMBL626071,Percent total excretion of N-methoxyacetaminophen glucuronide,,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,10231,,7449,,,BAO_0000218,CHEMBL626072,Percent total excretion of N-methoxyacetaminophen sulfate,,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,10232,,7449,,,BAO_0000218,CHEMBL626073,Percent total excretion of acetaminophen,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10233,,7768,,,BAO_0000218,CHEMBL626741,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10234,,17655,,,BAO_0000218,CHEMBL626742,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10235,,17735,,,BAO_0000218,CHEMBL626743,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10236,,5960,,,BAO_0000218,CHEMBL876792,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10237,,17735,,,BAO_0000218,CHEMBL626744,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10238,,7116,,,BAO_0000218,CHEMBL626745,Compound was tested for antidiuretic activity in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10239,,4878,,,BAO_0000218,CHEMBL626746,AUC in rat after 3mg/kg oral dose,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10240,,5939,,,BAO_0000218,CHEMBL626747,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10241,,5939,,,BAO_0000218,CHEMBL626748,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10242,,16367,,,BAO_0000218,CHEMBL626749,Bioavailability administered orally at a dose of 10 mg/kg to rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10243,,16366,,,BAO_0000218,CHEMBL626750,Oral Bioavailability was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10244,,4426,,,BAO_0000218,CHEMBL626751,Oral bioavailability in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10245,,4426,,,BAO_0000218,CHEMBL626913,Oral bioavailability in rat; Not performed.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10246,,5041,,,BAO_0000218,CHEMBL626914,Bioavailability,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10247,,5041,,,BAO_0000218,CHEMBL626915,Bioavailability was determined; ND denotes no data,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10248,,1500,,,BAO_0000218,CHEMBL626916,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10249,,1500,,,BAO_0000218,CHEMBL626917,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10250,,17409,,,BAO_0000218,CHEMBL626918,Binding towards rat plasma protein at 10 uM,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10251,,17409,,,BAO_0000218,CHEMBL626919,Binding towards rat plasma protein at 100 uM,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10252,,2959,,,BAO_0000218,CHEMBL626920,Bioavailability in rat (dose 20 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10253,,13501,,,BAO_0000218,CHEMBL621976,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10254,,6567,,,BAO_0000218,CHEMBL877599,Bioavailability in rat after 5 mg/kg oral gavage,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10255,,6571,,,BAO_0000218,CHEMBL621977,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10256,,6715,,,BAO_0000218,CHEMBL621978,Bioavailability in rat (dose 1 mg/kg i.v.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10257,,6715,,,BAO_0000218,CHEMBL621979,Bioavailability in rat (dose 3 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10258,,2932,,,BAO_0000218,CHEMBL621980,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10259,,4171,,,BAO_0000218,CHEMBL621981,Bioavailability of the compound in rats after administration of 30 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10260,,17509,,,BAO_0000218,CHEMBL621982,Bioavailability after administration of 10 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10261,,17509,,,BAO_0000218,CHEMBL882953,Bioavailability after administration of 2 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10262,,4527,,,BAO_0000218,CHEMBL621983,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10263,,4026,,,BAO_0000218,CHEMBL621984,Bioavailability in dogs was determined; high,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10264,,6659,,,BAO_0000218,CHEMBL621985,Bioavailability in monkey after intravenous administration at 1 mpk,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10265,,6659,,,BAO_0000218,CHEMBL621986,Bioavailability in monkey after peroral administration at 10 mpk,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10266,,6659,,,BAO_0000218,CHEMBL621987,Bioavailability in rat after intravenous administration at 1 mpk,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,10267,,6659,,,BAO_0000218,CHEMBL877600,Bioavailability in rat after intravenous administration at 2 mpk,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10268,,6659,,,BAO_0000218,CHEMBL621988,Bioavailability in rat after peroral administration at 30 mpk,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,10269,,6659,,,BAO_0000218,CHEMBL621989,Bioavailability in rat after peroral administration at at 100 mpk,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10270,,6597,,,BAO_0000218,CHEMBL621990,Bioavailability in rats was evaluated,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10271,,1202,,,BAO_0000218,CHEMBL621991,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10272,,1202,,,BAO_0000218,CHEMBL621992,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10273,,1202,,,BAO_0000218,CHEMBL621993,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10274,,1202,,,BAO_0000218,CHEMBL621994,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10275,,5207,,,BAO_0000218,CHEMBL621995,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10276,,5970,,,BAO_0000218,CHEMBL621996,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10277,,17538,,,BAO_0000218,CHEMBL621997,Oral bioavailability in rat (dose 10 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10278,,17538,,,BAO_0000218,CHEMBL621998,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10279,,1466,,,BAO_0000218,CHEMBL621999,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10280,,2879,,,BAO_0000218,CHEMBL622000,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10281,,2879,,,BAO_0000218,CHEMBL622001,Bioavailability was measured in rat after oral administration; 2-4,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10282,,2879,,,BAO_0000218,CHEMBL622002,Bioavailability was measured in rat after oral administration; 3-7,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10283,,3777,,,BAO_0000218,CHEMBL622003,Bioavailability in rat (intraduodenal administration),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10284,,3777,,,BAO_0000218,CHEMBL877601,Bioavailability in rat (intraduodenal administration),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10285,,3777,,,BAO_0000218,CHEMBL624871,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10286,,3777,,,BAO_0000218,CHEMBL622004,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10287,,5423,,,BAO_0000218,CHEMBL882954,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10288,,16365,,,BAO_0000218,CHEMBL622005,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10289,,16365,,,BAO_0000218,CHEMBL622006,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10290,,4239,,,BAO_0000218,CHEMBL622007,Bioavailability was measured in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10291,,5438,,,BAO_0000218,CHEMBL622008,Bioavailability was reported,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10292,,5334,,,BAO_0000218,CHEMBL622009,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10293,,5334,,,BAO_0000218,CHEMBL622010,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10294,,4199,,,BAO_0000218,CHEMBL622011,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10295,,4199,,,BAO_0000218,CHEMBL622012,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10296,,4199,,,BAO_0000218,CHEMBL622013,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10297,,4890,,,BAO_0000218,CHEMBL622014,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10298,,2792,,,BAO_0000218,CHEMBL624749,Bioavailability was determined at 3 mg/kg po dose in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10299,,5529,,,BAO_0000218,CHEMBL624750,Oral bioavailability in rat (dose 2 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10300,,6685,,,BAO_0000218,CHEMBL624751,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10301,,6685,,,BAO_0000218,CHEMBL624752,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10302,,6685,,,BAO_0000218,CHEMBL624753,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10303,,6005,,,BAO_0000218,CHEMBL624754,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10304,,6410,,,BAO_0000218,CHEMBL624755,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10305,,6410,,,BAO_0000218,CHEMBL624756,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10306,,6103,,,BAO_0000218,CHEMBL624757,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10307,,6410,,,BAO_0000218,CHEMBL624758,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10308,,6410,,,BAO_0000218,CHEMBL622270,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10309,,5353,,,BAO_0000218,CHEMBL622271,Bioavailability in rat (Sprague-Dawley),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10310,,4727,,,BAO_0000218,CHEMBL622272,Bioavailability in rat at the dose of 2 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10311,,17804,,,BAO_0000218,CHEMBL622273,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10312,,5809,,,BAO_0000218,CHEMBL622274,Bioavailability in rat (cannulated) (dose 2 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10313,,17804,,,BAO_0000218,CHEMBL622275,Bioavailability value of compound in rats was determined after peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10314,,3634,,,BAO_0000218,CHEMBL622276,Oral bioavailability in rat (dose 20 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10315,,3341,,,BAO_0000218,CHEMBL622277,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10316,,2690,,,BAO_0000218,CHEMBL622278,Oral bioavailability in rat (dose 5 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10317,,3184,,,BAO_0000218,CHEMBL622279,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10318,,740,,,BAO_0000218,CHEMBL622280,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10319,,1806,,,BAO_0000218,CHEMBL624083,Compound was evaluated for oral bioavailability in rats; 15-27 %,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10320,,4891,,,BAO_0000218,CHEMBL624084,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10321,,3634,,,BAO_0000218,CHEMBL624085,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10322,,64,,,BAO_0000218,CHEMBL624086,Compound was tested for bioavailability in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10323,,4839,,,BAO_0000218,CHEMBL624087,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10324,,1094,,,BAO_0000218,CHEMBL624088,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9544.0,0,,1,10325,,5005,,,BAO_0000218,CHEMBL624089,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,In vivo,U,,,22224,Macaca mulatta,Intermediate
,,,A,10116.0,0,,1,10326,,5005,,,BAO_0000218,CHEMBL624090,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),In vivo,U,,,22224,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10327,,4687,,,BAO_0000218,CHEMBL624091,Evaluated for the bioavailability in rat (in vivo),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10328,,17804,,,BAO_0000218,CHEMBL624092,F value of compound in rats was determined after peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10329,,5974,,,BAO_0000218,CHEMBL624093,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10330,,5974,,,BAO_0000218,CHEMBL624094,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10331,,5974,,,BAO_0000218,CHEMBL624095,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10332,,5974,,,BAO_0000218,CHEMBL624096,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10333,,1088,,,BAO_0000218,CHEMBL624097,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10334,,1742,,,BAO_0000218,CHEMBL624098,Maximum fall in carotid flow in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10335,,4689,,,BAO_0000218,CHEMBL874392,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10336,,2463,,,BAO_0000218,CHEMBL624099,Oral bioavailability in rat (dose 5 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10337,,5654,,,BAO_0000218,CHEMBL624100,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10338,,5654,,,BAO_0000218,CHEMBL624101,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10339,,6874,,,BAO_0000218,CHEMBL624102,Oral bioavailability in rat (male Wistar),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10340,,5633,,,BAO_0000218,CHEMBL624103,Oral bioavailability after administration (30 mg/kg) in rat; good,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10341,,5496,,,BAO_0000218,CHEMBL624104,Oral bioavailability at the dose of 2 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10342,,2358,,,BAO_0000218,CHEMBL624105,Oral bioavailability determined in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10343,,16456,,,BAO_0000218,CHEMBL624106,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10344,,5302,,,BAO_0000218,CHEMBL624107,Oral bioavailability in rat (dose single 10 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10345,,5302,,,BAO_0000218,CHEMBL623943,Oral bioavailability in rat (dose single 10 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10346,,5302,,,BAO_0000218,CHEMBL623944,Oral bioavailability in rat (dose 5 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10347,,11020,,,BAO_0000218,CHEMBL623945,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10348,,11020,,,BAO_0000218,CHEMBL623946,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10349,,11020,,,BAO_0000218,CHEMBL623947,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10350,,11020,,,BAO_0000218,CHEMBL623948,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10351,,11020,,,BAO_0000218,CHEMBL623949,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10352,,11020,,,BAO_0000218,CHEMBL623950,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10353,,11020,,,BAO_0000218,CHEMBL874398,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10354,,11020,,,BAO_0000218,CHEMBL623951,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10355,,11020,,,BAO_0000218,CHEMBL623952,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10356,,11020,,,BAO_0000218,CHEMBL623953,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10357,,11020,,,BAO_0000218,CHEMBL623954,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10358,,11020,,,BAO_0000218,CHEMBL623955,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10359,,11020,,,BAO_0000218,CHEMBL623956,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10360,,11020,,,BAO_0000218,CHEMBL627807,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10361,,11020,,,BAO_0000218,CHEMBL627808,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10362,,11020,,,BAO_0000218,CHEMBL627809,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10363,,11020,,,BAO_0000218,CHEMBL627810,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10364,,11020,,,BAO_0000218,CHEMBL627811,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10365,,11020,,,BAO_0000218,CHEMBL627812,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10366,,11020,,,BAO_0000218,CHEMBL627813,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10367,,11020,,,BAO_0000218,CHEMBL627814,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10368,,11020,,,BAO_0000218,CHEMBL875336,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10369,,11020,,,BAO_0000218,CHEMBL627815,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10370,,11020,,,BAO_0000218,CHEMBL627816,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10371,,11020,,,BAO_0000218,CHEMBL627817,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10372,,11020,,,BAO_0000218,CHEMBL627818,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10373,,11020,,,BAO_0000218,CHEMBL627819,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10374,,11020,,,BAO_0000218,CHEMBL627820,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10375,,11020,,,BAO_0000218,CHEMBL627821,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10376,,11020,,,BAO_0000218,CHEMBL628464,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10377,,11020,,,BAO_0000218,CHEMBL626239,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10378,,11020,,,BAO_0000218,CHEMBL626240,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10379,,11020,,,BAO_0000218,CHEMBL626241,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10380,,11020,,,BAO_0000218,CHEMBL626242,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10381,,11020,,,BAO_0000218,CHEMBL626243,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10382,,11020,,,BAO_0000218,CHEMBL626244,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10383,,11020,,,BAO_0000218,CHEMBL626907,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10384,,11020,,,BAO_0000218,CHEMBL626908,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10385,,11020,,,BAO_0000218,CHEMBL626909,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10386,,11020,,,BAO_0000218,CHEMBL626910,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,10387,,7449,,,BAO_0000218,CHEMBL875342,Percent total excretion of acetaminophen cysteine conjugate,,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,10388,,7449,,,BAO_0000218,CHEMBL626911,Percent total excretion of acetaminophen glucuronide,,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,10389,,7449,,,BAO_0000218,CHEMBL626912,Percent total excretion of acetaminophen sulfate,,N,,,50597,Rattus norvegicus,Intermediate
,,,F,10116.0,1,,1,10390,,7449,,,BAO_0000218,CHEMBL627065,Percent total excretion of acetaminophen-mercapturic acid,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10391,,3172,,,BAO_0000218,CHEMBL627066,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10392,,16456,,,BAO_0000218,CHEMBL627067,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,8656.0,0,,1,10393,,10839,,,BAO_0000218,CHEMBL627068,Biodistribution of compound in rat muscle after 5 min of administration,In vivo,U,2385.0,Muscle tissue,22224,ratrat,Autocuration
,,,A,8656.0,0,,1,10394,,10839,,,BAO_0000218,CHEMBL627069,Biodistribution of compound in rat muscle after 5 min of administration.,In vivo,U,2385.0,Muscle tissue,22224,ratrat,Autocuration
,,,A,9940.0,0,,1,10395,,5334,,,BAO_0000218,CHEMBL627070,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),In vivo,U,,,22224,Ovis aries,Autocuration
,,,A,9940.0,0,,1,10396,,5334,,,BAO_0000218,CHEMBL627071,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),In vivo,U,,,22224,Ovis aries,Autocuration
,,,A,9940.0,0,,1,10397,,5334,,,BAO_0000218,CHEMBL627072,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),In vivo,U,,,22224,Ovis aries,Autocuration
,,,A,9940.0,0,,1,10398,,5334,,,BAO_0000218,CHEMBL627073,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),In vivo,U,,,22224,Ovis aries,Autocuration
,,,A,9940.0,0,,1,10399,,5334,,,BAO_0000218,CHEMBL625387,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),In vivo,U,,,22224,Ovis aries,Autocuration
,,,A,9940.0,0,,1,10400,,5334,,,BAO_0000218,CHEMBL625388,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),In vivo,U,,,22224,Ovis aries,Autocuration
,,,A,9940.0,0,,1,10401,,5334,,,BAO_0000218,CHEMBL625389,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),In vivo,U,1969.0,Plasma,22224,Ovis aries,Autocuration
,,,A,9940.0,0,,1,10402,,5334,,,BAO_0000218,CHEMBL875343,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),In vivo,U,1969.0,Plasma,22224,Ovis aries,Autocuration
,,,A,8570.0,1,,1,10403,,1735,,,BAO_0000218,CHEMBL876795,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,N,,,50497,Serpentes,Intermediate
,,,A,8570.0,1,,1,10404,,1469,,,BAO_0000218,CHEMBL626552,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,N,,,50497,Serpentes,Intermediate
,,,A,8570.0,1,,1,10405,,1336,,,BAO_0000218,CHEMBL626553,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,N,,,50497,Serpentes,Intermediate
,,,A,9606.0,0,,1,10406,,12403,,,BAO_0000366,CHEMBL626554,The human biological plasma half life of the compound,,U,1969.0,Plasma,22224,Homo sapiens,Autocuration
,,,A,10116.0,1,,1,10407,,8151,,,BAO_0000218,CHEMBL626555,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10408,,8004,,,BAO_0000218,CHEMBL626556,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10409,,8004,,,BAO_0000218,CHEMBL626557,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10410,,8004,,,BAO_0000218,CHEMBL626558,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10411,,8004,,,BAO_0000218,CHEMBL626559,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10412,,8004,,,BAO_0000218,CHEMBL626560,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10413,,8004,,,BAO_0000218,CHEMBL876803,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10414,,8004,,,BAO_0000218,CHEMBL627964,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10415,,8004,,,BAO_0000218,CHEMBL627965,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10416,,8004,,,BAO_0000218,CHEMBL627966,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10417,,8004,,,BAO_0000218,CHEMBL627967,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10418,,8004,,,BAO_0000218,CHEMBL627968,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10419,,8004,,,BAO_0000218,CHEMBL627969,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10420,,8004,,,BAO_0000218,CHEMBL627970,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10421,,8004,,,BAO_0000218,CHEMBL627971,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10422,,8004,,,BAO_0000218,CHEMBL627972,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,B,9606.0,9,,1,10423,,15917,,,BAO_0000357,CHEMBL856029,Dissociation constant against binding to human cyclophilin A,,D,,,180,Homo sapiens,Expert
,,,B,9913.0,8,,1,10424,,12396,,,BAO_0000019,CHEMBL627973,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,H,,,11591,Bos taurus,Expert
,,,A,,0,,1,10425,,7065,,,BAO_0000019,CHEMBL627974,-Log C was determined by performing the electroshock minimum test,,U,,,22224,,Autocuration
,,,A,,0,,1,10426,,7065,,,BAO_0000019,CHEMBL627975,-Log C was determined by performing the foot shock test,,U,,,22224,,Autocuration
,,,A,,0,,1,10427,,7065,,,BAO_0000019,CHEMBL627976,-Log C was determined by performing the incl screen test,,U,,,22224,,Autocuration
,,,A,,0,,1,10428,,7065,,,BAO_0000019,CHEMBL627977,-Log C was determined by performing the maximum electroshock test,,U,,,22224,,Autocuration
,,,A,,0,,1,10429,,7065,,,BAO_0000019,CHEMBL627978,-Log C was determined by performing the pentylenetetrazole test,,U,,,22224,,Autocuration
,,,A,,0,,1,10430,,12415,,,BAO_0000019,CHEMBL627979,Tested for experimental arotinoid inhibitory dose,,U,,,22224,,Autocuration
,,,A,,0,,1,10431,,10256,,,BAO_0000019,CHEMBL876804,Negative log transformed activity,,U,,,22224,,Autocuration
,,,A,,0,,1,10432,,7991,,,BAO_0000019,CHEMBL627980,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,U,,,22224,,Autocuration
,,,A,10141.0,1,,1,10433,,14342,,,BAO_0000218,CHEMBL627981,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,N,,,50512,Cavia porcellus,Intermediate
,,,A,10141.0,1,,1,10434,,14342,,,BAO_0000218,CHEMBL627982,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,N,,,50512,Cavia porcellus,Intermediate
,,,A,10141.0,1,,1,10435,,14342,,,BAO_0000218,CHEMBL627983,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,N,,,50512,Cavia porcellus,Intermediate
,,,A,10141.0,1,,1,10436,,14342,,,BAO_0000218,CHEMBL627984,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,N,2116.0,Ileum,50512,Cavia porcellus,Intermediate
,,,P,,0,,1,10437,,6047,,,BAO_0000100,CHEMBL627985,Solubility in water was determined; values expressed as -log,,U,,,22229,,Autocuration
,,,A,,0,,1,10438,,17269,,,BAO_0000019,CHEMBL627986,Ratio of Kcat to that of Km was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,10439,,10026,,,BAO_0000019,CHEMBL627987,Observed first order rate constant,,U,,,22224,,Autocuration
,,,A,,0,,1,10440,,14583,,,BAO_0000019,CHEMBL627988,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,10441,,2661,,,BAO_0000218,CHEMBL627989,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10442,,2661,,,BAO_0000218,CHEMBL627990,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10443,,4029,,,BAO_0000218,CHEMBL876805,Oral Bioavailability after administration of 10 mg/kg in male rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10444,,17735,,,BAO_0000218,CHEMBL627991,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10445,,4576,,,BAO_0000218,CHEMBL627992,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10446,,17582,,,BAO_0000218,CHEMBL627993,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10447,,17651,,,BAO_0000218,CHEMBL622817,Oral bioavailability at 1 mg/kg was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10448,,17651,,,BAO_0000218,CHEMBL622818,Oral bioavailability at 10 mg/kg was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10449,,17670,,,BAO_0000218,CHEMBL622819,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10450,,5045,,,BAO_0000218,CHEMBL872267,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10451,,1696,,,BAO_0000218,CHEMBL622820,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10452,,17764,,,BAO_0000218,CHEMBL622821,Oral bioavailability after intravenous administration in rats at 24 uM/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10453,,6448,,,BAO_0000218,CHEMBL622822,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10454,,6596,,,BAO_0000218,CHEMBL622823,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10455,,17547,,,BAO_0000218,CHEMBL622824,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10456,,17771,,,BAO_0000218,CHEMBL622825,Oral bioavailability in rat at a dose of 3 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10457,,6495,,,BAO_0000218,CHEMBL622901,Oral bioavailability in rat after oral administration at 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10458,,4558,,,BAO_0000218,CHEMBL622902,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10459,,17596,,,BAO_0000218,CHEMBL621844,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10460,,6827,,,BAO_0000218,CHEMBL621845,Oral bioavailability in Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10461,,4026,,,BAO_0000218,CHEMBL621846,Oral bioavailability,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10462,,10,,,BAO_0000218,CHEMBL621847,Oral bioavailability in rat (dose 30 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10463,,17717,,,BAO_0000218,CHEMBL877609,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10464,,17717,,,BAO_0000218,CHEMBL621848,Bioavailability in rat (dose 3 mg/kg i.v.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10465,,17717,,,BAO_0000218,CHEMBL621849,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10466,,17717,,,BAO_0000218,CHEMBL622030,Oral bioavailability in rat (dose 60 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10467,,4796,,,BAO_0000218,CHEMBL622031,Percent oral bioavailability determined in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10468,,4883,,,BAO_0000218,CHEMBL622032,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10469,,2137,,,BAO_0000218,CHEMBL622033,The compound was evaluated for bioavailability in rats; 32-51,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10470,,2959,,,BAO_0000218,CHEMBL622034,Bioavailability in rat (dose 20 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10471,,1361,,,BAO_0000218,CHEMBL622035,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10472,,4727,,,BAO_0000218,CHEMBL882966,Bioavailability percent in rat at the dose of 2 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10473,,16423,,,BAO_0000218,CHEMBL622036,Bioavailability was evaluated after 20 uM/kg of peroral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10474,,5206,,,BAO_0000218,CHEMBL622037,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10475,,6448,,,BAO_0000218,CHEMBL622038,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10476,,17723,,,BAO_0000218,CHEMBL622039,Bioavailability in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10477,,17738,,,BAO_0000218,CHEMBL622040,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10478,,17738,,,BAO_0000218,CHEMBL622041,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10479,,17738,,,BAO_0000218,CHEMBL622042,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10480,,17738,,,BAO_0000218,CHEMBL622043,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10481,,17738,,,BAO_0000218,CHEMBL622044,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10482,,17738,,,BAO_0000218,CHEMBL622045,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10483,,17738,,,BAO_0000218,CHEMBL622046,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10484,,17738,,,BAO_0000218,CHEMBL622047,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10485,,17738,,,BAO_0000218,CHEMBL877610,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10486,,17738,,,BAO_0000218,CHEMBL622048,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10487,,17738,,,BAO_0000218,CHEMBL622049,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10488,,17738,,,BAO_0000218,CHEMBL622050,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10489,,17738,,,BAO_0000218,CHEMBL622051,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10490,,17738,,,BAO_0000218,CHEMBL622052,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10491,,17738,,,BAO_0000218,CHEMBL622053,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10492,,17738,,,BAO_0000218,CHEMBL622054,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10493,,17738,,,BAO_0000218,CHEMBL622055,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10494,,5237,,,BAO_0000218,CHEMBL622056,Oral bioavailability in rats was determined; High,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10495,,5503,,,BAO_0000218,CHEMBL622057,Oral bioavailability in the rat was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10496,,15765,,,BAO_0000218,CHEMBL628008,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10497,,15660,,,BAO_0000218,CHEMBL622058,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10498,,5978,,,BAO_0000218,CHEMBL622059,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10499,,5978,,,BAO_0000218,CHEMBL622060,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10500,,5978,,,BAO_0000218,CHEMBL622061,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10501,,5978,,,BAO_0000218,CHEMBL622062,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10502,,5656,,,BAO_0000218,CHEMBL622063,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10503,,3598,,,BAO_0000218,CHEMBL877611,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Expert
,,,A,10116.0,1,,1,10504,,4216,,,BAO_0000218,CHEMBL622064,Oral bioavailability of compound in Sprague Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10505,,17839,,,BAO_0000218,CHEMBL622065,Oral bioavailability of compound in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10506,,6570,,,BAO_0000218,CHEMBL622066,Oral bioavailability in rat (dose 2 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10507,,5334,,,BAO_0000218,CHEMBL622067,Oral bioavailability of compound in rat was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10508,,6886,,,BAO_0000218,CHEMBL622068,Oral bioavailability of compound in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10509,,5210,,,BAO_0000218,CHEMBL622069,Oral bioavailability of compound was determined in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10510,,4170,,,BAO_0000218,CHEMBL624796,Oral bioavailability at a dose of 30 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10511,,6028,,,BAO_0000218,CHEMBL624797,Oral bioavailability in rat (dose 10 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10512,,6028,,,BAO_0000218,CHEMBL623053,Oral bioavailability in rat (dose 10 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10513,,6078,,,BAO_0000218,CHEMBL623054,Oral bioavailability evaluated in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10514,,6168,,,BAO_0000218,CHEMBL623055,Oral bioavailability in fasted rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10515,,6168,,,BAO_0000218,CHEMBL623056,Oral bioavailability in fed rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10516,,5160,,,BAO_0000218,CHEMBL623057,Oral bioavailability in rat (mature male) (dose 30 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10517,,6057,,,BAO_0000218,CHEMBL623058,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10518,,6535,,,BAO_0000218,CHEMBL623059,Oral bioavailability in rat (dose 10 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10519,,6535,,,BAO_0000218,CHEMBL623060,Oral bioavailability in rat after administration of 10 mg/kg po,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10520,,4194,,,BAO_0000218,CHEMBL623061,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10521,,6230,,,BAO_0000218,CHEMBL623062,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10522,,6619,,,BAO_0000218,CHEMBL623063,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10523,,17607,,,BAO_0000218,CHEMBL623064,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10524,,4942,,,BAO_0000218,CHEMBL623065,Oral bioavailability in ratrs,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10525,,4942,,,BAO_0000218,CHEMBL623066,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10526,,6646,,,BAO_0000218,CHEMBL623067,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10527,,5237,,,BAO_0000218,CHEMBL623068,Oral bioavailability in rats was determined; High,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10528,,6646,,,BAO_0000218,CHEMBL623069,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10529,,4449,,,BAO_0000218,CHEMBL623070,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10530,,6057,,,BAO_0000218,CHEMBL623071,Oral bioavailability was calculated in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10531,,2552,,,BAO_0000218,CHEMBL623072,Oral bioavailability,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10532,,5496,,,BAO_0000218,CHEMBL623073,Oral bioavailability,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10533,,6484,,,BAO_0000218,CHEMBL623074,Oral bioavailability,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10534,,6485,,,BAO_0000218,CHEMBL623075,Oral bioavailability,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10535,,6616,,,BAO_0000218,CHEMBL623076,Oral bioavailability after i.v. administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10536,,4969,,,BAO_0000218,CHEMBL623077,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10537,,5862,,,BAO_0000218,CHEMBL623078,Oral bioavailability in rat (Sprague-Dawley),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10538,,4514,,,BAO_0000218,CHEMBL623079,Oral bioavailability in Sprague-Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10539,,4514,,,BAO_0000218,CHEMBL623080,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10540,,4514,,,BAO_0000218,CHEMBL623081,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10541,,5546,,,BAO_0000218,CHEMBL623082,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10542,,6168,,,BAO_0000218,CHEMBL874400,Oral bioavailability in fasted rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10543,,6168,,,BAO_0000218,CHEMBL623083,Oral bioavailability in fed rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10544,,3624,,,BAO_0000218,CHEMBL623084,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10545,,5213,,,BAO_0000218,CHEMBL623085,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10546,,5496,,,BAO_0000218,CHEMBL623086,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10547,,5553,,,BAO_0000218,CHEMBL623087,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10548,,5833,,,BAO_0000218,CHEMBL623088,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10549,,5836,,,BAO_0000218,CHEMBL623089,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10550,,5865,,,BAO_0000218,CHEMBL623090,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10551,,5960,,,BAO_0000218,CHEMBL623091,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10552,,6249,,,BAO_0000218,CHEMBL623092,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10553,,6448,,,BAO_0000218,CHEMBL623093,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10554,,6453,,,BAO_0000218,CHEMBL874401,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10555,,6640,,,BAO_0000218,CHEMBL623094,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10556,,17607,,,BAO_0000218,CHEMBL623095,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10557,,5939,,,BAO_0000218,CHEMBL623096,Oral bioavailability in rat after peroral administration at 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10558,,5939,,,BAO_0000218,CHEMBL624913,Oral bioavailability in rat after peroral administration at 5 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10559,,6281,,,BAO_0000218,CHEMBL624914,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10560,,5874,,,BAO_0000218,CHEMBL624915,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10561,,5213,,,BAO_0000218,CHEMBL624916,Oral bioavailability in rat; Not measured,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10562,,4964,,,BAO_0000218,CHEMBL624917,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10563,,11020,,,BAO_0000218,CHEMBL625157,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10564,,6251,,,BAO_0000218,CHEMBL625158,In vitro metabolic potential in rat liver microsomes,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10565,,1568,,,BAO_0000218,CHEMBL625159,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10566,,3032,,,BAO_0000218,CHEMBL625160,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10567,,3748,,,BAO_0000218,CHEMBL625161,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10568,,401,,,BAO_0000218,CHEMBL625162,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10569,,6512,,,BAO_0000218,CHEMBL625163,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10570,,17617,,,BAO_0000218,CHEMBL625164,Oral bioavailability in rats at 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10571,,6679,,,BAO_0000218,CHEMBL625165,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10572,,6742,,,BAO_0000218,CHEMBL625166,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10573,,589,,,BAO_0000218,CHEMBL625167,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10574,,589,,,BAO_0000218,CHEMBL625168,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10575,,3185,,,BAO_0000218,CHEMBL625169,Plasma clearance of the compound,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10576,,17596,,,BAO_0000218,CHEMBL626264,Plasma clearance at 10 mg/kg in rat upon intravenous administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10577,,2713,,,BAO_0000218,CHEMBL626265,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10578,,12500,,,BAO_0000218,CHEMBL626266,The compound was tested for plasma clearance in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10579,,12500,,,BAO_0000218,CHEMBL626267,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10580,,2713,,,BAO_0000218,CHEMBL626268,Plasma concentration upon oral administration of 1 mg/Kg in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10581,,1446,,,BAO_0000218,CHEMBL626269,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10582,,6227,,,BAO_0000218,CHEMBL626270,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10583,,4709,,,BAO_0000218,CHEMBL626271,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10584,,5510,,,BAO_0000218,CHEMBL626272,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10585,,5510,,,BAO_0000218,CHEMBL626273,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10586,,5510,,,BAO_0000218,CHEMBL875346,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10587,,5510,,,BAO_0000218,CHEMBL626274,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10588,,4514,,,BAO_0000218,CHEMBL626275,Compound was tested for protein binding in rat plasma,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10589,,2713,,,BAO_0000218,CHEMBL624646,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10590,,2713,,,BAO_0000218,CHEMBL624647,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10591,,5340,,,BAO_0000218,CHEMBL624648,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10592,,12058,,,BAO_0000218,CHEMBL624649,Area under curve ratio was determined (po/iv) in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10593,,11195,,,BAO_0000218,CHEMBL624650,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10594,,11195,,,BAO_0000218,CHEMBL624651,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10595,,11195,,,BAO_0000218,CHEMBL624652,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10596,,6495,,,BAO_0000218,CHEMBL624653,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10597,,6078,,,BAO_0000218,CHEMBL624654,Ratio of AUCbrain to AUCplasma,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10598,,5656,,,BAO_0000218,CHEMBL624655,Ratio of brain to plasma,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10599,,4910,,,BAO_0000218,CHEMBL624656,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10600,,4910,,,BAO_0000218,CHEMBL624657,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10601,,4910,,,BAO_0000218,CHEMBL624658,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10602,,10130,,,BAO_0000218,CHEMBL624659,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10603,,10130,,,BAO_0000218,CHEMBL624660,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10604,,10130,,,BAO_0000218,CHEMBL624661,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10605,,5213,,,BAO_0000218,CHEMBL624662,Steady state brain :blood ratio was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10606,,4910,,,BAO_0000218,CHEMBL625199,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10607,,4910,,,BAO_0000218,CHEMBL625200,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10608,,4910,,,BAO_0000218,CHEMBL625201,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10609,,4910,,,BAO_0000218,CHEMBL625202,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10610,,2083,,,BAO_0000218,CHEMBL625203,Percentage recovery after 3h incubation with rat hapatocytes was determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10611,,2082,,,BAO_0000218,CHEMBL625204,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10612,,2082,,,BAO_0000218,CHEMBL625205,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10613,,6351,,,BAO_0000218,CHEMBL625206,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,10614,,14583,,,BAO_0000019,CHEMBL625207,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,U,,,22224,,Autocuration
,,,A,,0,,1,10615,,14583,,,BAO_0000019,CHEMBL625208,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,U,,,22224,,Autocuration
,495.0,,A,9606.0,1,,1,10616,,4608,,Caco-2,BAO_0000218,CHEMBL625209,In vivo absorption in Caco-2 cell line monolayers was determined,,N,,,50587,Homo sapiens,Intermediate
,,,P,,0,,1,10617,,13668,,,BAO_0000100,CHEMBL625210,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,A,10116.0,1,,1,10618,,5669,,,BAO_0000218,CHEMBL625211,Area under curve was determine after peroral administration at 10 mpk in Rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9544.0,1,,1,10619,,5669,,,BAO_0000218,CHEMBL625212,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,N,,,50797,Macaca mulatta,Intermediate
,,,A,10116.0,1,,1,10620,,5669,,,BAO_0000218,CHEMBL625213,Area under curve was determine after peroral administration at 160 mpk in Rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10621,,5669,,,BAO_0000218,CHEMBL625214,Area under curve was determine after peroral administration at 20 mpk in Rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10622,,5669,,,BAO_0000218,CHEMBL874542,Area under curve was determine after peroral administration at 50 mpk in Rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,P,,0,,1,10623,,6472,,,BAO_0000100,CHEMBL625215,Calculated partition coefficient (clogP) (AlogP),,U,,,22229,,Autocuration
,,,A,,0,,1,10624,,15106,,,BAO_0000019,CHEMBL625216,Activated partial thromboplastin time measured,,U,,,22224,,Autocuration
,,,P,,0,,1,10625,,15207,,,BAO_0000100,CHEMBL625217,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,U,,,22224,,Autocuration
,,,P,,0,,1,10626,,15207,,,BAO_0000100,CHEMBL625218,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,10627,,13941,,,BAO_0000218,CHEMBL622864,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,10628,,13941,,,BAO_0000218,CHEMBL622865,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10629,,13941,,,BAO_0000218,CHEMBL622866,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,10630,,13941,,,BAO_0000218,CHEMBL622867,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10141.0,1,,1,10631,,15240,,,BAO_0000218,CHEMBL876808,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,N,1969.0,Plasma,50512,Cavia porcellus,Intermediate
,,,A,,0,,1,10632,,10655,,,BAO_0000019,CHEMBL627725,AUC in brain,,U,955.0,Brain,22224,,Autocuration
,,,A,,0,,1,10633,,10655,,,BAO_0000019,CHEMBL627726,AUC in serum,,U,1977.0,Serum,22224,,Autocuration
,,,A,,0,,1,10634,,6504,,,BAO_0000019,CHEMBL627727,AUC was determined,,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,10635,,10615,,,BAO_0000019,CHEMBL627728,AUC of the compound.,,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,10636,,10353,,,BAO_0000019,CHEMBL627729,AUC value (0-4 hr),,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,10637,,14907,,,BAO_0000019,CHEMBL627730,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,10638,,14907,,,BAO_0000019,CHEMBL627731,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,10639,,14907,,,BAO_0000019,CHEMBL627732,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,10640,,14907,,,BAO_0000019,CHEMBL627733,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,U,1969.0,Plasma,22224,,Autocuration
,,,A,10116.0,1,,1,10641,,16359,,,BAO_0000218,CHEMBL627734,AUC(area under curve) was determined after intravenous administration in rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10642,,16359,,,BAO_0000218,CHEMBL627735,AUC(area under curve) was determined after oral administration in rats,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10141.0,1,,1,10643,,15240,,,BAO_0000218,CHEMBL627736,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,N,1969.0,Plasma,50512,Cavia porcellus,Intermediate
,,,A,10116.0,1,,1,10644,,15240,,,BAO_0000218,CHEMBL876809,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,10645,,15469,,,BAO_0000019,CHEMBL627737,Area Under Curve after oral dosing of 100 uM/Kg,,U,,,22224,,Autocuration
,,,A,,0,,1,10646,,15469,,,BAO_0000019,CHEMBL627738,Area Under Curve after oral dosing of 30 uM/Kg,,U,,,22224,,Autocuration
,,,A,,0,,1,10647,,13520,,,BAO_0000019,CHEMBL627739,Area Under Curve was measured by ploting the graph between concentration verses time,,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,10648,,17025,,,BAO_0000218,CHEMBL626143,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,314293.0,0,,1,10649,,17025,,,BAO_0000218,CHEMBL626144,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,U,,,22224,Simiiformes,Autocuration
,,,A,9986.0,1,,1,10650,,17025,,,BAO_0000218,CHEMBL626145,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,N,,,50592,Oryctolagus cuniculus,Intermediate
,,,A,10116.0,1,,1,10651,,17025,,,BAO_0000218,CHEMBL626146,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10652,,12032,,,BAO_0000218,CHEMBL626147,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,10653,,10291,,,BAO_0000019,CHEMBL626148,Area under curve (AUC) was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,10654,,5767,,,BAO_0000218,CHEMBL626149,Area under curve (AUC) following ip administration at 1 mg/kg,,U,,,22224,,Autocuration
,,,A,,0,,1,10655,,1434,,,BAO_0000019,CHEMBL626150,Area under curve (AUC) was determined; ND is Not determined,,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,10656,,14925,,,BAO_0000218,CHEMBL626151,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10657,,14925,,,BAO_0000218,CHEMBL626152,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10658,,14925,,,BAO_0000218,CHEMBL626153,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,10659,,1434,,,BAO_0000019,CHEMBL626154,Area under curve (AUR) was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,10660,,11883,,,BAO_0000019,CHEMBL626155,Area under curve at 1 uM/dg administered intravenously,,U,,,22224,,Autocuration
,,,A,,0,,1,10661,,11883,,,BAO_0000019,CHEMBL626156,Area under curve at 10 uM/dg administered perorally,,U,,,22224,,Autocuration
,,,A,,0,,1,10662,,11883,,,BAO_0000019,CHEMBL626157,Area under curve at 2 uM/dg administered intravenously,,U,,,22224,,Autocuration
,,,A,,0,,1,10663,,11883,,,BAO_0000019,CHEMBL626158,Area under curve at 20 uM/dg administered perorally,,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,10664,,15233,,,BAO_0000218,CHEMBL626159,Area under curve at a peroral dose of 3 mg/kg in dog,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,10665,,15233,,,BAO_0000218,CHEMBL626160,Area under curve at a peroral dose of 3 mg/kg in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,10666,,15233,,,BAO_0000218,CHEMBL626161,Area under curve at an iv dose of 1 mg/kg in dog,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,10667,,15233,,,BAO_0000218,CHEMBL626162,Area under curve at an iv dose of 1 mg/kg in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,10668,,12978,,,BAO_0000019,CHEMBL626163,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,U,,,22224,,Autocuration
,,,A,,0,,1,10669,,12978,,,BAO_0000019,CHEMBL626164,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,10670,,11355,,,BAO_0000218,CHEMBL626165,Area under curve measured as conc vs time after intravenous administration to mice.,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,10671,,11355,,,BAO_0000218,CHEMBL626166,Area under curve measured as conc vs time after peroral administration to mice.,,N,,,50594,Mus musculus,Intermediate
,,,A,9615.0,1,,1,10672,,12923,,,BAO_0000218,CHEMBL626167,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10673,,12923,,,BAO_0000218,CHEMBL626168,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10674,,12923,,,BAO_0000218,CHEMBL877463,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10675,,12923,,,BAO_0000218,CHEMBL626169,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,10676,,17738,,,BAO_0000218,CHEMBL626170,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10677,,17738,,,BAO_0000218,CHEMBL626171,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10678,,17738,,,BAO_0000218,CHEMBL626172,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10679,,17738,,,BAO_0000218,CHEMBL626173,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10680,,17738,,,BAO_0000218,CHEMBL626174,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10681,,17738,,,BAO_0000218,CHEMBL626175,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10682,,17738,,,BAO_0000218,CHEMBL626176,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10683,,17738,,,BAO_0000218,CHEMBL626177,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10684,,17738,,,BAO_0000218,CHEMBL622499,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10685,,17738,,,BAO_0000218,CHEMBL622500,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10686,,17738,,,BAO_0000218,CHEMBL622501,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10687,,17738,,,BAO_0000218,CHEMBL622502,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10688,,17738,,,BAO_0000218,CHEMBL622503,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10689,,17738,,,BAO_0000218,CHEMBL877614,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10690,,17738,,,BAO_0000218,CHEMBL624839,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10691,,17738,,,BAO_0000218,CHEMBL624840,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10692,,17738,,,BAO_0000218,CHEMBL624841,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10693,,17738,,,BAO_0000218,CHEMBL624842,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10694,,17738,,,BAO_0000218,CHEMBL624843,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10695,,17738,,,BAO_0000218,CHEMBL624844,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10696,,17738,,,BAO_0000218,CHEMBL624845,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10697,,17738,,,BAO_0000218,CHEMBL621904,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10698,,11195,,,BAO_0000218,CHEMBL621905,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10699,,11195,,,BAO_0000218,CHEMBL874382,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10700,,11195,,,BAO_0000218,CHEMBL621906,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10701,,11195,,,BAO_0000218,CHEMBL621907,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10702,,11195,,,BAO_0000218,CHEMBL622096,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10703,,11195,,,BAO_0000218,CHEMBL622097,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10704,,11195,,,BAO_0000218,CHEMBL622098,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10705,,11195,,,BAO_0000218,CHEMBL622099,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10706,,11195,,,BAO_0000218,CHEMBL622100,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10707,,11195,,,BAO_0000218,CHEMBL622101,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10708,,11195,,,BAO_0000218,CHEMBL622102,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10709,,11195,,,BAO_0000218,CHEMBL622103,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10710,,11195,,,BAO_0000218,CHEMBL622104,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10711,,11195,,,BAO_0000218,CHEMBL622105,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10712,,11195,,,BAO_0000218,CHEMBL622106,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10713,,11195,,,BAO_0000218,CHEMBL622107,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10714,,11195,,,BAO_0000218,CHEMBL622108,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10715,,11195,,,BAO_0000218,CHEMBL622109,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10716,,11195,,,BAO_0000218,CHEMBL622110,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10717,,11195,,,BAO_0000218,CHEMBL622111,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10718,,11195,,,BAO_0000218,CHEMBL874383,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10719,,11195,,,BAO_0000218,CHEMBL622112,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,In vivo,N,14.0,Zone of skin,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10720,,11195,,,BAO_0000218,CHEMBL622113,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,In vivo,N,14.0,Zone of skin,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10721,,11195,,,BAO_0000218,CHEMBL622114,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,In vivo,N,14.0,Zone of skin,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10722,,11195,,,BAO_0000218,CHEMBL622115,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10723,,11195,,,BAO_0000218,CHEMBL622116,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10724,,6193,,,BAO_0000218,CHEMBL622117,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10725,,6803,,,BAO_0000218,CHEMBL622118,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10726,,6647,,,BAO_0000218,CHEMBL622119,Oral bioavailability in rats at 6 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10727,,6647,,,BAO_0000218,CHEMBL622120,Oral bioavailability in rat (dose 6 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10728,,6647,,,BAO_0000218,CHEMBL622121,Oral bioavailability in rats at 6 mg/kg dose; Not tested,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10729,,6640,,,BAO_0000218,CHEMBL622122,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10730,,6641,,,BAO_0000218,CHEMBL622123,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10731,,6641,,,BAO_0000218,CHEMBL622124,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10732,,6642,,,BAO_0000218,CHEMBL622125,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10733,,5472,,,BAO_0000218,CHEMBL622126,Oral bioavailability,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10734,,6141,,,BAO_0000218,CHEMBL620455,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10735,,4390,,,BAO_0000218,CHEMBL620456,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10736,,5472,,,BAO_0000218,CHEMBL620457,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10737,,5472,,,BAO_0000218,CHEMBL620458,Oral bioavailability was evaluated; Not tested,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10738,,5438,,,BAO_0000218,CHEMBL620459,Oral bioavailability,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10739,,4883,,,BAO_0000218,CHEMBL620460,Oral bioavailability in rat by oral dosing,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10740,,1908,,,BAO_0000218,CHEMBL620461,Oral bioavailability in rat (dose 10 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10741,,4853,,,BAO_0000218,CHEMBL620462,Oral bioavailability in rat (Sprague-Dawley),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10742,,4853,,,BAO_0000218,CHEMBL620463,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10743,,4853,,,BAO_0000218,CHEMBL620464,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10744,,4853,,,BAO_0000218,CHEMBL620465,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10745,,4853,,,BAO_0000218,CHEMBL620466,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10746,,4853,,,BAO_0000218,CHEMBL620467,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10747,,4853,,,BAO_0000218,CHEMBL620468,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10748,,12873,,,BAO_0000218,CHEMBL620469,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10749,,12873,,,BAO_0000218,CHEMBL620470,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10750,,3169,,,BAO_0000218,CHEMBL620471,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10751,,6305,,,BAO_0000218,CHEMBL620472,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10752,,4762,,,BAO_0000218,CHEMBL620473,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10753,,17847,,,BAO_0000218,CHEMBL620474,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10754,,6211,,,BAO_0000218,CHEMBL620475,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10755,,6011,,,BAO_0000218,CHEMBL620476,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10756,,6317,,,BAO_0000218,CHEMBL620477,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10757,,6644,,,BAO_0000218,CHEMBL620478,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10758,,6644,,,BAO_0000218,CHEMBL618768,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10759,,6644,,,BAO_0000218,CHEMBL618769,Oral bioavailability in rat after oral administration at 13 mg/kg dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10760,,6644,,,BAO_0000218,CHEMBL618770,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10761,,6113,,,BAO_0000218,CHEMBL618771,Oral bioavailability (dose 20 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10762,,5937,,,BAO_0000218,CHEMBL618772,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10763,,5711,,,BAO_0000218,CHEMBL618773,Oral bioavailability in rat at 10 mg/kg of the compound,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10764,,17717,,,BAO_0000218,CHEMBL875842,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10765,,17717,,,BAO_0000218,CHEMBL618774,Bioavailability in rat (dose 3 mg/kg i.v.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10766,,17717,,,BAO_0000218,CHEMBL618775,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10767,,17717,,,BAO_0000218,CHEMBL618776,Oral bioavailability in rat (dose 60 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10768,,4722,,,BAO_0000218,CHEMBL618777,Percent bioavailability (F) in rats after iv administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10769,,4722,,,BAO_0000218,CHEMBL618778,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10770,,4353,,,BAO_0000218,CHEMBL618779,Bioavailability in rat (dose 5 uM/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10771,,15662,,,BAO_0000218,CHEMBL618780,Oral bioavailability,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10772,,4756,,,BAO_0000218,CHEMBL618781,Bioavailability in rat (dose 2 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10773,,4756,,,BAO_0000218,CHEMBL618782,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10774,,3436,,,BAO_0000218,CHEMBL618783,Oral bioavailability in rat (dose 20 mg/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10775,,17800,,,BAO_0000218,CHEMBL618784,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10776,,15762,,,BAO_0000218,CHEMBL618785,Percent oral bioavailability evaluated in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10777,,5089,,,BAO_0000218,CHEMBL618786,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10778,,5089,,,BAO_0000218,CHEMBL618787,Percent oral bioavailability in rat; Not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10779,,3185,,,BAO_0000218,CHEMBL618788,Oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10780,,5145,,,BAO_0000218,CHEMBL618789,Bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10781,,3457,,,BAO_0000218,CHEMBL618790,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10782,,3457,,,BAO_0000218,CHEMBL618791,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10783,,5983,,,BAO_0000218,CHEMBL875843,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10784,,5739,,,BAO_0000218,CHEMBL618792,Oral bioavailability in rat (dose 20 mg/kg p.o.),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10785,,3579,,,BAO_0000218,CHEMBL623395,Cmax at a dose of 30 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,314293.0,0,,1,10786,,17788,,,BAO_0000218,CHEMBL623396,Cmax in monkeys at a dose of 1 mg/kg,In vivo,U,,,22224,Simiiformes,Autocuration
,,,A,10116.0,1,,1,10787,,14956,,,BAO_0000218,CHEMBL623397,Cmax in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10788,,17788,,,BAO_0000218,CHEMBL623398,Cmax in rats at a dose of 1 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,10789,,9750,,,BAO_0000218,CHEMBL623399,Cmax was measured in mice after an oral dose of 50 mg/kg.,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,,0,,1,10790,,12767,,,BAO_0000218,CHEMBL623400,"Cmax value at a dose of 12.7 uM/kg, po",In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,10791,,12767,,,BAO_0000218,CHEMBL623401,"Cmax value at a dose of 6.3 uM/kg, iv",In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,10792,,12767,,,BAO_0000218,CHEMBL623402,"Cmax value at a dose of 7.1 uM/kg, iv",In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,10793,,12703,,,BAO_0000218,CHEMBL623403,Cmax value of compound was determined after 1 hr,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,10794,,15778,,,BAO_0000218,CHEMBL623404,Cmax value of the compound,In vivo,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,10795,,12818,,,BAO_0000218,CHEMBL625997,Cmax value administered intraintestinal in rats.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10796,,14964,,,BAO_0000218,CHEMBL625998,Cmax value administered perorally was determined in rat; Not determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,10797,,15808,,,BAO_0000218,CHEMBL625999,Cmax value at the dose of 2.3 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,10798,,15808,,,BAO_0000218,CHEMBL626000,Cmax value at the dose of 5 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,10799,,15778,,,BAO_0000218,CHEMBL626001,Cmax value in the period of 8 hr after dosing. ,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,10800,,3715,,,BAO_0000218,CHEMBL626002,Cmax value at a oral dose of 20 mg/kg; Not tested,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,10801,,3715,,,BAO_0000218,CHEMBL626003,Cmax value at a oral dose of 20 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,10802,,1446,,,BAO_0000218,CHEMBL626004,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10141.0,1,,1,10803,,15240,,,BAO_0000218,CHEMBL626005,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,In vivo,N,,,50512,Cavia porcellus,Intermediate
,,,A,10116.0,1,,1,10804,,15240,,,BAO_0000218,CHEMBL626006,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10805,,14810,,,BAO_0000218,CHEMBL626007,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,10806,,14239,,,BAO_0000218,CHEMBL626008,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,In vivo,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,9615.0,1,,1,10807,,12555,,,BAO_0000218,CHEMBL626009,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,In vivo,N,2107.0,Liver,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10808,,10754,,,BAO_0000218,CHEMBL626010,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10090.0,1,,1,10809,,10754,,,BAO_0000218,CHEMBL626011,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,10810,,10754,,,BAO_0000218,CHEMBL626012,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,10811,,10754,,,BAO_0000218,CHEMBL626013,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,10812,,10754,,,BAO_0000218,CHEMBL626014,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,10813,,10754,,,BAO_0000218,CHEMBL877496,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,F,9615.0,1,,1,10814,,14600,,,BAO_0000218,CHEMBL626015,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,F,9615.0,1,,1,10815,,14600,,,BAO_0000218,CHEMBL626016,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,F,9615.0,1,,1,10816,,14600,,,BAO_0000218,CHEMBL626017,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10817,,13543,,,BAO_0000218,CHEMBL626018,Bioavailability as maximal plasma concentration in dogs,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10818,,13543,,,BAO_0000218,CHEMBL626692,Bioavailability as maximal plasma concentration in dogs,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,10819,,13543,,,BAO_0000218,CHEMBL626693,Bioavailability as maximal plasma concentration in rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,0,,1,10820,,13543,,,BAO_0000218,CHEMBL626694,Bioavailability as maximal plasma concentration in rats,In vivo,U,1969.0,Plasma,22224,Rattus norvegicus,Autocuration
,,,A,9615.0,1,,1,10821,,14600,,,BAO_0000218,CHEMBL626695,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,N,178.0,Blood,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10822,,14600,,,BAO_0000218,CHEMBL626696,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,N,178.0,Blood,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10823,,14600,,,BAO_0000218,CHEMBL626697,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,N,178.0,Blood,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10824,,14600,,,BAO_0000218,CHEMBL626859,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,In vivo,N,178.0,Blood,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10825,,14600,,,BAO_0000218,CHEMBL626860,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,N,178.0,Blood,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10826,,14600,,,BAO_0000218,CHEMBL626861,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,N,178.0,Blood,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,10827,,14681,,,BAO_0000218,CHEMBL626296,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,10828,,15905,,,BAO_0000218,CHEMBL626297,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,10829,,15905,,,BAO_0000218,CHEMBL626298,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,10116.0,1,,1,10830,,13304,,,BAO_0000218,CHEMBL626299,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10831,,15137,,,BAO_0000218,CHEMBL626300,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10832,,15137,,,BAO_0000218,CHEMBL626301,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10833,,15137,,,BAO_0000218,CHEMBL626962,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10834,,15137,,,BAO_0000218,CHEMBL626963,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10835,,15137,,,BAO_0000218,CHEMBL626964,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9541.0,1,,1,10836,,14839,,,BAO_0000218,CHEMBL626965,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,In vivo,N,1969.0,Plasma,100710,Macaca fascicularis,Intermediate
,,,A,10090.0,1,,1,10837,,14839,,,BAO_0000218,CHEMBL626966,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,10838,,14839,,,BAO_0000218,CHEMBL626967,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,9541.0,1,,1,10839,,14839,,,BAO_0000218,CHEMBL626968,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,In vivo,N,1969.0,Plasma,100710,Macaca fascicularis,Intermediate
,,,A,10116.0,1,,1,10840,,8418,,,BAO_0000218,CHEMBL626969,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10841,,8418,,,BAO_0000218,CHEMBL627126,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10842,,8418,,,BAO_0000218,CHEMBL631276,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10843,,8418,,,BAO_0000218,CHEMBL631277,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10844,,8418,,,BAO_0000218,CHEMBL631278,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10845,,8418,,,BAO_0000218,CHEMBL874457,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10846,,8418,,,BAO_0000218,CHEMBL631279,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10847,,8418,,,BAO_0000218,CHEMBL631280,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10848,,8418,,,BAO_0000218,CHEMBL631281,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10849,,8418,,,BAO_0000218,CHEMBL631968,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10850,,8418,,,BAO_0000218,CHEMBL631969,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10851,,8418,,,BAO_0000218,CHEMBL631970,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10852,,8418,,,BAO_0000218,CHEMBL631971,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10853,,8418,,,BAO_0000218,CHEMBL631972,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10854,,8418,,,BAO_0000218,CHEMBL630435,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10855,,8418,,,BAO_0000218,CHEMBL630436,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10856,,8418,,,BAO_0000218,CHEMBL630437,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10857,,8418,,,BAO_0000218,CHEMBL630438,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10858,,8418,,,BAO_0000218,CHEMBL630439,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10859,,8418,,,BAO_0000218,CHEMBL630440,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10860,,8418,,,BAO_0000218,CHEMBL630441,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10861,,8418,,,BAO_0000218,CHEMBL630442,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10862,,8418,,,BAO_0000218,CHEMBL625234,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10863,,8418,,,BAO_0000218,CHEMBL625235,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10864,,8418,,,BAO_0000218,CHEMBL625236,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10865,,8418,,,BAO_0000218,CHEMBL625237,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10866,,8418,,,BAO_0000218,CHEMBL626125,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10867,,8418,,,BAO_0000218,CHEMBL626126,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10868,,8418,,,BAO_0000218,CHEMBL626127,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10869,,8418,,,BAO_0000218,CHEMBL626128,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10870,,8418,,,BAO_0000218,CHEMBL626129,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10871,,8418,,,BAO_0000218,CHEMBL626130,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10872,,8418,,,BAO_0000218,CHEMBL626131,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10873,,8418,,,BAO_0000218,CHEMBL626132,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10874,,8418,,,BAO_0000218,CHEMBL626752,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10875,,8418,,,BAO_0000218,CHEMBL626753,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10876,,8418,,,BAO_0000218,CHEMBL626754,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10877,,8418,,,BAO_0000218,CHEMBL626755,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10878,,8418,,,BAO_0000218,CHEMBL626756,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10879,,8418,,,BAO_0000218,CHEMBL626757,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10880,,8418,,,BAO_0000218,CHEMBL626758,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10881,,8418,,,BAO_0000218,CHEMBL626759,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10882,,8418,,,BAO_0000218,CHEMBL626760,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,10883,,6996,,,BAO_0000218,CHEMBL626394,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10884,,6996,,,BAO_0000218,CHEMBL626395,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10885,,6996,,,BAO_0000218,CHEMBL626396,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10886,,6996,,,BAO_0000218,CHEMBL626397,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10887,,6996,,,BAO_0000218,CHEMBL626398,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10888,,6996,,,BAO_0000218,CHEMBL626399,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,10889,,6996,,,BAO_0000218,CHEMBL874653,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10890,,6996,,,BAO_0000218,CHEMBL626400,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10891,,6996,,,BAO_0000218,CHEMBL626401,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10892,,6996,,,BAO_0000218,CHEMBL626402,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10893,,6996,,,BAO_0000218,CHEMBL626403,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10894,,6996,,,BAO_0000218,CHEMBL626404,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10895,,6996,,,BAO_0000218,CHEMBL626405,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10896,,6996,,,BAO_0000218,CHEMBL625529,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10897,,6996,,,BAO_0000218,CHEMBL625530,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10898,,6996,,,BAO_0000218,CHEMBL625531,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10899,,6996,,,BAO_0000218,CHEMBL625532,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10900,,6996,,,BAO_0000218,CHEMBL625533,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10901,,6996,,,BAO_0000218,CHEMBL875474,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10902,,6996,,,BAO_0000218,CHEMBL625534,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10903,,6996,,,BAO_0000218,CHEMBL625535,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10904,,6996,,,BAO_0000218,CHEMBL625536,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10905,,6996,,,BAO_0000218,CHEMBL625537,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10906,,6996,,,BAO_0000218,CHEMBL625538,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10907,,6996,,,BAO_0000218,CHEMBL625539,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10908,,6996,,,BAO_0000218,CHEMBL625540,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10909,,6996,,,BAO_0000218,CHEMBL625541,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10910,,6996,,,BAO_0000218,CHEMBL625542,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10911,,6996,,,BAO_0000218,CHEMBL625543,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10912,,6996,,,BAO_0000218,CHEMBL625544,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,10913,,6996,,,BAO_0000218,CHEMBL625545,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10914,,6996,,,BAO_0000218,CHEMBL625546,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10915,,6996,,,BAO_0000218,CHEMBL625547,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10916,,6996,,,BAO_0000218,CHEMBL625548,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10917,,6996,,,BAO_0000218,CHEMBL625549,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10918,,6996,,,BAO_0000218,CHEMBL625550,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10919,,6996,,,BAO_0000218,CHEMBL625551,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10920,,6996,,,BAO_0000218,CHEMBL875475,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10921,,6996,,,BAO_0000218,CHEMBL625552,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10922,,6996,,,BAO_0000218,CHEMBL625553,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10923,,6996,,,BAO_0000218,CHEMBL625554,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10924,,6996,,,BAO_0000218,CHEMBL625555,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10925,,6996,,,BAO_0000218,CHEMBL625556,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10926,,6996,,,BAO_0000218,CHEMBL624986,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10927,,6996,,,BAO_0000218,CHEMBL624987,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10928,,6996,,,BAO_0000218,CHEMBL624988,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10929,,9025,,,BAO_0000218,CHEMBL624989,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10930,,9025,,,BAO_0000218,CHEMBL624990,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10931,,9025,,,BAO_0000218,CHEMBL874391,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10932,,9025,,,BAO_0000218,CHEMBL624991,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10933,,9025,,,BAO_0000218,CHEMBL624992,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10934,,9025,,,BAO_0000218,CHEMBL624993,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10935,,9025,,,BAO_0000218,CHEMBL624994,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10936,,9025,,,BAO_0000218,CHEMBL624995,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10937,,9025,,,BAO_0000218,CHEMBL624996,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10938,,9025,,,BAO_0000218,CHEMBL624997,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10939,,9025,,,BAO_0000218,CHEMBL624998,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10940,,9025,,,BAO_0000218,CHEMBL624999,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10941,,9025,,,BAO_0000218,CHEMBL882955,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10942,,9025,,,BAO_0000218,CHEMBL625000,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10943,,9025,,,BAO_0000218,CHEMBL625001,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10944,,9025,,,BAO_0000218,CHEMBL625089,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10945,,9025,,,BAO_0000218,CHEMBL625090,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10946,,9025,,,BAO_0000218,CHEMBL625091,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10947,,9025,,,BAO_0000218,CHEMBL625092,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10948,,9025,,,BAO_0000218,CHEMBL625093,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10949,,9025,,,BAO_0000218,CHEMBL625094,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10950,,9025,,,BAO_0000218,CHEMBL625095,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,10951,,2249,,,BAO_0000218,CHEMBL625096,Compound was evaluated for its bioavailability in the dogs,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,10952,,2249,,,BAO_0000218,CHEMBL625097,Compound was evaluated for its bioavailability in the rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,10953,,17515,,,BAO_0000218,CHEMBL882956,Compound was evaluated for oral bioavailability,In vivo,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,10954,,14541,,,BAO_0000218,CHEMBL625098,Compound was evaluated for percentage of Oral bioavailability in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10141.0,0,,1,10955,,12797,,,BAO_0000218,CHEMBL625099,Bioavailability in guinea pig,In vivo,U,,,22224,Cavia porcellus,Autocuration
,,,A,10116.0,1,,1,10956,,12797,,,BAO_0000218,CHEMBL625100,Compound was evaluated for the oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,10957,,12797,,,BAO_0000218,CHEMBL625101,Compound was evaluated for the oral bioavailability in dog,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,10958,,12797,,,BAO_0000218,CHEMBL874396,Compound was evaluated for the oral bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,F,9615.0,0,,1,10959,,11727,,,BAO_0000218,CHEMBL625102,Bioavailability in dog (dosed i.v.),In vivo,U,,,22224,Canis lupus familiaris,Autocuration
,,,A,9615.0,1,,1,10960,,13249,,,BAO_0000218,CHEMBL625103,Compound was tested for in vivo bioavailability in dog,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10026.0,1,,1,10961,,13249,,,BAO_0000218,CHEMBL625104,Compound was tested for in vivo bioavailability in hamsters,In vivo,N,,,100712,Cricetinae,Intermediate
,,,A,314293.0,0,,1,10962,,13249,,,BAO_0000218,CHEMBL625105,Compound was tested for in vivo bioavailability in monkey,In vivo,U,,,22224,Simiiformes,Autocuration
,,,A,10116.0,1,,1,10963,,13249,,,BAO_0000218,CHEMBL625106,Compound was tested for in vivo bioavailability in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,0,,1,10964,,9552,,,BAO_0000218,CHEMBL625107,Oral bioavailability in mouse,In vivo,U,,,22224,Mus musculus,Autocuration
,,,A,10090.0,1,,1,10965,,9552,,,BAO_0000218,CHEMBL625108,Compound was tested for percent of oral bioavailability in mice; 56-74,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,0,,1,10966,,14839,,,BAO_0000218,CHEMBL625109,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),In vivo,U,,,22224,Mus musculus,Autocuration
,,,A,9541.0,0,,1,10967,,14839,,,BAO_0000218,CHEMBL625110,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),In vivo,U,,,22224,Macaca fascicularis,Autocuration
,,,A,9541.0,0,,1,10968,,14839,,,BAO_0000218,CHEMBL625111,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),In vivo,U,,,22224,Macaca fascicularis,Autocuration
,,,A,10090.0,1,,1,10969,,14839,,,BAO_0000218,CHEMBL625112,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,10970,,14839,,,BAO_0000218,CHEMBL875334,Oral bioavailability in nude mice,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,9443.0,0,,1,10971,,11219,,,BAO_0000218,CHEMBL628617,Bioavailability in monkey (i.d. dosing),In vivo,U,,,22224,Primates,Autocuration
,,,A,10116.0,0,,1,10972,,9552,,,BAO_0000218,CHEMBL628618,Bioavailability in rat,In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,,0,,1,10973,,11732,,,BAO_0000218,CHEMBL628619,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,10974,,11732,,,BAO_0000218,CHEMBL628620,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,In vivo,U,,,22224,,Autocuration
,,,A,9541.0,1,,1,10975,,14839,,,BAO_0000218,CHEMBL628621,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",In vivo,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,10976,,14839,,,BAO_0000218,CHEMBL628622,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",In vivo,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,10977,,14839,,,BAO_0000218,CHEMBL628623,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",In vivo,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,10978,,14839,,,BAO_0000218,CHEMBL628624,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,In vivo,N,1969.0,Plasma,100710,Macaca fascicularis,Intermediate
,,,A,10090.0,1,,1,10979,,14839,,,BAO_0000218,CHEMBL628625,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,9541.0,1,,1,10980,,14839,,,BAO_0000218,CHEMBL628626,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,In vivo,N,1969.0,Plasma,100710,Macaca fascicularis,Intermediate
,,,A,10090.0,1,,1,10981,,14839,,,BAO_0000218,CHEMBL627041,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,10982,,14839,,,BAO_0000218,CHEMBL627042,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,10983,,14839,,,BAO_0000218,CHEMBL627043,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,,0,,1,10984,,13932,,,BAO_0000218,CHEMBL627044,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,10090.0,1,,1,10985,,11637,,,BAO_0000218,CHEMBL627045,Cmax in mouse plasma,In vivo,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,,0,,1,10986,,11637,,,BAO_0000218,CHEMBL627046,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,10116.0,1,,1,10987,,13960,,,BAO_0000218,CHEMBL627047,Maximal plasma concentration in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10988,,15905,,,BAO_0000218,CHEMBL627048,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10989,,14062,,,BAO_0000218,CHEMBL627049,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10990,,14062,,,BAO_0000218,CHEMBL627050,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10991,,14062,,,BAO_0000218,CHEMBL627051,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10992,,14062,,,BAO_0000218,CHEMBL627052,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10993,,14062,,,BAO_0000218,CHEMBL627053,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,10994,,14062,,,BAO_0000218,CHEMBL627054,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,10995,,15011,,,BAO_0000218,CHEMBL627055,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,10996,,15011,,,BAO_0000218,CHEMBL627056,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,10997,,15011,,,BAO_0000218,CHEMBL627057,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,10998,,15011,,,BAO_0000218,CHEMBL627058,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,10999,,15011,,,BAO_0000218,CHEMBL626211,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,,0,,1,11000,,10291,,,BAO_0000218,CHEMBL626212,Maximum Concentration of the compound.,In vivo,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,11001,,14599,,,BAO_0000218,CHEMBL626213,Maximum Concentration was measured after iv administration into Beagle dog,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11002,,14599,,,BAO_0000218,CHEMBL626214,Maximum Concentration was measured after iv administration into Beagle dog.,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11003,,14599,,,BAO_0000218,CHEMBL626215,Maximum Concentration was measured after po administration into Beagle dog,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11004,,14599,,,BAO_0000218,CHEMBL626216,Maximum Concentration was measured after po administration into Beagle dog.,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,11005,,12767,,,BAO_0000218,CHEMBL626217,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,In vivo,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,11006,,12767,,,BAO_0000218,CHEMBL626218,Maximum blood level reached after an iv dose of 12.2 uM/kg,In vivo,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,11007,,12767,,,BAO_0000218,CHEMBL626219,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,In vivo,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,11008,,12767,,,BAO_0000218,CHEMBL626220,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,In vivo,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,11009,,12767,,,BAO_0000218,CHEMBL626221,Maximum blood level reached after an oral dose of 5.0 mg/kg,In vivo,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,11010,,12767,,,BAO_0000218,CHEMBL626222,Maximum blood level reached at dose of 10.6 uM/kg orally,In vivo,U,178.0,Blood,22224,,Autocuration
,,,A,10141.0,1,,1,11011,,14706,,,BAO_0000218,CHEMBL626223,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,In vivo,N,,,50512,Cavia porcellus,Intermediate
,,,A,10141.0,1,,1,11012,,14706,,,BAO_0000218,CHEMBL626224,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,In vivo,N,,,50512,Cavia porcellus,Intermediate
,,,A,10116.0,1,,1,11013,,14793,,,BAO_0000218,CHEMBL626225,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11014,,14793,,,BAO_0000218,CHEMBL626226,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11015,,14793,,,BAO_0000218,CHEMBL626227,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11016,,14793,,,BAO_0000218,CHEMBL626228,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11017,,14793,,,BAO_0000218,CHEMBL626229,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11018,,14793,,,BAO_0000218,CHEMBL626921,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11019,,14793,,,BAO_0000218,CHEMBL876793,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11020,,14793,,,BAO_0000218,CHEMBL625309,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,1423.0,1,,1,11021,,10524,,,BAO_0000218,CHEMBL625310,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),In vivo,N,,,50278,Bacillus subtilis,Intermediate
,,,A,314293.0,0,,1,11022,,11871,,,BAO_0000218,CHEMBL625311,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,In vivo,U,,,22224,Simiiformes,Autocuration
,,,A,10116.0,1,,1,11023,,11871,,,BAO_0000218,CHEMBL625312,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,11024,,3437,,,BAO_0000218,CHEMBL625313,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,In vivo,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,11025,,12038,,,BAO_0000218,CHEMBL625314,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,11026,,12038,,,BAO_0000218,CHEMBL625315,Maximum concentration in male rats after iv administration of 20 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11027,,8418,,,BAO_0000218,CHEMBL625316,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11028,,8418,,,BAO_0000218,CHEMBL625317,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11029,,8418,,,BAO_0000218,CHEMBL625318,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11030,,8418,,,BAO_0000218,CHEMBL625319,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11031,,8418,,,BAO_0000218,CHEMBL625320,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11032,,8418,,,BAO_0000218,CHEMBL625321,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11033,,8418,,,BAO_0000218,CHEMBL625322,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11034,,8418,,,BAO_0000218,CHEMBL876801,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11035,,8418,,,BAO_0000218,CHEMBL625323,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11036,,8418,,,BAO_0000218,CHEMBL625324,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11037,,8418,,,BAO_0000218,CHEMBL625325,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11038,,8418,,,BAO_0000218,CHEMBL625326,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11039,,8418,,,BAO_0000218,CHEMBL625327,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11040,,8418,,,BAO_0000218,CHEMBL625328,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11041,,8418,,,BAO_0000218,CHEMBL625329,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11042,,8418,,,BAO_0000218,CHEMBL625330,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11043,,8418,,,BAO_0000218,CHEMBL627774,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11044,,8418,,,BAO_0000218,CHEMBL627775,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11045,,8418,,,BAO_0000218,CHEMBL627949,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11046,,8418,,,BAO_0000218,CHEMBL627950,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11047,,8418,,,BAO_0000218,CHEMBL627951,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11048,,8418,,,BAO_0000218,CHEMBL627952,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11049,,8418,,,BAO_0000218,CHEMBL627953,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11050,,8418,,,BAO_0000218,CHEMBL627954,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11051,,8418,,,BAO_0000218,CHEMBL627955,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11052,,8418,,,BAO_0000218,CHEMBL627956,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11053,,8418,,,BAO_0000218,CHEMBL876802,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11054,,8418,,,BAO_0000218,CHEMBL627957,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11055,,8418,,,BAO_0000218,CHEMBL627958,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11056,,8418,,,BAO_0000218,CHEMBL627959,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11057,,8418,,,BAO_0000218,CHEMBL627960,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11058,,8418,,,BAO_0000218,CHEMBL627961,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11059,,8418,,,BAO_0000218,CHEMBL627962,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11060,,9796,,,BAO_0000218,CHEMBL627963,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11061,,9796,,,BAO_0000218,CHEMBL624759,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11062,,9796,,,BAO_0000218,CHEMBL624760,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11063,,9796,,,BAO_0000218,CHEMBL624761,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11064,,9796,,,BAO_0000218,CHEMBL877607,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11065,,9796,,,BAO_0000218,CHEMBL624762,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11066,,9796,,,BAO_0000218,CHEMBL624763,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11067,,9796,,,BAO_0000218,CHEMBL624764,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11068,,9796,,,BAO_0000218,CHEMBL624765,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11069,,9796,,,BAO_0000218,CHEMBL624766,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11070,,6996,,,BAO_0000218,CHEMBL624767,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11071,,6996,,,BAO_0000218,CHEMBL624768,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11072,,6996,,,BAO_0000218,CHEMBL624769,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11073,,6996,,,BAO_0000218,CHEMBL624770,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11074,,6996,,,BAO_0000218,CHEMBL624771,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11075,,6996,,,BAO_0000218,CHEMBL624772,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,11076,,6996,,,BAO_0000218,CHEMBL624773,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11077,,6996,,,BAO_0000218,CHEMBL624774,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11078,,6996,,,BAO_0000218,CHEMBL624775,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11079,,6996,,,BAO_0000218,CHEMBL624776,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11080,,6996,,,BAO_0000218,CHEMBL624777,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11081,,6996,,,BAO_0000218,CHEMBL624778,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11082,,6996,,,BAO_0000218,CHEMBL624779,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11083,,6996,,,BAO_0000218,CHEMBL624780,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11084,,6996,,,BAO_0000218,CHEMBL624781,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11085,,6996,,,BAO_0000218,CHEMBL877608,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11086,,6996,,,BAO_0000218,CHEMBL624782,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11087,,6996,,,BAO_0000218,CHEMBL624783,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11088,,6996,,,BAO_0000218,CHEMBL624784,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11089,,6996,,,BAO_0000218,CHEMBL624785,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11090,,6996,,,BAO_0000218,CHEMBL624786,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11091,,6996,,,BAO_0000218,CHEMBL624787,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11092,,6996,,,BAO_0000218,CHEMBL628676,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11093,,6996,,,BAO_0000218,CHEMBL621842,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11094,,6996,,,BAO_0000218,CHEMBL621843,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11095,,6996,,,BAO_0000218,CHEMBL623873,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11096,,6996,,,BAO_0000218,CHEMBL623874,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11097,,6996,,,BAO_0000218,CHEMBL623875,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11098,,6996,,,BAO_0000218,CHEMBL623876,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11099,,6996,,,BAO_0000218,CHEMBL623877,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11100,,6996,,,BAO_0000218,CHEMBL623878,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11101,,6996,,,BAO_0000218,CHEMBL623879,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11102,,6996,,,BAO_0000218,CHEMBL623880,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11103,,6996,,,BAO_0000218,CHEMBL623881,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11104,,6996,,,BAO_0000218,CHEMBL623957,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11105,,6996,,,BAO_0000218,CHEMBL623958,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11106,,6996,,,BAO_0000218,CHEMBL623959,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11107,,6996,,,BAO_0000218,CHEMBL623960,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11108,,6996,,,BAO_0000218,CHEMBL623961,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11109,,6996,,,BAO_0000218,CHEMBL623962,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11110,,6996,,,BAO_0000218,CHEMBL624676,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11111,,6996,,,BAO_0000218,CHEMBL624677,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11112,,6996,,,BAO_0000218,CHEMBL624678,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11113,,6996,,,BAO_0000218,CHEMBL624679,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11114,,6996,,,BAO_0000218,CHEMBL624680,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,11115,,11732,,,BAO_0000218,CHEMBL624849,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,11116,,11732,,,BAO_0000218,CHEMBL624850,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,11117,,11732,,,BAO_0000218,CHEMBL874399,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,11118,,11732,,,BAO_0000218,CHEMBL624851,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,11119,,11732,,,BAO_0000218,CHEMBL624852,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,In vivo,U,,,22224,,Autocuration
,,,A,10116.0,0,,1,11120,,13359,,,BAO_0000218,CHEMBL624853,Oral bioavailability in rat (dose 10 mg/kg),In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,10116.0,0,,1,11121,,16618,,,BAO_0000218,CHEMBL624854,Oral bioavailability in rat (Sprague-Dawley),In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,10116.0,0,,1,11122,,13960,,,BAO_0000218,CHEMBL624855,Oral bioavailability in rat,In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,10116.0,0,,1,11123,,13917,,,BAO_0000218,CHEMBL624856,Oral bioavailability in rats was determined in vivo,In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,9615.0,0,,1,11124,,14266,,,BAO_0000218,CHEMBL882957,Oral bioavailability in dog,In vivo,U,,,22224,Canis lupus familiaris,Autocuration
,,,A,314293.0,0,,1,11125,,12359,,,BAO_0000218,CHEMBL624857,Oral bioavailability of compound in monkey,In vivo,U,,,22224,Simiiformes,Autocuration
,,,A,10116.0,1,,1,11126,,12359,,,BAO_0000218,CHEMBL622202,Oral bioavailability of compound in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,0,,1,11127,,12359,,,BAO_0000218,CHEMBL622203,Bioavailability in rat of PMEA prodrug,In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,10116.0,1,,1,11128,,12359,,,BAO_0000218,CHEMBL625522,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9544.0,0,,1,11129,,10791,,,BAO_0000218,CHEMBL622868,Serum conc at 3 hours following 25 mg/kg dose,In vivo,U,,,22224,Macaca mulatta,Autocuration
,,,A,9544.0,0,,1,11130,,10791,,,BAO_0000218,CHEMBL622869,Urine conc 0-5 hours following 25 mg/kg dose,In vivo,U,1088.0,Urine,22224,Macaca mulatta,Autocuration
,,,A,9544.0,0,,1,11131,,10791,,,BAO_0000218,CHEMBL622870,Urine conc 0-24 hours following 25 mg/kg dose,In vivo,U,1088.0,Urine,22224,Macaca mulatta,Autocuration
,,,A,9534.0,0,,1,11132,,138,,,BAO_0000218,CHEMBL622871,Oral bioavailability in African green monkeys; 20-25,In vivo,U,,,22224,Chlorocebus aethiops,Autocuration
,,,A,9541.0,1,,1,11133,,14521,,,BAO_0000218,CHEMBL620560,Oral bioavailability in cynomolgus monkey.,In vivo,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9615.0,0,,1,11134,,13953,,,BAO_0000218,CHEMBL620561,Oral bioavailability in dog,In vivo,U,,,22224,Canis lupus familiaris,Autocuration
,,,A,9615.0,1,,1,11135,,12836,,,BAO_0000218,CHEMBL620562,Oral bioavailability in dog at 10 mg/kg oral dose,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10026.0,1,,1,11136,,12836,,,BAO_0000218,CHEMBL620563,Oral bioavailability in hamster at 10 mg/kg oral dose,In vivo,N,,,100712,Cricetinae,Intermediate
,,,A,10116.0,1,,1,11137,,12836,,,BAO_0000218,CHEMBL620564,Oral bioavailability in rat at 10 mg/kg oral dose,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,0,,1,11138,,14521,,,BAO_0000218,CHEMBL872265,Oral bioavailability in rat,In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,10116.0,0,,1,11139,,13953,,,BAO_0000218,CHEMBL620565,Oral bioavailability in rat,In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,9347.0,0,,1,11140,,6799,,,BAO_0000218,CHEMBL620566,Oral bioavailability,In vivo,U,,,22224,Eutheria,Autocuration
,,,A,,0,,1,11141,,11311,,,BAO_0000218,CHEMBL620567,Oral bioavailability was determined; range 49-102%,In vivo,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,11142,,4013,,,BAO_0000218,CHEMBL620568,Oral bioavailability was determined in dogs,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,0,,1,11143,,4013,,,BAO_0000218,CHEMBL620569,Oral bioavailability in rat,In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,9347.0,0,,1,11144,,17591,,,BAO_0000218,CHEMBL620570,Oral bioavailability,In vivo,U,,,22224,Eutheria,Autocuration
,,,A,,0,,1,11145,,17591,,,BAO_0000218,CHEMBL620571,Oral bioavailability was determined; Not orally available,In vivo,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,11146,,15011,,,BAO_0000218,CHEMBL620572,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,0,,1,11147,,15011,,,BAO_0000218,CHEMBL620573,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),In vivo,U,,,22224,Mus musculus,Autocuration
,,,A,10090.0,0,,1,11148,,15011,,,BAO_0000218,CHEMBL620574,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,In vivo,U,,,22224,Mus musculus,Autocuration
,,,A,9544.0,0,,1,11149,,9552,,,BAO_0000218,CHEMBL620575,Oral bioavailability in Rhesus monkey,In vivo,U,,,22224,Macaca mulatta,Autocuration
,,,A,9615.0,0,,1,11150,,9552,,,BAO_0000218,CHEMBL620576,Oral bioavailability in dog (female mongrel),In vivo,U,,,22224,Canis lupus familiaris,Autocuration
,,,A,,0,,1,11151,,3639,,,BAO_0000218,CHEMBL875846,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,In vivo,U,,,22224,,Autocuration
,,,A,9615.0,0,,1,11152,,13397,,,BAO_0000218,CHEMBL620577,Oral bioavailability in dog,In vivo,U,,,22224,Canis lupus familiaris,Autocuration
,,,A,,0,,1,11153,,3031,,,BAO_0000218,CHEMBL620578,Percentage Bioavailability was evaluated.,In vivo,U,,,22224,,Autocuration
,,,A,10116.0,0,,1,11154,,12818,,,BAO_0000218,CHEMBL620579,Bioavailability in rat administered i.d.,In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,9347.0,0,,1,11155,,4847,,,BAO_0000218,CHEMBL621248,Bioavailability,In vivo,U,,,22224,Eutheria,Autocuration
,,,A,9615.0,0,,1,11156,,12421,,,BAO_0000218,CHEMBL625390,Bioavailability in dog (male Beagle) i.v. administration,In vivo,U,,,22224,Canis lupus familiaris,Autocuration
,,,A,10116.0,0,,1,11157,,11966,,,BAO_0000218,CHEMBL625391,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,9443.0,0,,1,11158,,11218,,,BAO_0000218,CHEMBL872266,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),In vivo,U,,,22224,Primates,Autocuration
,,,A,10116.0,0,,1,11159,,13129,,,BAO_0000218,CHEMBL625392,Oral bioavailability in rat (Sprague-Dawley) (male),In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,10116.0,1,,1,11160,,12350,,,BAO_0000218,CHEMBL625393,The oral bioavailability was measured on rats after oral administration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11161,,2231,,,BAO_0000218,CHEMBL625394,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9544.0,1,,1,11162,,2231,,,BAO_0000218,CHEMBL625395,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,In vivo,N,,,50797,Macaca mulatta,Intermediate
,,,A,10116.0,0,,1,11163,,12187,,,BAO_0000218,CHEMBL625396,Bioavailability in rat (dose 10 mg/kg i.d.),In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,9615.0,0,,1,11164,,12421,,,BAO_0000218,CHEMBL625397,Bioavailability in dog (male Beagle) i.v. administration,In vivo,U,,,22224,Canis lupus familiaris,Autocuration
,,,A,10090.0,1,,1,11165,,13256,,,BAO_0000218,CHEMBL625398,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11166,,13256,,,BAO_0000218,CHEMBL625399,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11167,,13256,,,BAO_0000218,CHEMBL626074,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,2037.0,Cerebellum,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11168,,13256,,,BAO_0000218,CHEMBL626075,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,11169,,2231,,,BAO_0000218,CHEMBL626076,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9544.0,1,,1,11170,,2231,,,BAO_0000218,CHEMBL626077,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,In vivo,N,1969.0,Plasma,50797,Macaca mulatta,Intermediate
,,,A,10116.0,1,,1,11171,,12178,,,BAO_0000218,CHEMBL626078,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,11172,,12178,,,BAO_0000218,CHEMBL625846,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),In vivo,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,11173,,12178,,,BAO_0000218,CHEMBL625847,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),In vivo,U,178.0,Blood,22224,,Autocuration
,,,A,10116.0,1,,1,11174,,15633,,,BAO_0000218,CHEMBL625848,Maximum concentration observed in rats at an oral dose of 50 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Expert
,,,A,10116.0,1,,1,11175,,14258,,,BAO_0000218,CHEMBL625849,Maximum concentration of compound in plasma administered orally to rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11176,,14224,,,BAO_0000218,CHEMBL626023,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11177,,14224,,,BAO_0000218,CHEMBL626024,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11178,,14224,,,BAO_0000218,CHEMBL626025,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,11179,,5566,,,BAO_0000218,CHEMBL626026,Maximum concentration after 10 mg/kg by oral administration,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,11180,,16935,,,BAO_0000218,CHEMBL626027,Maximum concentration at a dose of 1.5 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,11181,,16935,,,BAO_0000218,CHEMBL626028,Maximum concentration at a dose of 2.0 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,11182,,14224,,,BAO_0000218,CHEMBL626029,Maximum concentration in dog plasma,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,11183,,12536,,,BAO_0000218,CHEMBL626030,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,11184,,12536,,,BAO_0000218,CHEMBL626031,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,11185,,12536,,,BAO_0000218,CHEMBL626032,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,11186,,12536,,,BAO_0000218,CHEMBL626033,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,11187,,12536,,,BAO_0000218,CHEMBL626034,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,9615.0,1,,1,11188,,9994,,,BAO_0000218,CHEMBL626035,Maximum concentration in plasma after oral administration in dog (25 mg/kg),In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,11189,,1434,,,BAO_0000218,CHEMBL626036,Maximum concentration in plasma at Tmax,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,9615.0,1,,1,11190,,12836,,,BAO_0000218,CHEMBL626037,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Expert
,,,A,10026.0,1,,1,11191,,12836,,,BAO_0000218,CHEMBL626038,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,In vivo,N,1969.0,Plasma,100712,Cricetinae,Intermediate
,,,A,10116.0,1,,1,11192,,12836,,,BAO_0000218,CHEMBL626039,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11193,,12545,,,BAO_0000218,CHEMBL626040,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9986.0,1,,1,11194,,13856,,,BAO_0000218,CHEMBL626041,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,In vivo,N,1969.0,Plasma,50592,Oryctolagus cuniculus,Intermediate
,,,A,,0,,1,11195,,3550,,,BAO_0000218,CHEMBL626042,Maximum concentration was calculated,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,11196,,2632,,,BAO_0000218,CHEMBL626043,Maximum concentration was calculated.,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,11197,,5566,,,BAO_0000218,CHEMBL626044,Maximum concentration at a peroral dose of 10 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,11198,,11883,,,BAO_0000218,CHEMBL626045,Maximum concentration of the drug at 10 uM/dg administered perorally,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,11199,,11883,,,BAO_0000218,CHEMBL626046,Maximum concentration of the drug at 2 uM/dg administered intravenously,In vivo,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,11200,,14122,,,BAO_0000218,CHEMBL626047,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10026.0,1,,1,11201,,14122,,,BAO_0000218,CHEMBL626048,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",In vivo,N,1969.0,Plasma,100712,Cricetinae,Intermediate
,,,A,10116.0,1,,1,11202,,14122,,,BAO_0000218,CHEMBL626049,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11203,,12542,,,BAO_0000218,CHEMBL626050,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11204,,12542,,,BAO_0000218,CHEMBL874541,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10026.0,1,,1,11205,,12542,,,BAO_0000218,CHEMBL622826,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,In vivo,N,1969.0,Plasma,100712,Cricetinae,Intermediate
,,,A,10026.0,1,,1,11206,,12542,,,BAO_0000218,CHEMBL622827,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,In vivo,N,1969.0,Plasma,100712,Cricetinae,Intermediate
,,,A,10116.0,1,,1,11207,,12542,,,BAO_0000218,CHEMBL622828,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11208,,14080,,,BAO_0000218,CHEMBL622829,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11209,,11911,,,BAO_0000218,CHEMBL876806,Maximum concentration reached following intravenous administration in male rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11210,,13204,,,BAO_0000218,CHEMBL622830,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,11211,,13204,,,BAO_0000218,CHEMBL622831,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11212,,14346,,,BAO_0000218,CHEMBL626794,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,11213,,14346,,,BAO_0000218,CHEMBL626795,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11214,,14346,,,BAO_0000218,CHEMBL626796,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11215,,14346,,,BAO_0000218,CHEMBL626797,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11216,,14127,,,BAO_0000218,CHEMBL626798,Maximum drug concentration is determined after oral dosing in rats.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11217,,14339,,,BAO_0000218,CHEMBL626799,Maximum observed concentration in oral (5 mg/kg) fasted dogs,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11218,,14339,,,BAO_0000218,CHEMBL626800,Maximum observed concentration in oral (5 mg/kg) fed dogs,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,11219,,13494,,,BAO_0000218,CHEMBL626801,Maximum plasma concentration,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,10116.0,1,,1,11220,,14925,,,BAO_0000218,CHEMBL876816,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11221,,14474,,,BAO_0000218,CHEMBL626802,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11222,,14474,,,BAO_0000218,CHEMBL626803,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,11223,,13917,,,BAO_0000218,CHEMBL626804,Maximum plasma concentration following oral administration of 30 umol/kg,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,10116.0,1,,1,11224,,9796,,,BAO_0000218,CHEMBL626805,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11225,,9796,,,BAO_0000218,CHEMBL626309,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11226,,9796,,,BAO_0000218,CHEMBL626310,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11227,,9796,,,BAO_0000218,CHEMBL626311,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11228,,9796,,,BAO_0000218,CHEMBL626312,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11229,,9796,,,BAO_0000218,CHEMBL626313,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11230,,9796,,,BAO_0000218,CHEMBL626314,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11231,,9796,,,BAO_0000218,CHEMBL626315,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11232,,9796,,,BAO_0000218,CHEMBL626316,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11233,,9796,,,BAO_0000218,CHEMBL626317,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11234,,8363,,,BAO_0000218,CHEMBL626318,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11235,,8363,,,BAO_0000218,CHEMBL626319,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11236,,8363,,,BAO_0000218,CHEMBL626320,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11237,,8363,,,BAO_0000218,CHEMBL875053,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11238,,8363,,,BAO_0000218,CHEMBL626321,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11239,,8363,,,BAO_0000218,CHEMBL626322,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11240,,8363,,,BAO_0000218,CHEMBL626323,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11241,,8363,,,BAO_0000218,CHEMBL626324,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11242,,8363,,,BAO_0000218,CHEMBL626325,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11243,,8363,,,BAO_0000218,CHEMBL626326,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11244,,8363,,,BAO_0000218,CHEMBL626327,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11245,,8363,,,BAO_0000218,CHEMBL626328,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11246,,8684,,,BAO_0000218,CHEMBL626329,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11247,,8684,,,BAO_0000218,CHEMBL626330,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11248,,8684,,,BAO_0000218,CHEMBL626331,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11249,,8684,,,BAO_0000218,CHEMBL626332,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11250,,8684,,,BAO_0000218,CHEMBL626333,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11251,,8684,,,BAO_0000218,CHEMBL626334,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11252,,8684,,,BAO_0000218,CHEMBL626335,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11253,,8684,,,BAO_0000218,CHEMBL624798,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11254,,8684,,,BAO_0000218,CHEMBL624799,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11255,,8684,,,BAO_0000218,CHEMBL624800,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11256,,8684,,,BAO_0000218,CHEMBL624801,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11257,,8684,,,BAO_0000218,CHEMBL624802,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11258,,8684,,,BAO_0000218,CHEMBL624803,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11259,,8684,,,BAO_0000218,CHEMBL624804,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11260,,8684,,,BAO_0000218,CHEMBL624805,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11261,,8684,,,BAO_0000218,CHEMBL624806,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11262,,8684,,,BAO_0000218,CHEMBL624807,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11263,,8684,,,BAO_0000218,CHEMBL624808,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11264,,8684,,,BAO_0000218,CHEMBL624809,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11265,,8684,,,BAO_0000218,CHEMBL624810,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11266,,8684,,,BAO_0000218,CHEMBL877618,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11267,,8684,,,BAO_0000218,CHEMBL624811,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11268,,8684,,,BAO_0000218,CHEMBL624812,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11269,,8684,,,BAO_0000218,CHEMBL624813,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11270,,8684,,,BAO_0000218,CHEMBL624814,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11271,,8684,,,BAO_0000218,CHEMBL624815,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11272,,8684,,,BAO_0000218,CHEMBL624816,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11273,,8684,,,BAO_0000218,CHEMBL624817,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11274,,6996,,,BAO_0000218,CHEMBL624818,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11275,,6996,,,BAO_0000218,CHEMBL624819,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11276,,6996,,,BAO_0000218,CHEMBL624820,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11277,,6996,,,BAO_0000218,CHEMBL624821,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11278,,6996,,,BAO_0000218,CHEMBL624822,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11279,,6996,,,BAO_0000218,CHEMBL624823,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,562.0,1,,1,11280,,15599,,,BAO_0000218,CHEMBL624824,Observed diffusion coefficient in organic solvent for Escherichia coli,,N,,,50212,Escherichia coli,Intermediate
,,,A,10116.0,1,,1,11281,,9614,,,BAO_0000218,CHEMBL624825,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11282,,9614,,,BAO_0000218,CHEMBL624826,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11283,,9614,,,BAO_0000218,CHEMBL876817,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,2081.0,Cardiac atrium,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11284,,9614,,,BAO_0000218,CHEMBL624827,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,2081.0,Cardiac atrium,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11285,,9614,,,BAO_0000218,CHEMBL624828,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11286,,9614,,,BAO_0000218,CHEMBL624829,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11287,,9614,,,BAO_0000218,CHEMBL624830,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11288,,9614,,,BAO_0000218,CHEMBL624831,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11289,,9614,,,BAO_0000218,CHEMBL624832,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,2081.0,Cardiac atrium,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11290,,9614,,,BAO_0000218,CHEMBL624833,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,2081.0,Cardiac atrium,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11291,,9614,,,BAO_0000218,CHEMBL624834,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11292,,9614,,,BAO_0000218,CHEMBL624835,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11293,,9614,,,BAO_0000218,CHEMBL624836,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11294,,9614,,,BAO_0000218,CHEMBL624837,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11295,,9071,,,BAO_0000218,CHEMBL624838,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11296,,9071,,,BAO_0000218,CHEMBL622188,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11297,,9071,,,BAO_0000218,CHEMBL622189,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11298,,9071,,,BAO_0000218,CHEMBL622190,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11299,,9071,,,BAO_0000218,CHEMBL625170,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11300,,9071,,,BAO_0000218,CHEMBL625171,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11301,,9071,,,BAO_0000218,CHEMBL625172,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11302,,9071,,,BAO_0000218,CHEMBL625173,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11303,,9071,,,BAO_0000218,CHEMBL625174,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11304,,9071,,,BAO_0000218,CHEMBL625175,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11305,,9071,,,BAO_0000218,CHEMBL625176,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11306,,9071,,,BAO_0000218,CHEMBL625177,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11307,,9071,,,BAO_0000218,CHEMBL625178,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11308,,9071,,,BAO_0000218,CHEMBL625179,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11309,,9071,,,BAO_0000218,CHEMBL625180,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,11310,,10677,,,BAO_0000218,CHEMBL625181,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,11311,,9750,,,BAO_0000218,CHEMBL625182,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,N,1088.0,Urine,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,11312,,8319,,,BAO_0000218,CHEMBL625183,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11313,,8319,,,BAO_0000218,CHEMBL875848,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11314,,8319,,,BAO_0000218,CHEMBL622260,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11315,,8319,,,BAO_0000218,CHEMBL622261,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11316,,8319,,,BAO_0000218,CHEMBL622262,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11317,,8319,,,BAO_0000218,CHEMBL622263,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11318,,8319,,,BAO_0000218,CHEMBL622418,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11319,,8319,,,BAO_0000218,CHEMBL622419,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,11320,,13256,,,BAO_0000218,CHEMBL623388,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11321,,13256,,,BAO_0000218,CHEMBL623389,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11322,,13256,,,BAO_0000218,CHEMBL623390,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11323,,13256,,,BAO_0000218,CHEMBL623391,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11324,,13256,,,BAO_0000218,CHEMBL623392,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11325,,13256,,,BAO_0000218,CHEMBL623393,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,2037.0,Cerebellum,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11326,,13256,,,BAO_0000218,CHEMBL623394,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11327,,13256,,,BAO_0000218,CHEMBL618885,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11328,,13256,,,BAO_0000218,CHEMBL618886,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11329,,13256,,,BAO_0000218,CHEMBL618887,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11330,,13256,,,BAO_0000218,CHEMBL619535,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11331,,13256,,,BAO_0000218,CHEMBL619536,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11332,,13256,,,BAO_0000218,CHEMBL619537,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,2037.0,Cerebellum,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11333,,13256,,,BAO_0000218,CHEMBL619705,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11334,,13256,,,BAO_0000218,CHEMBL619706,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11335,,13256,,,BAO_0000218,CHEMBL619707,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11336,,13256,,,BAO_0000218,CHEMBL619708,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11337,,13256,,,BAO_0000218,CHEMBL625219,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11338,,13256,,,BAO_0000218,CHEMBL625220,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11339,,13256,,,BAO_0000218,CHEMBL625221,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,2037.0,Cerebellum,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11340,,13256,,,BAO_0000218,CHEMBL625222,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11341,,13256,,,BAO_0000218,CHEMBL625223,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11342,,13256,,,BAO_0000218,CHEMBL625224,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11343,,13256,,,BAO_0000218,CHEMBL625225,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,11344,,8829,,,BAO_0000218,CHEMBL625226,Biodistribution in Rat blood after 24 hours of iv administration,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11345,,8829,,,BAO_0000218,CHEMBL625227,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11346,,8829,,,BAO_0000218,CHEMBL625228,Biodistribution in Rat blood after 30 minutes of iv administration,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11347,,8829,,,BAO_0000218,CHEMBL875354,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11348,,8829,,,BAO_0000218,CHEMBL625229,Biodistribution in Rat blood after 5 minutes of iv administration,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11349,,8829,,,BAO_0000218,CHEMBL625230,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11350,,8829,,,BAO_0000218,CHEMBL625231,Biodistribution in Rat heart after 24 hours of iv administration,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11351,,8829,,,BAO_0000218,CHEMBL625900,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11352,,8829,,,BAO_0000218,CHEMBL625901,Biodistribution in Rat heart after 30 minutes of iv administration,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11353,,8829,,,BAO_0000218,CHEMBL625902,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11354,,8829,,,BAO_0000218,CHEMBL625903,Biodistribution in Rat heart after 5 minutes of iv administration,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11355,,8829,,,BAO_0000218,CHEMBL625904,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11356,,8829,,,BAO_0000218,CHEMBL625905,Biodistribution in Rat liver after 24 hours of iv administration,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11357,,8829,,,BAO_0000218,CHEMBL627861,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11358,,8829,,,BAO_0000218,CHEMBL627862,Biodistribution in Rat liver after 30 minutes of iv administration,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11359,,8829,,,BAO_0000218,CHEMBL627863,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11360,,8829,,,BAO_0000218,CHEMBL627769,Biodistribution in Rat liver after 30 minutes of iv administration,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11361,,13249,,,BAO_0000218,CHEMBL627770,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,9541.0,1,,1,11362,,13622,,,BAO_0000218,CHEMBL627771,Cmax in cynomolgus monkey (PO dose),In vivo,N,,,100710,Macaca fascicularis,Intermediate
,,,A,10116.0,1,,1,11363,,13622,,,BAO_0000218,CHEMBL627772,Cmax in rat (PO dose),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11364,,13622,,,BAO_0000218,CHEMBL627773,Cmax in rat (PO dose),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11365,,13494,,,BAO_0000218,CHEMBL621922,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11366,,12170,,,BAO_0000218,CHEMBL621923,Cmax in rat plasma after oral dose (10 mg/kg),In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,11367,,12170,,,BAO_0000218,CHEMBL621924,Cmax in plasma after oral dose (10 mg/kg),In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,9615.0,1,,1,11368,,17025,,,BAO_0000218,CHEMBL621925,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,314293.0,0,,1,11369,,17025,,,BAO_0000218,CHEMBL621926,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,In vivo,U,1969.0,Plasma,22224,Simiiformes,Autocuration
,,,A,9986.0,1,,1,11370,,17025,,,BAO_0000218,CHEMBL621927,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,In vivo,N,1969.0,Plasma,50592,Oryctolagus cuniculus,Intermediate
,,,A,10116.0,1,,1,11371,,17025,,,BAO_0000218,CHEMBL621928,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11372,,14187,,,BAO_0000218,CHEMBL621929,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,11373,,14816,,,BAO_0000218,CHEMBL621930,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,In vivo,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,11374,,17820,,,BAO_0000218,CHEMBL621931,Maximum plasma concentration after oral dosing in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,11375,,14380,,,BAO_0000218,CHEMBL621932,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,11376,,14380,,,BAO_0000218,CHEMBL621933,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,9615.0,1,,1,11377,,14691,,,BAO_0000218,CHEMBL621934,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11378,,14691,,,BAO_0000218,CHEMBL621935,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,11379,,13375,,,BAO_0000218,CHEMBL621936,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,11380,,6236,,,BAO_0000218,CHEMBL621937,Maximum plasma concentration was determined,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,11381,,14380,,,BAO_0000218,CHEMBL621938,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,11382,,14380,,,BAO_0000218,CHEMBL621939,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,11383,,14380,,,BAO_0000218,CHEMBL621940,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,11384,,14380,,,BAO_0000218,CHEMBL621941,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,11385,,14380,,,BAO_0000218,CHEMBL621942,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,11386,,14380,,,BAO_0000218,CHEMBL626178,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,11387,,14380,,,BAO_0000218,CHEMBL626179,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,11388,,14380,,,BAO_0000218,CHEMBL626180,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,10116.0,1,,1,11389,,13622,,,BAO_0000218,CHEMBL626181,Plasma Cmax in rat (PO dose),In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11390,,15372,,,BAO_0000218,CHEMBL626182,Maximum serum concentration after po dose of 5.22 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11391,,15372,,,BAO_0000218,CHEMBL626183,Maximum serum concentration after po dose of 5.46 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11392,,15372,,,BAO_0000218,CHEMBL626184,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11393,,15372,,,BAO_0000218,CHEMBL626185,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11394,,14925,,,BAO_0000218,CHEMBL626186,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11395,,14925,,,BAO_0000218,CHEMBL877589,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,11396,,11883,,,BAO_0000218,CHEMBL626187,Maximum concentration of the drug at 1 uM/dg administered intravenously,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,11397,,11883,,,BAO_0000218,CHEMBL626188,Maximum concentration of the drug at 20 uM/dg administered perorally,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,11398,,13391,,,BAO_0000218,CHEMBL626189,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,11399,,13391,,,BAO_0000218,CHEMBL626855,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,In vivo,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,11400,,13391,,,BAO_0000218,CHEMBL623781,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,In vivo,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,11401,,13391,,,BAO_0000218,CHEMBL623782,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,In vivo,U,178.0,Blood,22224,,Autocuration
,,,A,10116.0,1,,1,11402,,16360,,,BAO_0000218,CHEMBL623783,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11403,,3673,,,BAO_0000218,CHEMBL623784,Cmax in dog plasma after 1mg/kg oral dose,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11404,,14431,,,BAO_0000218,CHEMBL623785,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,11405,,14431,,,BAO_0000218,CHEMBL623786,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11406,,14964,,,BAO_0000218,CHEMBL623787,Oral maximum concentration in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11407,,14964,,,BAO_0000218,CHEMBL623788,Oral maximum concentration in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,11408,,14209,,,BAO_0000218,CHEMBL623789,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,In vivo,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11409,,11355,,,BAO_0000218,CHEMBL623790,Peak concentration in blood after intravenous administration to mice,In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11410,,11355,,,BAO_0000218,CHEMBL623791,Peak concentration in blood after peroral administration to mice,In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,11411,,11966,,,BAO_0000218,CHEMBL623792,Peak concentration in rat plasma was determined,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,314293.0,0,,1,11412,,8918,,,BAO_0000218,CHEMBL623793,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,In vivo,U,1969.0,Plasma,22224,Simiiformes,Autocuration
,,,A,10090.0,1,,1,11413,,8918,,,BAO_0000218,CHEMBL623794,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,In vivo,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,11414,,8918,,,BAO_0000218,CHEMBL623795,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11415,,8684,,,BAO_0000218,CHEMBL623796,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11416,,8684,,,BAO_0000218,CHEMBL623797,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11417,,8684,,,BAO_0000218,CHEMBL623798,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11418,,8684,,,BAO_0000218,CHEMBL623799,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11419,,8684,,,BAO_0000218,CHEMBL624490,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11420,,8684,,,BAO_0000218,CHEMBL624491,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11421,,8684,,,BAO_0000218,CHEMBL624492,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11422,,8684,,,BAO_0000218,CHEMBL624493,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11423,,8684,,,BAO_0000218,CHEMBL877595,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11424,,8684,,,BAO_0000218,CHEMBL624494,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11425,,8684,,,BAO_0000218,CHEMBL624495,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11426,,8684,,,BAO_0000218,CHEMBL624681,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11427,,8684,,,BAO_0000218,CHEMBL624682,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11428,,8684,,,BAO_0000218,CHEMBL624683,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11429,,8684,,,BAO_0000218,CHEMBL624684,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11430,,8684,,,BAO_0000218,CHEMBL624685,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11431,,8684,,,BAO_0000218,CHEMBL624686,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11432,,8684,,,BAO_0000218,CHEMBL624687,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11433,,8684,,,BAO_0000218,CHEMBL624688,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11434,,8684,,,BAO_0000218,CHEMBL627161,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11435,,8684,,,BAO_0000218,CHEMBL622127,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11436,,8684,,,BAO_0000218,CHEMBL622128,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11437,,8684,,,BAO_0000218,CHEMBL874384,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11438,,8684,,,BAO_0000218,CHEMBL624898,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11439,,8684,,,BAO_0000218,CHEMBL624899,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11440,,8684,,,BAO_0000218,CHEMBL624900,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11441,,8684,,,BAO_0000218,CHEMBL624901,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11442,,8684,,,BAO_0000218,CHEMBL624902,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11443,,8684,,,BAO_0000218,CHEMBL624903,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11444,,8684,,,BAO_0000218,CHEMBL624904,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11445,,8684,,,BAO_0000218,CHEMBL624905,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11446,,8684,,,BAO_0000218,CHEMBL624906,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11447,,8684,,,BAO_0000218,CHEMBL624907,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11448,,8684,,,BAO_0000218,CHEMBL624908,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11449,,8684,,,BAO_0000218,CHEMBL624909,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11450,,8684,,,BAO_0000218,CHEMBL624910,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11451,,8684,,,BAO_0000218,CHEMBL624911,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11452,,8684,,,BAO_0000218,CHEMBL874388,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11453,,8684,,,BAO_0000218,CHEMBL624912,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11454,,8684,,,BAO_0000218,CHEMBL622930,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11455,,8684,,,BAO_0000218,CHEMBL623121,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11456,,8684,,,BAO_0000218,CHEMBL623122,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11457,,8684,,,BAO_0000218,CHEMBL623123,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11458,,8684,,,BAO_0000218,CHEMBL623124,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11459,,8684,,,BAO_0000218,CHEMBL623125,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11460,,8684,,,BAO_0000218,CHEMBL623126,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11461,,8684,,,BAO_0000218,CHEMBL623127,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11462,,8684,,,BAO_0000218,CHEMBL623128,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11463,,8684,,,BAO_0000218,CHEMBL623129,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11464,,8684,,,BAO_0000218,CHEMBL623130,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11465,,8684,,,BAO_0000218,CHEMBL623131,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11466,,8684,,,BAO_0000218,CHEMBL623132,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11467,,8319,,,BAO_0000218,CHEMBL623133,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11468,,8319,,,BAO_0000218,CHEMBL623134,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11469,,8319,,,BAO_0000218,CHEMBL874389,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11470,,8319,,,BAO_0000218,CHEMBL623135,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11471,,8319,,,BAO_0000218,CHEMBL623136,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11472,,8319,,,BAO_0000218,CHEMBL623137,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11473,,8319,,,BAO_0000218,CHEMBL623138,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11474,,8319,,,BAO_0000218,CHEMBL623139,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11475,,8319,,,BAO_0000218,CHEMBL623140,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11476,,8319,,,BAO_0000218,CHEMBL623141,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11477,,8319,,,BAO_0000218,CHEMBL623142,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11478,,8319,,,BAO_0000218,CHEMBL623143,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,11479,,14571,,,BAO_0000218,CHEMBL623144,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,N,1088.0,Urine,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,11480,,14571,,,BAO_0000218,CHEMBL623405,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11481,,8319,,,BAO_0000218,CHEMBL624074,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11482,,8319,,,BAO_0000218,CHEMBL624075,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11483,,8319,,,BAO_0000218,CHEMBL624076,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11484,,8319,,,BAO_0000218,CHEMBL624077,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11485,,8319,,,BAO_0000218,CHEMBL624078,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11486,,8319,,,BAO_0000218,CHEMBL624079,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11487,,8319,,,BAO_0000218,CHEMBL624261,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11488,,8319,,,BAO_0000218,CHEMBL624262,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11489,,8319,,,BAO_0000218,CHEMBL624263,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11490,,8319,,,BAO_0000218,CHEMBL624264,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11491,,8319,,,BAO_0000218,CHEMBL624265,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11492,,8319,,,BAO_0000218,CHEMBL624266,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11493,,8319,,,BAO_0000218,CHEMBL624267,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11494,,8319,,,BAO_0000218,CHEMBL624268,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11495,,8319,,,BAO_0000218,CHEMBL875227,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11496,,8319,,,BAO_0000218,CHEMBL624269,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11497,,8319,,,BAO_0000218,CHEMBL624270,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11498,,8319,,,BAO_0000218,CHEMBL624271,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11499,,8319,,,BAO_0000218,CHEMBL624272,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11500,,8319,,,BAO_0000218,CHEMBL624273,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11501,,12064,,,BAO_0000218,CHEMBL624274,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11502,,12064,,,BAO_0000218,CHEMBL624275,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11503,,12064,,,BAO_0000218,CHEMBL624276,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11504,,12038,,,BAO_0000218,CHEMBL624277,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,11505,,14314,,,BAO_0000019,CHEMBL624278,% dose converted to 2-amino-5-chlorophenyl sulfate,,U,,,22224,,Autocuration
,,,A,,0,,1,11506,,14314,,,BAO_0000019,CHEMBL624279,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,11507,,11488,,,BAO_0000218,CHEMBL624280,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,N,1988.0,Feces,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11508,,11488,,,BAO_0000218,CHEMBL624281,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,N,1988.0,Feces,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11509,,11488,,,BAO_0000218,CHEMBL622933,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,N,1988.0,Feces,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11510,,11488,,,BAO_0000218,CHEMBL622934,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,N,1988.0,Feces,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11511,,8829,,,BAO_0000218,CHEMBL622935,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11512,,8829,,,BAO_0000218,CHEMBL622936,Biodistribution in Rat liver after 5 minutes of iv administration,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11513,,8829,,,BAO_0000218,CHEMBL875228,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11514,,8829,,,BAO_0000218,CHEMBL622937,Biodistribution in Rat lung after 24 hours of iv administration,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11515,,8829,,,BAO_0000218,CHEMBL622938,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11516,,8829,,,BAO_0000218,CHEMBL619736,Biodistribution in Rat lung after 30 minutes of iv administration,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11517,,8829,,,BAO_0000218,CHEMBL625117,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11518,,8829,,,BAO_0000218,CHEMBL625118,Biodistribution in Rat lung after 5 minutes of iv administration,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11519,,8829,,,BAO_0000218,CHEMBL625119,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11520,,14972,,,BAO_0000218,CHEMBL625120,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",In vivo,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11521,,14972,,,BAO_0000218,CHEMBL625121,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11522,,14972,,,BAO_0000218,CHEMBL625122,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",In vivo,N,10000006.0,Thalamus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11523,,14608,,,BAO_0000218,CHEMBL622204,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11524,,14608,,,BAO_0000218,CHEMBL877503,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11525,,14608,,,BAO_0000218,CHEMBL627127,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,11526,,14608,,,BAO_0000218,CHEMBL627128,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,U,10000000.0,Hippocampus,22224,,Autocuration
,,,A,,0,,1,11527,,14608,,,BAO_0000218,CHEMBL627129,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,U,10000000.0,Hippocampus,22224,,Autocuration
,,,A,,0,,1,11528,,14608,,,BAO_0000218,CHEMBL627130,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,U,10000000.0,Hippocampus,22224,,Autocuration
,,,A,10116.0,1,,1,11529,,14608,,,BAO_0000218,CHEMBL627131,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11530,,14608,,,BAO_0000218,CHEMBL627132,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11531,,14608,,,BAO_0000218,CHEMBL627133,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11532,,14608,,,BAO_0000218,CHEMBL627134,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11533,,14608,,,BAO_0000218,CHEMBL627135,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11534,,14608,,,BAO_0000218,CHEMBL627136,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11535,,14608,,,BAO_0000218,CHEMBL628435,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11536,,14608,,,BAO_0000218,CHEMBL628436,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11537,,14608,,,BAO_0000218,CHEMBL628437,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11538,,14608,,,BAO_0000218,CHEMBL628438,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11539,,14608,,,BAO_0000218,CHEMBL628439,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11540,,14608,,,BAO_0000218,CHEMBL628440,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11541,,14608,,,BAO_0000218,CHEMBL628441,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11542,,14608,,,BAO_0000218,CHEMBL628442,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11543,,14608,,,BAO_0000218,CHEMBL628443,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11544,,14608,,,BAO_0000218,CHEMBL628444,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11545,,14608,,,BAO_0000218,CHEMBL628445,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11546,,14608,,,BAO_0000218,CHEMBL877504,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11547,,14608,,,BAO_0000218,CHEMBL628446,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11548,,14608,,,BAO_0000218,CHEMBL626874,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11549,,14608,,,BAO_0000218,CHEMBL626875,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11550,,14608,,,BAO_0000218,CHEMBL626876,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11551,,14608,,,BAO_0000218,CHEMBL626877,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11552,,14608,,,BAO_0000218,CHEMBL626878,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11553,,14608,,,BAO_0000218,CHEMBL626879,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,314293.0,0,,1,11554,,8918,,,BAO_0000218,CHEMBL626880,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,In vivo,U,1969.0,Plasma,22224,Simiiformes,Autocuration
,,,A,10090.0,1,,1,11555,,8918,,,BAO_0000218,CHEMBL626881,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,In vivo,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,11556,,8918,,,BAO_0000218,CHEMBL626882,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11557,,14470,,,BAO_0000218,CHEMBL626883,Peak plasma concentration was measured in dogs,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,11558,,14393,,,BAO_0000218,CHEMBL626884,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11559,,14886,,,BAO_0000218,CHEMBL626885,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11560,,14886,,,BAO_0000218,CHEMBL626886,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11561,,14886,,,BAO_0000218,CHEMBL626887,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11562,,14393,,,BAO_0000218,CHEMBL626888,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11563,,13465,,,BAO_0000218,CHEMBL626889,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,314293.0,0,,1,11564,,13465,,,BAO_0000218,CHEMBL626761,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,In vivo,U,,,22224,Simiiformes,Autocuration
,,,A,9615.0,1,,1,11565,,13465,,,BAO_0000218,CHEMBL626762,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11566,,13465,,,BAO_0000218,CHEMBL626763,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,11567,,13465,,,BAO_0000218,CHEMBL626764,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11568,,13465,,,BAO_0000218,CHEMBL626765,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11569,,13465,,,BAO_0000218,CHEMBL626766,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,11570,,13465,,,BAO_0000218,CHEMBL626767,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11571,,13465,,,BAO_0000218,CHEMBL626768,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11572,,13465,,,BAO_0000218,CHEMBL626769,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11573,,13465,,,BAO_0000218,CHEMBL874463,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,314293.0,0,,1,11574,,13465,,,BAO_0000218,CHEMBL626770,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,In vivo,U,,,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,11575,,13465,,,BAO_0000218,CHEMBL626771,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,In vivo,U,,,22224,Simiiformes,Autocuration
,,,A,10116.0,1,,1,11576,,13465,,,BAO_0000218,CHEMBL626772,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9541.0,1,,1,11577,,14731,,,BAO_0000218,CHEMBL626773,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,In vivo,N,,,100710,Macaca fascicularis,Intermediate
,,,A,10090.0,1,,1,11578,,14731,,,BAO_0000218,CHEMBL626774,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,9615.0,1,,1,11579,,13376,,,BAO_0000218,CHEMBL626775,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11580,,13376,,,BAO_0000218,CHEMBL626776,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,11581,,14443,,,BAO_0000218,CHEMBL626777,Maximum concentration (Cmax) in rat when administered orally,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,314293.0,0,,1,11582,,13465,,,BAO_0000218,CHEMBL626778,Maximal concentration in monkey plasma after 25 mg/kg oral dose,In vivo,U,1969.0,Plasma,22224,Simiiformes,Autocuration
,,,A,10116.0,0,,1,11583,,16359,,,BAO_0000218,CHEMBL626779,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,10116.0,0,,1,11584,,16359,,,BAO_0000218,CHEMBL626780,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,,0,,1,11585,,15618,,,BAO_0000218,CHEMBL626781,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,10116.0,1,,1,11586,,14554,,,BAO_0000218,CHEMBL632164,Pharmacokinetic profile Cmax was evaluated in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11587,,11537,,,BAO_0000218,CHEMBL632165,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10090.0,1,,1,11588,,11537,,,BAO_0000218,CHEMBL632166,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,9615.0,1,,1,11589,,11537,,,BAO_0000218,CHEMBL632167,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10090.0,1,,1,11590,,11537,,,BAO_0000218,CHEMBL632168,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,0,,1,11591,,2021,,,BAO_0000218,CHEMBL632169,Cmax in rat plasma,In vivo,U,1969.0,Plasma,22224,Rattus norvegicus,Autocuration
,,,A,9615.0,1,,1,11592,,5932,,,BAO_0000218,CHEMBL632170,Cmax in dog plasma after 30mg/kg oral dose,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,11593,,5932,,,BAO_0000218,CHEMBL632171,Cmax in rat plasma after 30mg/kg oral dose,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11594,,17320,,,BAO_0000218,CHEMBL632172,Plasma level in rats at 30 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,11595,,15831,,,BAO_0000218,CHEMBL632173,Tested for maximum plasma concentration in mice,In vivo,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,11596,,15078,,,BAO_0000218,CHEMBL632174,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11597,,14941,,,BAO_0000218,CHEMBL632175,The Cmax values in female wistar rats.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11598,,15343,,,BAO_0000218,CHEMBL632176,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,11599,,15343,,,BAO_0000218,CHEMBL632177,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11600,,14856,,,BAO_0000218,CHEMBL632178,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11601,,13129,,,BAO_0000218,CHEMBL632179,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11602,,13098,,,BAO_0000218,CHEMBL632180,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11603,,13098,,,BAO_0000218,CHEMBL632181,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11604,,13098,,,BAO_0000218,CHEMBL632182,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,0,,1,11605,,15478,,,BAO_0000218,CHEMBL632183,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,In vivo,U,178.0,Blood,22224,Mus musculus,Autocuration
,,,A,9615.0,1,,1,11606,,15341,,,BAO_0000218,CHEMBL632184,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,11607,,15341,,,BAO_0000218,CHEMBL874470,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11608,,8684,,,BAO_0000218,CHEMBL631302,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11609,,8684,,,BAO_0000218,CHEMBL631303,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11610,,8684,,,BAO_0000218,CHEMBL631304,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11611,,8684,,,BAO_0000218,CHEMBL631305,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11612,,8684,,,BAO_0000218,CHEMBL631306,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11613,,8684,,,BAO_0000218,CHEMBL631307,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11614,,8684,,,BAO_0000218,CHEMBL631308,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11615,,8684,,,BAO_0000218,CHEMBL625557,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11616,,8684,,,BAO_0000218,CHEMBL625558,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11617,,8684,,,BAO_0000218,CHEMBL625559,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11618,,8684,,,BAO_0000218,CHEMBL625560,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11619,,8684,,,BAO_0000218,CHEMBL625561,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11620,,8684,,,BAO_0000218,CHEMBL625562,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11621,,8684,,,BAO_0000218,CHEMBL875320,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11622,,8684,,,BAO_0000218,CHEMBL625563,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11623,,8684,,,BAO_0000218,CHEMBL625564,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11624,,8684,,,BAO_0000218,CHEMBL625565,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11625,,8684,,,BAO_0000218,CHEMBL625566,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11626,,8684,,,BAO_0000218,CHEMBL625567,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11627,,8684,,,BAO_0000218,CHEMBL625568,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11628,,8684,,,BAO_0000218,CHEMBL628217,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11629,,8684,,,BAO_0000218,CHEMBL628218,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11630,,8684,,,BAO_0000218,CHEMBL628219,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11631,,8684,,,BAO_0000218,CHEMBL628220,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,11632,,8926,,,BAO_0000019,CHEMBL628221,Distribution in the blood after 120 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11633,,8926,,,BAO_0000019,CHEMBL628222,Distribution in the blood after 15 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11634,,8926,,,BAO_0000019,CHEMBL628223,Distribution in the blood after 30 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11635,,8926,,,BAO_0000019,CHEMBL628224,Distribution in the blood after 5 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11636,,8926,,,BAO_0000019,CHEMBL628225,Distribution in the blood after 60 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11637,,8926,,,BAO_0000019,CHEMBL628226,Distribution in the blood after 90 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11638,,8926,,,BAO_0000019,CHEMBL628227,Distribution in the bone after 120 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11639,,8926,,,BAO_0000019,CHEMBL875481,Distribution in the bone after 15 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11640,,8926,,,BAO_0000019,CHEMBL628228,Distribution in the bone after 30 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11641,,8926,,,BAO_0000019,CHEMBL628229,Distribution in the bone after 5 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11642,,8926,,,BAO_0000019,CHEMBL628230,Distribution in the bone after 60 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11643,,8926,,,BAO_0000019,CHEMBL628231,Distribution in the bone after 90 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11644,,8926,,,BAO_0000019,CHEMBL628232,Distribution in the heart after 120 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11645,,8926,,,BAO_0000019,CHEMBL628233,Distribution in the heart after 15 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11646,,8926,,,BAO_0000019,CHEMBL628234,Distribution in the heart after 30 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11647,,8926,,,BAO_0000019,CHEMBL628235,Distribution in the heart after 5 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11648,,8926,,,BAO_0000019,CHEMBL628236,Distribution in the heart after 60 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11649,,8926,,,BAO_0000019,CHEMBL628237,Distribution in the heart after 90 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11650,,8926,,,BAO_0000019,CHEMBL628238,Distribution in the kidneys after 120 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11651,,8926,,,BAO_0000019,CHEMBL628239,Distribution in the kidneys after 15 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11652,,8926,,,BAO_0000019,CHEMBL628240,Distribution in the kidneys after 30 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11653,,8926,,,BAO_0000019,CHEMBL628241,Distribution in the kidneys after 5 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11654,,8926,,,BAO_0000019,CHEMBL628242,Distribution in the kidneys after 60 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11655,,8926,,,BAO_0000019,CHEMBL875482,Distribution in the kidneys after 90 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11656,,8926,,,BAO_0000019,CHEMBL628243,Distribution in the liver after 120 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11657,,8926,,,BAO_0000019,CHEMBL628244,Distribution in the liver after 15 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11658,,8926,,,BAO_0000019,CHEMBL628245,Distribution in the liver after 30 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11659,,8926,,,BAO_0000019,CHEMBL628246,Distribution in the liver after 5 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11660,,8926,,,BAO_0000019,CHEMBL628247,Distribution in the liver after 60 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11661,,8926,,,BAO_0000019,CHEMBL628248,Distribution in the liver after 90 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11662,,8926,,,BAO_0000019,CHEMBL628249,Distribution in the lung after 120 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,11663,,14839,,,BAO_0000218,CHEMBL625452,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11664,,14839,,,BAO_0000218,CHEMBL625453,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11665,,14839,,,BAO_0000218,CHEMBL625454,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11666,,14839,,,BAO_0000218,CHEMBL623844,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,11667,,12178,,,BAO_0000218,CHEMBL623845,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11668,,12178,,,BAO_0000218,CHEMBL623846,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,11669,,12178,,,BAO_0000218,CHEMBL623847,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,U,,,22224,,Autocuration
,,,A,9541.0,1,,1,11670,,12186,,,BAO_0000218,CHEMBL623848,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,11671,,12186,,,BAO_0000218,CHEMBL623849,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,11672,,12186,,,BAO_0000218,CHEMBL623850,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,11673,,12186,,,BAO_0000218,CHEMBL623851,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,N,,,100710,Macaca fascicularis,Intermediate
,,,A,314293.0,0,,1,11674,,12187,,,BAO_0000218,CHEMBL623852,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,U,,,22224,Simiiformes,Autocuration
,,,A,9669.0,1,,1,11675,,12187,,,BAO_0000218,CHEMBL624551,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,N,,,50506,Mustela putorius furo,Intermediate
,,,A,9669.0,1,,1,11676,,12187,,,BAO_0000218,CHEMBL624552,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,N,,,50506,Mustela putorius furo,Intermediate
,,,A,314293.0,0,,1,11677,,12187,,,BAO_0000218,CHEMBL624553,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,U,,,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,11678,,12187,,,BAO_0000218,CHEMBL624554,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,U,,,22224,Simiiformes,Autocuration
,,,A,10116.0,1,,1,11679,,12187,,,BAO_0000218,CHEMBL624555,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11680,,12187,,,BAO_0000218,CHEMBL624741,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11681,,14122,,,BAO_0000218,CHEMBL624742,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10026.0,1,,1,11682,,14122,,,BAO_0000218,CHEMBL624743,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,N,,,100712,Cricetinae,Intermediate
,,,A,10116.0,1,,1,11683,,14122,,,BAO_0000218,CHEMBL877606,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,11684,,13391,,,BAO_0000218,CHEMBL624744,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,U,,,22224,,Autocuration
,,,A,,0,,1,11685,,13391,,,BAO_0000218,CHEMBL624745,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,11686,,13391,,,BAO_0000218,CHEMBL624746,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,11687,,13391,,,BAO_0000218,CHEMBL624747,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,11688,,16360,,,BAO_0000019,CHEMBL624748,Oral absorption expressed as Area under curve was determined,,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,11689,,3673,,,BAO_0000218,CHEMBL622504,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11690,,14122,,,BAO_0000218,CHEMBL622505,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10026.0,1,,1,11691,,14122,,,BAO_0000218,CHEMBL622506,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,N,,,100712,Cricetinae,Intermediate
,,,A,10026.0,1,,1,11692,,14122,,,BAO_0000218,CHEMBL622507,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,N,,,100712,Cricetinae,Intermediate
,,,A,10116.0,1,,1,11693,,14122,,,BAO_0000218,CHEMBL622508,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,11694,,13889,,,BAO_0000019,CHEMBL622509,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,11695,,14393,,,BAO_0000218,CHEMBL622510,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11696,,17279,,,BAO_0000218,CHEMBL622511,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9541.0,1,,1,11697,,14548,,,BAO_0000218,CHEMBL622512,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,11698,,14548,,,BAO_0000218,CHEMBL622513,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,11699,,14548,,,BAO_0000218,CHEMBL622514,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9615.0,1,,1,11700,,14548,,,BAO_0000218,CHEMBL622515,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11701,,14548,,,BAO_0000218,CHEMBL622516,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,11702,,14548,,,BAO_0000218,CHEMBL622517,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11703,,14548,,,BAO_0000218,CHEMBL622518,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11704,,14548,,,BAO_0000218,CHEMBL622519,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11705,,14608,,,BAO_0000218,CHEMBL622520,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11706,,14608,,,BAO_0000218,CHEMBL622521,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,11707,,14608,,,BAO_0000218,CHEMBL625113,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,N,14.0,Zone of skin,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,11708,,14608,,,BAO_0000218,CHEMBL625114,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,N,14.0,Zone of skin,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11709,,14608,,,BAO_0000218,CHEMBL874397,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,N,14.0,Zone of skin,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11710,,14608,,,BAO_0000218,CHEMBL625115,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11711,,14608,,,BAO_0000218,CHEMBL625116,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11712,,14608,,,BAO_0000218,CHEMBL623932,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11713,,14608,,,BAO_0000218,CHEMBL623933,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11714,,14608,,,BAO_0000218,CHEMBL623934,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11715,,14608,,,BAO_0000218,CHEMBL623935,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11716,,14608,,,BAO_0000218,CHEMBL623936,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11717,,14608,,,BAO_0000218,CHEMBL623937,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11718,,14608,,,BAO_0000218,CHEMBL623938,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,11719,,15383,,,BAO_0000218,CHEMBL623939,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11720,,15383,,,BAO_0000218,CHEMBL623940,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11721,,15383,,,BAO_0000218,CHEMBL623941,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11722,,15383,,,BAO_0000218,CHEMBL627216,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11723,,15383,,,BAO_0000218,CHEMBL623942,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11724,,15383,,,BAO_0000218,CHEMBL618793,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11725,,15383,,,BAO_0000218,CHEMBL618794,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11726,,15383,,,BAO_0000218,CHEMBL618795,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11727,,15383,,,BAO_0000218,CHEMBL618796,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11728,,15383,,,BAO_0000218,CHEMBL618797,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11729,,15383,,,BAO_0000218,CHEMBL618798,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11730,,15383,,,BAO_0000218,CHEMBL618799,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11731,,15383,,,BAO_0000218,CHEMBL618800,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11732,,15383,,,BAO_0000218,CHEMBL618801,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11733,,15383,,,BAO_0000218,CHEMBL618802,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11734,,15383,,,BAO_0000218,CHEMBL618803,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11735,,15383,,,BAO_0000218,CHEMBL618804,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11736,,15383,,,BAO_0000218,CHEMBL618805,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11737,,15383,,,BAO_0000218,CHEMBL618806,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11738,,15383,,,BAO_0000218,CHEMBL618807,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11739,,15383,,,BAO_0000218,CHEMBL618808,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11740,,15383,,,BAO_0000218,CHEMBL618809,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11741,,15383,,,BAO_0000218,CHEMBL618810,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,2385.0,Muscle tissue,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11742,,15383,,,BAO_0000218,CHEMBL618811,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,N,2385.0,Muscle tissue,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11743,,15383,,,BAO_0000218,CHEMBL875844,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,2385.0,Muscle tissue,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11744,,15383,,,BAO_0000218,CHEMBL618812,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,2385.0,Muscle tissue,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11745,,15383,,,BAO_0000218,CHEMBL618813,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,2385.0,Muscle tissue,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11746,,15383,,,BAO_0000218,CHEMBL618814,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11747,,15383,,,BAO_0000218,CHEMBL618815,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11748,,15383,,,BAO_0000218,CHEMBL618816,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11749,,15383,,,BAO_0000218,CHEMBL618817,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11750,,15383,,,BAO_0000218,CHEMBL620544,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,11751,,15341,,,BAO_0000218,CHEMBL626230,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11752,,15341,,,BAO_0000218,CHEMBL626231,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11753,,15341,,,BAO_0000218,CHEMBL626232,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11754,,14906,,,BAO_0000218,CHEMBL626233,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,11755,,14906,,,BAO_0000218,CHEMBL626234,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11756,,14906,,,BAO_0000218,CHEMBL875341,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9606.0,1,,1,11757,,14215,,,BAO_0000218,CHEMBL626235,The maximum plasma concentration (100 mg/kg) administered orally in human,In vivo,N,1969.0,Plasma,50587,Homo sapiens,Intermediate
,,,A,9481.0,0,,1,11758,,14215,,,BAO_0000218,CHEMBL626236,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,In vivo,U,1969.0,Plasma,22224,Callithrix,Autocuration
,,,A,314293.0,0,,1,11759,,14215,,,BAO_0000218,CHEMBL626237,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,In vivo,U,1969.0,Plasma,22224,Simiiformes,Autocuration
,,,A,9615.0,1,,1,11760,,14215,,,BAO_0000218,CHEMBL626238,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,9606.0,1,,1,11761,,14215,,,BAO_0000218,CHEMBL622412,The maximum plasma concentration (200 mg/kg) administered orally in human,In vivo,N,1969.0,Plasma,50587,Homo sapiens,Intermediate
,,,A,10116.0,1,,1,11762,,14215,,,BAO_0000218,CHEMBL623114,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9481.0,0,,1,11763,,14215,,,BAO_0000218,CHEMBL623115,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,In vivo,U,1969.0,Plasma,22224,Callithrix,Autocuration
,,,A,314293.0,0,,1,11764,,14215,,,BAO_0000218,CHEMBL623116,The maximum plasma concentration (25 mg/kg) administered orally in monkey,In vivo,U,1969.0,Plasma,22224,Simiiformes,Autocuration
,,,A,9615.0,0,,1,11765,,14215,,,BAO_0000218,CHEMBL623117,The maximum plasma concentration (30 mg/kg) administered orally in dog,In vivo,U,1969.0,Plasma,22224,Canis lupus familiaris,Autocuration
,,,A,9606.0,1,,1,11766,,14215,,,BAO_0000218,CHEMBL623118,The maximum plasma concentration (400 mg/kg) administered orally in human,In vivo,N,1969.0,Plasma,50587,Homo sapiens,Intermediate
,,,A,10116.0,1,,1,11767,,14215,,,BAO_0000218,CHEMBL623119,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11768,,14215,,,BAO_0000218,CHEMBL623120,The maximum plasma concentration (50 mg/kg) administered orally in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9606.0,1,,1,11769,,14215,,,BAO_0000218,CHEMBL623286,The maximum plasma concentration (800 mg/kg) administered orally in human,In vivo,N,1969.0,Plasma,50587,Homo sapiens,Intermediate
,,,A,10116.0,1,,1,11770,,14067,,,BAO_0000218,CHEMBL623287,The maximum plasma concentration was measured on rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11771,,12350,,,BAO_0000218,CHEMBL623288,The maximum plasma concentration was measured on rats after oral administration,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11772,,14813,,,BAO_0000218,CHEMBL623289,Plasma drug Cmax in rat (PO dose),In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,11773,,12536,,,BAO_0000218,CHEMBL623290,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,In vivo,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,11774,,14169,,,BAO_0000218,CHEMBL623291,maximum Plasma concentration in Dog was determined after Peroral administration,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,11775,,14169,,,BAO_0000218,CHEMBL623292,maximum Plasma concentration in Rats was determined after Peroral administration,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,11776,,15604,,,BAO_0000218,CHEMBL623293,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,314293.0,0,,1,11777,,15604,,,BAO_0000218,CHEMBL623294,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,In vivo,U,1969.0,Plasma,22224,Simiiformes,Autocuration
,,,A,10116.0,1,,1,11778,,15604,,,BAO_0000218,CHEMBL623295,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,11779,,14387,,,BAO_0000218,CHEMBL623296,maximum concentration was measured when administered through oral route in mice,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11780,,15115,,,BAO_0000218,CHEMBL875349,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,N,,,50594,Mus musculus,Intermediate
,,,A,314293.0,0,,1,11781,,15115,,,BAO_0000019,CHEMBL623297,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,U,,,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,11782,,15115,,,BAO_0000019,CHEMBL623298,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,U,,,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,11783,,15115,,,BAO_0000019,CHEMBL623299,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,U,,,22224,Simiiformes,Autocuration
,,,A,10116.0,1,,1,11784,,16359,,,BAO_0000218,CHEMBL623300,Pharmacokinetic parameter was evaluated in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,11785,,12829,,,BAO_0000218,CHEMBL623301,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11786,,12829,,,BAO_0000218,CHEMBL623302,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11787,,12829,,,BAO_0000218,CHEMBL623303,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11788,,12829,,,BAO_0000218,CHEMBL623304,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11789,,12829,,,BAO_0000218,CHEMBL623305,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,11790,,15137,,,BAO_0000218,CHEMBL623306,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11791,,15137,,,BAO_0000218,CHEMBL623307,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11792,,15137,,,BAO_0000218,CHEMBL623308,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,11793,,15137,,,BAO_0000218,CHEMBL623309,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11794,,13509,,,BAO_0000218,CHEMBL623310,Plasma Concentration after 120 min of oral administration to mice,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11795,,13509,,,BAO_0000218,CHEMBL623311,Plasma Concentration after 30 min of oral administration to mice,,N,,,50594,Mus musculus,Intermediate
,,,A,9541.0,1,,1,11796,,13509,,,BAO_0000218,CHEMBL623312,Plasma Concentration after 60 min of oral administration to mice,,N,,,100710,Macaca fascicularis,Intermediate
,,,A,10090.0,1,,1,11797,,13509,,,BAO_0000218,CHEMBL875350,Plasma Concentration after 60 min of oral administration to mice; Not determined,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11798,,13509,,,BAO_0000218,CHEMBL628635,Plasma Concentration after 90 min of oral administration to mice,,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,11799,,12064,,,BAO_0000218,CHEMBL628636,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11800,,12064,,,BAO_0000218,CHEMBL628637,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11801,,12064,,,BAO_0000218,CHEMBL628058,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11802,,10677,,,BAO_0000218,CHEMBL628059,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11803,,10677,,,BAO_0000218,CHEMBL628060,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,11804,,8926,,,BAO_0000019,CHEMBL628061,Distribution in the lung after 15 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11805,,8926,,,BAO_0000019,CHEMBL628062,Distribution in the lung after 30 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11806,,8926,,,BAO_0000019,CHEMBL628063,Distribution in the lung after 5 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11807,,8926,,,BAO_0000019,CHEMBL628064,Distribution in the lung after 60 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11808,,8926,,,BAO_0000019,CHEMBL628065,Distribution in the lung after 90 min of intravenous administration,,U,,,22224,,Autocuration
,,,A,,0,,1,11809,,8926,,,BAO_0000019,CHEMBL628066,Distribution in the muscle after 120 min of intravenous administration,,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,,0,,1,11810,,8926,,,BAO_0000019,CHEMBL628067,Distribution in the muscle after 15 min of intravenous administration,,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,10090.0,1,,1,11811,,8926,,,BAO_0000218,CHEMBL874646,Distribution in the muscle after 30 min of intravenous administration,,N,2385.0,Muscle tissue,50594,Mus musculus,Intermediate
,,,A,,0,,1,11812,,8926,,,BAO_0000019,CHEMBL628068,Distribution in the muscle after 5 min of intravenous administration,,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,,0,,1,11813,,8926,,,BAO_0000019,CHEMBL628069,Distribution in the muscle after 60 min of intravenous administration,,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,,0,,1,11814,,8926,,,BAO_0000019,CHEMBL628070,Distribution in the muscle after 90 min of intravenous administration,,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,,0,,1,11815,,8926,,,BAO_0000019,CHEMBL628071,Distribution in the spleen after 120 min of intravenous administration,,U,2106.0,Spleen,22224,,Autocuration
,,,A,,0,,1,11816,,8926,,,BAO_0000019,CHEMBL628072,Distribution in the spleen after 15 min of intravenous administration,,U,2106.0,Spleen,22224,,Autocuration
,,,A,,0,,1,11817,,8926,,,BAO_0000019,CHEMBL628073,Distribution in the spleen after 30 min of intravenous administration,,U,2106.0,Spleen,22224,,Autocuration
,,,A,,0,,1,11818,,8926,,,BAO_0000019,CHEMBL628074,Distribution in the spleen after 5 min of intravenous administration,,U,2106.0,Spleen,22224,,Autocuration
,,,A,,0,,1,11819,,8926,,,BAO_0000019,CHEMBL628075,Distribution in the spleen after 60 min of intravenous administration,,U,2106.0,Spleen,22224,,Autocuration
,,,A,,0,,1,11820,,8926,,,BAO_0000019,CHEMBL628076,Distribution in the spleen after 90 min of intravenous administration,,U,2106.0,Spleen,22224,,Autocuration
,,,A,10116.0,1,,1,11821,,7570,,,BAO_0000218,CHEMBL628077,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,N,1235.0,Adrenal cortex,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11822,,7570,,,BAO_0000218,CHEMBL628078,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11823,,7570,,,BAO_0000218,CHEMBL628079,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11824,,7570,,,BAO_0000218,CHEMBL628080,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,N,992.0,Female gonad,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11825,,7570,,,BAO_0000218,CHEMBL628081,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11826,,7570,,,BAO_0000218,CHEMBL628082,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,N,1235.0,Adrenal cortex,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11827,,7570,,,BAO_0000218,CHEMBL874647,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11828,,7570,,,BAO_0000218,CHEMBL626406,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11829,,7570,,,BAO_0000218,CHEMBL626407,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,N,992.0,Female gonad,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11830,,7570,,,BAO_0000218,CHEMBL626408,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11831,,8608,,,BAO_0000218,CHEMBL626409,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11832,,8608,,,BAO_0000218,CHEMBL626410,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11833,,8608,,,BAO_0000218,CHEMBL626411,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11834,,8608,,,BAO_0000218,CHEMBL626412,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11835,,8608,,,BAO_0000218,CHEMBL626413,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11836,,8608,,,BAO_0000218,CHEMBL626414,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11837,,8608,,,BAO_0000218,CHEMBL626415,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11838,,8608,,,BAO_0000218,CHEMBL626416,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11839,,8608,,,BAO_0000218,CHEMBL627062,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11840,,8608,,,BAO_0000218,CHEMBL627063,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11841,,8608,,,BAO_0000218,CHEMBL627064,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11842,,8608,,,BAO_0000218,CHEMBL627227,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11843,,8608,,,BAO_0000218,CHEMBL627228,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11844,,8608,,,BAO_0000218,CHEMBL627229,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11845,,8608,,,BAO_0000218,CHEMBL625792,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11846,,8608,,,BAO_0000218,CHEMBL625793,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11847,,8608,,,BAO_0000218,CHEMBL625794,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11848,,8608,,,BAO_0000218,CHEMBL625795,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,11849,,13792,,,BAO_0000218,CHEMBL625796,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,N,,,50594,Mus musculus,Intermediate
,,,A,9615.0,1,,1,11850,,13376,,,BAO_0000218,CHEMBL625797,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,11851,,13376,,,BAO_0000218,CHEMBL625798,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,11852,,14380,,,BAO_0000218,CHEMBL875613,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,U,,,22224,,Autocuration
,,,A,,0,,1,11853,,14380,,,BAO_0000218,CHEMBL625799,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,U,,,22224,,Autocuration
,,,A,,0,,1,11854,,14380,,,BAO_0000218,CHEMBL625800,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,U,,,22224,,Autocuration
,,,A,,0,,1,11855,,14380,,,BAO_0000218,CHEMBL625801,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,U,,,22224,,Autocuration
,,,A,,0,,1,11856,,14380,,,BAO_0000218,CHEMBL625802,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,U,,,22224,,Autocuration
,,,A,,0,,1,11857,,14380,,,BAO_0000218,CHEMBL625803,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,U,,,22224,,Autocuration
,,,A,,0,,1,11858,,14380,,,BAO_0000019,CHEMBL625804,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,U,,,22224,,Autocuration
,,,A,,0,,1,11859,,14380,,,BAO_0000218,CHEMBL622530,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,11860,,13701,,,BAO_0000218,CHEMBL622531,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11861,,13701,,,BAO_0000218,CHEMBL622532,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11862,,13701,,,BAO_0000218,CHEMBL623176,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11863,,13701,,,BAO_0000218,CHEMBL623177,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11864,,13701,,,BAO_0000218,CHEMBL623178,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11865,,13701,,,BAO_0000218,CHEMBL623179,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11866,,13701,,,BAO_0000218,CHEMBL623180,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11867,,13701,,,BAO_0000218,CHEMBL623181,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11868,,13701,,,BAO_0000218,CHEMBL624131,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11869,,13701,,,BAO_0000218,CHEMBL624132,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11870,,13701,,,BAO_0000218,CHEMBL624133,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11871,,13701,,,BAO_0000218,CHEMBL624846,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11872,,13701,,,BAO_0000218,CHEMBL624847,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11873,,13701,,,BAO_0000218,CHEMBL624848,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11874,,13701,,,BAO_0000218,CHEMBL625012,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11875,,13701,,,BAO_0000218,CHEMBL625013,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11876,,13701,,,BAO_0000218,CHEMBL625014,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11877,,13701,,,BAO_0000218,CHEMBL625015,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11878,,13701,,,BAO_0000218,CHEMBL625016,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11879,,13701,,,BAO_0000218,CHEMBL625017,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11880,,13701,,,BAO_0000218,CHEMBL625018,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11881,,13701,,,BAO_0000218,CHEMBL625019,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11882,,13701,,,BAO_0000218,CHEMBL625020,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11883,,13701,,,BAO_0000218,CHEMBL625021,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,11884,,14393,,,BAO_0000218,CHEMBL625022,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,11885,,14731,,,BAO_0000218,CHEMBL625023,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,N,,,50594,Mus musculus,Intermediate
,,,A,9541.0,1,,1,11886,,14731,,,BAO_0000218,CHEMBL625024,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,11887,,14731,,,BAO_0000218,CHEMBL627626,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,N,,,100710,Macaca fascicularis,Intermediate
,,,A,,0,,1,11888,,13758,,,BAO_0000218,CHEMBL627627,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,U,955.0,Brain,22224,,Autocuration
,,,A,,0,,1,11889,,13758,,,BAO_0000218,CHEMBL627628,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,U,1977.0,Serum,22224,,Autocuration
,,,A,,0,,1,11890,,13758,,,BAO_0000218,CHEMBL627629,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,U,955.0,Brain,22224,,Autocuration
,,,A,,0,,1,11891,,13758,,,BAO_0000218,CHEMBL627630,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,U,1977.0,Serum,22224,,Autocuration
,,,A,,0,,1,11892,,16359,,,BAO_0000019,CHEMBL627631,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,U,,,22224,,Autocuration
,,,A,,0,,1,11893,,16359,,,BAO_0000218,CHEMBL629515,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,11894,,15383,,,BAO_0000218,CHEMBL629516,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11895,,15383,,,BAO_0000218,CHEMBL629517,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11896,,15383,,,BAO_0000218,CHEMBL629518,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11897,,15383,,,BAO_0000218,CHEMBL877499,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11898,,15383,,,BAO_0000218,CHEMBL629519,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11899,,15383,,,BAO_0000218,CHEMBL629520,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11900,,15383,,,BAO_0000218,CHEMBL629521,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11901,,14439,,,BAO_0000218,CHEMBL629522,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11902,,14439,,,BAO_0000218,CHEMBL629523,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11903,,14439,,,BAO_0000218,CHEMBL629524,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11904,,14439,,,BAO_0000218,CHEMBL629525,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11905,,14439,,,BAO_0000218,CHEMBL629526,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11906,,14439,,,BAO_0000218,CHEMBL629527,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11907,,14439,,,BAO_0000218,CHEMBL629528,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11908,,14439,,,BAO_0000218,CHEMBL629529,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11909,,14439,,,BAO_0000218,CHEMBL629530,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11910,,14439,,,BAO_0000218,CHEMBL629531,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11911,,14439,,,BAO_0000218,CHEMBL628656,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,11912,,14439,,,BAO_0000218,CHEMBL628657,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,11913,,13751,,,BAO_0000218,CHEMBL628658,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11914,,13751,,,BAO_0000218,CHEMBL628659,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11915,,13751,,,BAO_0000218,CHEMBL877500,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11916,,13751,,,BAO_0000218,CHEMBL628660,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11917,,13751,,,BAO_0000218,CHEMBL628661,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11918,,13751,,,BAO_0000218,CHEMBL628662,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11919,,13751,,,BAO_0000218,CHEMBL628663,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11920,,13751,,,BAO_0000218,CHEMBL628664,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11921,,13751,,,BAO_0000218,CHEMBL628665,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11922,,13751,,,BAO_0000218,CHEMBL628666,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11923,,13751,,,BAO_0000218,CHEMBL628667,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11924,,13751,,,BAO_0000218,CHEMBL628668,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11925,,13751,,,BAO_0000218,CHEMBL628669,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11926,,13751,,,BAO_0000218,CHEMBL628670,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11927,,13751,,,BAO_0000218,CHEMBL628671,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11928,,13751,,,BAO_0000218,CHEMBL628672,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11929,,13751,,,BAO_0000218,CHEMBL630300,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11930,,13751,,,BAO_0000218,CHEMBL629787,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11931,,13751,,,BAO_0000218,CHEMBL629788,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11932,,13751,,,BAO_0000218,CHEMBL629789,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11933,,13751,,,BAO_0000218,CHEMBL629790,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11934,,13751,,,BAO_0000218,CHEMBL629791,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11935,,13751,,,BAO_0000218,CHEMBL629792,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11936,,13751,,,BAO_0000218,CHEMBL629793,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11937,,13751,,,BAO_0000218,CHEMBL629794,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11938,,10677,,,BAO_0000218,CHEMBL874459,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11939,,10677,,,BAO_0000218,CHEMBL629795,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11940,,10677,,,BAO_0000218,CHEMBL629796,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11941,,10677,,,BAO_0000218,CHEMBL629797,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11942,,10677,,,BAO_0000218,CHEMBL629798,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11943,,10911,,,BAO_0000218,CHEMBL629799,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,N,2369.0,Adrenal gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11944,,10911,,,BAO_0000218,CHEMBL629800,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,N,2369.0,Adrenal gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11945,,10911,,,BAO_0000218,CHEMBL629801,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,N,2369.0,Adrenal gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11946,,10911,,,BAO_0000218,CHEMBL629802,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,In vivo,N,2369.0,Adrenal gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11947,,10911,,,BAO_0000218,CHEMBL629803,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,N,2369.0,Adrenal gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11948,,10911,,,BAO_0000218,CHEMBL629804,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11949,,10911,,,BAO_0000218,CHEMBL629805,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11950,,10911,,,BAO_0000218,CHEMBL629806,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11951,,10911,,,BAO_0000218,CHEMBL629807,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11952,,10911,,,BAO_0000218,CHEMBL629808,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11953,,10911,,,BAO_0000218,CHEMBL629809,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11954,,10911,,,BAO_0000218,CHEMBL629810,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11955,,10911,,,BAO_0000218,CHEMBL629811,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11956,,10911,,,BAO_0000218,CHEMBL629812,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11957,,10911,,,BAO_0000218,CHEMBL629813,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11958,,10911,,,BAO_0000218,CHEMBL874460,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11959,,10911,,,BAO_0000218,CHEMBL629814,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11960,,10911,,,BAO_0000218,CHEMBL629815,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11961,,10911,,,BAO_0000218,CHEMBL629816,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11962,,10911,,,BAO_0000218,CHEMBL629817,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11963,,10911,,,BAO_0000218,CHEMBL626643,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11964,,10911,,,BAO_0000218,CHEMBL626644,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11965,,10911,,,BAO_0000218,CHEMBL626806,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11966,,10911,,,BAO_0000218,CHEMBL626807,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11967,,10911,,,BAO_0000218,CHEMBL627261,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11968,,10911,,,BAO_0000218,CHEMBL627262,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11969,,10911,,,BAO_0000218,CHEMBL627263,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11970,,10911,,,BAO_0000218,CHEMBL627264,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11971,,10911,,,BAO_0000218,CHEMBL627265,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11972,,10911,,,BAO_0000218,CHEMBL627266,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11973,,10911,,,BAO_0000218,CHEMBL627267,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11974,,10911,,,BAO_0000218,CHEMBL627268,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11975,,10911,,,BAO_0000218,CHEMBL627269,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11976,,10911,,,BAO_0000218,CHEMBL627270,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11977,,8608,,,BAO_0000218,CHEMBL627271,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11978,,8608,,,BAO_0000218,CHEMBL627946,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11979,,8608,,,BAO_0000218,CHEMBL875472,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11980,,8608,,,BAO_0000218,CHEMBL627947,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11981,,8608,,,BAO_0000218,CHEMBL627948,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11982,,8608,,,BAO_0000218,CHEMBL628113,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11983,,8608,,,BAO_0000218,CHEMBL628114,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11984,,8608,,,BAO_0000218,CHEMBL628115,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11985,,8608,,,BAO_0000218,CHEMBL628116,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11986,,8608,,,BAO_0000218,CHEMBL628117,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11987,,8608,,,BAO_0000218,CHEMBL628118,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11988,,8608,,,BAO_0000218,CHEMBL628119,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11989,,8608,,,BAO_0000218,CHEMBL628120,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11990,,8608,,,BAO_0000218,CHEMBL628121,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11991,,8608,,,BAO_0000218,CHEMBL628122,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11992,,8608,,,BAO_0000218,CHEMBL627297,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11993,,8608,,,BAO_0000218,CHEMBL627298,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11994,,8608,,,BAO_0000218,CHEMBL627299,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11995,,8608,,,BAO_0000218,CHEMBL627300,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11996,,8608,,,BAO_0000218,CHEMBL627301,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11997,,8608,,,BAO_0000218,CHEMBL627302,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11998,,8608,,,BAO_0000218,CHEMBL627303,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,11999,,8608,,,BAO_0000218,CHEMBL627304,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12000,,8608,,,BAO_0000218,CHEMBL627305,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12001,,8608,,,BAO_0000218,CHEMBL627306,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12002,,8608,,,BAO_0000218,CHEMBL623982,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12003,,8608,,,BAO_0000218,CHEMBL623983,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12004,,8608,,,BAO_0000218,CHEMBL623984,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12005,,8608,,,BAO_0000218,CHEMBL623985,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12006,,8608,,,BAO_0000218,CHEMBL623986,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12007,,8608,,,BAO_0000218,CHEMBL623987,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12008,,8608,,,BAO_0000218,CHEMBL623988,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12009,,8608,,,BAO_0000218,CHEMBL623989,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12010,,8608,,,BAO_0000218,CHEMBL622215,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12011,,8608,,,BAO_0000218,CHEMBL622216,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12012,,8608,,,BAO_0000218,CHEMBL877481,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12013,,16359,,,BAO_0000218,CHEMBL622217,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,12014,,13701,,,BAO_0000218,CHEMBL622218,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,12015,,14554,,,BAO_0000218,CHEMBL622219,Pharmacokinetic profile AUC was evaluated in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12016,,6241,,,BAO_0000019,CHEMBL622220,Pharmacokinetic property (Area under curve),,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,12017,,11537,,,BAO_0000218,CHEMBL622221,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10090.0,1,,1,12018,,11537,,,BAO_0000218,CHEMBL622222,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,N,,,50594,Mus musculus,Intermediate
,,,A,9615.0,1,,1,12019,,11537,,,BAO_0000218,CHEMBL622223,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10090.0,1,,1,12020,,11537,,,BAO_0000218,CHEMBL622224,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,N,,,50594,Mus musculus,Intermediate
,,,A,,0,,1,12021,,13118,,,BAO_0000019,CHEMBL622225,Plasma concentration (AUC) was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,12022,,13118,,,BAO_0000019,CHEMBL622226,Plasma concentration (AUC) was determined; Not detectable,,U,,,22224,,Autocuration
,,,A,10141.0,1,,1,12023,,9562,,,BAO_0000218,CHEMBL624154,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,N,,,50512,Cavia porcellus,Intermediate
,,,A,10116.0,1,,1,12024,,10363,,,BAO_0000218,CHEMBL624155,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12025,,10363,,,BAO_0000218,CHEMBL624156,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12026,,10363,,,BAO_0000218,CHEMBL624157,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12027,,10363,,,BAO_0000218,CHEMBL624158,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12028,,12504,,,BAO_0000218,CHEMBL624159,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12029,,12504,,,BAO_0000218,CHEMBL624160,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12030,,12504,,,BAO_0000218,CHEMBL624161,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12031,,12504,,,BAO_0000218,CHEMBL624162,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,12032,,13317,,,BAO_0000218,CHEMBL624163,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,12033,,15078,,,BAO_0000218,CHEMBL624164,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12034,,14941,,,BAO_0000218,CHEMBL624165,The AUC(0-infinity) values in female wistar rats.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12035,,15078,,,BAO_0000218,CHEMBL624166,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12036,,15078,,,BAO_0000218,CHEMBL624167,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12037,,14941,,,BAO_0000218,CHEMBL624168,The AUC(0-t)values in female wistar rats.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12038,,14067,,,BAO_0000218,CHEMBL624169,The Area under the concentration time curve of compound was measured on rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9606.0,1,,1,12039,,14215,,,BAO_0000218,CHEMBL624170,The area under curve (100 mg/kg) administered orally in humans,,N,,,50587,Homo sapiens,Intermediate
,,,A,9481.0,0,,1,12040,,14215,,,BAO_0000218,CHEMBL624171,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,U,,,22224,Callithrix,Autocuration
,,,A,314293.0,0,,1,12041,,14215,,,BAO_0000218,CHEMBL624172,The area under curve (12.5 mg/kg) administered intravenously in monkey,,U,,,22224,Simiiformes,Autocuration
,,,A,9615.0,1,,1,12042,,14215,,,BAO_0000218,CHEMBL624173,The area under curve (15 mg/kg) administered intravenously in dog,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9606.0,1,,1,12043,,14215,,,BAO_0000218,CHEMBL877488,The area under curve (200 mg/kg) administered orally in humans,,N,,,50587,Homo sapiens,Intermediate
,,,A,10116.0,1,,1,12044,,14215,,,BAO_0000218,CHEMBL624174,The area under curve (25 mg/kg) administered intravenously in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9481.0,0,,1,12045,,14215,,,BAO_0000218,CHEMBL624175,The area under curve (25 mg/kg) administered orally in marmoset,,U,,,22224,Callithrix,Autocuration
,,,A,314293.0,0,,1,12046,,14215,,,BAO_0000218,CHEMBL624176,The area under curve (25 mg/kg) administered orally in monkey,,U,,,22224,Simiiformes,Autocuration
,,,A,9615.0,1,,1,12047,,14215,,,BAO_0000218,CHEMBL624177,The area under curve (30 mg/kg) administered orally in dog,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9606.0,1,,1,12048,,14215,,,BAO_0000218,CHEMBL624178,The area under curve (400 mg/kg) administered orally in humans,,N,,,50587,Homo sapiens,Intermediate
,,,A,10116.0,1,,1,12049,,14215,,,BAO_0000218,CHEMBL624179,The area under curve (50 mg/kg) administered orally in fasted rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12050,,14215,,,BAO_0000218,CHEMBL627689,The area under curve (50 mg/kg) administered orally in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9606.0,1,,1,12051,,14215,,,BAO_0000218,CHEMBL627690,The area under curve (800 mg/kg) administered orally in humans,,N,,,50587,Homo sapiens,Intermediate
,,,A,,0,,1,12052,,11324,,,BAO_0000019,CHEMBL627691,The compound was evaluated for area under the curve,,U,,,22224,,Autocuration
,,,A,9481.0,0,,1,12053,,11324,,,BAO_0000019,CHEMBL627692,The compound was evaluated for area under the curve in marmosets,,U,,,22224,Callithrix,Autocuration
,,,A,9481.0,0,,1,12054,,11324,,,BAO_0000019,CHEMBL627693,The compound was evaluated for area under the curve in marmosets,,U,,,22224,Callithrix,Autocuration
,,,A,10116.0,1,,1,12055,,13875,,,BAO_0000218,CHEMBL627694,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12056,,13875,,,BAO_0000218,CHEMBL627695,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12057,,13875,,,BAO_0000218,CHEMBL627696,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,12058,,13875,,,BAO_0000218,CHEMBL627697,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12059,,13875,,,BAO_0000218,CHEMBL627698,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12060,,13875,,,BAO_0000218,CHEMBL627699,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12061,,13807,,,BAO_0000218,CHEMBL627700,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12062,,14127,,,BAO_0000218,CHEMBL627701,Total drug exposure is determined after oral dosing in rats.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12063,,15116,,,BAO_0000218,CHEMBL627702,Total drug exposure (5 mg/kg) when administered intravenously,,U,,,22224,,Autocuration
,,,A,,0,,1,12064,,15116,,,BAO_0000218,CHEMBL627703,Total drug exposure (5 mg/kg) when administered orally,,U,,,22224,,Autocuration
,,,A,314293.0,0,,1,12065,,15604,,,BAO_0000218,CHEMBL626873,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,U,,,22224,Simiiformes,Autocuration
,,,A,10116.0,1,,1,12066,,15604,,,BAO_0000218,CHEMBL629583,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,12067,,15604,,,BAO_0000218,CHEMBL629584,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12068,,15604,,,BAO_0000218,CHEMBL629585,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,12069,,13751,,,BAO_0000218,CHEMBL629586,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12070,,13751,,,BAO_0000218,CHEMBL629587,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12071,,13751,,,BAO_0000218,CHEMBL629588,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12072,,13751,,,BAO_0000218,CHEMBL629589,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12073,,13751,,,BAO_0000218,CHEMBL629590,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12074,,13751,,,BAO_0000218,CHEMBL629591,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12075,,13751,,,BAO_0000218,CHEMBL629592,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12076,,13751,,,BAO_0000218,CHEMBL629593,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12077,,13751,,,BAO_0000218,CHEMBL629594,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12078,,13751,,,BAO_0000218,CHEMBL629595,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12079,,13751,,,BAO_0000218,CHEMBL630290,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12080,,13751,,,BAO_0000218,CHEMBL627137,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12081,,13751,,,BAO_0000218,CHEMBL627138,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12082,,13751,,,BAO_0000218,CHEMBL627139,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12083,,13751,,,BAO_0000218,CHEMBL627140,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12084,,13751,,,BAO_0000218,CHEMBL627141,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12085,,13751,,,BAO_0000218,CHEMBL627142,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12086,,13751,,,BAO_0000218,CHEMBL627143,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12087,,13751,,,BAO_0000218,CHEMBL874449,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12088,,13751,,,BAO_0000218,CHEMBL627144,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12089,,13751,,,BAO_0000218,CHEMBL627145,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12090,,13751,,,BAO_0000218,CHEMBL627146,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12091,,13751,,,BAO_0000218,CHEMBL627147,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12092,,13751,,,BAO_0000218,CHEMBL627148,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12093,,13751,,,BAO_0000218,CHEMBL627149,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12094,,13751,,,BAO_0000218,CHEMBL632160,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12095,,13751,,,BAO_0000218,CHEMBL632161,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12096,,13751,,,BAO_0000218,CHEMBL632162,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12097,,13751,,,BAO_0000218,CHEMBL632163,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12098,,13751,,,BAO_0000218,CHEMBL874469,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12099,,13751,,,BAO_0000218,CHEMBL627182,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12100,,13751,,,BAO_0000218,CHEMBL627183,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12101,,13751,,,BAO_0000218,CHEMBL627184,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12102,,13751,,,BAO_0000218,CHEMBL627185,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12103,,13751,,,BAO_0000218,CHEMBL627186,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12104,,13751,,,BAO_0000218,CHEMBL627187,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12105,,13751,,,BAO_0000218,CHEMBL627188,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12106,,13751,,,BAO_0000218,CHEMBL627189,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12107,,13751,,,BAO_0000218,CHEMBL627190,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12108,,13751,,,BAO_0000218,CHEMBL627191,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12109,,13751,,,BAO_0000218,CHEMBL627192,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12110,,13751,,,BAO_0000218,CHEMBL627193,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12111,,10911,,,BAO_0000218,CHEMBL874590,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12112,,10911,,,BAO_0000218,CHEMBL627194,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12113,,10911,,,BAO_0000218,CHEMBL627195,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12114,,10911,,,BAO_0000218,CHEMBL627196,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,N,992.0,Female gonad,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12115,,10911,,,BAO_0000218,CHEMBL627197,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,N,992.0,Female gonad,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12116,,10911,,,BAO_0000218,CHEMBL627198,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,N,992.0,Female gonad,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12117,,10911,,,BAO_0000218,CHEMBL627199,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,In vivo,N,992.0,Female gonad,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12118,,10911,,,BAO_0000218,CHEMBL627200,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,N,992.0,Female gonad,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12119,,10911,,,BAO_0000218,CHEMBL627201,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12120,,10911,,,BAO_0000218,CHEMBL627202,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12121,,10911,,,BAO_0000218,CHEMBL627203,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12122,,10911,,,BAO_0000218,CHEMBL627204,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12123,,10911,,,BAO_0000218,CHEMBL627205,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12124,,10911,,,BAO_0000218,CHEMBL627206,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12125,,10911,,,BAO_0000218,CHEMBL627207,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12126,,10911,,,BAO_0000218,CHEMBL627208,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12127,,10911,,,BAO_0000218,CHEMBL627209,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12128,,10911,,,BAO_0000218,CHEMBL627210,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12129,,10911,,,BAO_0000218,CHEMBL627211,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12130,,10911,,,BAO_0000218,CHEMBL627212,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12131,,10911,,,BAO_0000218,CHEMBL627213,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12132,,10911,,,BAO_0000218,CHEMBL626599,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12133,,10911,,,BAO_0000218,CHEMBL626600,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12134,,10911,,,BAO_0000218,CHEMBL626601,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12135,,8081,,,BAO_0000019,CHEMBL627484,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,U,,,22224,,Autocuration
,,,A,9541.0,1,,1,12136,,17248,,,BAO_0000218,CHEMBL627485,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,N,1969.0,Plasma,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,12137,,17248,,,BAO_0000218,CHEMBL628147,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,N,1969.0,Plasma,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,12138,,17248,,,BAO_0000218,CHEMBL628148,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,N,1969.0,Plasma,100710,Macaca fascicularis,Intermediate
,,,A,9615.0,1,,1,12139,,17248,,,BAO_0000218,CHEMBL628149,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12140,,17248,,,BAO_0000218,CHEMBL628150,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12141,,17248,,,BAO_0000218,CHEMBL628318,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12142,,17248,,,BAO_0000218,CHEMBL628319,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12143,,15592,,,BAO_0000218,CHEMBL875609,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,12144,,7040,,,BAO_0000019,CHEMBL628320,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,U,,,22224,,Autocuration
,,,A,,0,,1,12145,,7040,,,BAO_0000019,CHEMBL628321,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,U,,,22224,,Autocuration
,,,A,,0,,1,12146,,7040,,,BAO_0000019,CHEMBL628322,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,U,,,22224,,Autocuration
,,,A,,0,,1,12147,,7040,,,BAO_0000019,CHEMBL628323,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,U,,,22224,,Autocuration
,,,A,,0,,1,12148,,7040,,,BAO_0000019,CHEMBL628324,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,U,,,22224,,Autocuration
,,,A,,0,,1,12149,,7040,,,BAO_0000019,CHEMBL628325,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,U,,,22224,,Autocuration
,,,A,,0,,1,12150,,7040,,,BAO_0000019,CHEMBL628326,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,12151,,9614,,,BAO_0000218,CHEMBL628327,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,N,1236.0,Adrenal medulla,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12152,,9614,,,BAO_0000218,CHEMBL628328,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,N,1236.0,Adrenal medulla,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12153,,9614,,,BAO_0000218,CHEMBL628329,"Concentration of compound in blood of dog 1, after administering intravenously",,N,178.0,Blood,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,12154,,8608,,,BAO_0000218,CHEMBL628330,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12155,,8608,,,BAO_0000218,CHEMBL628331,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12156,,8608,,,BAO_0000218,CHEMBL628332,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12157,,8608,,,BAO_0000218,CHEMBL628333,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12158,,8608,,,BAO_0000218,CHEMBL628334,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12159,,8608,,,BAO_0000218,CHEMBL628335,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12160,,8608,,,BAO_0000218,CHEMBL628336,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12161,,8608,,,BAO_0000218,CHEMBL628337,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12162,,8608,,,BAO_0000218,CHEMBL628338,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12163,,8608,,,BAO_0000218,CHEMBL875610,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12164,,8608,,,BAO_0000218,CHEMBL628339,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12165,,8608,,,BAO_0000218,CHEMBL628340,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12166,,8608,,,BAO_0000218,CHEMBL628341,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12167,,8608,,,BAO_0000218,CHEMBL622214,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12168,,8608,,,BAO_0000218,CHEMBL623167,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12169,,8608,,,BAO_0000218,CHEMBL623168,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12170,,8608,,,BAO_0000218,CHEMBL623169,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12171,,8608,,,BAO_0000218,CHEMBL623170,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12172,,8608,,,BAO_0000218,CHEMBL627224,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12173,,8608,,,BAO_0000218,CHEMBL875634,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12174,,8608,,,BAO_0000218,CHEMBL627225,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12175,,8608,,,BAO_0000218,CHEMBL627226,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12176,,8608,,,BAO_0000218,CHEMBL626083,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12177,,8608,,,BAO_0000218,CHEMBL626084,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12178,,8608,,,BAO_0000218,CHEMBL626085,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12179,,8608,,,BAO_0000218,CHEMBL626086,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12180,,8608,,,BAO_0000218,CHEMBL626087,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12181,,8608,,,BAO_0000218,CHEMBL626088,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12182,,8608,,,BAO_0000218,CHEMBL626089,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12183,,8608,,,BAO_0000218,CHEMBL626090,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12184,,8608,,,BAO_0000218,CHEMBL626091,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12185,,8608,,,BAO_0000218,CHEMBL626092,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12186,,8608,,,BAO_0000218,CHEMBL626093,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12187,,8608,,,BAO_0000218,CHEMBL626094,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12188,,8608,,,BAO_0000218,CHEMBL626095,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12189,,8608,,,BAO_0000218,CHEMBL626096,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,314293.0,0,,1,12190,,15604,,,BAO_0000218,CHEMBL626097,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,U,,,22224,Simiiformes,Autocuration
,,,A,10116.0,1,,1,12191,,15604,,,BAO_0000218,CHEMBL626098,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12192,,1806,,,BAO_0000218,CHEMBL626099,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,12193,,1806,,,BAO_0000218,CHEMBL626100,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,U,1969.0,Plasma,22224,,Autocuration
,,,A,9615.0,1,,1,12194,,17237,,,BAO_0000218,CHEMBL626101,AUC 0-inf in dog,,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10141.0,1,,1,12195,,17237,,,BAO_0000218,CHEMBL626102,AUC 0-inf in guinea pig,,N,1969.0,Plasma,50512,Cavia porcellus,Intermediate
,,,A,9615.0,1,,1,12196,,17237,,,BAO_0000218,CHEMBL626103,AUC 0-t in dog,,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10141.0,1,,1,12197,,17237,,,BAO_0000218,CHEMBL628391,AUC 0-t in guinea pig,,N,1969.0,Plasma,50512,Cavia porcellus,Intermediate
,,,A,10116.0,1,,1,12198,,15194,,,BAO_0000218,CHEMBL628392,The compound was tested for brain to plasma partition in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12199,,15194,,,BAO_0000218,CHEMBL628393,The compound was tested for brain to plasma partition in rat.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12200,,8787,,,BAO_0000019,CHEMBL628394,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,U,178.0,Blood,22224,,Autocuration
,,,A,9615.0,1,,1,12201,,17025,,,BAO_0000218,CHEMBL628395,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,314293.0,0,,1,12202,,17025,,,BAO_0000218,CHEMBL628396,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,U,,,22224,Simiiformes,Autocuration
,,,A,9986.0,1,,1,12203,,17025,,,BAO_0000218,CHEMBL628397,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,N,,,50592,Oryctolagus cuniculus,Intermediate
,,,A,10116.0,1,,1,12204,,17025,,,BAO_0000218,CHEMBL628398,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9544.0,1,,1,12205,,4236,,,BAO_0000218,CHEMBL628399,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,N,,,50797,Macaca mulatta,Intermediate
,,,A,9615.0,1,,1,12206,,15343,,,BAO_0000218,CHEMBL628400,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,12207,,15343,,,BAO_0000218,CHEMBL874907,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12208,,17720,,,BAO_0000019,CHEMBL628401,Area under curve of the compound was determined,,U,,,22224,,Autocuration
,,,A,314293.0,0,,1,12209,,17788,,,BAO_0000218,CHEMBL628402,AUC in monkeys at a dose of 1 mg/kg,,U,1969.0,Plasma,22224,Simiiformes,Autocuration
,,,A,10116.0,1,,1,12210,,17788,,,BAO_0000218,CHEMBL628403,AUC in rats at a dose of 1 mg/kg,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12211,,8778,,,BAO_0000019,CHEMBL628404,Compound was evaluated for the overall absorbance loss at pH of 2,,U,,,22224,,Autocuration
,,,A,,0,,1,12212,,8778,,,BAO_0000019,CHEMBL628405,Compound was evaluated for the overall absorbance loss at pH of 4,,U,,,22224,,Autocuration
,,,A,,0,,1,12213,,8778,,,BAO_0000019,CHEMBL628406,Compound was evaluated for the overall absorbance loss at pH of 7,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,12214,,2249,,,BAO_0000218,CHEMBL628407,Compound was evaluated for its absorption in the rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12215,,8881,,,BAO_0000218,CHEMBL628408,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12216,,8881,,,BAO_0000218,CHEMBL629171,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12217,,8881,,,BAO_0000218,CHEMBL629172,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12218,,8881,,,BAO_0000218,CHEMBL629173,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12219,,15286,,,BAO_0000218,CHEMBL629174,In vitro percent permeability into rat ileum,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12220,,15286,,,BAO_0000218,CHEMBL629175,In vitro percent permeability into rat ileum; Range is 10-17,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12221,,15286,,,BAO_0000218,CHEMBL629176,In vitro percent permeability into rat ileum; Range is 10-18,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12222,,15286,,,BAO_0000218,CHEMBL629177,In vitro percent permeability into rat ileum; Range is 10-19,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12223,,15286,,,BAO_0000218,CHEMBL629178,In vitro percent permeability into rat ileum; Range is 12-15,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12224,,15286,,,BAO_0000218,CHEMBL631869,In vitro percent permeability into rat ileum; Range is 13-19,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12225,,15286,,,BAO_0000218,CHEMBL631870,In vitro percent permeability into rat ileum; Range is 14-17,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12226,,15286,,,BAO_0000218,CHEMBL631871,In vitro percent permeability into rat ileum; Range is 15-18,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12227,,15286,,,BAO_0000218,CHEMBL631872,In vitro percent permeability into rat ileum; Range is 2-5,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12228,,15286,,,BAO_0000221,CHEMBL875775,In vitro percent permeability into rat ileum; Range is 23-42,,U,2116.0,Ileum,22224,,Autocuration
,,,A,10116.0,1,,1,12229,,15286,,,BAO_0000218,CHEMBL631873,In vitro percent permeability into rat ileum; Range is 28-36,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12230,,15286,,,BAO_0000218,CHEMBL631874,In vitro percent permeability into rat ileum; Range is 29-35,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12231,,15286,,,BAO_0000218,CHEMBL631875,In vitro percent permeability into rat ileum; Range is 46-66,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12232,,15286,,,BAO_0000218,CHEMBL631876,In vitro percent permeability into rat ileum; Range is 50-68,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12233,,15286,,,BAO_0000218,CHEMBL631877,In vitro percent permeability into rat ileum; Range is 78-81,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12234,,15286,,,BAO_0000218,CHEMBL631878,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12235,,15286,,,BAO_0000218,CHEMBL631879,In vitro percent permeability into rat ileum; nd indicates not detected,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12236,,15286,,,BAO_0000218,CHEMBL631880,In vitro percent permeability into rat ileum; nt indicates not detected,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12237,,15286,,,BAO_0000218,CHEMBL631881,In vitro percent permeability into rat ileum; nt indicates not tested,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12238,,13770,,,BAO_0000218,CHEMBL631882,Compound was tested for oral absorption in bile-duct cannulated rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12239,,13770,,,BAO_0000218,CHEMBL630749,Compound was tested for oral absorption in bile-duct cannulated rats.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9606.0,1,,1,12240,,5202,,,BAO_0000218,CHEMBL630750,Oral absorption using Caco-2 cell monolayers.,,N,,,50587,Homo sapiens,Intermediate
,,,A,9606.0,1,,1,12241,,14920,,,BAO_0000218,CHEMBL630253,Percent of the drug absorbed after administration to humans was determined,,N,,,50587,Homo sapiens,Intermediate
,,,A,10116.0,1,,1,12242,,14103,,,BAO_0000218,CHEMBL630254,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12243,,14103,,,BAO_0000218,CHEMBL630255,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12244,,14103,,,BAO_0000218,CHEMBL630256,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12245,,13751,,,BAO_0000218,CHEMBL875781,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12246,,13751,,,BAO_0000218,CHEMBL630257,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12247,,13751,,,BAO_0000218,CHEMBL630258,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12248,,15807,,,BAO_0000218,CHEMBL630259,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12249,,15807,,,BAO_0000218,CHEMBL630260,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12250,,15807,,,BAO_0000218,CHEMBL630261,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12251,,14950,,,BAO_0000218,CHEMBL630262,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12252,,14950,,,BAO_0000218,CHEMBL630263,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12253,,14950,,,BAO_0000218,CHEMBL630264,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12254,,14950,,,BAO_0000218,CHEMBL630265,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12255,,14950,,,BAO_0000218,CHEMBL630266,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12256,,14950,,,BAO_0000218,CHEMBL630267,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12257,,14950,,,BAO_0000218,CHEMBL630268,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12258,,14950,,,BAO_0000218,CHEMBL630269,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12259,,14950,,,BAO_0000218,CHEMBL630270,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12260,,14950,,,BAO_0000218,CHEMBL630141,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12261,,14950,,,BAO_0000218,CHEMBL630142,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12262,,14950,,,BAO_0000218,CHEMBL630143,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12263,,14950,,,BAO_0000218,CHEMBL630144,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12264,,14950,,,BAO_0000218,CHEMBL630145,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,N,2367.0,Prostate gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12265,,14950,,,BAO_0000218,CHEMBL630146,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,N,2367.0,Prostate gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12266,,14950,,,BAO_0000218,CHEMBL630147,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12267,,14950,,,BAO_0000218,CHEMBL630148,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12268,,14950,,,BAO_0000218,CHEMBL630149,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12269,,14950,,,BAO_0000218,CHEMBL630150,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12270,,14950,,,BAO_0000218,CHEMBL630151,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12271,,14950,,,BAO_0000218,CHEMBL632031,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12272,,14950,,,BAO_0000218,CHEMBL632032,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12273,,14950,,,BAO_0000218,CHEMBL632033,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12274,,14950,,,BAO_0000218,CHEMBL632034,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12275,,14950,,,BAO_0000218,CHEMBL632035,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12276,,14950,,,BAO_0000218,CHEMBL632036,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12277,,14950,,,BAO_0000218,CHEMBL632037,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12278,,8631,,,BAO_0000218,CHEMBL632038,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12279,,8631,,,BAO_0000218,CHEMBL632039,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12280,,8631,,,BAO_0000218,CHEMBL632040,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12281,,8631,,,BAO_0000218,CHEMBL632041,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,12282,,9614,,,BAO_0000218,CHEMBL632042,"Concentration of compound in blood of dog 2, after administering intravenously",,N,178.0,Blood,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12283,,9614,,,BAO_0000218,CHEMBL632043,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12284,,9614,,,BAO_0000218,CHEMBL632044,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12285,,9614,,,BAO_0000218,CHEMBL632045,"Concentration of compound in liver of dog 1, after administering intravenously",,N,2107.0,Liver,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12286,,9614,,,BAO_0000218,CHEMBL632046,"Concentration of compound in liver of dog 2, after administering intravenously",,N,2107.0,Liver,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12287,,9614,,,BAO_0000218,CHEMBL632047,"Concentration of compound in lung of dog 1, after administering intravenously",,N,2048.0,Lung,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12288,,9614,,,BAO_0000218,CHEMBL632048,"Concentration of compound in lung of dog 2, after administering intravenously",,N,2048.0,Lung,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12289,,9614,,,BAO_0000218,CHEMBL632049,"Concentration of compound in muscle of dog 1, after administering intravenously",,N,2385.0,Muscle tissue,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12290,,9614,,,BAO_0000218,CHEMBL876418,"Concentration of compound in muscle of dog 2, after administering intravenously",,N,2385.0,Muscle tissue,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12291,,9614,,,BAO_0000218,CHEMBL632050,"Concentration of compound in spleen of dog 1,after administering intravenously",,N,2106.0,Spleen,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12292,,9614,,,BAO_0000218,CHEMBL632051,"Concentration of compound in spleen of dog 2, after administering intravenously",,N,2106.0,Spleen,50588,Canis lupus familiaris,Intermediate
,,,F,,0,,1,12293,,10353,,,BAO_0000218,CHEMBL632052,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,U,,,22224,,Autocuration
,,,F,,0,,1,12294,,10353,,,BAO_0000218,CHEMBL632053,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,U,,,22224,,Autocuration
,,,A,,0,,1,12295,,10353,,,BAO_0000218,CHEMBL632054,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,U,,,22224,,Autocuration
,,,F,,0,,1,12296,,10353,,,BAO_0000218,CHEMBL632055,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,U,,,22224,,Autocuration
,,,F,,0,,1,12297,,10353,,,BAO_0000218,CHEMBL631181,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,U,,,22224,,Autocuration
,,,A,,0,,1,12298,,9196,,,BAO_0000218,CHEMBL631182,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12299,,9196,,,BAO_0000218,CHEMBL631183,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12300,,9196,,,BAO_0000218,CHEMBL631184,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12301,,9196,,,BAO_0000218,CHEMBL629774,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12302,,9196,,,BAO_0000218,CHEMBL629775,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12303,,9196,,,BAO_0000218,CHEMBL876549,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12304,,9196,,,BAO_0000218,CHEMBL628172,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12305,,9196,,,BAO_0000218,CHEMBL628173,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12306,,9196,,,BAO_0000218,CHEMBL628174,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12307,,9196,,,BAO_0000218,CHEMBL628175,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12308,,9196,,,BAO_0000218,CHEMBL628176,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12309,,9196,,,BAO_0000218,CHEMBL628177,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12310,,9196,,,BAO_0000218,CHEMBL628178,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12311,,9196,,,BAO_0000218,CHEMBL628179,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12312,,9196,,,BAO_0000218,CHEMBL628180,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,U,,,22224,,Autocuration
,,,A,,0,,1,12313,,9196,,,BAO_0000218,CHEMBL628181,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12314,,9196,,,BAO_0000218,CHEMBL628182,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12315,,9196,,,BAO_0000218,CHEMBL628183,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12316,,9196,,,BAO_0000218,CHEMBL628184,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,U,,,22224,,Autocuration
,,,A,,0,,1,12317,,9196,,,BAO_0000218,CHEMBL628185,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12318,,9196,,,BAO_0000218,CHEMBL875617,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12319,,9196,,,BAO_0000218,CHEMBL628186,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,U,,,22224,,Autocuration
,,,A,,0,,1,12320,,9196,,,BAO_0000218,CHEMBL628187,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12321,,9196,,,BAO_0000218,CHEMBL628188,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12322,,9196,,,BAO_0000218,CHEMBL628189,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12323,,9196,,,BAO_0000218,CHEMBL628190,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,U,,,22224,,Autocuration
,,,A,,0,,1,12324,,9196,,,BAO_0000218,CHEMBL628191,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12325,,9196,,,BAO_0000218,CHEMBL626513,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,12326,,8608,,,BAO_0000218,CHEMBL626514,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12327,,8608,,,BAO_0000218,CHEMBL626515,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12328,,8608,,,BAO_0000218,CHEMBL626516,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12329,,8608,,,BAO_0000218,CHEMBL626517,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12330,,8608,,,BAO_0000218,CHEMBL626518,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12331,,8608,,,BAO_0000218,CHEMBL626519,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12332,,8608,,,BAO_0000218,CHEMBL626520,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12333,,8608,,,BAO_0000218,CHEMBL626521,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12334,,8608,,,BAO_0000218,CHEMBL626522,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12335,,8608,,,BAO_0000218,CHEMBL626523,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12336,,8608,,,BAO_0000218,CHEMBL626524,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12337,,8608,,,BAO_0000218,CHEMBL626688,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12338,,8608,,,BAO_0000218,CHEMBL626689,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12339,,8608,,,BAO_0000218,CHEMBL626690,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12340,,8608,,,BAO_0000218,CHEMBL626691,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12341,,8608,,,BAO_0000218,CHEMBL627319,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12342,,8608,,,BAO_0000218,CHEMBL624052,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12343,,8608,,,BAO_0000218,CHEMBL624053,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12344,,8085,,,BAO_0000218,CHEMBL624054,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12345,,8085,,,BAO_0000218,CHEMBL624055,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12346,,8085,,,BAO_0000218,CHEMBL624056,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12347,,8085,,,BAO_0000218,CHEMBL624057,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12348,,8085,,,BAO_0000218,CHEMBL622281,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12349,,8085,,,BAO_0000218,CHEMBL622282,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12350,,8085,,,BAO_0000218,CHEMBL622283,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12351,,8085,,,BAO_0000218,CHEMBL622284,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12352,,8085,,,BAO_0000218,CHEMBL622285,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12353,,8085,,,BAO_0000218,CHEMBL622286,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,P,,0,,1,12354,,7657,,,BAO_0000100,CHEMBL622287,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,12355,,8935,,,BAO_0000218,CHEMBL622288,Partition coefficient (logD7.4),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12356,,13792,,,BAO_0000218,CHEMBL622289,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12357,,13792,,,BAO_0000218,CHEMBL622290,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12358,,13792,,,BAO_0000218,CHEMBL622291,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12359,,13792,,,BAO_0000218,CHEMBL622292,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12360,,13792,,,BAO_0000218,CHEMBL622293,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12361,,13792,,,BAO_0000218,CHEMBL622294,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12362,,13792,,,BAO_0000218,CHEMBL622295,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,12363,,13792,,,BAO_0000218,CHEMBL622296,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12364,,14103,,,BAO_0000218,CHEMBL874409,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12365,,14103,,,BAO_0000218,CHEMBL622297,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12366,,14103,,,BAO_0000218,CHEMBL622298,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12367,,14103,,,BAO_0000218,CHEMBL622299,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12368,,14103,,,BAO_0000218,CHEMBL622300,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12369,,14103,,,BAO_0000218,CHEMBL622301,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12370,,14103,,,BAO_0000218,CHEMBL622302,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12371,,14103,,,BAO_0000218,CHEMBL622303,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12372,,14103,,,BAO_0000218,CHEMBL622304,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12373,,14103,,,BAO_0000218,CHEMBL622305,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12374,,14103,,,BAO_0000218,CHEMBL622306,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12375,,14103,,,BAO_0000218,CHEMBL626864,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12376,,14103,,,BAO_0000218,CHEMBL626865,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12377,,14103,,,BAO_0000218,CHEMBL626866,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12378,,14103,,,BAO_0000218,CHEMBL626867,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12379,,14103,,,BAO_0000218,CHEMBL626868,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12380,,14103,,,BAO_0000218,CHEMBL626869,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12381,,14103,,,BAO_0000218,CHEMBL626870,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12382,,14103,,,BAO_0000218,CHEMBL626871,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12383,,14103,,,BAO_0000218,CHEMBL626872,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12384,,14103,,,BAO_0000218,CHEMBL632185,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12385,,14103,,,BAO_0000218,CHEMBL632186,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12386,,12904,,,BAO_0000019,CHEMBL629310,Amount of acetic acid produced by the compound,,U,,,22224,,Autocuration
,,,A,,0,,1,12387,,12904,,,BAO_0000019,CHEMBL629311,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,12388,,9663,,,BAO_0000218,CHEMBL629312,Log of (Cbrain/Cblood) in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12389,,7652,,,BAO_0000221,CHEMBL629313,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,U,,,22224,,Autocuration
,,,A,,0,,1,12390,,7652,,,BAO_0000221,CHEMBL629314,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,U,,,22224,,Autocuration
,,,A,,0,,1,12391,,7652,,,BAO_0000221,CHEMBL629315,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,U,,,22224,,Autocuration
,,,B,,0,,1,12392,,7652,,,BAO_0000219,CHEMBL629316,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,U,,,22224,,Autocuration
,,,A,,0,,1,12393,,7652,,,BAO_0000221,CHEMBL629317,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,U,,,22224,,Autocuration
,,,A,,0,,1,12394,,7652,,,BAO_0000019,CHEMBL629318,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,U,,,22224,,Autocuration
,,,A,,0,,1,12395,,7652,,,BAO_0000019,CHEMBL877497,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,U,,,22224,,Autocuration
,,,A,,0,,1,12396,,7652,,,BAO_0000019,CHEMBL629319,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,U,,,22224,,Autocuration
,,,A,,0,,1,12397,,7652,,,BAO_0000019,CHEMBL629320,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,U,,,22224,,Autocuration
,,,A,,0,,1,12398,,7652,,,BAO_0000019,CHEMBL629496,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,U,,,22224,,Autocuration
,,,A,,0,,1,12399,,7652,,,BAO_0000019,CHEMBL629497,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,U,,,22224,,Autocuration
,,,A,,0,,1,12400,,7652,,,BAO_0000019,CHEMBL629498,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,U,,,22224,,Autocuration
,,,A,,0,,1,12401,,7652,,,BAO_0000019,CHEMBL629499,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,U,,,22224,,Autocuration
,,,A,,0,,1,12402,,7652,,,BAO_0000019,CHEMBL629500,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,U,,,22224,,Autocuration
,,,A,,0,,1,12403,,7652,,,BAO_0000019,CHEMBL629501,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,U,,,22224,,Autocuration
,,,A,,0,,1,12404,,7652,,,BAO_0000019,CHEMBL629502,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,U,,,22224,,Autocuration
,,,F,,0,,1,12405,,8267,,,BAO_0000218,CHEMBL629503,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,In vivo,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,12406,,8267,,,BAO_0000218,CHEMBL629504,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,12407,,14479,,,BAO_0000019,CHEMBL629505,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,U,,,22224,,Autocuration
,,,A,,0,,1,12408,,17515,,,BAO_0000019,CHEMBL629506,Compound was evaluated for total body clearance,,U,,,22224,,Autocuration
,,,A,,0,,1,12409,,17515,,,BAO_0000019,CHEMBL629507,Compound was evaluated for volume of distribution at steady state,,U,,,22224,,Autocuration
,,,A,,0,,1,12410,,8142,,,BAO_0000019,CHEMBL877498,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,U,,,22224,,Autocuration
,,,A,,0,,1,12411,,14849,,,BAO_0000019,CHEMBL629508,Percentage of the diamine which is monoprotonated at pH 7.4,,U,,,22224,,Autocuration
,,,A,,0,,1,12412,,7653,,,BAO_0000019,CHEMBL629509,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,12413,,8631,,,BAO_0000218,CHEMBL629510,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12414,,8631,,,BAO_0000218,CHEMBL629511,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12415,,8631,,,BAO_0000218,CHEMBL629512,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12416,,8631,,,BAO_0000218,CHEMBL629513,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12417,,8631,,,BAO_0000218,CHEMBL629514,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12418,,8631,,,BAO_0000218,CHEMBL628447,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12419,,8631,,,BAO_0000218,CHEMBL628448,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12420,,8631,,,BAO_0000218,CHEMBL628449,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12421,,8631,,,BAO_0000218,CHEMBL631119,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12422,,8631,,,BAO_0000218,CHEMBL631120,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12423,,8631,,,BAO_0000218,CHEMBL631121,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12424,,8631,,,BAO_0000218,CHEMBL874458,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12425,,8631,,,BAO_0000218,CHEMBL631122,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12426,,8631,,,BAO_0000218,CHEMBL631123,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12427,,8631,,,BAO_0000218,CHEMBL631124,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12428,,8631,,,BAO_0000218,CHEMBL631125,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12429,,8631,,,BAO_0000218,CHEMBL631290,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12430,,8631,,,BAO_0000218,CHEMBL631291,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12431,,8631,,,BAO_0000218,CHEMBL631292,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12432,,8631,,,BAO_0000218,CHEMBL631293,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12433,,8631,,,BAO_0000218,CHEMBL631294,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12434,,8631,,,BAO_0000218,CHEMBL631295,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12435,,8631,,,BAO_0000218,CHEMBL631296,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12436,,8631,,,BAO_0000218,CHEMBL631297,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12437,,10263,,,BAO_0000218,CHEMBL631298,Maximum biodistribution (Bmax) was determined.,,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,12438,,12364,,,BAO_0000218,CHEMBL631299,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12439,,12364,,,BAO_0000218,CHEMBL631300,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12440,,12364,,,BAO_0000218,CHEMBL631301,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12441,,12364,,,BAO_0000218,CHEMBL630291,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,N,,,50594,Mus musculus,Intermediate
,,,A,,0,,1,12442,,14793,,,BAO_0000218,CHEMBL630292,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,U,,,22224,,Autocuration
,,,A,,0,,1,12443,,14793,,,BAO_0000218,CHEMBL630293,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,U,,,22224,,Autocuration
,,,A,,0,,1,12444,,14793,,,BAO_0000218,CHEMBL630294,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,U,,,22224,,Autocuration
,,,A,,0,,1,12445,,14793,,,BAO_0000218,CHEMBL630295,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,U,,,22224,,Autocuration
,,,A,,0,,1,12446,,14793,,,BAO_0000218,CHEMBL630296,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,U,,,22224,,Autocuration
,,,A,,0,,1,12447,,14793,,,BAO_0000218,CHEMBL626782,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,U,,,22224,,Autocuration
,,,A,,0,,1,12448,,14793,,,BAO_0000218,CHEMBL626783,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,U,,,22224,,Autocuration
,,,A,,0,,1,12449,,14793,,,BAO_0000218,CHEMBL626784,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,U,,,22224,,Autocuration
,,,A,,0,,1,12450,,14793,,,BAO_0000218,CHEMBL626785,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,U,,,22224,,Autocuration
,,,A,,0,,1,12451,,14793,,,BAO_0000218,CHEMBL626786,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,U,,,22224,,Autocuration
,,,A,,0,,1,12452,,9196,,,BAO_0000218,CHEMBL626787,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12453,,9196,,,BAO_0000218,CHEMBL626788,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,U,,,22224,,Autocuration
,,,A,,0,,1,12454,,9196,,,BAO_0000218,CHEMBL625927,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,12455,,8374,,,BAO_0000218,CHEMBL625928,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12456,,8374,,,BAO_0000218,CHEMBL625929,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12457,,8374,,,BAO_0000218,CHEMBL625930,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12458,,8374,,,BAO_0000218,CHEMBL625931,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12459,,8374,,,BAO_0000218,CHEMBL627230,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12460,,8374,,,BAO_0000218,CHEMBL627231,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12461,,8374,,,BAO_0000218,CHEMBL627232,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12462,,8374,,,BAO_0000218,CHEMBL627233,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12463,,8374,,,BAO_0000218,CHEMBL875470,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12464,,8374,,,BAO_0000218,CHEMBL627234,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12465,,8374,,,BAO_0000218,CHEMBL627235,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12466,,8374,,,BAO_0000218,CHEMBL627236,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12467,,8374,,,BAO_0000218,CHEMBL627237,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12468,,8374,,,BAO_0000218,CHEMBL627238,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12469,,8374,,,BAO_0000218,CHEMBL627239,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12470,,8374,,,BAO_0000218,CHEMBL627240,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12471,,8374,,,BAO_0000218,CHEMBL627241,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12472,,8374,,,BAO_0000218,CHEMBL627242,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12473,,8374,,,BAO_0000218,CHEMBL627243,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12474,,8374,,,BAO_0000218,CHEMBL627244,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12475,,8374,,,BAO_0000218,CHEMBL627245,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12476,,8374,,,BAO_0000218,CHEMBL627246,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12477,,8374,,,BAO_0000218,CHEMBL627247,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12478,,8374,,,BAO_0000218,CHEMBL627248,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12479,,8374,,,BAO_0000218,CHEMBL627249,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12480,,8374,,,BAO_0000218,CHEMBL625569,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12481,,8374,,,BAO_0000218,CHEMBL625570,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12482,,8374,,,BAO_0000218,CHEMBL625571,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12483,,8374,,,BAO_0000218,CHEMBL625572,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12484,,8374,,,BAO_0000218,CHEMBL625573,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12485,,8374,,,BAO_0000218,CHEMBL625574,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12486,,8374,,,BAO_0000218,CHEMBL626245,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12487,,8374,,,BAO_0000218,CHEMBL626246,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12488,,9196,,,BAO_0000218,CHEMBL626247,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12489,,9196,,,BAO_0000218,CHEMBL626248,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12490,,9196,,,BAO_0000218,CHEMBL626249,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12491,,9196,,,BAO_0000218,CHEMBL626420,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12492,,9196,,,BAO_0000218,CHEMBL626421,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12493,,9196,,,BAO_0000218,CHEMBL626422,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12494,,9196,,,BAO_0000218,CHEMBL626423,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12495,,9196,,,BAO_0000218,CHEMBL626424,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,12496,,12023,,,BAO_0000218,CHEMBL626425,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,12497,,12023,,,BAO_0000218,CHEMBL875476,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9541.0,1,,1,12498,,12023,,,BAO_0000218,CHEMBL626426,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,N,,,100710,Macaca fascicularis,Intermediate
,,,P,,0,,1,12499,,10580,,,BAO_0000100,CHEMBL626427,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,U,,,22224,,Autocuration
,,,P,,0,,1,12500,,10580,,,BAO_0000100,CHEMBL626428,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,U,,,22224,,Autocuration
,,,A,,0,,1,12501,,16032,,,BAO_0000019,CHEMBL626429,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,U,,,22224,,Autocuration
,,,A,,0,,1,12502,,16032,,,BAO_0000019,CHEMBL625025,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,U,1088.0,Urine,22224,,Autocuration
,,,A,10116.0,1,,1,12503,,8594,,,BAO_0000218,CHEMBL625026,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12504,,8594,,,BAO_0000218,CHEMBL625027,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12505,,8594,,,BAO_0000218,CHEMBL874410,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12506,,8594,,,BAO_0000218,CHEMBL625028,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12507,,8594,,,BAO_0000218,CHEMBL625029,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12508,,8594,,,BAO_0000218,CHEMBL625030,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12509,,8594,,,BAO_0000218,CHEMBL625031,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12510,,8594,,,BAO_0000218,CHEMBL625032,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12511,,8594,,,BAO_0000218,CHEMBL625033,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12512,,8594,,,BAO_0000218,CHEMBL625034,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12513,,8594,,,BAO_0000218,CHEMBL624872,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12514,,8594,,,BAO_0000218,CHEMBL624873,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12515,,8594,,,BAO_0000218,CHEMBL624874,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12516,,8594,,,BAO_0000218,CHEMBL624875,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12517,,8594,,,BAO_0000218,CHEMBL624876,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12518,,8594,,,BAO_0000218,CHEMBL624877,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12519,,8594,,,BAO_0000218,CHEMBL624878,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12520,,8594,,,BAO_0000218,CHEMBL624879,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12521,,8594,,,BAO_0000218,CHEMBL624880,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12522,,8594,,,BAO_0000218,CHEMBL624881,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12523,,8594,,,BAO_0000218,CHEMBL624882,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12524,,8594,,,BAO_0000218,CHEMBL624883,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12525,,8594,,,BAO_0000218,CHEMBL624884,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12526,,8594,,,BAO_0000218,CHEMBL624885,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12527,,8594,,,BAO_0000218,CHEMBL624886,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12528,,8594,,,BAO_0000218,CHEMBL624887,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12529,,8594,,,BAO_0000218,CHEMBL624888,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12530,,8594,,,BAO_0000218,CHEMBL624889,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12531,,8594,,,BAO_0000218,CHEMBL624890,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12532,,8594,,,BAO_0000218,CHEMBL621964,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12533,,8594,,,BAO_0000218,CHEMBL621965,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12534,,8594,,,BAO_0000218,CHEMBL621966,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12535,,8594,,,BAO_0000218,CHEMBL621967,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12536,,8594,,,BAO_0000218,CHEMBL622164,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12537,,7653,,,BAO_0000019,CHEMBL623097,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,U,,,22224,,Autocuration
,,,A,,0,,1,12538,,7653,,,BAO_0000019,CHEMBL623098,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,U,,,22224,,Autocuration
,,,A,,0,,1,12539,,7653,,,BAO_0000019,CHEMBL623099,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,U,,,22224,,Autocuration
,,,A,,0,,1,12540,,7653,,,BAO_0000019,CHEMBL623100,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,12541,,9104,,,BAO_0000218,CHEMBL628673,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12542,,9104,,,BAO_0000218,CHEMBL628674,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12543,,9104,,,BAO_0000218,CHEMBL628675,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12544,,9104,,,BAO_0000218,CHEMBL627644,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12545,,9104,,,BAO_0000218,CHEMBL627645,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12546,,9104,,,BAO_0000218,CHEMBL627646,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12547,,9104,,,BAO_0000218,CHEMBL627647,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12548,,9104,,,BAO_0000218,CHEMBL627648,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12549,,12902,,,BAO_0000218,CHEMBL627649,Free level in rat plasma,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12550,,6614,,,BAO_0000019,CHEMBL628313,Level reaching in blood plasma of rat or human was determined,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,12551,,9663,,,BAO_0000218,CHEMBL628314,Log (Cbrain/Cblood) in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12552,,17658,,,BAO_0000019,CHEMBL628315,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,U,,,22224,,Autocuration
,,,A,,0,,1,12553,,17658,,,BAO_0000019,CHEMBL628316,Mean percentage of compound transport through membrane; expressed as membrane transport,,U,,,22224,,Autocuration
,,,A,,0,,1,12554,,14314,,,BAO_0000218,CHEMBL628317,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,U,,,22224,,Autocuration
,,,A,,0,,1,12555,,7385,,,BAO_0000019,CHEMBL628473,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,U,,,22224,,Autocuration
,,,A,,0,,1,12556,,7385,,,BAO_0000019,CHEMBL628474,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,U,,,22224,,Autocuration
,,,A,,0,,1,12557,,7385,,,BAO_0000019,CHEMBL628475,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,U,,,22224,,Autocuration
,,,A,,0,,1,12558,,1329,,,BAO_0000019,CHEMBL628476,Net water uptake by a carrier mediated transport (%cm) mechanism,,U,,,22224,,Autocuration
,,,A,314293.0,0,,1,12559,,12187,,,BAO_0000218,CHEMBL628477,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,U,,,22224,Simiiformes,Autocuration
,,,A,9669.0,1,,1,12560,,12187,,,BAO_0000218,CHEMBL628478,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,N,,,50506,Mustela putorius furo,Intermediate
,,,A,9669.0,1,,1,12561,,12187,,,BAO_0000218,CHEMBL628479,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,N,,,50506,Mustela putorius furo,Intermediate
,,,A,314293.0,0,,1,12562,,12187,,,BAO_0000218,CHEMBL628480,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,U,,,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,12563,,12187,,,BAO_0000218,CHEMBL628481,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,U,,,22224,Simiiformes,Autocuration
,,,A,10116.0,1,,1,12564,,12187,,,BAO_0000218,CHEMBL628482,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12565,,12187,,,BAO_0000218,CHEMBL628483,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12566,,9278,,,BAO_0000218,CHEMBL628484,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12567,,9278,,,BAO_0000218,CHEMBL628485,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9541.0,1,,1,12568,,9278,,,BAO_0000218,CHEMBL628486,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,N,1969.0,Plasma,100710,Macaca fascicularis,Intermediate
,,,A,9606.0,1,,1,12569,,9278,,,BAO_0000218,CHEMBL628487,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,N,1969.0,Plasma,50587,Homo sapiens,Intermediate
,,,A,10116.0,1,,1,12570,,9278,,,BAO_0000218,CHEMBL628488,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12571,,9278,,,BAO_0000218,CHEMBL628489,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12572,,9278,,,BAO_0000218,CHEMBL628490,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9541.0,1,,1,12573,,12186,,,BAO_0000218,CHEMBL628491,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,12574,,12186,,,BAO_0000218,CHEMBL877507,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,N,,,100710,Macaca fascicularis,Intermediate
,,,A,,0,,1,12575,,12186,,,BAO_0000218,CHEMBL628492,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,U,,,22224,,Autocuration
,,,A,314293.0,0,,1,12576,,12041,,,BAO_0000019,CHEMBL628493,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,U,,,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,12577,,12041,,,BAO_0000019,CHEMBL628494,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,U,,,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,12578,,12041,,,BAO_0000019,CHEMBL628495,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,U,,,22224,Simiiformes,Autocuration
,,,A,9606.0,1,,1,12579,,6737,,,BAO_0000218,CHEMBL628496,Permeability in Caco-2 assay at 10E-6,,N,,,50587,Homo sapiens,Intermediate
,,,A,,0,,1,12580,,13758,,,BAO_0000218,CHEMBL628497,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,U,955.0,Brain,22224,,Autocuration
,,,A,,0,,1,12581,,13758,,,BAO_0000218,CHEMBL628498,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,U,955.0,Brain,22224,,Autocuration
,,,A,,0,,1,12582,,5676,,,BAO_0000019,CHEMBL628499,Plasma protein binding was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,12583,,14793,,,BAO_0000218,CHEMBL627656,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,U,,,22224,,Autocuration
,,,A,,0,,1,12584,,14793,,,BAO_0000218,CHEMBL627657,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,U,,,22224,,Autocuration
,,,A,,0,,1,12585,,14793,,,BAO_0000218,CHEMBL626808,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,U,,,22224,,Autocuration
,,,A,,0,,1,12586,,14793,,,BAO_0000218,CHEMBL626809,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,U,,,22224,,Autocuration
,,,A,,0,,1,12587,,14793,,,BAO_0000218,CHEMBL626810,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,U,,,22224,,Autocuration
,,,A,,0,,1,12588,,14793,,,BAO_0000218,CHEMBL626811,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,U,,,22224,,Autocuration
,,,A,,0,,1,12589,,14793,,,BAO_0000218,CHEMBL874465,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,U,,,22224,,Autocuration
,,,A,,0,,1,12590,,14793,,,BAO_0000218,CHEMBL626812,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,U,,,22224,,Autocuration
,,,A,,0,,1,12591,,14793,,,BAO_0000218,CHEMBL626813,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,U,,,22224,,Autocuration
,,,A,,0,,1,12592,,14793,,,BAO_0000218,CHEMBL626814,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,U,,,22224,,Autocuration
,,,A,,0,,1,12593,,14000,,,BAO_0000019,CHEMBL626815,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,U,,,22224,,Autocuration
,,,A,,0,,1,12594,,5948,,,BAO_0000019,CHEMBL628566,Partition coefficient (logP),,U,,,22224,,Autocuration
,,,P,,0,,1,12595,,13824,,,BAO_0000100,CHEMBL628567,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,U,,,22229,,Autocuration
,,,P,,0,,1,12596,,10778,,,BAO_0000100,CHEMBL628568,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,A,9615.0,1,,1,12597,,17237,,,BAO_0000218,CHEMBL628569,C max in dog,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10141.0,1,,1,12598,,17237,,,BAO_0000218,CHEMBL628570,C max in guinea pig,In vivo,N,,,50512,Cavia porcellus,Intermediate
,,,A,,0,,1,12599,,2809,,,BAO_0000218,CHEMBL628571,C max value was evaluated,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,12600,,11954,,,BAO_0000218,CHEMBL628572,Cmax value after oral dose of 0.1 mg//kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,12601,,11954,,,BAO_0000218,CHEMBL628573,Cmax value after oral dose of 0.3 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,12602,,11954,,,BAO_0000218,CHEMBL628574,Cmax value after oral dose of 1 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,12603,,11954,,,BAO_0000218,CHEMBL628575,Cmax value after oral dose of 10 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,12604,,11954,,,BAO_0000218,CHEMBL628576,Cmax value after oral dose of 23.4 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,12605,,11954,,,BAO_0000218,CHEMBL628577,Cmax value after oral dose of 3 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,12606,,11954,,,BAO_0000218,CHEMBL628578,Cmax value after oral dose of 3.87 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,12607,,12768,,,BAO_0000218,CHEMBL874466,Cmax value in female Beagle dogs,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,12608,,12768,,,BAO_0000218,CHEMBL628579,Cmax value in male rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12609,,12780,,,BAO_0000218,CHEMBL628580,Cmax value in rat plasma when administered 20 mg/kg perorally,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,12610,,15592,,,BAO_0000218,CHEMBL628581,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12611,,15592,,,BAO_0000218,CHEMBL628582,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12612,,17025,,,BAO_0000218,CHEMBL628583,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,314293.0,0,,1,12613,,17025,,,BAO_0000218,CHEMBL625782,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,U,,,22224,Simiiformes,Autocuration
,,,A,9986.0,1,,1,12614,,17025,,,BAO_0000218,CHEMBL625783,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,N,,,50592,Oryctolagus cuniculus,Intermediate
,,,A,10116.0,1,,1,12615,,17025,,,BAO_0000218,CHEMBL625784,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9544.0,1,,1,12616,,4236,,,BAO_0000218,CHEMBL625785,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,N,1969.0,Plasma,50797,Macaca mulatta,Intermediate
,,,A,10116.0,1,,1,12617,,15791,,,BAO_0000218,CHEMBL625786,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12618,,11149,,,BAO_0000019,CHEMBL874467,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,12619,,15592,,,BAO_0000218,CHEMBL625787,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,12721.0,1,,1,12620,,15778,,,BAO_0000218,CHEMBL625964,cytotoxicity against HIV protease enzyme.,,N,,,50677,Human immunodeficiency virus,Intermediate
,,,A,10090.0,1,,1,12621,,12745,,,BAO_0000218,CHEMBL625965,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12622,,12745,,,BAO_0000218,CHEMBL625966,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,N,,,50594,Mus musculus,Intermediate
,,,A,9615.0,1,,1,12623,,13941,,,BAO_0000218,CHEMBL625967,The plasma clearance in dog.,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,12624,,13941,,,BAO_0000218,CHEMBL625968,The plasma clearance in rat.,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12625,,16449,,,BAO_0000218,CHEMBL625969,Clearance from plasma in male Sprague-Dawley rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9541.0,1,,1,12626,,16449,,,BAO_0000218,CHEMBL625970,Clearance from plasma in male cynomolgus monkeys,In vivo,N,1969.0,Plasma,100710,Macaca fascicularis,Intermediate
,,,A,9615.0,1,,1,12627,,14224,,,BAO_0000218,CHEMBL625971,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12628,,14224,,,BAO_0000218,CHEMBL625972,Clearance of compound in dog plasma,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,9606.0,1,,1,12629,,14224,,,BAO_0000218,CHEMBL625973,Clearance of compound in human plasma,In vivo,N,1969.0,Plasma,50587,Homo sapiens,Intermediate
,,,A,9615.0,1,,1,12630,,14317,,,BAO_0000218,CHEMBL625974,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12631,,14317,,,BAO_0000218,CHEMBL625975,Clearance of compound when administered intravenously as an individual dose to a single dog.,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12632,,14224,,,BAO_0000218,CHEMBL625976,"Clearance (10 mg/kg, intravenously) in dog plasma",In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12633,,17237,,,BAO_0000218,CHEMBL625977,Clearance value in dog,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10141.0,1,,1,12634,,17237,,,BAO_0000218,CHEMBL625978,Clearance value in guinea pig,In vivo,N,,,50512,Cavia porcellus,Intermediate
,,,A,10116.0,1,,1,12635,,14187,,,BAO_0000218,CHEMBL874468,Clearance values in rats after iv administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12636,,4806,,,BAO_0000218,CHEMBL625421,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,9986.0,1,,1,12637,,15025,,,BAO_0000218,CHEMBL625422,In vivo clearance (5 mg/kg) was determined in rabbits,In vivo,N,,,50592,Oryctolagus cuniculus,Intermediate
,,,A,10116.0,1,,1,12638,,13197,,,BAO_0000218,CHEMBL625423,Plasma Clearance rate was determined for the compound in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9520.0,0,,1,12639,,13197,,,BAO_0000218,CHEMBL625424,Plasma Clearance rate was determined for the compound in squirrel monkeys,In vivo,U,,,22224,Saimiri,Autocuration
,,,A,10116.0,1,,1,12640,,13960,,,BAO_0000218,CHEMBL625425,Plasma clearance in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12641,,17820,,,BAO_0000218,CHEMBL625426,Plasma clearance of the compound,In vivo,U,,,22224,,Autocuration
,,,A,10141.0,1,,1,12642,,14706,,,BAO_0000218,CHEMBL625427,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,In vivo,N,,,50512,Cavia porcellus,Intermediate
,,,A,10141.0,1,,1,12643,,14706,,,BAO_0000218,CHEMBL625428,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,In vivo,N,,,50512,Cavia porcellus,Intermediate
,,,A,,0,,1,12644,,6504,,,BAO_0000218,CHEMBL625429,Plasma clearance was determined,In vivo,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,12645,,14925,,,BAO_0000218,CHEMBL625430,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,12646,,13197,,,BAO_0000218,CHEMBL625431,Plasma clearance rate was determined for the compound in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9520.0,0,,1,12647,,13197,,,BAO_0000218,CHEMBL627307,Plasma clearance rate was determined for the compound in squirrel monkeys,In vivo,U,,,22224,Saimiri,Autocuration
,,,A,,0,,1,12648,,3437,,,BAO_0000218,CHEMBL627308,Slow clearance (CL) was determined,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,12649,,9196,,,BAO_0000218,CHEMBL627309,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12650,,9196,,,BAO_0000218,CHEMBL627310,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,U,,,22224,,Autocuration
,,,A,,0,,1,12651,,9196,,,BAO_0000218,CHEMBL627311,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12652,,9196,,,BAO_0000218,CHEMBL627312,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12653,,9196,,,BAO_0000218,CHEMBL627313,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12654,,9196,,,BAO_0000218,CHEMBL627314,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12655,,9196,,,BAO_0000218,CHEMBL627315,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12656,,9196,,,BAO_0000218,CHEMBL627316,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12657,,9196,,,BAO_0000218,CHEMBL627317,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12658,,9196,,,BAO_0000218,CHEMBL627318,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12659,,9196,,,BAO_0000218,CHEMBL627999,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12660,,9196,,,BAO_0000218,CHEMBL628000,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12661,,9196,,,BAO_0000218,CHEMBL628001,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12662,,9196,,,BAO_0000218,CHEMBL628002,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12663,,9196,,,BAO_0000218,CHEMBL625610,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12664,,9196,,,BAO_0000218,CHEMBL625611,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12665,,9196,,,BAO_0000218,CHEMBL625612,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12666,,9196,,,BAO_0000218,CHEMBL625613,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12667,,9196,,,BAO_0000218,CHEMBL875479,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12668,,9196,,,BAO_0000218,CHEMBL625614,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12669,,9196,,,BAO_0000218,CHEMBL625615,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,U,,,22224,,Autocuration
,,,A,,0,,1,12670,,9196,,,BAO_0000218,CHEMBL626302,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,12671,,8374,,,BAO_0000218,CHEMBL626303,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12672,,8374,,,BAO_0000218,CHEMBL627420,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12673,,13477,,,BAO_0000218,CHEMBL627421,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12674,,13477,,,BAO_0000218,CHEMBL625695,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12675,,13477,,,BAO_0000218,CHEMBL625696,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,12676,,10009,,,BAO_0000218,CHEMBL875606,Distribution of compound in mice brain was measured after 1 hr,,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12677,,10009,,,BAO_0000218,CHEMBL625697,Distribution of compound in mice brain was measured after 24 hr r,,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12678,,10009,,,BAO_0000218,CHEMBL625698,Distribution of compound in mice brain was measured after 2 hr,,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12679,,10009,,,BAO_0000218,CHEMBL625699,Distribution of compound in mice brain was measured after 3 hr,,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12680,,10009,,,BAO_0000218,CHEMBL625700,Distribution of compound in mice brain was measured after 6 hr,,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12681,,10009,,,BAO_0000218,CHEMBL625701,Distribution of compound in mice liver was measured after 1 hr,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12682,,10009,,,BAO_0000218,CHEMBL625702,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12683,,10009,,,BAO_0000218,CHEMBL625703,Distribution of compound in mice liver was measured after 2 hr,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12684,,10009,,,BAO_0000218,CHEMBL625704,Distribution of compound in mice liver was measured after 3 hr,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,12685,,10009,,,BAO_0000218,CHEMBL625705,Distribution of compound in mice liver was measured after 6 hr,,N,,,50594,Mus musculus,Intermediate
,,,A,9615.0,1,,1,12686,,8170,,,BAO_0000218,CHEMBL625706,Distribution in dog adrenal medulla 30 min after administration.,,N,1236.0,Adrenal medulla,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12687,,8170,,,BAO_0000218,CHEMBL625707,Distribution in dog adrenal medulla 72 hours after administration.,,N,1236.0,Adrenal medulla,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12688,,8170,,,BAO_0000218,CHEMBL625708,Distribution in female dog Ovary 24 hours after administration.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12689,,8170,,,BAO_0000218,CHEMBL625709,Distribution in female dog Ovary 72 hours after administration.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12690,,8170,,,BAO_0000218,CHEMBL624180,Distribution in female dog adipose 24 hours after administration.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12691,,8170,,,BAO_0000218,CHEMBL624181,Distribution in female dog adipose 72 hours after administration.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12692,,8170,,,BAO_0000218,CHEMBL624182,Distribution in female dog adrenal cortex 72 hours after administration.,,N,1235.0,Adrenal cortex,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12693,,8170,,,BAO_0000218,CHEMBL624183,Distribution in female dog adrenal cortex 72 hours after administration.,,N,1235.0,Adrenal cortex,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,12694,,8594,,,BAO_0000218,CHEMBL624184,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12695,,8594,,,BAO_0000218,CHEMBL877489,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12696,,8594,,,BAO_0000218,CHEMBL624185,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12697,,8594,,,BAO_0000218,CHEMBL624186,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12698,,8594,,,BAO_0000218,CHEMBL624187,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12699,,8594,,,BAO_0000218,CHEMBL624188,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12700,,8594,,,BAO_0000218,CHEMBL624189,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12701,,8594,,,BAO_0000218,CHEMBL624190,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12702,,8594,,,BAO_0000218,CHEMBL624191,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12703,,8594,,,BAO_0000218,CHEMBL624192,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12704,,8594,,,BAO_0000218,CHEMBL624193,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12705,,8594,,,BAO_0000218,CHEMBL624194,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12706,,8594,,,BAO_0000218,CHEMBL624891,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12707,,8594,,,BAO_0000218,CHEMBL624892,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12708,,8594,,,BAO_0000218,CHEMBL624893,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12709,,8594,,,BAO_0000218,CHEMBL627632,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12710,,8594,,,BAO_0000218,CHEMBL627633,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12711,,8594,,,BAO_0000218,CHEMBL627634,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12712,,8594,,,BAO_0000218,CHEMBL627635,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12713,,8594,,,BAO_0000218,CHEMBL627636,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12714,,8594,,,BAO_0000218,CHEMBL626816,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12715,,8594,,,BAO_0000218,CHEMBL626817,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12716,,8594,,,BAO_0000218,CHEMBL626818,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12717,,8594,,,BAO_0000218,CHEMBL626819,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12718,,8594,,,BAO_0000218,CHEMBL626820,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12719,,8594,,,BAO_0000218,CHEMBL626821,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12720,,8594,,,BAO_0000218,CHEMBL626822,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12721,,8594,,,BAO_0000218,CHEMBL626823,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12722,,8594,,,BAO_0000218,CHEMBL626824,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12723,,8594,,,BAO_0000218,CHEMBL626825,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12724,,8594,,,BAO_0000218,CHEMBL626826,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12725,,8594,,,BAO_0000218,CHEMBL626827,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12726,,8594,,,BAO_0000218,CHEMBL626828,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12727,,8594,,,BAO_0000218,CHEMBL626829,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12728,,8594,,,BAO_0000218,CHEMBL626830,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12729,,8594,,,BAO_0000218,CHEMBL627150,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12730,,8594,,,BAO_0000218,CHEMBL627151,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12731,,8594,,,BAO_0000218,CHEMBL627152,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12732,,8594,,,BAO_0000218,CHEMBL627153,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12733,,12904,,,BAO_0000019,CHEMBL627154,Rate of acetate production by the compound was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,12734,,12904,,,BAO_0000019,CHEMBL627155,Rate of acetate production by the compound was determined; Not determined,,U,,,22224,,Autocuration
,,,A,,0,,1,12735,,3730,,,BAO_0000019,CHEMBL627156,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,U,,,22224,,Autocuration
,,,A,,0,,1,12736,,3627,,,BAO_0000019,CHEMBL627157,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,U,,,22224,,Autocuration
,,,A,9986.0,1,,1,12737,,13799,,,BAO_0000218,CHEMBL627158,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,N,,,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12738,,13799,,,BAO_0000218,CHEMBL627159,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,N,1969.0,Plasma,50592,Oryctolagus cuniculus,Intermediate
,,,A,10090.0,1,,1,12739,,13799,,,BAO_0000218,CHEMBL627160,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,12740,,13799,,,BAO_0000218,CHEMBL628540,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12741,,13799,,,BAO_0000218,CHEMBL628541,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12742,,13799,,,BAO_0000218,CHEMBL628542,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,P,,0,,1,12743,,6629,,,BAO_0000100,CHEMBL628543,Solubility after at a pH 1.2,,U,,,22229,,Autocuration
,,,P,,0,,1,12744,,6629,,,BAO_0000100,CHEMBL628544,Solubility after at pH 1.2,,U,,,22229,,Autocuration
,,,P,,0,,1,12745,,6629,,,BAO_0000100,CHEMBL628545,Solubility after injection of water,,U,,,22229,,Autocuration
,,,A,,0,,1,12746,,14000,,,BAO_0000019,CHEMBL628546,Statistical significance of IC 50 values; Expressed as R value,,U,,,22224,,Autocuration
,,,A,,0,,1,12747,,8267,,,BAO_0000019,CHEMBL874455,Systemic availability with respect to methyldopa was determined,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,12748,,13799,,,BAO_0000218,CHEMBL628547,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12749,,13799,,,BAO_0000218,CHEMBL628548,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9986.0,1,,1,12750,,7132,,,BAO_0000218,CHEMBL628549,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,N,1988.0,Feces,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12751,,7132,,,BAO_0000218,CHEMBL628550,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,N,1988.0,Feces,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12752,,7132,,,BAO_0000218,CHEMBL628551,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,N,1988.0,Feces,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12753,,7132,,,BAO_0000218,CHEMBL628552,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12754,,7132,,,BAO_0000218,CHEMBL628553,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12755,,7132,,,BAO_0000218,CHEMBL628554,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12756,,7132,,,BAO_0000218,CHEMBL628555,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12757,,7132,,,BAO_0000218,CHEMBL628556,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12758,,7132,,,BAO_0000218,CHEMBL628557,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,N,2113.0,Kidney,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12759,,7132,,,BAO_0000218,CHEMBL628558,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,N,1988.0,Feces,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12760,,7132,,,BAO_0000218,CHEMBL628559,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,N,1988.0,Feces,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12761,,7132,,,BAO_0000218,CHEMBL628560,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,N,1988.0,Feces,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12762,,7132,,,BAO_0000218,CHEMBL874456,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12763,,7132,,,BAO_0000218,CHEMBL628561,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,N,1988.0,Feces,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12764,,7132,,,BAO_0000218,CHEMBL628562,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,N,1988.0,Feces,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12765,,7132,,,BAO_0000218,CHEMBL628563,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12766,,7132,,,BAO_0000218,CHEMBL628564,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12767,,7132,,,BAO_0000218,CHEMBL628565,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12768,,7132,,,BAO_0000218,CHEMBL631248,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12769,,7132,,,BAO_0000218,CHEMBL631249,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12770,,7132,,,BAO_0000218,CHEMBL627214,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,N,2113.0,Kidney,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12771,,7132,,,BAO_0000218,CHEMBL874591,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,N,1988.0,Feces,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12772,,7132,,,BAO_0000218,CHEMBL627215,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,N,1988.0,Feces,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12773,,7132,,,BAO_0000218,CHEMBL625471,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,N,1988.0,Feces,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12774,,7132,,,BAO_0000218,CHEMBL625472,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,N,,,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12775,,7132,,,BAO_0000218,CHEMBL625473,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,N,,,50592,Oryctolagus cuniculus,Intermediate
,,,A,9615.0,1,,1,12776,,13317,,,BAO_0000218,CHEMBL625474,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12777,,15341,,,BAO_0000218,CHEMBL625475,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,12778,,15341,,,BAO_0000218,CHEMBL625476,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12779,,15341,,,BAO_0000218,CHEMBL625477,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12780,,15341,,,BAO_0000218,CHEMBL625478,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12781,,12801,,,BAO_0000218,CHEMBL625479,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,In vitro,N,,esophageal tunica muscularis mucosae,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12782,,12801,,,BAO_0000218,CHEMBL625480,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,In vitro,N,,esophageal tunica muscularis mucosae,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12783,,14856,,,BAO_0000218,CHEMBL625481,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12784,,14062,,,BAO_0000218,CHEMBL625482,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12785,,14062,,,BAO_0000218,CHEMBL625483,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12786,,14062,,,BAO_0000218,CHEMBL625484,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12787,,14062,,,BAO_0000218,CHEMBL625485,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,12788,,14346,,,BAO_0000218,CHEMBL625486,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,12789,,14346,,,BAO_0000218,CHEMBL625487,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12790,,14346,,,BAO_0000218,CHEMBL625488,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12791,,14346,,,BAO_0000218,CHEMBL625489,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12792,,14346,,,BAO_0000218,CHEMBL625490,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,12793,,14346,,,BAO_0000218,CHEMBL625491,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,12794,,14346,,,BAO_0000218,CHEMBL625492,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9606.0,1,,1,12795,,15711,,,BAO_0000218,CHEMBL625493,plasma clearance in human,In vivo,N,1969.0,Plasma,50587,Homo sapiens,Intermediate
,,,A,10116.0,1,,1,12796,,14886,,,BAO_0000218,CHEMBL625494,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12797,,14886,,,BAO_0000218,CHEMBL625495,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12798,,14886,,,BAO_0000218,CHEMBL625496,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,P,,0,,1,12799,,4115,,,BAO_0000100,CHEMBL625497,1-Octanol/water partition coefficient measured at 7.4,,U,,,22229,,Autocuration
,,,P,,0,,1,12800,,13733,,,BAO_0000100,CHEMBL625498,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,A,,0,,1,12801,,12102,,,BAO_0000019,CHEMBL625499,Partition coefficient (logP),,U,,,22224,,Autocuration
,,,P,,0,,1,12802,,12676,,,BAO_0000100,CHEMBL625500,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,12803,,13733,,,BAO_0000100,CHEMBL625501,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,12804,,13740,,,BAO_0000100,CHEMBL625502,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,12805,,12766,,,BAO_0000100,CHEMBL625503,Calculated partition coefficient (clogP) (relative to BAY K 8644),,U,,,22229,,Autocuration
,,,P,,0,,1,12806,,2764,,,BAO_0000100,CHEMBL625504,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,12807,,12355,,,BAO_0000100,CHEMBL625505,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,12808,,11314,,,BAO_0000100,CHEMBL625506,Calculated partition coefficient of the compound,,U,,,22229,,Autocuration
,,,A,,0,,1,12809,,12706,,,BAO_0000019,CHEMBL625507,Partition coefficient (logP),,U,,,22224,,Autocuration
,,,P,,0,,1,12810,,12645,,,BAO_0000100,CHEMBL625508,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,12811,,13668,,,BAO_0000100,CHEMBL625509,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,12812,,12819,,,BAO_0000100,CHEMBL625510,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,12813,,13668,,,BAO_0000100,CHEMBL883125,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,12814,,13017,,,BAO_0000100,CHEMBL625511,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,A,,0,,1,12815,,2448,,,BAO_0000019,CHEMBL874650,Partition coefficient of the compound,,U,,,22224,,Autocuration
,,,A,,0,,1,12816,,11526,,,BAO_0000019,CHEMBL625512,Partition coefficient of the compound,,U,,,22224,,Autocuration
,,,A,,0,,1,12817,,12426,,,BAO_0000019,CHEMBL625513,Partition coefficient of compound was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,12818,,2448,,,BAO_0000019,CHEMBL625514,Partition coefficient was determined,,U,,,22224,,Autocuration
,,,P,,0,,1,12819,,12001,,,BAO_0000100,CHEMBL625515,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,12820,,12426,,,BAO_0000100,CHEMBL625516,partition coefficient of compound was determined,,U,,,22229,,Autocuration
,,,A,9615.0,1,,1,12821,,13204,,,BAO_0000218,CHEMBL625517,The total body administered intravenously in dog,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,12822,,13204,,,BAO_0000218,CHEMBL625518,The total body administered intravenously in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,12823,,13889,,,BAO_0000218,CHEMBL625519,Time taken for the administration to female NIH mice weighing 25-30 g.,,N,,,50594,Mus musculus,Intermediate
,,,A,,0,,1,12824,,13889,,,BAO_0000019,CHEMBL625520,Time taken for the administration,,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,12825,,17025,,,BAO_0000218,CHEMBL874651,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,314293.0,0,,1,12826,,17025,,,BAO_0000218,CHEMBL625521,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,In vivo,U,,,22224,Simiiformes,Autocuration
,,,A,9986.0,1,,1,12827,,17025,,,BAO_0000218,CHEMBL623171,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,In vivo,N,,,50592,Oryctolagus cuniculus,Intermediate
,,,A,10116.0,1,,1,12828,,17025,,,BAO_0000218,CHEMBL623853,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12829,,15067,,,BAO_0000019,CHEMBL623854,Plasma clearance for the compound was determined.,,U,,,22224,,Autocuration
,,,P,,0,,1,12830,,3091,,,BAO_0000100,CHEMBL874405,CLog P value of the compound,,U,,,22224,,Autocuration
,,,P,,0,,1,12831,,15592,,,BAO_0000100,CHEMBL623855,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,12832,,14738,,,BAO_0000100,CHEMBL623856,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,12833,,14738,,,BAO_0000100,CHEMBL623857,ClogP value of the compound; nd ='no data',,U,,,22224,,Autocuration
,,,P,,0,,1,12834,,14738,,,BAO_0000100,CHEMBL623858,ClogP value of the compound; nd ='not determined',,U,,,22224,,Autocuration
,,,P,,0,,1,12835,,6076,,,BAO_0000100,CHEMBL623859,CLog P was determined,,U,,,22224,,Autocuration
,,,P,,0,,1,12836,,17840,,,BAO_0000100,CHEMBL839829,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,A,,0,,1,12837,,13589,,,BAO_0000019,CHEMBL623860,CLogP was calculated,,U,,,22224,,Autocuration
,,,A,,0,,1,12838,,17655,,,BAO_0000019,CHEMBL623861,CLogP value was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,12839,,5867,,,BAO_0000019,CHEMBL623862,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,U,,,22224,,Autocuration
,,,P,,0,,1,12840,,5867,,,BAO_0000100,CHEMBL874406,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,12841,,10783,,,BAO_0000100,CHEMBL623863,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,12842,,14849,,,BAO_0000100,CHEMBL624021,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,A,9615.0,1,,1,12843,,8170,,,BAO_0000218,CHEMBL624022,Distribution in female dog adrenal medulla 24 hours after administration.,,N,1236.0,Adrenal medulla,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12844,,8170,,,BAO_0000218,CHEMBL624023,Distribution in female dog adrenal medulla 72 hours after administration.,,N,1236.0,Adrenal medulla,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12845,,8170,,,BAO_0000218,CHEMBL624024,Distribution in female dog bile 24 hours after administration.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12846,,8170,,,BAO_0000218,CHEMBL624025,Distribution in female dog bile 72 hr after administration.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12847,,8170,,,BAO_0000218,CHEMBL624026,Distribution in female dog blood 24 hours after administration.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12848,,8170,,,BAO_0000218,CHEMBL624027,Distribution in female dog blood 72 hours after administration.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12849,,8170,,,BAO_0000218,CHEMBL624028,Distribution in female dog heart 24 hours after administration.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12850,,8170,,,BAO_0000218,CHEMBL624029,Distribution in female dog heart 72 hours after administration.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12851,,8170,,,BAO_0000218,CHEMBL624030,Distribution in female dog kidney 24 hours after administration.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12852,,8170,,,BAO_0000218,CHEMBL624031,Distribution in female dog kidney 72 hours after administration.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12853,,8170,,,BAO_0000218,CHEMBL624032,Distribution in female dog large intestine 24 hours after administration.,,N,160.0,Intestine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12854,,8170,,,BAO_0000218,CHEMBL874407,Distribution in female dog large intestine 72 hours after administration.,,N,160.0,Intestine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12855,,8170,,,BAO_0000218,CHEMBL624033,Distribution in female dog liver 24 hours after administration.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12856,,8170,,,BAO_0000218,CHEMBL624034,Distribution in female dog liver 72 hours after administration.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12857,,8170,,,BAO_0000218,CHEMBL624035,Distribution in female dog lung 24 hours after administration.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12858,,8170,,,BAO_0000218,CHEMBL624036,Distribution in female dog lung 72 hours after administration.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12859,,8170,,,BAO_0000218,CHEMBL624037,Distribution in female dog muscle 24 hours after administration.,,N,2385.0,Muscle tissue,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12860,,8170,,,BAO_0000218,CHEMBL624038,Distribution in female dog muscle 72 hours after administration.,,N,2385.0,Muscle tissue,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12861,,8170,,,BAO_0000218,CHEMBL624039,Distribution in female dog pancreas 24 hours after administration.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12862,,8170,,,BAO_0000218,CHEMBL624040,Distribution in female dog pancreas 72 hours after administration.,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12863,,8170,,,BAO_0000218,CHEMBL624041,Distribution in female dog small intestine 24 hours after administration.,,N,160.0,Intestine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12864,,8170,,,BAO_0000218,CHEMBL624042,Distribution in female dog small intestine 72 hours after administration.,,N,160.0,Intestine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12865,,8170,,,BAO_0000218,CHEMBL624043,Distribution in female dog spleen 24 hours after administration.,,N,2106.0,Spleen,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12866,,8170,,,BAO_0000218,CHEMBL624044,Distribution in female dog spleen 72 hours after administration.,,N,2106.0,Spleen,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12867,,8170,,,BAO_0000218,CHEMBL624045,Distribution in female dog stomach 24 hours after administration.,,N,945.0,Stomach,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12868,,8170,,,BAO_0000218,CHEMBL624046,Distribution in female dog stomach 72 hours after administration.,,N,945.0,Stomach,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12869,,8170,,,BAO_0000218,CHEMBL624047,Distribution in female dog thyroid 24 hours after administration.,,N,2046.0,Thyroid gland,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12870,,8170,,,BAO_0000218,CHEMBL624048,Distribution in female dog thyroid 72 hours after administration.,,N,2046.0,Thyroid gland,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12871,,8170,,,BAO_0000218,CHEMBL874408,Distribution in female dog urine 24 hours after administration.,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12872,,8170,,,BAO_0000218,CHEMBL624049,Distribution in female dog urine 72 hr after administration.,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,12873,,14283,,,BAO_0000218,CHEMBL624050,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,12874,,5623,,,BAO_0000019,CHEMBL624051,Plasma concentration at 7 hr after intravenous dosing,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,12875,,13477,,,BAO_0000218,CHEMBL623278,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12876,,13477,,,BAO_0000218,CHEMBL623279,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12877,,13477,,,BAO_0000218,CHEMBL623280,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12878,,13477,,,BAO_0000218,CHEMBL623963,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12879,,13477,,,BAO_0000218,CHEMBL623964,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12880,,13477,,,BAO_0000218,CHEMBL623965,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12881,,13477,,,BAO_0000218,CHEMBL623966,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12882,,13477,,,BAO_0000218,CHEMBL874415,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12883,,13477,,,BAO_0000218,CHEMBL623967,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12884,,13477,,,BAO_0000218,CHEMBL623968,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12885,,13477,,,BAO_0000218,CHEMBL623969,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12886,,13477,,,BAO_0000218,CHEMBL628409,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12887,,13477,,,BAO_0000218,CHEMBL628410,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12888,,13477,,,BAO_0000218,CHEMBL628411,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12889,,13477,,,BAO_0000218,CHEMBL628412,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12890,,12553,,,BAO_0000019,CHEMBL628413,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,U,,,22224,,Autocuration
,,,A,,0,,1,12891,,14548,,,BAO_0000019,CHEMBL628414,The concentration in plasmat; Not determined,,U,1969.0,Plasma,22224,,Autocuration
,,,A,10116.0,1,,1,12892,,14393,,,BAO_0000218,CHEMBL628415,Tissue level at 10 mg/kg/po in wistar rats in blood,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12893,,14393,,,BAO_0000218,CHEMBL628416,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12894,,14393,,,BAO_0000218,CHEMBL628417,Tissue level at 10 mg/kg/po in wistar rats in heart,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12895,,14393,,,BAO_0000218,CHEMBL874908,Tissue level at 10 mg/kg/po in wistar rats in liver,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12896,,14393,,,BAO_0000218,CHEMBL628418,Tissue level at 10 mg/kg/po in wistar rats in plasma,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12897,,14393,,,BAO_0000218,CHEMBL628419,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12898,,14393,,,BAO_0000218,CHEMBL628420,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12899,,1629,,,BAO_0000019,CHEMBL628421,Water solubility at 37 degree C.,,U,,,22224,,Autocuration
,,,P,,0,,1,12900,,8194,,,BAO_0000100,CHEMBL626726,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,U,,,22229,,Autocuration
,,,P,,0,,1,12901,,8194,,,BAO_0000100,CHEMBL626727,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,U,,,22229,,Autocuration
,,,A,10116.0,1,,1,12902,,8594,,,BAO_0000218,CHEMBL626728,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12903,,8594,,,BAO_0000218,CHEMBL626729,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12904,,8594,,,BAO_0000218,CHEMBL626730,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12905,,8594,,,BAO_0000218,CHEMBL626731,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12906,,8594,,,BAO_0000218,CHEMBL626732,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12907,,8594,,,BAO_0000218,CHEMBL626733,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12908,,8594,,,BAO_0000218,CHEMBL626734,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12909,,8594,,,BAO_0000218,CHEMBL626735,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12910,,8594,,,BAO_0000218,CHEMBL874909,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12911,,8594,,,BAO_0000218,CHEMBL626736,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12912,,8594,,,BAO_0000218,CHEMBL626737,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12913,,8594,,,BAO_0000218,CHEMBL630999,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12914,,8594,,,BAO_0000218,CHEMBL631000,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12915,,8594,,,BAO_0000218,CHEMBL631001,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12916,,8594,,,BAO_0000218,CHEMBL631002,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12917,,8594,,,BAO_0000218,CHEMBL631003,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12918,,8594,,,BAO_0000218,CHEMBL631004,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12919,,8594,,,BAO_0000218,CHEMBL631005,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12920,,8594,,,BAO_0000218,CHEMBL631006,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12921,,8594,,,BAO_0000218,CHEMBL631007,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12922,,8594,,,BAO_0000218,CHEMBL631008,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12923,,8594,,,BAO_0000218,CHEMBL631009,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12924,,8594,,,BAO_0000218,CHEMBL631010,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12925,,8594,,,BAO_0000218,CHEMBL631011,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12926,,8594,,,BAO_0000218,CHEMBL631012,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12927,,8594,,,BAO_0000218,CHEMBL630271,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12928,,8594,,,BAO_0000218,CHEMBL630272,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12929,,8594,,,BAO_0000218,CHEMBL630273,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12930,,8594,,,BAO_0000218,CHEMBL630274,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12931,,8594,,,BAO_0000218,CHEMBL630275,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12932,,8594,,,BAO_0000218,CHEMBL875782,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12933,,8594,,,BAO_0000218,CHEMBL630276,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12934,,8594,,,BAO_0000218,CHEMBL630277,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12935,,8594,,,BAO_0000218,CHEMBL630278,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,12936,,8594,,,BAO_0000218,CHEMBL630279,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12937,,8151,,,BAO_0000019,CHEMBL630280,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,U,,,22224,,Autocuration
,,,A,,0,,1,12938,,8151,,,BAO_0000019,CHEMBL630281,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,U,,,22224,,Autocuration
,,,A,9986.0,1,,1,12939,,7132,,,BAO_0000218,CHEMBL630282,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,N,,,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12940,,7132,,,BAO_0000218,CHEMBL630283,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,N,,,50592,Oryctolagus cuniculus,Intermediate
,,,A,,0,,1,12941,,5797,,,BAO_0000019,CHEMBL630284,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,U,,,22224,,Autocuration
,,,A,,0,,1,12942,,7849,,,BAO_0000019,CHEMBL630285,Alkylating activity was determined,,U,,,22224,,Autocuration
,,Microsomes,A,,0,,1,12943,,14220,,,BAO_0000251,CHEMBL630286,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,U,,,22224,,Autocuration
,,,A,9986.0,1,,1,12944,,8650,,,BAO_0000218,CHEMBL630069,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,N,,,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12945,,8650,,,BAO_0000218,CHEMBL630070,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,N,,,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12946,,8650,,,BAO_0000218,CHEMBL630071,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,N,,,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12947,,8650,,,BAO_0000218,CHEMBL630072,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,N,,,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12948,,8650,,,BAO_0000218,CHEMBL875110,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,N,,,50592,Oryctolagus cuniculus,Intermediate
,,,A,10116.0,1,,1,12949,,7116,,,BAO_0000218,CHEMBL630073,Compound was tested for antidiuretic activity in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,12950,,14131,,,BAO_0000019,CHEMBL630074,Compound was tested for inactivation kinetic values,,U,,,22224,,Autocuration
,,,A,,0,,1,12951,,7415,,,BAO_0000218,CHEMBL630075,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,12952,,13178,,,BAO_0000019,CHEMBL630076,Dissociation rate calculated from the first-order equation using the t1/2 value,,U,,,22224,,Autocuration
,,,P,,0,,1,12953,,8815,,,BAO_0000100,CHEMBL630077,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,U,,,22229,,Autocuration
,,,P,,0,,1,12954,,1450,,,BAO_0000100,CHEMBL630078,Aqueous solubility was measured,,U,,,22229,,Autocuration
,,,P,,0,,1,12955,,1450,,,BAO_0000100,CHEMBL630079,Aqueous solubility was measured at a pH 4,,U,,,22229,,Autocuration
,,,P,,0,,1,12956,,1450,,,BAO_0000100,CHEMBL630080,Aqueous solubility (pH 7),,U,,,22229,,Autocuration
,,,P,,0,,1,12957,,1450,,,BAO_0000100,CHEMBL630081,Aqueous solubility was measured at a pH 9,,U,,,22229,,Autocuration
,,,A,,0,,1,12958,,12711,,,BAO_0000019,CHEMBL630082,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,U,,,22224,,Autocuration
,,,A,,0,,1,12959,,12711,,,BAO_0000019,CHEMBL630083,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,U,,,22224,,Autocuration
,,,A,,0,,1,12960,,12711,,,BAO_0000019,CHEMBL630084,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,U,,,22224,,Autocuration
,,,P,,0,,1,12961,,15032,,,BAO_0000100,CHEMBL629198,Aqueous solubility of the compound,,U,,,22229,,Autocuration
,,,P,,0,,1,12962,,9964,,,BAO_0000100,CHEMBL629199,Aqueous solubility at 37 degree Celsius at pH 7.38,,U,,,22229,,Autocuration
,,,P,,0,,1,12963,,14962,,,BAO_0000100,CHEMBL629200,Aqueous solubility in pH 7.4 phosphate buffer,,U,,,22229,,Autocuration
,,,A,9615.0,1,,1,12964,,12487,,,BAO_0000218,CHEMBL629201,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,12965,,12487,,,BAO_0000218,CHEMBL629202,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9606.0,1,,1,12966,,10026,,,BAO_0000218,CHEMBL875111,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,N,,,50587,Homo sapiens,Intermediate
,,,A,9606.0,1,,1,12967,,10026,,,BAO_0000218,CHEMBL629203,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,N,,,50587,Homo sapiens,Intermediate
,,,A,9606.0,1,,1,12968,,10026,,,BAO_0000218,CHEMBL629204,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,N,,,50587,Homo sapiens,Intermediate
,,,A,9606.0,1,,1,12969,,10026,,,BAO_0000218,CHEMBL629205,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,N,,,50587,Homo sapiens,Intermediate
,,,A,9606.0,1,,1,12970,,10026,,,BAO_0000218,CHEMBL629206,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,N,,,50587,Homo sapiens,Intermediate
,,,A,,0,,1,12971,,10026,,,BAO_0000019,CHEMBL631185,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,12972,,7415,,,BAO_0000218,CHEMBL631186,Compound was evaluated for the average bile flow rat in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9986.0,1,,1,12973,,17025,,,BAO_0000218,CHEMBL631187,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,N,,,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,12974,,17025,,,BAO_0000218,CHEMBL631188,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,N,,,50592,Oryctolagus cuniculus,Intermediate
,,,A,,0,,1,12975,,10184,,,BAO_0000019,CHEMBL876419,Average half life period was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,12976,,10184,,,BAO_0000019,CHEMBL631189,Average half life period was determined,,U,,,22224,,Autocuration
,,,A,10298.0,1,,1,12977,,8613,,,BAO_0000218,CHEMBL631190,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,12978,,8613,,,BAO_0000218,CHEMBL631191,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,12979,,8613,,,BAO_0000218,CHEMBL631192,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,12980,,8613,,,BAO_0000218,CHEMBL632400,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,12981,,8613,,,BAO_0000218,CHEMBL630564,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,12982,,8613,,,BAO_0000218,CHEMBL630565,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,12983,,8613,,,BAO_0000218,CHEMBL630566,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,12984,,8613,,,BAO_0000218,CHEMBL631229,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,12985,,8613,,,BAO_0000218,CHEMBL631230,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,N,,,50602,Human herpesvirus 1,Intermediate
,,,P,,0,,1,12986,,6030,,,BAO_0000100,CHEMBL876428,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,12987,,6147,,,BAO_0000100,CHEMBL631231,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,12988,,14556,,,BAO_0000100,CHEMBL631232,Calculated partition coefficient (clogP) (MacLogP),,U,,,22229,,Autocuration
,,,A,,0,,1,12989,,768,,,BAO_0000019,CHEMBL631233,Hydrophilicity was determined,,U,,,22224,,Autocuration
,,,P,,0,,1,12990,,14452,,,BAO_0000100,CHEMBL631234,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,A,,0,,1,12991,,5237,,,BAO_0000019,CHEMBL883126,Increased absorption was determined,,U,,,22224,,Autocuration
,,,P,,0,,1,12992,,14378,,,BAO_0000100,CHEMBL631235,Lipophilicity value was evaluated,,U,,,22224,,Autocuration
,,,P,,0,,1,12993,,14418,,,BAO_0000100,CHEMBL631236,Log P value of the compound.,,U,,,22224,,Autocuration
,,,A,,0,,1,12994,,5249,,,BAO_0000019,CHEMBL631237,Partition coefficient of compound was determined,,U,,,22224,,Autocuration
,,,P,,0,,1,12995,,14621,,,BAO_0000100,CHEMBL631238,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,12996,,12542,,,BAO_0000100,CHEMBL876429,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,A,,0,,1,12997,,12542,,,BAO_0000019,CHEMBL631414,Partition coefficient was measured by medchem software; Not calculated,,U,,,22224,,Autocuration
,,,P,,0,,1,12998,,12542,,,BAO_0000100,CHEMBL631415,Partition coefficient was measured by octanol-water using standard shake-flask method,,U,,,22224,,Autocuration
,,,P,,0,,1,12999,,15462,,,BAO_0000100,CHEMBL631416,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,A,,0,,1,13000,,14884,,,BAO_0000019,CHEMBL631417,Partition coefficient (logP),,U,,,22224,,Autocuration
,,,P,,0,,1,13001,,16526,,,BAO_0000100,CHEMBL631418,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13002,,13693,,,BAO_0000100,CHEMBL631419,The Octanol/Water partition coefficient CLogP,,U,,,22229,,Autocuration
,,,A,,0,,1,13003,,13693,,,BAO_0000019,CHEMBL631420,The pharmacokinetic parameter C Log p was reported,,U,,,22224,,Autocuration
,,,P,,0,,1,13004,,13779,,,BAO_0000100,CHEMBL631421,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13005,,14772,,,BAO_0000100,CHEMBL631422,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13006,,14393,,,BAO_0000100,CHEMBL631423,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,A,10116.0,1,,1,13007,,14793,,,BAO_0000218,CHEMBL876430,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13008,,14793,,,BAO_0000218,CHEMBL631424,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,13009,,13744,,,BAO_0000218,CHEMBL631425,Compound was administered intravenously in dog to evaluate plasma clearance values,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,314293.0,0,,1,13010,,13744,,,BAO_0000218,CHEMBL631426,Compound was administered intravenously in monkey to evaluate plasma clearance values,In vivo,U,1969.0,Plasma,22224,Simiiformes,Autocuration
,,,A,10090.0,1,,1,13011,,13744,,,BAO_0000218,CHEMBL631427,Compound was administered intravenously in mouse to evaluate plasma clearance values,In vivo,N,1969.0,Plasma,50594,Mus musculus,Intermediate
,,,A,9615.0,1,,1,13012,,13207,,,BAO_0000218,CHEMBL631428,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,Microsomes,A,9544.0,1,,1,13013,,5669,,,BAO_0000218,CHEMBL631429,Intrinsic clearance in Rhesus liver microsome,In vitro,N,2107.0,Liver,50797,Macaca mulatta,Intermediate
,,Microsomes,A,9615.0,1,,1,13014,,5669,,,BAO_0000218,CHEMBL631430,Intrinsic clearance in dog liver microsome,In vitro,N,2107.0,Liver,50588,Canis lupus familiaris,Intermediate
,,Microsomes,A,10116.0,1,,1,13015,,5669,,,BAO_0000218,CHEMBL631431,Intrinsic clearance in rat liver microsome,In vitro,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,9544.0,1,,1,13016,,4853,,,BAO_0000218,CHEMBL631432,Low plasma clearance was calculated in rhesus monkey,In vivo,N,1969.0,Plasma,50797,Macaca mulatta,Intermediate
,,,A,9615.0,1,,1,13017,,16452,,,BAO_0000218,CHEMBL631433,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,13018,,11954,,,BAO_0000218,CHEMBL631434,Plasma clearance after intravenous dose of 0.3 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13019,,11954,,,BAO_0000218,CHEMBL631435,Plasma clearance after intravenous dose of 1 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13020,,11954,,,BAO_0000218,CHEMBL631436,Plasma clearance after intravenous dose of 3 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13021,,11954,,,BAO_0000218,CHEMBL631437,Plasma clearance after intravenous dose of 3.87 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,13022,,5669,,,BAO_0000218,CHEMBL631438,Plasma clearance after peroral administration at 10 mpk in Rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9544.0,1,,1,13023,,5669,,,BAO_0000218,CHEMBL876431,Plasma clearance after peroral administration at 10 mpk in Rhesus,In vivo,N,,,50797,Macaca mulatta,Intermediate
,,,A,9615.0,1,,1,13024,,5669,,,BAO_0000218,CHEMBL631439,Plasma clearance after peroral administration at 10 mpk in dog,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,13025,,13662,,,BAO_0000218,CHEMBL631440,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,13026,,8272,,,BAO_0000019,CHEMBL631441,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,U,,,22224,,Autocuration
,,,A,,0,,1,13027,,13410,,,BAO_0000019,CHEMBL631442,Critical Micellar concentration was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,13028,,13410,,,BAO_0000019,CHEMBL626525,Critical Micellar concentration of the compound. was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,13029,,12628,,,BAO_0000019,CHEMBL627168,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,U,,,22224,,Autocuration
,,,A,,0,,1,13030,,9675,,,BAO_0000019,CHEMBL875618,Critical micellar concentration was measured in water by the dye solubilization method,,U,,,22224,,Autocuration
,,,B,,0,,1,13031,,12628,,,BAO_0000019,CHEMBL626612,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,U,,,22224,,Autocuration
,,,A,,0,,1,13032,,12766,,,BAO_0000019,CHEMBL626613,CMR value (relative to BAY K 8644),,U,,,22224,,Autocuration
,,,A,,0,,1,13033,,7849,,,BAO_0000019,CHEMBL626614,Carbamoylating activity was determined,,U,,,22224,,Autocuration
,,,A,314293.0,0,,1,13034,,12187,,,BAO_0000218,CHEMBL626615,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,U,,,22224,Simiiformes,Autocuration
,,,A,,0,,1,13035,,2040,,,BAO_0000019,CHEMBL626616,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,U,,,22224,,Autocuration
,,,A,,0,,1,13036,,2040,,,BAO_0000019,CHEMBL626617,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,13037,,14180,,,BAO_0000218,CHEMBL626618,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,13038,,14180,,,BAO_0000218,CHEMBL626619,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,13039,,14474,,,BAO_0000218,CHEMBL626620,"Clearance rate at 0.46 mg/kg, iv, in dogs",In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,13040,,14474,,,BAO_0000218,CHEMBL626621,"Clearance rate at 5.5 mg/kg, iv, in rat",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9541.0,1,,1,13041,,14548,,,BAO_0000218,CHEMBL626622,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,In vivo,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9541.0,1,,1,13042,,14548,,,BAO_0000218,CHEMBL626623,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,In vivo,N,,,100710,Macaca fascicularis,Intermediate
,,,A,9615.0,1,,1,13043,,14548,,,BAO_0000218,CHEMBL626624,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,13044,,14548,,,BAO_0000218,CHEMBL626625,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13045,,6125,,,BAO_0000218,CHEMBL626626,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Ex vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,13046,,6874,,,BAO_0000218,CHEMBL626627,Tested for the total clearance of the compound,In vivo,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,13047,,15343,,,BAO_0000218,CHEMBL626628,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,13048,,6236,,,BAO_0000218,CHEMBL626629,Total body clearance was determined,In vivo,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,13049,,11510,,,BAO_0000218,CHEMBL626630,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13050,,11510,,,BAO_0000218,CHEMBL626631,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,P,,0,,1,13051,,8194,,,BAO_0000100,CHEMBL626632,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,U,,,22229,,Autocuration
,,,P,,0,,1,13052,,8194,,,BAO_0000100,CHEMBL626633,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,U,,,22229,,Autocuration
,,,P,,0,,1,13053,,8194,,,BAO_0000100,CHEMBL626634,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,U,,,22229,,Autocuration
,,,P,,0,,1,13054,,8194,,,BAO_0000100,CHEMBL626635,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,U,,,22229,,Autocuration
,,,P,,0,,1,13055,,8194,,,BAO_0000100,CHEMBL626636,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,U,,,22229,,Autocuration
,,,P,,0,,1,13056,,8194,,,BAO_0000100,CHEMBL626637,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,U,,,22229,,Autocuration
,,,A,4754.0,1,,1,13057,,13273,,,BAO_0000218,CHEMBL626638,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,N,,,50339,Pneumocystis carinii,Intermediate
,,,A,4754.0,1,,1,13058,,13273,,,BAO_0000218,CHEMBL626639,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,N,,,50339,Pneumocystis carinii,Intermediate
,,,A,4754.0,1,,1,13059,,13273,,,BAO_0000218,CHEMBL626640,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,N,,,50339,Pneumocystis carinii,Intermediate
,,,A,4754.0,1,,1,13060,,13273,,,BAO_0000218,CHEMBL626641,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,N,,,50339,Pneumocystis carinii,Intermediate
,,,A,4754.0,1,,1,13061,,13273,,,BAO_0000218,CHEMBL627272,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,N,,,50339,Pneumocystis carinii,Intermediate
,,,A,4754.0,1,,1,13062,,13273,,,BAO_0000218,CHEMBL627273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,N,,,50339,Pneumocystis carinii,Intermediate
,,,A,4754.0,1,,1,13063,,13273,,,BAO_0000218,CHEMBL627441,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,N,,,50339,Pneumocystis carinii,Intermediate
,,,A,4754.0,1,,1,13064,,13273,,,BAO_0000218,CHEMBL628355,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,N,,,50339,Pneumocystis carinii,Intermediate
,,,A,4754.0,1,,1,13065,,13273,,,BAO_0000218,CHEMBL628356,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,N,,,50339,Pneumocystis carinii,Intermediate
,,,A,4754.0,1,,1,13066,,13273,,,BAO_0000218,CHEMBL628357,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,N,,,50339,Pneumocystis carinii,Intermediate
,,,A,4754.0,1,,1,13067,,13273,,,BAO_0000218,CHEMBL628358,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,N,,,50339,Pneumocystis carinii,Intermediate
,,,A,4754.0,1,,1,13068,,13273,,,BAO_0000218,CHEMBL622307,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,N,,,50339,Pneumocystis carinii,Intermediate
,,,A,,0,,1,13069,,13118,,,BAO_0000019,CHEMBL622527,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,U,,,22224,,Autocuration
,,,A,,0,,1,13070,,13118,,,BAO_0000019,CHEMBL622528,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,U,,,22224,,Autocuration
,,,A,,0,,1,13071,,13118,,,BAO_0000019,CHEMBL622529,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,U,,,22224,,Autocuration
,,,A,,0,,1,13072,,13118,,,BAO_0000019,CHEMBL622992,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,U,,,22224,,Autocuration
,,,A,,0,,1,13073,,13118,,,BAO_0000019,CHEMBL622993,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,U,,,22224,,Autocuration
,,,A,,0,,1,13074,,13118,,,BAO_0000019,CHEMBL622994,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,13075,,10633,,,BAO_0000218,CHEMBL622995,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13076,,10633,,,BAO_0000218,CHEMBL622996,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13077,,10633,,,BAO_0000218,CHEMBL622997,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13078,,10633,,,BAO_0000218,CHEMBL622998,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,13079,,5767,,,BAO_0000218,CHEMBL622999,Cp max following ip administration at 1 mg/kg,,U,,,22224,,Autocuration
,,,A,,0,,1,13080,,3302,,,BAO_0000218,CHEMBL623000,Maximum concentration in plasma was reported at 0.5 hour,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,13081,,3302,,,BAO_0000218,CHEMBL623001,Maximum concentration in plasma was reported at 2 hour,In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,10090.0,1,,1,13082,,12467,,,BAO_0000218,CHEMBL623002,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,N,,,50594,Mus musculus,Intermediate
,,,P,,0,,1,13083,,11778,,,BAO_0000100,CHEMBL623003,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,U,,,22229,,Autocuration
,,,A,,0,,1,13084,,4321,,,BAO_0000019,CHEMBL623004,Steady state concentration was evaluated,,U,,,22224,,Autocuration
,,,A,,0,,1,13085,,14884,,,BAO_0000019,CHEMBL623005,Partition coefficient (logP),,U,,,22224,,Autocuration
,,,A,,0,,1,13086,,15234,,,BAO_0000019,CHEMBL623006,Partition coefficient (logD7.4),,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,13087,,14198,,,BAO_0000218,CHEMBL623007,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13088,,14198,,,BAO_0000218,CHEMBL623008,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13089,,14198,,,BAO_0000218,CHEMBL876654,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,In vivo,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13090,,14198,,,BAO_0000218,CHEMBL623009,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13091,,14198,,,BAO_0000218,CHEMBL623010,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13092,,14198,,,BAO_0000218,CHEMBL623011,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13093,,14198,,,BAO_0000218,CHEMBL623012,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,In vivo,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,13094,,8151,,,BAO_0000019,CHEMBL623013,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,U,,,22224,,Autocuration
,,,A,,0,,1,13095,,8151,,,BAO_0000019,CHEMBL623014,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,U,,,22224,,Autocuration
,,,A,,0,,1,13096,,8151,,,BAO_0000019,CHEMBL623015,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,U,1088.0,Urine,22224,,Autocuration
,,,A,,0,,1,13097,,8151,,,BAO_0000019,CHEMBL623016,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,U,1088.0,Urine,22224,,Autocuration
,,,A,,0,,1,13098,,8151,,,BAO_0000019,CHEMBL624858,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,U,1088.0,Urine,22224,,Autocuration
,,,A,10116.0,1,,1,13099,,8151,,,BAO_0000218,CHEMBL624859,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13100,,8151,,,BAO_0000218,CHEMBL624860,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13101,,8151,,,BAO_0000218,CHEMBL624861,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13102,,8151,,,BAO_0000218,CHEMBL624862,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13103,,8151,,,BAO_0000218,CHEMBL624863,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13104,,8151,,,BAO_0000218,CHEMBL876655,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,13105,,6996,,,BAO_0000218,CHEMBL624864,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13106,,6996,,,BAO_0000218,CHEMBL624865,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13107,,6996,,,BAO_0000218,CHEMBL624866,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,N,,,50588,Canis lupus familiaris,Intermediate
,,,F,9615.0,1,,1,13108,,6996,,,BAO_0000218,CHEMBL624867,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,N,,,50588,Canis lupus familiaris,Expert
,,,A,9615.0,1,,1,13109,,6996,,,BAO_0000218,CHEMBL624868,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13110,,6996,,,BAO_0000218,CHEMBL628450,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13111,,6996,,,BAO_0000218,CHEMBL628451,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13112,,6996,,,BAO_0000218,CHEMBL628452,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13113,,6996,,,BAO_0000218,CHEMBL628453,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13114,,6996,,,BAO_0000218,CHEMBL628454,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13115,,6996,,,BAO_0000218,CHEMBL628455,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13116,,6996,,,BAO_0000218,CHEMBL628456,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13117,,6996,,,BAO_0000218,CHEMBL628457,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13118,,6996,,,BAO_0000218,CHEMBL877505,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13119,,6996,,,BAO_0000218,CHEMBL628458,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13120,,6996,,,BAO_0000218,CHEMBL628459,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13121,,6996,,,BAO_0000218,CHEMBL628460,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13122,,6996,,,BAO_0000218,CHEMBL628461,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,N,,,50588,Canis lupus familiaris,Intermediate
,,,B,,0,,1,13123,,6996,,,BAO_0000218,CHEMBL628462,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,13124,,6996,,,BAO_0000218,CHEMBL628463,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,N,,,50588,Canis lupus familiaris,Intermediate
,,,F,10116.0,1,,1,13125,,6996,,,BAO_0000218,CHEMBL625666,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,N,,,50597,Rattus norvegicus,Expert
,,,B,,0,,1,13126,,6996,,,BAO_0000218,CHEMBL625667,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,13127,,6996,,,BAO_0000218,CHEMBL625668,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,N,,,50597,Rattus norvegicus,Expert
,,,A,10116.0,1,,1,13128,,6996,,,BAO_0000218,CHEMBL625669,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,13129,,7114,,,BAO_0000019,CHEMBL625670,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,13130,,7114,,,BAO_0000218,CHEMBL625671,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10298.0,1,,1,13131,,8613,,,BAO_0000218,CHEMBL625672,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,13132,,8613,,,BAO_0000218,CHEMBL625673,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,13133,,8613,,,BAO_0000218,CHEMBL625674,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,13134,,8613,,,BAO_0000218,CHEMBL625675,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,13135,,8613,,,BAO_0000218,CHEMBL627637,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,13136,,8613,,,BAO_0000218,CHEMBL627638,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,13137,,8613,,,BAO_0000218,CHEMBL627639,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,13138,,8613,,,BAO_0000218,CHEMBL627640,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,13139,,8613,,,BAO_0000218,CHEMBL627641,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,13140,,8613,,,BAO_0000218,CHEMBL627642,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,13141,,8613,,,BAO_0000218,CHEMBL877506,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10090.0,1,,1,13142,,8613,,,BAO_0000218,CHEMBL627275,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,N,,,50594,Mus musculus,Intermediate
,,,A,9669.0,1,,1,13143,,11219,,,BAO_0000218,CHEMBL627643,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,N,,,50506,Mustela putorius furo,Intermediate
,,,A,9669.0,1,,1,13144,,11219,,,BAO_0000218,CHEMBL631246,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,N,,,50506,Mustela putorius furo,Intermediate
,,,A,9669.0,1,,1,13145,,11219,,,BAO_0000218,CHEMBL631247,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,N,,,50506,Mustela putorius furo,Intermediate
,,,A,9669.0,1,,1,13146,,11219,,,BAO_0000218,CHEMBL629532,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,N,,,50506,Mustela putorius furo,Intermediate
,,,A,9669.0,1,,1,13147,,11219,,,BAO_0000218,CHEMBL629533,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,N,,,50506,Mustela putorius furo,Intermediate
,,,A,9669.0,1,,1,13148,,11219,,,BAO_0000218,CHEMBL629534,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,N,,,50506,Mustela putorius furo,Intermediate
,,,A,9669.0,1,,1,13149,,11219,,,BAO_0000218,CHEMBL629535,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,N,,,50506,Mustela putorius furo,Intermediate
,,,A,,0,,1,13150,,14837,,,BAO_0000019,CHEMBL625932,Pharmacokinetic parameter :drug bound to plasma was reported,,U,,,22224,,Autocuration
,,,A,,0,,1,13151,,14837,,,BAO_0000019,CHEMBL625933,compound was evaluated for drug bound in plasma,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,13152,,15343,,,BAO_0000218,CHEMBL625934,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9347.0,0,,1,13153,,13761,,,BAO_0000218,CHEMBL625935,Bioavailability,,U,,,22224,Eutheria,Autocuration
,,,A,10116.0,1,,1,13154,,14810,,,BAO_0000218,CHEMBL625936,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13155,,14810,,,BAO_0000218,CHEMBL625937,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,13156,,13249,,,BAO_0000218,CHEMBL625938,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,13157,,9267,,,BAO_0000218,CHEMBL625939,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,N,1970.0,Bile,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13158,,9267,,,BAO_0000218,CHEMBL625940,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,N,1970.0,Bile,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13159,,9267,,,BAO_0000218,CHEMBL874464,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,N,1970.0,Bile,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13160,,9267,,,BAO_0000218,CHEMBL625941,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,N,1970.0,Bile,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13161,,9267,,,BAO_0000218,CHEMBL625942,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,N,1970.0,Bile,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13162,,9267,,,BAO_0000218,CHEMBL625943,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,N,1970.0,Bile,50597,Rattus norvegicus,Intermediate
,,,A,9606.0,1,,1,13163,,15549,,,BAO_0000218,CHEMBL625944,In vitro protein binding in human serum at 5 ug/ml,,N,1977.0,Serum,50587,Homo sapiens,Intermediate
,,,A,,0,,1,13164,,10929,,,BAO_0000019,CHEMBL625945,Serum protein binding ability was measured,,U,,,22224,,Autocuration
,,,A,,0,,1,13165,,15444,,,BAO_0000019,CHEMBL625946,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,U,,,22224,,Autocuration
,,,A,9615.0,0,,1,13166,,12860,,,BAO_0000218,CHEMBL625947,Oral bioavailability in dog,In vivo,U,,,22224,Canis lupus familiaris,Autocuration
,,,A,10116.0,1,,1,13167,,12170,,,BAO_0000218,CHEMBL625948,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,13168,,15173,,,BAO_0000218,CHEMBL625949,Absolute oral bioavailability at an iv dose of 14 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13169,,15173,,,BAO_0000218,CHEMBL625950,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,9347.0,0,,1,13170,,15173,,,BAO_0000218,CHEMBL625951,Oral bioavailability (dose 15 mg/kg i.v.),In vivo,U,,,22224,Eutheria,Autocuration
,,,A,,0,,1,13171,,15173,,,BAO_0000218,CHEMBL625952,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13172,,15173,,,BAO_0000218,CHEMBL625953,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13173,,15173,,,BAO_0000218,CHEMBL625954,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13174,,15173,,,BAO_0000218,CHEMBL882959,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,In vivo,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,13175,,11767,,,BAO_0000218,CHEMBL625955,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9669.0,0,,1,13176,,11219,,,BAO_0000218,CHEMBL625956,Bioavailability in ferret,In vivo,U,,,22224,Mustela putorius furo,Autocuration
,,,A,9541.0,1,,1,13177,,12186,,,BAO_0000218,CHEMBL625957,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,In vivo,N,,,100710,Macaca fascicularis,Intermediate
,,,A,10116.0,1,,1,13178,,11510,,,BAO_0000218,CHEMBL625958,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13179,,11510,,,BAO_0000218,CHEMBL625959,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13180,,11510,,,BAO_0000218,CHEMBL626642,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13181,,11510,,,BAO_0000218,CHEMBL631330,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13182,,11510,,,BAO_0000218,CHEMBL631331,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13183,,11510,,,BAO_0000218,CHEMBL631332,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13184,,11510,,,BAO_0000218,CHEMBL631333,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13185,,11510,,,BAO_0000218,CHEMBL632018,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13186,,11510,,,BAO_0000218,CHEMBL632019,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13187,,11510,,,BAO_0000218,CHEMBL632020,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13188,,11510,,,BAO_0000218,CHEMBL632021,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13189,,11510,,,BAO_0000218,CHEMBL632022,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13190,,11510,,,BAO_0000218,CHEMBL632023,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13191,,11510,,,BAO_0000218,CHEMBL632024,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13192,,11510,,,BAO_0000218,CHEMBL874472,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13193,,11510,,,BAO_0000218,CHEMBL632025,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13194,,11510,,,BAO_0000218,CHEMBL632026,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13195,,11510,,,BAO_0000218,CHEMBL632027,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13196,,11510,,,BAO_0000218,CHEMBL632028,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13197,,11510,,,BAO_0000218,CHEMBL626430,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13198,,11510,,,BAO_0000218,CHEMBL626431,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13199,,11510,,,BAO_0000218,CHEMBL626432,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13200,,11510,,,BAO_0000218,CHEMBL626433,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13201,,11510,,,BAO_0000218,CHEMBL626434,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13202,,11510,,,BAO_0000218,CHEMBL627280,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13203,,11510,,,BAO_0000218,CHEMBL627281,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13204,,11510,,,BAO_0000218,CHEMBL627282,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,13205,,7199,,,BAO_0000019,CHEMBL627283,Total body clearance was measured at given dose,,U,,,22224,,Autocuration
,,,A,,0,,1,13206,,7199,,,BAO_0000218,CHEMBL627284,Total body clearance was measured at given dose.,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,13207,,7095,,,BAO_0000218,CHEMBL627285,Metabolic clearance from the body in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,13208,,7095,,,BAO_0000218,CHEMBL627286,Renal clearance from the body,In vivo,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,13209,,7095,,,BAO_0000218,CHEMBL875477,Renal clearance from the body in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13210,,12528,,,BAO_0000218,CHEMBL627287,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,13211,,12528,,,BAO_0000218,CHEMBL627288,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,13212,,7095,,,BAO_0000218,CHEMBL627289,Total clearance from the body in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13213,,14223,,,BAO_0000218,CHEMBL627290,Clearance into cortex from rat plasma or PBS,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,13214,,13569,,,BAO_0000218,CHEMBL627291,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13215,,13569,,,BAO_0000218,CHEMBL627292,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13216,,13569,,,BAO_0000218,CHEMBL627293,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13217,,13569,,,BAO_0000218,CHEMBL627294,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13218,,13569,,,BAO_0000218,CHEMBL875478,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13219,,13979,,,BAO_0000218,CHEMBL627295,Clearance was determined,In vivo,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,13220,,14315,,,BAO_0000218,CHEMBL627296,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,9986.0,1,,1,13221,,14315,,,BAO_0000218,CHEMBL626119,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,In vivo,N,,,50592,Oryctolagus cuniculus,Intermediate
,,,A,10116.0,1,,1,13222,,14315,,,BAO_0000218,CHEMBL626120,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13223,,12174,,,BAO_0000218,CHEMBL626121,Clearance in rat after iv dose (100 ug/kg),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10141.0,0,,1,13224,,12797,,,BAO_0000218,CHEMBL626122,Clearance in guinea pig,In vivo,U,,,22224,Cavia porcellus,Autocuration
,,,A,10116.0,1,,1,13225,,12797,,,BAO_0000218,CHEMBL626123,Compound was evaluated for clearance in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,13226,,12797,,,BAO_0000218,CHEMBL623456,Compound was evaluated for the clearance in dog,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,13227,,12797,,,BAO_0000218,CHEMBL623457,Compound was evaluated for the clearance in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13228,,11500,,,BAO_0000218,CHEMBL623458,Compound was tested in vivo for clearance after iv administration in the rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,13229,,15173,,,BAO_0000218,CHEMBL623459,IV clearance determined at an iv dose of 14 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13230,,15173,,,BAO_0000218,CHEMBL875484,IV clearance determined at an iv dose of 15.2 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13231,,15173,,,BAO_0000218,CHEMBL623460,IV clearance determined at an iv dose of 15 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13232,,15173,,,BAO_0000218,CHEMBL623461,IV clearance determined at an peroral dose of 30 mg/kg.,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13233,,15173,,,BAO_0000218,CHEMBL623462,IV clearance determined at an peroral dose of 30.2 mg/kg.,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13234,,15173,,,BAO_0000218,CHEMBL627386,IV clearance determined at an peroral dose of 30.3 mg/kg.,In vivo,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,13235,,14198,,,BAO_0000218,CHEMBL627387,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13236,,14198,,,BAO_0000218,CHEMBL627388,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13237,,14198,,,BAO_0000218,CHEMBL627389,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13238,,14198,,,BAO_0000218,CHEMBL627390,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13239,,14198,,,BAO_0000218,CHEMBL627391,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13240,,14198,,,BAO_0000218,CHEMBL627392,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13241,,14198,,,BAO_0000218,CHEMBL627393,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13242,,14198,,,BAO_0000218,CHEMBL627394,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,In vivo,N,3126.0,Trachea,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13243,,14198,,,BAO_0000218,CHEMBL627395,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13244,,14198,,,BAO_0000218,CHEMBL875485,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,In vivo,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13245,,14198,,,BAO_0000218,CHEMBL627396,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13246,,14198,,,BAO_0000218,CHEMBL627397,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13247,,14198,,,BAO_0000218,CHEMBL627398,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13248,,14198,,,BAO_0000218,CHEMBL627399,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13249,,14198,,,BAO_0000218,CHEMBL627400,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13250,,14198,,,BAO_0000218,CHEMBL627401,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13251,,14198,,,BAO_0000218,CHEMBL627402,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13252,,14198,,,BAO_0000218,CHEMBL627403,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13253,,14198,,,BAO_0000218,CHEMBL627404,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13254,,14198,,,BAO_0000218,CHEMBL623101,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13255,,14198,,,BAO_0000218,CHEMBL877480,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13256,,14198,,,BAO_0000218,CHEMBL623102,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,In vivo,N,3126.0,Trachea,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13257,,14198,,,BAO_0000218,CHEMBL623103,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13258,,14198,,,BAO_0000218,CHEMBL623104,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,In vivo,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13259,,14198,,,BAO_0000218,CHEMBL623105,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13260,,14198,,,BAO_0000218,CHEMBL623106,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13261,,14198,,,BAO_0000218,CHEMBL623107,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13262,,14198,,,BAO_0000218,CHEMBL623108,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,In vivo,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13263,,14198,,,BAO_0000218,CHEMBL623109,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13264,,14198,,,BAO_0000218,CHEMBL623110,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13265,,14198,,,BAO_0000218,CHEMBL623111,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13266,,14198,,,BAO_0000218,CHEMBL625060,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13267,,14198,,,BAO_0000218,CHEMBL625061,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13268,,14198,,,BAO_0000218,CHEMBL625062,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13269,,14198,,,BAO_0000218,CHEMBL625063,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13270,,14198,,,BAO_0000218,CHEMBL625064,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,In vivo,N,3126.0,Trachea,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13271,,14198,,,BAO_0000218,CHEMBL625065,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,In vivo,N,10000001.0,Bone,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13272,,14198,,,BAO_0000218,CHEMBL625066,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,In vivo,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13273,,14198,,,BAO_0000218,CHEMBL625067,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13274,,14198,,,BAO_0000218,CHEMBL625068,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13275,,14198,,,BAO_0000218,CHEMBL622159,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13276,,14198,,,BAO_0000218,CHEMBL622160,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,In vivo,N,160.0,Intestine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13277,,14198,,,BAO_0000218,CHEMBL622161,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13278,,14198,,,BAO_0000218,CHEMBL622162,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13279,,14198,,,BAO_0000218,CHEMBL622163,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13280,,14198,,,BAO_0000218,CHEMBL622313,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13281,,14198,,,BAO_0000218,CHEMBL622314,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13282,,14198,,,BAO_0000218,CHEMBL622315,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13283,,14198,,,BAO_0000218,CHEMBL622316,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,In vivo,N,3126.0,Trachea,50597,Rattus norvegicus,Intermediate
,,,A,562.0,1,,1,13284,,15599,,,BAO_0000218,CHEMBL877486,Normal diffusion coefficient in water for Escherichia coli,,N,,,50212,Escherichia coli,Intermediate
,,,A,,0,,1,13285,,8204,,,BAO_0000019,CHEMBL622317,Average max percent decrease in RVR (renal vascular resistance) was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,13286,,8204,,,BAO_0000019,CHEMBL622318,Average max percent decrease in RVR (renal vascular resistance) was determined.,,U,,,22224,,Autocuration
,,,A,,0,,1,13287,,6154,,,BAO_0000019,CHEMBL622319,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,U,,,22224,,Autocuration
,,,A,,0,,1,13288,,6154,,,BAO_0000019,CHEMBL622320,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,U,,,22224,,Autocuration
,,,A,,0,,1,13289,,6154,,,BAO_0000019,CHEMBL622321,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,U,,,22224,,Autocuration
,,,A,,0,,1,13290,,6154,,,BAO_0000019,CHEMBL622322,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,U,,,22224,,Autocuration
,,,A,,0,,1,13291,,7114,,,BAO_0000019,CHEMBL622323,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,13292,,7114,,,BAO_0000218,CHEMBL622324,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,13293,,8133,,,BAO_0000218,CHEMBL622325,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13294,,8133,,,BAO_0000218,CHEMBL622326,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13295,,8133,,,BAO_0000218,CHEMBL877487,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13296,,8133,,,BAO_0000218,CHEMBL622327,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13297,,8133,,,BAO_0000218,CHEMBL622328,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13298,,8133,,,BAO_0000218,CHEMBL622329,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13299,,8133,,,BAO_0000218,CHEMBL622330,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13300,,8133,,,BAO_0000218,CHEMBL622331,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13301,,8133,,,BAO_0000218,CHEMBL622332,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13302,,8133,,,BAO_0000218,CHEMBL622333,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,314293.0,0,,1,13303,,8133,,,BAO_0000218,CHEMBL627658,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,U,1088.0,Urine,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,13304,,8133,,,BAO_0000218,CHEMBL630428,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,U,1088.0,Urine,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,13305,,8133,,,BAO_0000218,CHEMBL630429,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,U,1088.0,Urine,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,13306,,8133,,,BAO_0000218,CHEMBL630430,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,U,1088.0,Urine,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,13307,,8133,,,BAO_0000218,CHEMBL630431,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,U,1088.0,Urine,22224,Simiiformes,Autocuration
,,,A,10116.0,1,,1,13308,,8133,,,BAO_0000218,CHEMBL630432,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13309,,8133,,,BAO_0000218,CHEMBL630433,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13310,,8133,,,BAO_0000218,CHEMBL630434,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13311,,8133,,,BAO_0000218,CHEMBL629372,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13312,,8133,,,BAO_0000218,CHEMBL629553,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13313,,8133,,,BAO_0000218,CHEMBL629554,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13314,,8133,,,BAO_0000218,CHEMBL874447,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13315,,8133,,,BAO_0000218,CHEMBL629555,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13316,,8133,,,BAO_0000218,CHEMBL629556,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13317,,8133,,,BAO_0000218,CHEMBL629557,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13318,,8133,,,BAO_0000218,CHEMBL629558,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13319,,8133,,,BAO_0000218,CHEMBL629559,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13320,,8133,,,BAO_0000218,CHEMBL629560,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,13321,,8133,,,BAO_0000218,CHEMBL629561,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13322,,8133,,,BAO_0000218,CHEMBL629562,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13323,,8133,,,BAO_0000218,CHEMBL629563,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13324,,8133,,,BAO_0000218,CHEMBL629564,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13325,,8133,,,BAO_0000218,CHEMBL629565,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13326,,8133,,,BAO_0000218,CHEMBL629566,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13327,,8133,,,BAO_0000218,CHEMBL629567,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13328,,8133,,,BAO_0000218,CHEMBL629568,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13329,,8133,,,BAO_0000218,CHEMBL629569,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13330,,8133,,,BAO_0000218,CHEMBL629570,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,314293.0,0,,1,13331,,8133,,,BAO_0000218,CHEMBL629571,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,U,1088.0,Urine,22224,Simiiformes,Autocuration
,,,A,10116.0,0,,1,13332,,12170,,,BAO_0000218,CHEMBL629572,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,10116.0,0,,1,13333,,12170,,,BAO_0000218,CHEMBL629573,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,9347.0,0,,1,13334,,4985,,,BAO_0000218,CHEMBL629574,Bioavailability (dose 20 mg/kg),In vivo,U,,,22224,Eutheria,Autocuration
,,,A,9615.0,0,,1,13335,,15145,,,BAO_0000218,CHEMBL629575,Bioavailability in dog,In vivo,U,,,22224,Canis lupus familiaris,Autocuration
,,,A,10116.0,0,,1,13336,,14080,,,BAO_0000218,CHEMBL874448,Bioavailability in rat (Sprague-Dawley) (male),In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,9443.0,0,,1,13337,,11219,,,BAO_0000218,CHEMBL629576,Bioavailability in monkey (dose 10 mg/kg i.d.),In vivo,U,,,22224,Primates,Autocuration
,,,A,10116.0,0,,1,13338,,15145,,,BAO_0000218,CHEMBL629577,Bioavailability in rat,In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,10116.0,0,,1,13339,,15145,,,BAO_0000218,CHEMBL629578,Bioavailability in rat,In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,9615.0,0,,1,13340,,1202,,,BAO_0000218,CHEMBL629579,Bioavailability in dog (dose 3.0 mg/kg p.o.),In vivo,U,,,22224,Canis lupus familiaris,Autocuration
,,,A,9615.0,0,,1,13341,,1202,,,BAO_0000218,CHEMBL882958,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,In vivo,U,,,22224,Canis lupus familiaris,Autocuration
,,,A,9598.0,1,,1,13342,,1202,,,BAO_0000218,CHEMBL629580,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,In vivo,N,,,50505,Pan troglodytes,Intermediate
,,,A,9347.0,0,,1,13343,,4026,,,BAO_0000218,CHEMBL629581,Bioavailability,In vivo,U,,,22224,Eutheria,Autocuration
,,,A,9520.0,0,,1,13344,,1492,,,BAO_0000218,CHEMBL629582,Bioavailability in squirrel monkey,In vivo,U,,,22224,Saimiri,Autocuration
,,,A,9615.0,1,,1,13345,,12793,,,BAO_0000218,CHEMBL628522,Bioavailability was evaluated in dog,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10026.0,1,,1,13346,,12793,,,BAO_0000218,CHEMBL625432,Bioavailability was evaluated in hamster,In vivo,N,,,100712,Cricetinae,Intermediate
,,,A,10116.0,0,,1,13347,,12793,,,BAO_0000218,CHEMBL625433,Bioavailability in rat,In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,10116.0,1,,1,13348,,14793,,,BAO_0000218,CHEMBL625434,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13349,,14793,,,BAO_0000218,CHEMBL625435,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,0,,1,13350,,14793,,,BAO_0000218,CHEMBL625436,Bioavailability in rat (dose 10 mg/kg p.o.),In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,9541.0,1,,1,13351,,14731,,,BAO_0000218,CHEMBL874588,Bioavailability was measured in cynomolgus monkeys.,In vivo,N,,,100710,Macaca fascicularis,Intermediate
,,,A,10090.0,1,,1,13352,,14731,,,BAO_0000218,CHEMBL625437,Bioavailability was measured in nude mice.,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,9669.0,0,,1,13353,,12187,,,BAO_0000218,CHEMBL625438,Bioavailability in ferret (dose 10 mg/kg i.d.),In vivo,U,,,22224,Mustela putorius furo,Autocuration
,,,A,314293.0,0,,1,13354,,12187,,,BAO_0000218,CHEMBL625439,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),In vivo,U,,,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,13355,,12187,,,BAO_0000218,CHEMBL625440,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",In vivo,U,,,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,13356,,12187,,,BAO_0000218,CHEMBL625441,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),In vivo,U,,,22224,Simiiformes,Autocuration
,,,A,10116.0,0,,1,13357,,12187,,,BAO_0000218,CHEMBL625442,Bioavailability in rat (dose 10 mg/kg i.d.),In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,10116.0,1,,1,13358,,12187,,,BAO_0000218,CHEMBL625443,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,13359,,17431,,,BAO_0000218,CHEMBL625444,Bioavailability was determined; extremely poor,In vivo,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,13360,,13318,,,BAO_0000218,CHEMBL625445,% bioavailability in mice after oral administration of prodrug,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,9615.0,1,,1,13361,,9025,,,BAO_0000218,CHEMBL625446,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13362,,9025,,,BAO_0000218,CHEMBL882960,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13363,,9025,,,BAO_0000218,CHEMBL625447,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13364,,9025,,,BAO_0000218,CHEMBL625448,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13365,,9025,,,BAO_0000218,CHEMBL625449,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13366,,9025,,,BAO_0000218,CHEMBL874589,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13367,,9025,,,BAO_0000218,CHEMBL625450,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13368,,9025,,,BAO_0000218,CHEMBL625451,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13369,,9025,,,BAO_0000218,CHEMBL626584,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13370,,9025,,,BAO_0000218,CHEMBL626585,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13371,,9025,,,BAO_0000218,CHEMBL626586,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13372,,9025,,,BAO_0000218,CHEMBL626587,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13373,,9025,,,BAO_0000218,CHEMBL626588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13374,,9025,,,BAO_0000218,CHEMBL626589,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13375,,9025,,,BAO_0000218,CHEMBL626590,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13376,,9025,,,BAO_0000218,CHEMBL626591,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13377,,9025,,,BAO_0000218,CHEMBL627181,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13378,,9025,,,BAO_0000218,CHEMBL628083,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,13379,,15173,,,BAO_0000218,CHEMBL628084,IV clearance determined at an peroral dose of 15 mg/kg.,In vivo,U,,,22224,,Autocuration
,,,F,102285.0,1,,1,13380,,7732,,,BAO_0000218,CHEMBL628085,Mouse oral clearance was measured against Hymenolepiasis nana.,In vivo,N,,,50064,Hymenolepis nana,Expert
,,,F,6339.0,1,,1,13381,,7732,,,BAO_0000218,CHEMBL628086,Mouse oral clearance was measured against Nematospiroides dubius,In vivo,N,,,50545,Heligmosomoides polygyrus,Expert
,,,F,,0,,1,13382,,7732,,,BAO_0000218,CHEMBL628087,Mouse oral clearance was measured against N. dubius; NT is Not Tested,In vivo,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,13383,,7732,,,BAO_0000218,CHEMBL628088,Mouse oral clearance was measured against N. nana; NT is Not Tested,In vivo,N,,,50594,Mus musculus,Intermediate
,,,B,,0,,1,13384,,7732,,,BAO_0000218,CHEMBL628089,Mouse oral clearance was measured against N. nana; NT is Not Tested,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13385,,8328,,,BAO_0000218,CHEMBL628090,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13386,,8328,,,BAO_0000218,CHEMBL628091,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13387,,8328,,,BAO_0000218,CHEMBL628092,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13388,,8328,,,BAO_0000218,CHEMBL628093,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13389,,8328,,,BAO_0000218,CHEMBL875607,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13390,,8328,,,BAO_0000218,CHEMBL625710,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13391,,8328,,,BAO_0000218,CHEMBL625711,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13392,,8328,,,BAO_0000218,CHEMBL625712,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13393,,8328,,,BAO_0000218,CHEMBL625713,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,In vivo,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,13394,,13376,,,BAO_0000218,CHEMBL625714,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9544.0,1,,1,13395,,13477,,,BAO_0000218,CHEMBL625715,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,In vivo,N,,,50797,Macaca mulatta,Intermediate
,,,A,10116.0,1,,1,13396,,13477,,,BAO_0000218,CHEMBL625716,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13397,,13477,,,BAO_0000218,CHEMBL625717,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13398,,13313,,,BAO_0000218,CHEMBL625718,Plasma clearance was determined for the compound in rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13399,,12504,,,BAO_0000218,CHEMBL625719,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13400,,12504,,,BAO_0000218,CHEMBL625720,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13401,,12504,,,BAO_0000218,CHEMBL625721,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13402,,12504,,,BAO_0000218,CHEMBL625722,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13403,,13129,,,BAO_0000218,CHEMBL625723,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,6339.0,1,,1,13404,,7732,,,BAO_0000218,CHEMBL625724,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,In vivo,N,,,50545,Heligmosomoides polygyrus,Intermediate
,,,A,6339.0,1,,1,13405,,7732,,,BAO_0000218,CHEMBL625725,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,In vivo,N,,,50545,Heligmosomoides polygyrus,Intermediate
,,,A,6339.0,1,,1,13406,,7732,,,BAO_0000218,CHEMBL625726,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,In vivo,N,,,50545,Heligmosomoides polygyrus,Intermediate
,,,A,6339.0,1,,1,13407,,7732,,,BAO_0000218,CHEMBL875608,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,In vivo,N,,,50545,Heligmosomoides polygyrus,Intermediate
,,,A,6339.0,1,,1,13408,,7732,,,BAO_0000218,CHEMBL625727,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,In vivo,N,,,50545,Heligmosomoides polygyrus,Intermediate
,,,A,10116.0,0,,1,13409,,9278,,,BAO_0000218,CHEMBL625728,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,In vivo,U,1088.0,Urine,22224,Rattus norvegicus,Autocuration
,,,A,10116.0,0,,1,13410,,9278,,,BAO_0000218,CHEMBL625729,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,10116.0,0,,1,13411,,9278,,,BAO_0000218,CHEMBL625730,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,10116.0,0,,1,13412,,9278,,,BAO_0000218,CHEMBL625731,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,In vivo,U,1088.0,Urine,22224,Rattus norvegicus,Autocuration
,,,A,10116.0,0,,1,13413,,9278,,,BAO_0000218,CHEMBL626417,Urinary clearance was determined in rat at 25 mg/kg os dosage,In vivo,U,1088.0,Urine,22224,Rattus norvegicus,Autocuration
,,,A,9606.0,1,,1,13414,,9278,,,BAO_0000218,CHEMBL626418,Urinary clearance was determined at 100 mg/kg oral dosage in human,In vivo,N,1088.0,Urine,50587,Homo sapiens,Intermediate
,,,A,9615.0,1,,1,13415,,9278,,,BAO_0000218,CHEMBL626419,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,In vivo,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13416,,5932,,,BAO_0000218,CHEMBL626592,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,13417,,5932,,,BAO_0000218,CHEMBL626593,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13418,,5182,,,BAO_0000218,CHEMBL626594,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,13419,,10499,,,BAO_0000218,CHEMBL625035,Clearance rate in dogs,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,13420,,6051,,,BAO_0000019,CHEMBL625036,Compound was measured for intrinsic clearance,In vitro,U,,,22224,,Autocuration
,,,P,,0,,1,13421,,17508,,,BAO_0000100,CHEMBL625037,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13422,,6228,,,BAO_0000100,CHEMBL625038,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13423,,6231,,,BAO_0000100,CHEMBL625039,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13424,,17740,,,BAO_0000100,CHEMBL625040,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13425,,6495,,,BAO_0000100,CHEMBL625041,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13426,,2171,,,BAO_0000100,CHEMBL625042,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,A,,0,,1,13427,,3255,,,BAO_0000019,CHEMBL874411,Partition coefficient of the compound,,U,,,22224,,Autocuration
,,,A,,0,,1,13428,,6821,,,BAO_0000019,CHEMBL625043,Permeability,,U,,,22224,,Autocuration
,,,P,,0,,1,13429,,2685,,,BAO_0000100,CHEMBL625044,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,A,,0,,1,13430,,17584,,,BAO_0000019,CHEMBL625045,Partition coefficient (logD),,U,,,22224,,Autocuration
,,,P,,0,,1,13431,,13824,,,BAO_0000100,CHEMBL625046,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,U,,,22229,,Autocuration
,,,P,,0,,1,13432,,13824,,,BAO_0000100,CHEMBL625047,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,U,,,22229,,Autocuration
,,,P,,0,,1,13433,,16479,,,BAO_0000100,CHEMBL625048,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13434,,11997,,,BAO_0000100,CHEMBL625049,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13435,,2988,,,BAO_0000100,CHEMBL625050,Calculated logarithm of partition coefficient (P) was determined,,U,,,22229,,Autocuration
,,,P,,0,,1,13436,,931,,,BAO_0000100,CHEMBL625051,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13437,,4381,,,BAO_0000100,CHEMBL874412,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13438,,4397,,,BAO_0000100,CHEMBL625052,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13439,,5889,,,BAO_0000100,CHEMBL625053,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,A,,0,,1,13440,,6154,,,BAO_0000019,CHEMBL623250,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,U,,,22224,,Autocuration
,,,A,,0,,1,13441,,6154,,,BAO_0000019,CHEMBL623251,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,U,,,22224,,Autocuration
,,,A,,0,,1,13442,,6154,,,BAO_0000019,CHEMBL623252,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,U,,,22224,,Autocuration
,,,A,,0,,1,13443,,6154,,,BAO_0000019,CHEMBL623253,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,U,,,22224,,Autocuration
,,,A,,0,,1,13444,,6154,,,BAO_0000019,CHEMBL623254,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,U,,,22224,,Autocuration
,,,A,,0,,1,13445,,6154,,,BAO_0000019,CHEMBL623255,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,U,,,22224,,Autocuration
,,,A,,0,,1,13446,,6887,,,BAO_0000019,CHEMBL626831,Percent degradation of compound at a pH of 1 over a 18 hr period,,U,,,22224,,Autocuration
,,,A,,0,,1,13447,,6887,,,BAO_0000019,CHEMBL877494,Percent degradation of compound at pH of 1 over an 18 hr period,,U,,,22224,,Autocuration
,,,A,,0,,1,13448,,14116,,,BAO_0000019,CHEMBL626832,Delta Logarithm of Partition Coefficient value was determined.,,U,,,22224,,Autocuration
,,,A,,0,,1,13449,,11137,,,BAO_0000019,CHEMBL626833,Delta logPoct-cyc,,U,,,22224,,Autocuration
,,,P,,0,,1,13450,,7230,,,BAO_0000100,CHEMBL626834,Lipophilicity estimated on reversed phase TLC,,U,,,22224,,Autocuration
,,,A,,0,,1,13451,,15741,,,BAO_0000019,CHEMBL626835,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,U,,,22224,,Autocuration
,,,A,,0,,1,13452,,9663,,,BAO_0000019,CHEMBL626836,Delta logPoct-cyc,,U,,,22224,,Autocuration
,,,P,,0,,1,13453,,9663,,,BAO_0000100,CHEMBL626837,Change in logarithm of partition coefficient of the compound,,U,,,22229,,Autocuration
,,,A,,0,,1,13454,,13807,,,BAO_0000019,CHEMBL626838,Delta logD (pH 6.5),,U,,,22224,,Autocuration
,,,P,,0,,1,13455,,13807,,,BAO_0000100,CHEMBL626839,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,U,,,22224,,Autocuration
,,,A,,0,,1,13456,,17425,,,BAO_0000019,CHEMBL626840,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,U,,,22224,,Autocuration
,,,A,,0,,1,13457,,12143,,,BAO_0000019,CHEMBL626841,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,U,,,22224,,Autocuration
,,,A,,0,,1,13458,,12608,,,BAO_0000219,CHEMBL626842,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,U,,,22224,,Autocuration
,,,A,,0,,1,13459,,12608,,,BAO_0000219,CHEMBL626843,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,13460,,8649,,,BAO_0000218,CHEMBL626844,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13461,,8649,,,BAO_0000218,CHEMBL877495,Amount of deuterium retained was reported after normal workup in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13462,,8649,,,BAO_0000218,CHEMBL626845,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13463,,8649,,,BAO_0000218,CHEMBL626846,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13464,,8649,,,BAO_0000218,CHEMBL626847,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13465,,8649,,,BAO_0000218,CHEMBL628677,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13466,,8649,,,BAO_0000218,CHEMBL628678,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,13467,,9659,,,BAO_0000019,CHEMBL628679,Compound was subjected to electrochemical oxidation,,U,,,22224,,Autocuration
,,,A,,0,,1,13468,,9659,,,BAO_0000019,CHEMBL628680,Compound was subjected to photochemical oxidation,,U,,,22224,,Autocuration
,,,A,,0,,1,13469,,9659,,,BAO_0000019,CHEMBL628681,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,U,,,22224,,Autocuration
,,,A,,0,,1,13470,,9659,,,BAO_0000019,CHEMBL628682,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,U,,,22224,,Autocuration
,,,A,,0,,1,13471,,9659,,,BAO_0000019,CHEMBL628683,Oxidation of compound by methemoglobin in presence of hydroperoxide,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,13472,,9607,,,BAO_0000218,CHEMBL628684,Percent diffusion through fuzzy rat skin after 48 h of incubation,,N,,,50597,Rattus norvegicus,Intermediate
,,,P,,0,,1,13473,,7057,,,BAO_0000100,CHEMBL877501,Dissociation constant (pKa),,U,,,22229,,Autocuration
,,,P,,0,,1,13474,,7057,,,BAO_0000100,CHEMBL628685,Dissociation constant value of the compound; ND means not determined.,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,13475,,7911,,,BAO_0000218,CHEMBL628686,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13476,,7911,,,BAO_0000218,CHEMBL628687,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13477,,7911,,,BAO_0000218,CHEMBL628688,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13478,,7911,,,BAO_0000218,CHEMBL628689,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13479,,7911,,,BAO_0000218,CHEMBL628690,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13480,,7911,,,BAO_0000218,CHEMBL629363,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13481,,7911,,,BAO_0000218,CHEMBL629364,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13482,,7911,,,BAO_0000218,CHEMBL629365,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13483,,7911,,,BAO_0000218,CHEMBL629366,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13484,,7911,,,BAO_0000218,CHEMBL629367,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13485,,7911,,,BAO_0000218,CHEMBL629368,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,N,1988.0,Feces,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13486,,7911,,,BAO_0000218,CHEMBL877502,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,13487,,13792,,,BAO_0000218,CHEMBL629369,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,N,2037.0,Cerebellum,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13488,,13792,,,BAO_0000218,CHEMBL629370,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,314293.0,0,,1,13489,,8133,,,BAO_0000218,CHEMBL629371,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,U,1088.0,Urine,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,13490,,8133,,,BAO_0000218,CHEMBL626276,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,U,1088.0,Urine,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,13491,,8133,,,BAO_0000218,CHEMBL626277,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,U,1088.0,Urine,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,13492,,8133,,,BAO_0000218,CHEMBL631250,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,U,1088.0,Urine,22224,Simiiformes,Autocuration
,,,A,10116.0,1,,1,13493,,8133,,,BAO_0000218,CHEMBL631251,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13494,,8133,,,BAO_0000218,CHEMBL631252,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13495,,8133,,,BAO_0000218,CHEMBL631253,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13496,,8133,,,BAO_0000218,CHEMBL631254,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13497,,8133,,,BAO_0000218,CHEMBL631255,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13498,,8133,,,BAO_0000218,CHEMBL631256,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13499,,8133,,,BAO_0000218,CHEMBL631257,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13500,,8133,,,BAO_0000218,CHEMBL628009,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13501,,8133,,,BAO_0000218,CHEMBL628010,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13502,,8133,,,BAO_0000218,CHEMBL628011,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13503,,8133,,,BAO_0000218,CHEMBL628012,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13504,,8133,,,BAO_0000218,CHEMBL628013,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13505,,8133,,,BAO_0000218,CHEMBL628014,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,13506,,8133,,,BAO_0000218,CHEMBL628015,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13507,,8133,,,BAO_0000218,CHEMBL628016,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13508,,8133,,,BAO_0000218,CHEMBL874461,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13509,,8133,,,BAO_0000218,CHEMBL628017,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13510,,8133,,,BAO_0000218,CHEMBL628018,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13511,,8133,,,BAO_0000218,CHEMBL628019,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13512,,8133,,,BAO_0000218,CHEMBL628020,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13513,,8133,,,BAO_0000218,CHEMBL628021,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13514,,8133,,,BAO_0000218,CHEMBL628022,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13515,,8133,,,BAO_0000218,CHEMBL628023,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,314293.0,0,,1,13516,,8133,,,BAO_0000218,CHEMBL628024,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,U,1088.0,Urine,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,13517,,8133,,,BAO_0000218,CHEMBL628025,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,U,1088.0,Urine,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,13518,,8133,,,BAO_0000218,CHEMBL628026,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,U,1088.0,Urine,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,13519,,8133,,,BAO_0000218,CHEMBL628027,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,U,1088.0,Urine,22224,Simiiformes,Autocuration
,,,A,314293.0,0,,1,13520,,8133,,,BAO_0000218,CHEMBL628028,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,U,1088.0,Urine,22224,Simiiformes,Autocuration
,,,A,10116.0,1,,1,13521,,8133,,,BAO_0000218,CHEMBL628029,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13522,,8133,,,BAO_0000218,CHEMBL628030,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13523,,8133,,,BAO_0000218,CHEMBL628031,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13524,,8133,,,BAO_0000218,CHEMBL628032,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13525,,8133,,,BAO_0000218,CHEMBL628033,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13526,,8133,,,BAO_0000218,CHEMBL628034,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13527,,8133,,,BAO_0000218,CHEMBL628035,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13528,,8133,,,BAO_0000218,CHEMBL628036,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13529,,8133,,,BAO_0000218,CHEMBL874462,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,13530,,9025,,,BAO_0000218,CHEMBL628037,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13531,,9025,,,BAO_0000218,CHEMBL628123,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13532,,9025,,,BAO_0000218,CHEMBL628124,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13533,,9025,,,BAO_0000218,CHEMBL628125,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13534,,9025,,,BAO_0000218,CHEMBL628126,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13535,,9025,,,BAO_0000218,CHEMBL628127,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13536,,9025,,,BAO_0000218,CHEMBL628128,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13537,,9025,,,BAO_0000218,CHEMBL628129,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13538,,9025,,,BAO_0000218,CHEMBL628130,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13539,,9025,,,BAO_0000218,CHEMBL628131,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13540,,9025,,,BAO_0000218,CHEMBL628132,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13541,,9025,,,BAO_0000218,CHEMBL628133,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13542,,9025,,,BAO_0000218,CHEMBL628134,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13543,,9025,,,BAO_0000218,CHEMBL628135,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13544,,9025,,,BAO_0000218,CHEMBL628136,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13545,,9025,,,BAO_0000218,CHEMBL628137,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13546,,9025,,,BAO_0000218,CHEMBL628138,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13547,,9025,,,BAO_0000218,CHEMBL628139,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13548,,9025,,,BAO_0000218,CHEMBL628140,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13549,,9025,,,BAO_0000218,CHEMBL628141,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13550,,9025,,,BAO_0000218,CHEMBL628142,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13551,,9025,,,BAO_0000218,CHEMBL628143,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13552,,9025,,,BAO_0000218,CHEMBL628144,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13553,,9025,,,BAO_0000218,CHEMBL628145,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13554,,9025,,,BAO_0000218,CHEMBL628146,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13555,,9025,,,BAO_0000218,CHEMBL625355,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13556,,9025,,,BAO_0000218,CHEMBL625356,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13557,,9025,,,BAO_0000218,CHEMBL625357,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13558,,9025,,,BAO_0000218,CHEMBL625527,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13559,,9025,,,BAO_0000218,CHEMBL875473,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13560,,9025,,,BAO_0000218,CHEMBL625528,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,13561,,9025,,,BAO_0000218,CHEMBL626304,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,13562,,9025,,,BAO_0000218,CHEMBL624138,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,In vivo,N,1637.0,Artery,50588,Canis lupus familiaris,Intermediate
,,,P,,0,,1,13563,,6448,,,BAO_0000100,CHEMBL624139,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13564,,17221,,,BAO_0000100,CHEMBL624140,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13565,,6545,,,BAO_0000100,CHEMBL624141,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13566,,577,,,BAO_0000100,CHEMBL624142,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13567,,6285,,,BAO_0000100,CHEMBL624143,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13568,,6500,,,BAO_0000100,CHEMBL624144,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13569,,6716,,,BAO_0000100,CHEMBL624145,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13570,,13658,,,BAO_0000100,CHEMBL624146,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13571,,6549,,,BAO_0000100,CHEMBL624147,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13572,,14685,,,BAO_0000100,CHEMBL883123,Calculated partition coefficient (clogP) (MacLogP),,U,,,22229,,Autocuration
,,,A,,0,,1,13573,,6893,,,BAO_0000019,CHEMBL624148,Partition coefficient (logP),,U,,,22224,,Autocuration
,,,A,,0,,1,13574,,3687,,,BAO_0000019,CHEMBL874416,Kinetic parameter was determined,,U,,,22224,,Autocuration
,,,P,,0,,1,13575,,4207,,,BAO_0000100,CHEMBL624149,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13576,,4626,,,BAO_0000100,CHEMBL624150,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13577,,1021,,,BAO_0000100,CHEMBL624151,Lipophilicity was determined,,U,,,22224,,Autocuration
,,,P,,0,,1,13578,,3777,,,BAO_0000100,CHEMBL624152,Lipophilicity was determined,,U,,,22224,,Autocuration
,,,P,,0,,1,13579,,17533,,,BAO_0000100,CHEMBL622139,Lipophilicity was determined,,U,,,22224,,Autocuration
,,,P,,0,,1,13580,,6524,,,BAO_0000100,CHEMBL622140,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13581,,17533,,,BAO_0000100,CHEMBL622141,Lipophilicity was determined,,U,,,22224,,Autocuration
,,,P,,0,,1,13582,,6480,,,BAO_0000100,CHEMBL622142,Lipophilicity in octanol-water,,U,,,22224,,Autocuration
,,,P,,0,,1,13583,,17606,,,BAO_0000100,CHEMBL622143,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,P,,0,,1,13584,,6863,,,BAO_0000100,CHEMBL622144,Octanol-water partition coefficient was determined,,U,,,22229,,Autocuration
,,,A,,0,,1,13585,,1356,,,BAO_0000019,CHEMBL877473,Partition coefficient (logP),,U,,,22224,,Autocuration
,,,P,,0,,1,13586,,3326,,,BAO_0000100,CHEMBL622145,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,A,,0,,1,13587,,1356,,,BAO_0000019,CHEMBL622146,Partition coefficient was determined; ND means not determined,,U,,,22224,,Autocuration
,,,P,,0,,1,13588,,12984,,,BAO_0000100,CHEMBL622147,Calculated partition coefficient (clogP),,U,,,22229,,Autocuration
,,,A,,0,,1,13589,,17363,,,BAO_0000019,CHEMBL622148,Partition coefficient of the compound,,U,,,22224,,Autocuration
,,,A,,0,,1,13590,,6827,,,BAO_0000019,CHEMBL883124,Permeability was determined,,U,,,22224,,Autocuration
,,,P,,0,,1,13591,,261,,,BAO_0000100,CHEMBL622149,The compound was evaluated for the partition coefficient,,U,,,22229,,Autocuration
,,,A,,0,,1,13592,,2685,,,BAO_0000019,CHEMBL622150,Partition coefficient (logP),,U,,,22224,,Autocuration
,,,P,,0,,1,13593,,414,,,BAO_0000100,CHEMBL622151,The lipophilicity was reported,,U,,,22224,,Autocuration
,,,P,,0,,1,13594,,15769,,,BAO_0000100,CHEMBL622152,logarithm of the octanol-water partition coefficient for the compound,,U,,,22229,,Autocuration
,,,A,,0,,1,13595,,17248,,,BAO_0000019,CHEMBL622153,Clogp value was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,13596,,16935,,,BAO_0000218,CHEMBL877474,Clp at a dose of 1.5 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13597,,16935,,,BAO_0000218,CHEMBL622154,Clp at a dose of 2.0 mg/kg,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13598,,14832,,,BAO_0000218,CHEMBL622155,"Clp, plasma clearance at a dose of 10 mg/kg",In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,,0,,1,13599,,14832,,,BAO_0000218,CHEMBL622156,"Clp, plasma clearance at a dose of 50 mg/kg",In vivo,U,1969.0,Plasma,22224,,Autocuration
,,,A,10116.0,1,,1,13600,,2399,,,BAO_0000218,CHEMBL622157,Compound was tested for plasma clearance in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13601,,2399,,,BAO_0000218,CHEMBL622158,Compound was tested for plasma clearance in rat; Not determined,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13602,,6227,,,BAO_0000218,CHEMBL622807,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9544.0,1,,1,13603,,6227,,,BAO_0000218,CHEMBL622808,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,In vivo,N,,,50797,Macaca mulatta,Intermediate
,,,A,,0,,1,13604,,5623,,,BAO_0000218,CHEMBL622809,Plasma clearance by iv administration at a dose 0.003 ug/mL,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13605,,4854,,,BAO_0000218,CHEMBL622810,Plasma clearance determined,In vivo,U,,,22224,,Autocuration
,,,A,10026.0,1,,1,13606,,4493,,,BAO_0000218,CHEMBL876653,Plasma clearance after iv administration at 3 mg/kg in hamster,In vivo,N,,,100712,Cricetinae,Intermediate
,,,A,10026.0,1,,1,13607,,4493,,,BAO_0000218,CHEMBL622811,Plasma clearance after iv administration at 4 mg/kg in hamster,In vivo,N,,,100712,Cricetinae,Intermediate
,,,A,10116.0,1,,1,13608,,14956,,,BAO_0000218,CHEMBL622986,Rate of clearance in rat was determined,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13609,,15372,,,BAO_0000218,CHEMBL622987,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13610,,15372,,,BAO_0000218,CHEMBL622988,Total plasma clearance after iv dose of 5.10 mg/kg in rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13611,,15372,,,BAO_0000218,CHEMBL622989,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13612,,15372,,,BAO_0000218,CHEMBL622990,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,314293.0,0,,1,13613,,15604,,,BAO_0000218,CHEMBL622991,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,In vivo,U,1969.0,Plasma,22224,Simiiformes,Autocuration
,,,A,10116.0,1,,1,13614,,15604,,,BAO_0000218,CHEMBL622227,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,In vivo,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,13615,,15604,,,BAO_0000218,CHEMBL622228,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,13616,,14964,,,BAO_0000218,CHEMBL622229,Clpl value in rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10141.0,1,,1,13617,,15240,,,BAO_0000218,CHEMBL622230,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,In vivo,N,,,50512,Cavia porcellus,Intermediate
,,,A,10116.0,1,,1,13618,,16449,,,BAO_0000218,CHEMBL622231,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9541.0,1,,1,13619,,16449,,,BAO_0000218,CHEMBL622232,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,In vivo,N,,,100710,Macaca fascicularis,Intermediate
,,,A,,0,,1,13620,,12902,,,BAO_0000218,CHEMBL622233,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13621,,12902,,,BAO_0000218,CHEMBL622234,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13622,,12902,,,BAO_0000218,CHEMBL622235,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13623,,12902,,,BAO_0000218,CHEMBL622236,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13624,,12902,,,BAO_0000218,CHEMBL622237,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13625,,12902,,,BAO_0000218,CHEMBL877482,Cmax in minutes at a po dose of 10.0(pmol/g/h).,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13626,,12902,,,BAO_0000218,CHEMBL622238,Cmax in minutes at a po dose of 20.0(pmol/g/h).,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13627,,12902,,,BAO_0000218,CHEMBL622239,Cmax in minutes at a po dose of 40.0(pmol/g/h).,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,13628,,11149,,,BAO_0000218,CHEMBL622240,Cmax was calculated as maximum concentration reached in the blood,In vivo,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,13629,,11149,,,BAO_0000218,CHEMBL622241,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,In vivo,U,178.0,Blood,22224,,Autocuration
,,,A,10116.0,1,,1,13630,,5669,,,BAO_0000218,CHEMBL631013,Cmax was determine after peroral administration at 10 mpk in Rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9544.0,1,,1,13631,,5669,,,BAO_0000218,CHEMBL631014,Cmax was determine after peroral administration at 10 mpk in Rhesus,In vivo,N,,,50797,Macaca mulatta,Intermediate
,,,A,9615.0,1,,1,13632,,5669,,,BAO_0000218,CHEMBL631015,Cmax was determine after peroral administration at 10 mpk in dog,In vivo,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,13633,,5669,,,BAO_0000218,CHEMBL631016,Cmax was determine after peroral administration at 160 mpk in Rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13634,,5669,,,BAO_0000218,CHEMBL631017,Cmax was determine after peroral administration at 20 mpk in Rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13635,,5669,,,BAO_0000218,CHEMBL631018,Cmax was determine after peroral administration at 50 mpk in Rat,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,13636,,4236,,,BAO_0000218,CHEMBL631019,Cmax was determined,In vivo,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,13637,,13792,,,BAO_0000218,CHEMBL875761,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13638,,13792,,,BAO_0000218,CHEMBL631020,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13639,,13792,,,BAO_0000218,CHEMBL631669,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13640,,13792,,,BAO_0000218,CHEMBL631670,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13641,,13792,,,BAO_0000218,CHEMBL631671,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,N,2435.0,Striatum,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,13642,,8418,,,BAO_0000218,CHEMBL631672,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13643,,8418,,,BAO_0000218,CHEMBL631673,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13644,,8418,,,BAO_0000218,CHEMBL631856,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13645,,8418,,,BAO_0000218,CHEMBL631857,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13646,,8418,,,BAO_0000218,CHEMBL631858,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13647,,8418,,,BAO_0000218,CHEMBL631859,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13648,,8418,,,BAO_0000218,CHEMBL631860,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13649,,8418,,,BAO_0000218,CHEMBL631861,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13650,,8418,,,BAO_0000218,CHEMBL631862,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13651,,8418,,,BAO_0000218,CHEMBL631863,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13652,,8418,,,BAO_0000218,CHEMBL631864,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13653,,8418,,,BAO_0000218,CHEMBL631865,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13654,,8418,,,BAO_0000218,CHEMBL631866,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13655,,8418,,,BAO_0000218,CHEMBL629360,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13656,,8418,,,BAO_0000218,CHEMBL629361,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13657,,8418,,,BAO_0000218,CHEMBL629362,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13658,,8418,,,BAO_0000218,CHEMBL630740,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13659,,8418,,,BAO_0000218,CHEMBL630741,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13660,,8418,,,BAO_0000218,CHEMBL630742,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13661,,8418,,,BAO_0000218,CHEMBL630743,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13662,,8418,,,BAO_0000218,CHEMBL630744,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13663,,8418,,,BAO_0000218,CHEMBL630745,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13664,,8418,,,BAO_0000218,CHEMBL630746,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13665,,8418,,,BAO_0000218,CHEMBL630747,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13666,,8418,,,BAO_0000218,CHEMBL630748,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13667,,8418,,,BAO_0000218,CHEMBL632056,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13668,,8418,,,BAO_0000218,CHEMBL632057,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13669,,8418,,,BAO_0000218,CHEMBL632058,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13670,,8418,,,BAO_0000218,CHEMBL632059,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13671,,8418,,,BAO_0000218,CHEMBL632060,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13672,,8418,,,BAO_0000218,CHEMBL632061,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13673,,8418,,,BAO_0000218,CHEMBL629207,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13674,,8418,,,BAO_0000218,CHEMBL629208,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13675,,8418,,,BAO_0000218,CHEMBL629209,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13676,,8418,,,BAO_0000218,CHEMBL629210,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13677,,8418,,,BAO_0000218,CHEMBL629211,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13678,,8418,,,BAO_0000218,CHEMBL629212,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13679,,8418,,,BAO_0000218,CHEMBL629213,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13680,,8133,,,BAO_0000218,CHEMBL629214,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13681,,8133,,,BAO_0000218,CHEMBL629215,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13682,,8133,,,BAO_0000218,CHEMBL635154,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13683,,6996,,,BAO_0000218,CHEMBL629216,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13684,,6996,,,BAO_0000218,CHEMBL629217,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13685,,6996,,,BAO_0000218,CHEMBL629218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13686,,6996,,,BAO_0000218,CHEMBL629219,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13687,,6996,,,BAO_0000218,CHEMBL629220,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13688,,6996,,,BAO_0000218,CHEMBL629221,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13689,,6996,,,BAO_0000218,CHEMBL631127,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13690,,6996,,,BAO_0000218,CHEMBL631128,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13691,,6996,,,BAO_0000218,CHEMBL631129,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13692,,6996,,,BAO_0000218,CHEMBL631130,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13693,,6996,,,BAO_0000218,CHEMBL631131,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13694,,6996,,,BAO_0000218,CHEMBL631132,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13695,,6996,,,BAO_0000218,CHEMBL631133,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13696,,6996,,,BAO_0000218,CHEMBL631134,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13697,,6996,,,BAO_0000218,CHEMBL875120,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13698,,6996,,,BAO_0000218,CHEMBL631135,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13699,,6996,,,BAO_0000218,CHEMBL631136,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13700,,6996,,,BAO_0000218,CHEMBL631137,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13701,,6996,,,BAO_0000218,CHEMBL631138,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13702,,6996,,,BAO_0000218,CHEMBL631139,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13703,,6996,,,BAO_0000218,CHEMBL631140,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13704,,6996,,,BAO_0000218,CHEMBL631141,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13705,,6996,,,BAO_0000218,CHEMBL631142,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13706,,6996,,,BAO_0000218,CHEMBL631143,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13707,,6996,,,BAO_0000218,CHEMBL631144,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,13708,,6996,,,BAO_0000218,CHEMBL631145,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13709,,6996,,,BAO_0000218,CHEMBL631146,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13710,,6996,,,BAO_0000218,CHEMBL631147,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13711,,6996,,,BAO_0000218,CHEMBL631148,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13712,,6996,,,BAO_0000218,CHEMBL631149,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13713,,6996,,,BAO_0000218,CHEMBL631150,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13714,,6996,,,BAO_0000218,CHEMBL631151,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13715,,6996,,,BAO_0000218,CHEMBL631152,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13716,,6996,,,BAO_0000218,CHEMBL631443,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13717,,6996,,,BAO_0000218,CHEMBL631444,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13718,,6996,,,BAO_0000218,CHEMBL631445,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13719,,6996,,,BAO_0000218,CHEMBL631446,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13720,,6996,,,BAO_0000218,CHEMBL631447,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13721,,6996,,,BAO_0000218,CHEMBL631448,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13722,,6996,,,BAO_0000218,CHEMBL631449,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13723,,6996,,,BAO_0000218,CHEMBL631450,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13724,,6996,,,BAO_0000218,CHEMBL629724,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10090.0,1,,1,13725,,9716,,,BAO_0000218,CHEMBL629725,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,N,14.0,Zone of skin,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13726,,9716,,,BAO_0000218,CHEMBL629726,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,N,14.0,Zone of skin,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13727,,9716,,,BAO_0000218,CHEMBL629727,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13728,,9716,,,BAO_0000218,CHEMBL630404,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13729,,9716,,,BAO_0000218,CHEMBL630405,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13730,,9716,,,BAO_0000218,CHEMBL630406,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13731,,9716,,,BAO_0000218,CHEMBL630407,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,N,945.0,Stomach,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13732,,9716,,,BAO_0000218,CHEMBL630573,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,N,945.0,Stomach,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13733,,9716,,,BAO_0000218,CHEMBL630574,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,N,945.0,Stomach,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13734,,9716,,,BAO_0000218,CHEMBL630575,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,N,945.0,Stomach,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13735,,9716,,,BAO_0000218,CHEMBL630576,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13736,,9716,,,BAO_0000218,CHEMBL630577,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13737,,9716,,,BAO_0000218,CHEMBL630578,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13738,,9716,,,BAO_0000218,CHEMBL630579,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13739,,12192,,,BAO_0000218,CHEMBL630580,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13740,,12192,,,BAO_0000218,CHEMBL630581,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13741,,12192,,,BAO_0000218,CHEMBL630582,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13742,,12192,,,BAO_0000218,CHEMBL630583,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13743,,12192,,,BAO_0000218,CHEMBL630584,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13744,,12192,,,BAO_0000218,CHEMBL630585,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13745,,12192,,,BAO_0000218,CHEMBL630586,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13746,,12192,,,BAO_0000218,CHEMBL630587,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13747,,12192,,,BAO_0000218,CHEMBL630588,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13748,,12192,,,BAO_0000218,CHEMBL630589,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13749,,12192,,,BAO_0000218,CHEMBL630590,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,N,,,50594,Mus musculus,Intermediate
,,,A,,0,,1,13750,,12192,,,BAO_0000019,CHEMBL630591,Removal of 238-Plutonium(IV) in feces at 24 h,,U,1988.0,Feces,22224,,Autocuration
,,,A,,0,,1,13751,,12192,,,BAO_0000019,CHEMBL630592,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,U,1988.0,Feces,22224,,Autocuration
,,,A,,0,,1,13752,,12192,,,BAO_0000019,CHEMBL630593,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,U,,,22224,,Autocuration
,,,A,,0,,1,13753,,12192,,,BAO_0000019,CHEMBL630594,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,U,,,22224,,Autocuration
,,,A,,0,,1,13754,,12192,,,BAO_0000019,CHEMBL630595,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,U,1088.0,Urine,22224,,Autocuration
,,,A,,0,,1,13755,,12192,,,BAO_0000019,CHEMBL630596,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,U,1088.0,Urine,22224,,Autocuration
,,,A,,0,,1,13756,,12192,,,BAO_0000019,CHEMBL630597,Removal of 238-Plutonium(IV) in urine after 0-24 h,,U,1088.0,Urine,22224,,Autocuration
,,,A,,0,,1,13757,,12192,,,BAO_0000019,CHEMBL630598,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,U,1088.0,Urine,22224,,Autocuration
,,,A,,0,,1,13758,,12192,,,BAO_0000019,CHEMBL630599,Removal of 238-Plutonium(IV) in urine after 0-4 h,,U,1088.0,Urine,22224,,Autocuration
,,,A,,0,,1,13759,,12192,,,BAO_0000019,CHEMBL630600,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,U,1088.0,Urine,22224,,Autocuration
,,,A,,0,,1,13760,,12192,,,BAO_0000019,CHEMBL630601,Removal of 238-Plutonium(IV) in urine after 4-24 h,,U,1088.0,Urine,22224,,Autocuration
,,,A,,0,,1,13761,,12192,,,BAO_0000019,CHEMBL630602,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,U,1088.0,Urine,22224,,Autocuration
,,,A,,0,,1,13762,,12192,,,BAO_0000019,CHEMBL630603,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,U,1088.0,Urine,22224,,Autocuration
,,,A,,0,,1,13763,,12192,,,BAO_0000019,CHEMBL630604,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,U,1088.0,Urine,22224,,Autocuration
,,,A,10116.0,1,,1,13764,,12017,,,BAO_0000218,CHEMBL624869,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13765,,12017,,,BAO_0000218,CHEMBL624870,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13766,,12017,,,BAO_0000218,CHEMBL623189,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13767,,12017,,,BAO_0000218,CHEMBL623190,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13768,,12017,,,BAO_0000218,CHEMBL623191,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13769,,12017,,,BAO_0000218,CHEMBL623192,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13770,,12017,,,BAO_0000218,CHEMBL623193,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13771,,12017,,,BAO_0000218,CHEMBL623194,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13772,,12017,,,BAO_0000218,CHEMBL623195,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13773,,12017,,,BAO_0000218,CHEMBL623196,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13774,,11836,,,BAO_0000218,CHEMBL623197,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13775,,11836,,,BAO_0000218,CHEMBL623198,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13776,,11836,,,BAO_0000218,CHEMBL623199,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13777,,11836,,,BAO_0000218,CHEMBL623200,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13778,,11836,,,BAO_0000218,CHEMBL623201,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13779,,11836,,,BAO_0000218,CHEMBL623202,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13780,,11836,,,BAO_0000218,CHEMBL623203,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13781,,11836,,,BAO_0000218,CHEMBL623204,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13782,,11836,,,BAO_0000218,CHEMBL623205,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13783,,11836,,,BAO_0000218,CHEMBL623206,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13784,,11836,,,BAO_0000218,CHEMBL623207,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13785,,11836,,,BAO_0000218,CHEMBL623208,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13786,,11836,,,BAO_0000218,CHEMBL623209,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13787,,11836,,,BAO_0000218,CHEMBL623210,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13788,,11836,,,BAO_0000218,CHEMBL623211,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13789,,11836,,,BAO_0000218,CHEMBL623212,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,13790,,12640,,,BAO_0000019,CHEMBL623213,Tested in vitro for intrinsic activity relative to quinpirole,,U,,,22224,,Autocuration
,,,A,,0,,1,13791,,14218,,,BAO_0000019,CHEMBL623214,"Relative ion enhancement, determined in pulsed ultrafiltration",,U,,,22224,,Autocuration
,,,A,,0,,1,13792,,11296,,,BAO_0000019,CHEMBL623215,% ionization at the pH 7.4 at 37 degree Centigrade,,U,,,22224,,Autocuration
,,,A,,0,,1,13793,,10929,,,BAO_0000019,CHEMBL623216,Percentage ionization was measured,,U,,,22224,,Autocuration
,,,A,9913.0,1,,1,13794,,13841,,,BAO_0000218,CHEMBL623217,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,N,,,50591,Bos taurus,Intermediate
,,,A,,0,,1,13795,,10431,,,BAO_0000019,CHEMBL623218,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,U,,,22224,,Autocuration
,,,A,,0,,1,13796,,10431,,,BAO_0000019,CHEMBL623913,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,U,,,22224,,Autocuration
,,,A,,0,,1,13797,,10431,,,BAO_0000019,CHEMBL623914,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,U,,,22224,,Autocuration
,,,P,,0,,1,13798,,8826,,,BAO_0000100,CHEMBL623915,Compound was evaluated for the partition coefficient in octanol/water,,U,,,22229,,Autocuration
,,,P,,0,,1,13799,,8826,,,BAO_0000100,CHEMBL624080,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,U,,,22229,,Autocuration
,,,A,,0,,1,13800,,9884,,,BAO_0000019,CHEMBL624081,Equilibrium constant measured by the pulse radiolysis at pH 7,,U,,,22224,,Autocuration
,,,A,9606.0,1,,1,13801,,9827,,,BAO_0000218,CHEMBL624082,In vitro hydrolytic rate constant determined in human blood,,N,,,50587,Homo sapiens,Intermediate
,,,A,9606.0,1,,1,13802,,10009,,,BAO_0000218,CHEMBL625054,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,N,,,50587,Homo sapiens,Intermediate
,,,A,,0,,1,13803,,10009,,,BAO_0000019,CHEMBL877485,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,13804,,10009,,,BAO_0000218,CHEMBL625055,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13805,,10009,,,BAO_0000218,CHEMBL625056,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,N,,,50594,Mus musculus,Intermediate
,,,A,9606.0,1,,1,13806,,10009,,,BAO_0000218,CHEMBL625057,In vitro oxidation of compound in presence of human plasma,,N,,,50587,Homo sapiens,Intermediate
,,,A,,0,,1,13807,,10009,,,BAO_0000019,CHEMBL625058,In vitro oxidation of compound in presence of hydrogen peroxide,,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,13808,,10009,,,BAO_0000218,CHEMBL625059,In vitro oxidation of compound in presence of mouse brain homogenate,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13809,,10009,,,BAO_0000218,CHEMBL629536,In vitro oxidation of compound in presence of mouse liver homogenate,,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,13810,,11510,,,BAO_0000218,CHEMBL629537,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13811,,11510,,,BAO_0000218,CHEMBL629538,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13812,,11510,,,BAO_0000218,CHEMBL629539,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13813,,11510,,,BAO_0000218,CHEMBL874445,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13814,,11510,,,BAO_0000218,CHEMBL629540,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13815,,11510,,,BAO_0000218,CHEMBL629541,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13816,,11510,,,BAO_0000218,CHEMBL629542,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13817,,11510,,,BAO_0000218,CHEMBL630243,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13818,,11510,,,BAO_0000218,CHEMBL630244,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13819,,11510,,,BAO_0000218,CHEMBL630245,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13820,,11510,,,BAO_0000218,CHEMBL630246,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13821,,11510,,,BAO_0000218,CHEMBL630247,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13822,,11510,,,BAO_0000218,CHEMBL630248,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13823,,13100,,,BAO_0000218,CHEMBL630249,Biodistribution in rat blood at 240 minutes after dose administration.,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13824,,13100,,,BAO_0000218,CHEMBL630250,Biodistribution in rat blood at 30 minutes after dose administration.,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13825,,13100,,,BAO_0000218,CHEMBL630251,Biodistribution in rat blood at 360 minutes after dose administration.,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13826,,13100,,,BAO_0000218,CHEMBL630252,Biodistribution in rat blood at 3 hr after dose administration.,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13827,,13100,,,BAO_0000218,CHEMBL630408,Biodistribution in rat blood at 60 minutes after dose administration.,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13828,,13100,,,BAO_0000218,CHEMBL630409,Biodistribution in rat cerebellum at 120 minutes after dose administration.,In vivo,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13829,,13100,,,BAO_0000218,CHEMBL874446,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,In vivo,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13830,,13100,,,BAO_0000218,CHEMBL630410,Biodistribution in rat cerebellum at 15 minutes after dose administration.,In vivo,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13831,,13100,,,BAO_0000218,CHEMBL630411,Biodistribution in rat cerebellum at 240 minutes after dose administration.,In vivo,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13832,,13100,,,BAO_0000218,CHEMBL630412,Biodistribution in rat cerebellum at 30 minutes after dose administration.,In vivo,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13833,,13100,,,BAO_0000218,CHEMBL630413,Biodistribution in rat cerebellum at 360 minutes after dose administration.,In vivo,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13834,,13100,,,BAO_0000218,CHEMBL630414,Biodistribution in rat cerebellum at 3 hr after dose administration.,In vivo,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13835,,13100,,,BAO_0000218,CHEMBL630415,Biodistribution in rat cerebellum at 60 minutes after dose administration.,In vivo,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13836,,13100,,,BAO_0000218,CHEMBL630416,Biodistribution in rat cortex at 120 minutes after dose administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13837,,13100,,,BAO_0000218,CHEMBL630417,Biodistribution in rat cortex at 1440 minutes after dose administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13838,,13100,,,BAO_0000218,CHEMBL630418,Biodistribution in rat cortex at 15 minutes after dose administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13839,,13100,,,BAO_0000218,CHEMBL630419,Biodistribution in rat cortex at 240 minutes after dose administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13840,,13100,,,BAO_0000218,CHEMBL630420,Biodistribution in rat cortex at 30 minutes after dose administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13841,,13100,,,BAO_0000218,CHEMBL630421,Biodistribution in rat cortex at 360 minutes after dose administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13842,,13100,,,BAO_0000218,CHEMBL630422,Biodistribution in rat cortex at 3 hr after dose administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13843,,13100,,,BAO_0000218,CHEMBL630423,Biodistribution in rat cortex at 60 minutes after dose administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13844,,13100,,,BAO_0000218,CHEMBL630424,Biodistribution in rat heart at 120 minutes after dose administration.,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13845,,13100,,,BAO_0000218,CHEMBL630425,Biodistribution in rat heart at 15 minutes after dose administration.,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13846,,13100,,,BAO_0000218,CHEMBL629462,Biodistribution in rat heart at 240 minutes after dose administration.,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13847,,13100,,,BAO_0000218,CHEMBL630426,Biodistribution in rat heart at 30 minutes after dose administration.,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13848,,13100,,,BAO_0000218,CHEMBL630427,Biodistribution in rat heart at 360 minutes after dose administration.,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13849,,13100,,,BAO_0000218,CHEMBL625877,Biodistribution in rat heart at 3 hr after dose administration.,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13850,,13100,,,BAO_0000218,CHEMBL625878,Biodistribution in rat heart at 60 minutes after dose administration.,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13851,,13100,,,BAO_0000218,CHEMBL625879,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,In vivo,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13852,,13100,,,BAO_0000218,CHEMBL625880,Biodistribution in rat hippocampus at 240 minutes after dose administration.,In vivo,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13853,,13100,,,BAO_0000218,CHEMBL625881,Biodistribution in rat hippocampus at 30 minutes after dose administration.,In vivo,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13854,,13100,,,BAO_0000218,CHEMBL625882,Biodistribution in rat hippocampus at 360 minutes after dose administration.,In vivo,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13855,,13100,,,BAO_0000218,CHEMBL625883,Biodistribution in rat hippocampus at 15 minutes after dose administration.,In vivo,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13856,,13100,,,BAO_0000218,CHEMBL625884,Biodistribution in rat kidney at 120 minutes after dose administration.,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13857,,13100,,,BAO_0000218,CHEMBL625885,Biodistribution in rat kidney at 1440 minutes after dose administration.,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13858,,13100,,,BAO_0000218,CHEMBL628649,Biodistribution in rat kidney at 15 minutes after dose administration.,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13859,,13100,,,BAO_0000218,CHEMBL628650,Biodistribution in rat kidney at 240 minutes after dose administration.,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13860,,13100,,,BAO_0000218,CHEMBL628651,Biodistribution in rat kidney at 30 minutes after dose administration.,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13861,,13100,,,BAO_0000218,CHEMBL628652,Biodistribution in rat kidney at 360 minutes after dose administration.,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13862,,13100,,,BAO_0000218,CHEMBL628653,Biodistribution in rat kidney at 60 minutes after dose administration.,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13863,,13100,,,BAO_0000218,CHEMBL628654,Biodistribution in rat liver at 120 minutes after dose administration.,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13864,,13100,,,BAO_0000218,CHEMBL628655,Biodistribution in rat liver at 1440 minutes after dose administration.,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13865,,13100,,,BAO_0000218,CHEMBL625238,Biodistribution in rat liver at 15 minutes after dose administration.,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13866,,13100,,,BAO_0000218,CHEMBL625239,Biodistribution in rat liver at 240 minutes after dose administration.,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13867,,13100,,,BAO_0000218,CHEMBL625240,Biodistribution in rat liver at 30 minutes after dose administration.,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13868,,13100,,,BAO_0000218,CHEMBL625241,Biodistribution in rat liver at 360 minutes after dose administration.,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13869,,13100,,,BAO_0000218,CHEMBL625242,Biodistribution in rat liver at 60 minutes after dose administration.,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13870,,13100,,,BAO_0000218,CHEMBL874587,Biodistribution in rat lung at 120 minutes after dose administration.,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13871,,13100,,,BAO_0000218,CHEMBL625405,Biodistribution in rat lung at 1440 minutes after dose administration.,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13872,,13100,,,BAO_0000218,CHEMBL625406,Biodistribution in rat lung at 15 minutes after dose administration.,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13873,,13100,,,BAO_0000218,CHEMBL625407,Biodistribution in rat lung at 240 minutes after dose administration.,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13874,,13100,,,BAO_0000218,CHEMBL625408,Biodistribution in rat lung at 30 minutes after dose administration.,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13875,,13100,,,BAO_0000218,CHEMBL625409,Biodistribution in rat lung at 360 minutes after dose administration.,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13876,,12361,,,BAO_0000218,CHEMBL625410,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,N,1515.0,Thoracic aorta,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13877,,12361,,,BAO_0000218,CHEMBL625411,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,N,1515.0,Thoracic aorta,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13878,,12361,,,BAO_0000218,CHEMBL625412,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,N,1515.0,Thoracic aorta,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13879,,12361,,,BAO_0000218,CHEMBL625413,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,N,1515.0,Thoracic aorta,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13880,,12361,,,BAO_0000218,CHEMBL625414,Percent of maximal contractile response to compound in rat thoracic aorta strips v,,N,1515.0,Thoracic aorta,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13881,,12361,,,BAO_0000218,CHEMBL625415,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,N,1515.0,Thoracic aorta,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13882,,12361,,,BAO_0000218,CHEMBL625416,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,N,1515.0,Thoracic aorta,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13883,,12712,,,BAO_0000218,CHEMBL625417,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13884,,7415,,,BAO_0000218,CHEMBL625418,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,N,1988.0,Feces,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13885,,7415,,,BAO_0000218,CHEMBL625419,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13886,,7415,,,BAO_0000218,CHEMBL625420,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13887,,7415,,,BAO_0000218,CHEMBL626996,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13888,,7415,,,BAO_0000218,CHEMBL626997,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,N,1988.0,Feces,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13889,,7415,,,BAO_0000218,CHEMBL626998,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13890,,7415,,,BAO_0000218,CHEMBL626999,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,13891,,8050,,,BAO_0000218,CHEMBL627000,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13892,,8050,,,BAO_0000218,CHEMBL627001,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13893,,8050,,,BAO_0000218,CHEMBL627002,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13894,,8050,,,BAO_0000218,CHEMBL627003,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13895,,8050,,,BAO_0000218,CHEMBL627004,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,N,1088.0,Urine,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13896,,8050,,,BAO_0000218,CHEMBL627005,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,N,1088.0,Urine,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13897,,8050,,,BAO_0000218,CHEMBL874594,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,N,1088.0,Urine,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13898,,8050,,,BAO_0000218,CHEMBL627006,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,N,1088.0,Urine,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13899,,8050,,,BAO_0000218,CHEMBL627007,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,N,1088.0,Urine,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13900,,8050,,,BAO_0000218,CHEMBL627884,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,N,1088.0,Urine,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13901,,8050,,,BAO_0000218,CHEMBL627885,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,N,1088.0,Urine,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13902,,8050,,,BAO_0000218,CHEMBL627886,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,N,1088.0,Urine,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13903,,8050,,,BAO_0000218,CHEMBL627887,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,N,1088.0,Urine,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13904,,8050,,,BAO_0000218,CHEMBL627888,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,N,1088.0,Urine,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13905,,8050,,,BAO_0000218,CHEMBL628057,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,N,1088.0,Urine,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,13906,,8050,,,BAO_0000218,CHEMBL627405,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,N,1088.0,Urine,50594,Mus musculus,Intermediate
,,,A,9615.0,1,,1,13907,,12582,,,BAO_0000218,CHEMBL627406,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13908,,12582,,,BAO_0000218,CHEMBL627407,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13909,,12582,,,BAO_0000218,CHEMBL627408,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13910,,12582,,,BAO_0000218,CHEMBL627409,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13911,,12582,,,BAO_0000218,CHEMBL875486,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13912,,12582,,,BAO_0000218,CHEMBL627410,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13913,,12582,,,BAO_0000218,CHEMBL627411,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13914,,12582,,,BAO_0000218,CHEMBL627412,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13915,,12582,,,BAO_0000218,CHEMBL627413,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13916,,12582,,,BAO_0000218,CHEMBL627414,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13917,,12582,,,BAO_0000218,CHEMBL627415,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13918,,12582,,,BAO_0000218,CHEMBL627416,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13919,,12582,,,BAO_0000218,CHEMBL627417,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13920,,12582,,,BAO_0000218,CHEMBL627418,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13921,,12582,,,BAO_0000218,CHEMBL627419,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13922,,12582,,,BAO_0000218,CHEMBL627320,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,13923,,12582,,,BAO_0000218,CHEMBL627321,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,13924,,12017,,,BAO_0000218,CHEMBL627322,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13925,,12017,,,BAO_0000218,CHEMBL627323,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13926,,12017,,,BAO_0000218,CHEMBL627491,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13927,,12017,,,BAO_0000218,CHEMBL627492,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13928,,12017,,,BAO_0000218,CHEMBL627493,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13929,,12017,,,BAO_0000218,CHEMBL627494,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13930,,12017,,,BAO_0000218,CHEMBL627495,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13931,,12017,,,BAO_0000218,CHEMBL627496,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13932,,12017,,,BAO_0000218,CHEMBL627497,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13933,,12017,,,BAO_0000218,CHEMBL627498,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13934,,12017,,,BAO_0000218,CHEMBL627499,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13935,,12017,,,BAO_0000218,CHEMBL627500,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13936,,12017,,,BAO_0000218,CHEMBL627501,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13937,,12017,,,BAO_0000218,CHEMBL625616,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13938,,12017,,,BAO_0000218,CHEMBL625617,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13939,,12017,,,BAO_0000218,CHEMBL625618,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13940,,12017,,,BAO_0000218,CHEMBL625619,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13941,,12017,,,BAO_0000218,CHEMBL625620,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13942,,12017,,,BAO_0000218,CHEMBL625621,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13943,,12017,,,BAO_0000218,CHEMBL625622,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13944,,12017,,,BAO_0000218,CHEMBL625788,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13945,,12017,,,BAO_0000218,CHEMBL625789,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13946,,12017,,,BAO_0000218,CHEMBL625790,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13947,,12017,,,BAO_0000218,CHEMBL625791,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13948,,12017,,,BAO_0000218,CHEMBL622334,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13949,,12017,,,BAO_0000218,CHEMBL622335,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13950,,12017,,,BAO_0000218,CHEMBL622336,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13951,,12017,,,BAO_0000218,CHEMBL622337,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13952,,12017,,,BAO_0000218,CHEMBL622338,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13953,,12017,,,BAO_0000218,CHEMBL622339,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13954,,12017,,,BAO_0000218,CHEMBL624153,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13955,,12017,,,BAO_0000218,CHEMBL628430,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13956,,12017,,,BAO_0000218,CHEMBL628431,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13957,,12017,,,BAO_0000218,CHEMBL628432,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13958,,12017,,,BAO_0000218,CHEMBL628433,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13959,,12017,,,BAO_0000218,CHEMBL628434,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13960,,12017,,,BAO_0000218,CHEMBL626789,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13961,,12017,,,BAO_0000218,CHEMBL626790,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13962,,12017,,,BAO_0000218,CHEMBL626791,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13963,,12017,,,BAO_0000218,CHEMBL626792,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13964,,12017,,,BAO_0000218,CHEMBL626793,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13965,,11510,,,BAO_0000218,CHEMBL627436,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13966,,11510,,,BAO_0000218,CHEMBL627437,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13967,,11510,,,BAO_0000218,CHEMBL627438,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13968,,11510,,,BAO_0000218,CHEMBL627439,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13969,,11510,,,BAO_0000218,CHEMBL627440,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13970,,11510,,,BAO_0000218,CHEMBL627602,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13971,,11510,,,BAO_0000218,CHEMBL627603,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13972,,11510,,,BAO_0000218,CHEMBL627604,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13973,,11510,,,BAO_0000218,CHEMBL627605,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13974,,11510,,,BAO_0000218,CHEMBL627606,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13975,,11510,,,BAO_0000218,CHEMBL627607,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13976,,11510,,,BAO_0000218,CHEMBL627608,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13977,,11510,,,BAO_0000218,CHEMBL627609,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13978,,11510,,,BAO_0000218,CHEMBL627610,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13979,,11510,,,BAO_0000218,CHEMBL627611,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,13980,,11510,,,BAO_0000218,CHEMBL627612,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,P,,0,,1,13981,,8362,,,BAO_0000100,CHEMBL627613,Octanol:water partition coefficient is evaluated,,U,,,22229,,Autocuration
,,,P,,0,,1,13982,,8257,,,BAO_0000100,CHEMBL627614,Partition coefficient in 1-octanol/water system,,U,,,22224,,Autocuration
,,,P,,0,,1,13983,,8257,,,BAO_0000100,CHEMBL627615,Partition coefficient in 1-octanol/water system measured using radio active compounds,,U,,,22224,,Autocuration
,,,P,,0,,1,13984,,9468,,,BAO_0000100,CHEMBL627616,Partition coefficient in octanol/water system was determined,,U,,,22224,,Autocuration
,,,P,,0,,1,13985,,9468,,,BAO_0000100,CHEMBL627617,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,U,,,22224,,Autocuration
,,,A,,0,,1,13986,,10568,,,BAO_0000019,CHEMBL627618,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,U,,,22224,,Autocuration
,,,A,,0,,1,13987,,10568,,,BAO_0000019,CHEMBL627619,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,U,,,22224,,Autocuration
,,,A,,0,,1,13988,,15359,,,BAO_0000019,CHEMBL627620,Pseudo-first-order rate constant of the compound,,U,,,22224,,Autocuration
,,,A,,0,,1,13989,,15359,,,BAO_0000019,CHEMBL627621,Pseudo-first-order rate constant with 1-min time point,,U,,,22224,,Autocuration
,,,A,,0,,1,13990,,15359,,,BAO_0000019,CHEMBL627622,Pseudo-first-order rate constant without 1-min time point,,U,,,22224,,Autocuration
,,,A,,0,,1,13991,,10431,,,BAO_0000019,CHEMBL627623,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,U,,,22224,,Autocuration
,,,A,,0,,1,13992,,10431,,,BAO_0000019,CHEMBL627624,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,U,,,22224,,Autocuration
,,,A,,0,,1,13993,,10431,,,BAO_0000019,CHEMBL627625,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,U,,,22224,,Autocuration
,,,A,,0,,1,13994,,15704,,,BAO_0000019,CHEMBL628523,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,U,,,22224,,Autocuration
,,,A,,0,,1,13995,,15287,,,BAO_0000019,CHEMBL628524,The alkaline hydrolysis second order rate constant(K OH) of the compound,,U,,,22224,,Autocuration
,,,A,,0,,1,13996,,7516,,,BAO_0000019,CHEMBL628525,The efflux rate constant of the compound,,U,,,22224,,Autocuration
,,,A,,0,,1,13997,,12973,,,BAO_0000019,CHEMBL625732,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,U,,,22224,,Autocuration
,,,A,,0,,1,13998,,12973,,,BAO_0000019,CHEMBL625733,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,U,,,22224,,Autocuration
,,,F,,0,,1,13999,,12973,,,BAO_0000019,CHEMBL625734,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,U,,,22224,,Autocuration
,,,A,,0,,1,14000,,12973,,,BAO_0000019,CHEMBL625913,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,U,,,22224,,Autocuration
,,,A,,0,,1,14001,,8696,,,BAO_0000019,CHEMBL625914,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,U,,,22224,,Autocuration
,,,A,,0,,1,14002,,15052,,,BAO_0000019,CHEMBL625915,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,U,,,22224,,Autocuration
,,,A,,0,,1,14003,,15052,,,BAO_0000019,CHEMBL625916,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,U,,,22224,,Autocuration
,,,A,,0,,1,14004,,10503,,,BAO_0000019,CHEMBL625917,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,U,,,22224,,Autocuration
,,,A,,0,,1,14005,,8354,,,BAO_0000019,CHEMBL625918,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,14006,,8354,,,BAO_0000019,CHEMBL625919,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,14007,,8354,,,BAO_0000019,CHEMBL625920,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,14008,,8354,,,BAO_0000019,CHEMBL874453,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,14009,,8354,,,BAO_0000019,CHEMBL625921,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,14010,,10503,,,BAO_0000019,CHEMBL625922,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,U,,,22224,,Autocuration
,,,A,,0,,1,14011,,8354,,,BAO_0000019,CHEMBL625923,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,14012,,8354,,,BAO_0000019,CHEMBL625924,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,14013,,8354,,,BAO_0000019,CHEMBL625925,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,14014,,8354,,,BAO_0000019,CHEMBL625926,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,14015,,13100,,,BAO_0000218,CHEMBL627704,Biodistribution in rat lung at 60 minutes after dose administration.,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14016,,13100,,,BAO_0000218,CHEMBL627705,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14017,,13100,,,BAO_0000218,CHEMBL627706,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14018,,13100,,,BAO_0000218,CHEMBL627707,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14019,,13100,,,BAO_0000218,CHEMBL627708,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14020,,13100,,,BAO_0000218,CHEMBL628361,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14021,,13100,,,BAO_0000218,CHEMBL628362,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14022,,13100,,,BAO_0000218,CHEMBL628363,Biodistribution in rat striatum at 120 minutes after dose administration.,In vivo,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14023,,13100,,,BAO_0000218,CHEMBL628364,Biodistribution in rat striatum at 1440 minutes after dose administration.,In vivo,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14024,,13100,,,BAO_0000218,CHEMBL628365,Biodistribution in rat striatum at 15 minutes after dose administration.,In vivo,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14025,,13100,,,BAO_0000218,CHEMBL874454,Biodistribution in rat striatum at 240 minutes after dose administration.,In vivo,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14026,,13100,,,BAO_0000218,CHEMBL628531,Biodistribution in rat striatum at 30 minutes after dose administration.,In vivo,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14027,,13100,,,BAO_0000218,CHEMBL628532,Biodistribution in rat striatum at 360 minutes after dose administration.,In vivo,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14028,,13100,,,BAO_0000218,CHEMBL628533,Biodistribution in rat striatum at 3 hr after dose administration.,In vivo,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14029,,13100,,,BAO_0000218,CHEMBL628534,Biodistribution in rat striatum at 60 minutes after dose administration.,In vivo,N,2435.0,Striatum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14030,,13100,,,BAO_0000218,CHEMBL628535,Biodistribution in rat thyroid at 120 minutes after dose administration.,In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14031,,13100,,,BAO_0000218,CHEMBL628536,Biodistribution in rat thyroid at 1440 minutes after dose administration.,In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14032,,13100,,,BAO_0000218,CHEMBL628537,Biodistribution in rat thyroid at 15 minutes after dose administration.,In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14033,,13100,,,BAO_0000218,CHEMBL628538,Biodistribution in rat thyroid at 240 minutes after dose administration.,In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14034,,13100,,,BAO_0000218,CHEMBL628539,Biodistribution in rat thyroid at 30 minutes after dose administration.,In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14035,,13100,,,BAO_0000218,CHEMBL630297,Biodistribution in rat thyroid at 360 minutes after dose administration.,In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14036,,13100,,,BAO_0000218,CHEMBL630298,Biodistribution in rat thyroid at 60 minutes after dose administration.,In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14037,,13100,,,BAO_0000218,CHEMBL630299,Biodistribution in rest of brain of rat 120 minutes after dose administration.,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14038,,13100,,,BAO_0000218,CHEMBL628094,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14039,,13100,,,BAO_0000218,CHEMBL628095,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14040,,13100,,,BAO_0000218,CHEMBL874648,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14041,,13100,,,BAO_0000218,CHEMBL628096,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14042,,13100,,,BAO_0000218,CHEMBL628097,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14043,,13100,,,BAO_0000218,CHEMBL628098,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,14044,,13331,,,BAO_0000019,CHEMBL628099,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,U,,,22224,,Autocuration
,,,A,,0,,1,14045,,13331,,,BAO_0000019,CHEMBL628100,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,U,,,22224,,Autocuration
,,,A,,0,,1,14046,,13331,,,BAO_0000019,CHEMBL628101,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,U,,,22224,,Autocuration
,,,A,,0,,1,14047,,13331,,,BAO_0000019,CHEMBL628102,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,U,,,22224,,Autocuration
,,,A,,0,,1,14048,,13331,,,BAO_0000019,CHEMBL628103,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,U,,,22224,,Autocuration
,,,A,,0,,1,14049,,13331,,,BAO_0000019,CHEMBL628104,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,U,,,22224,,Autocuration
,,,A,,0,,1,14050,,13331,,,BAO_0000019,CHEMBL628105,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,U,,,22224,,Autocuration
,,,A,,0,,1,14051,,13331,,,BAO_0000019,CHEMBL628106,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,14052,,10086,,,BAO_0000218,CHEMBL628107,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,F,,0,,1,14053,,10086,,,BAO_0000218,CHEMBL628108,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,U,1088.0,Urine,22224,,Autocuration
,,,A,10116.0,1,,1,14054,,10086,,,BAO_0000218,CHEMBL628109,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,F,,0,,1,14055,,10086,,,BAO_0000218,CHEMBL625299,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,U,1088.0,Urine,22224,,Autocuration
,,,A,10116.0,1,,1,14056,,10086,,,BAO_0000218,CHEMBL625300,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14057,,10086,,,BAO_0000218,CHEMBL625301,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14058,,10086,,,BAO_0000218,CHEMBL625302,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14059,,10086,,,BAO_0000218,CHEMBL874649,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14060,,13248,,,BAO_0000218,CHEMBL625303,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14061,,13248,,,BAO_0000218,CHEMBL625463,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9606.0,1,,1,14062,,14527,,,BAO_0000218,CHEMBL625464,In vitro metabolism in human liver microsomes,,N,2107.0,Liver,50587,Homo sapiens,Intermediate
,,,A,9606.0,1,,1,14063,,3008,,,BAO_0000218,CHEMBL625465,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,N,,,50587,Homo sapiens,Intermediate
,,,A,9615.0,1,,1,14064,,12582,,,BAO_0000218,CHEMBL625466,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14065,,12582,,,BAO_0000218,CHEMBL625467,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,14066,,12582,,,BAO_0000218,CHEMBL625468,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14067,,12582,,,BAO_0000218,CHEMBL625469,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14068,,12582,,,BAO_0000218,CHEMBL625470,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14069,,12582,,,BAO_0000218,CHEMBL632418,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14070,,12582,,,BAO_0000218,CHEMBL627250,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14071,,12582,,,BAO_0000218,CHEMBL627251,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14072,,12582,,,BAO_0000218,CHEMBL627252,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14073,,12582,,,BAO_0000218,CHEMBL627253,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14074,,12582,,,BAO_0000218,CHEMBL627254,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14075,,12582,,,BAO_0000218,CHEMBL875471,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14076,,12582,,,BAO_0000218,CHEMBL627255,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14077,,12582,,,BAO_0000218,CHEMBL627256,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14078,,12582,,,BAO_0000218,CHEMBL627257,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14079,,12582,,,BAO_0000218,CHEMBL627258,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14080,,12582,,,BAO_0000218,CHEMBL627259,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14081,,12582,,,BAO_0000218,CHEMBL627260,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14082,,12582,,,BAO_0000218,CHEMBL623256,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14083,,12582,,,BAO_0000218,CHEMBL874413,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14084,,12582,,,BAO_0000218,CHEMBL623257,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14085,,12582,,,BAO_0000218,CHEMBL623258,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14086,,12582,,,BAO_0000218,CHEMBL623259,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14087,,12582,,,BAO_0000218,CHEMBL623260,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14088,,12582,,,BAO_0000218,CHEMBL623261,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14089,,12582,,,BAO_0000218,CHEMBL623262,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14090,,12582,,,BAO_0000218,CHEMBL623263,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14091,,12582,,,BAO_0000218,CHEMBL623264,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14092,,12582,,,BAO_0000218,CHEMBL623265,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14093,,12582,,,BAO_0000218,CHEMBL623266,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14094,,12582,,,BAO_0000218,CHEMBL623267,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14095,,12582,,,BAO_0000218,CHEMBL623268,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14096,,12582,,,BAO_0000218,CHEMBL623269,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14097,,12582,,,BAO_0000218,CHEMBL623270,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14098,,12582,,,BAO_0000218,CHEMBL623271,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14099,,12582,,,BAO_0000218,CHEMBL623272,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14100,,12582,,,BAO_0000218,CHEMBL623273,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14101,,12582,,,BAO_0000218,CHEMBL623274,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14102,,12582,,,BAO_0000218,CHEMBL874414,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14103,,12582,,,BAO_0000218,CHEMBL623275,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14104,,12582,,,BAO_0000218,CHEMBL629150,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14105,,12582,,,BAO_0000218,CHEMBL623276,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14106,,12582,,,BAO_0000218,CHEMBL623277,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14107,,12582,,,BAO_0000218,CHEMBL623112,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14108,,12582,,,BAO_0000218,CHEMBL623113,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14109,,12582,,,BAO_0000218,CHEMBL623800,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14110,,12582,,,BAO_0000218,CHEMBL623801,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14111,,12017,,,BAO_0000218,CHEMBL623802,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14112,,12017,,,BAO_0000218,CHEMBL623803,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14113,,12017,,,BAO_0000218,CHEMBL623970,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14114,,12017,,,BAO_0000218,CHEMBL623971,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,995.0,Uterus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14115,,14045,,,BAO_0000218,CHEMBL623972,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14116,,14045,,,BAO_0000218,CHEMBL623973,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14117,,14045,,,BAO_0000218,CHEMBL623974,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14118,,14045,,,BAO_0000218,CHEMBL623975,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14119,,14045,,,BAO_0000218,CHEMBL623976,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14120,,14045,,,BAO_0000218,CHEMBL623977,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14121,,14045,,,BAO_0000218,CHEMBL623978,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14122,,14045,,,BAO_0000218,CHEMBL623979,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14123,,14045,,,BAO_0000218,CHEMBL623980,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14124,,14045,,,BAO_0000218,CHEMBL623981,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14125,,14045,,,BAO_0000218,CHEMBL626278,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14126,,14045,,,BAO_0000218,CHEMBL626279,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,14127,,14045,,,BAO_0000218,CHEMBL626280,Biodistribution in mice bladder plus excreted urine was determined,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14128,,14045,,,BAO_0000218,CHEMBL626281,"Percentage biodistribution in mouse blood, 10 minutes post injection",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14129,,14045,,,BAO_0000218,CHEMBL626282,"Percentage biodistribution in mouse blood, 30 minutes post injection",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14130,,14045,,,BAO_0000218,CHEMBL626283,"Percentage biodistribution in mouse blood, 5 minutes post injection",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14131,,14045,,,BAO_0000218,CHEMBL626284,"Percentage biodistribution in mouse blood, 60 minutes post injection",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14132,,14045,,,BAO_0000218,CHEMBL626285,"Percentage biodistribution in mouse brain, 10 minutes post injection",,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14133,,14045,,,BAO_0000218,CHEMBL626286,"Percentage biodistribution in mouse brain, 30 minutes post injection",,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14134,,14045,,,BAO_0000218,CHEMBL626287,"Percentage biodistribution in mouse brain, 5 minutes post injection",,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14135,,14045,,,BAO_0000218,CHEMBL626288,"Percentage biodistribution in mouse brain, 60 minutes post injection",,N,955.0,Brain,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14136,,14045,,,BAO_0000218,CHEMBL626289,"Percentage biodistribution in mouse heart, 10 minutes post injection",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14137,,14045,,,BAO_0000218,CHEMBL626290,"Percentage biodistribution in mouse heart, 30 minutes post injection",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14138,,14045,,,BAO_0000218,CHEMBL626291,"Percentage biodistribution in mouse heart, 5 minutes post injection",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14139,,14045,,,BAO_0000218,CHEMBL839888,"Percentage biodistribution in mouse heart, 60 minutes post injection",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14140,,14045,,,BAO_0000218,CHEMBL626292,"Percentage biodistribution in mouse intestine, 10 minutes post injection",,N,160.0,Intestine,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14141,,14045,,,BAO_0000218,CHEMBL626293,"Percentage biodistribution in mouse intestine, 30 minutes post injection",,N,160.0,Intestine,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14142,,14045,,,BAO_0000218,CHEMBL626294,"Percentage biodistribution in mouse intestine, 5 minutes post injection",,N,160.0,Intestine,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14143,,14045,,,BAO_0000218,CHEMBL626295,"Percentage biodistribution in mouse intestine, 60 minutes post injection",,N,160.0,Intestine,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14144,,14045,,,BAO_0000218,CHEMBL627659,"Percentage biodistribution in mouse liver, 10 minutes post injection",,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14145,,14045,,,BAO_0000218,CHEMBL627660,"Percentage biodistribution in mouse liver, 30 minutes of post injection",,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14146,,14045,,,BAO_0000218,CHEMBL627661,"Percentage biodistribution in mouse liver, 5 minutes post injection",,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14147,,14045,,,BAO_0000218,CHEMBL627662,Biodistribution in mice liver at 60 minutes of post injection,In vivo,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14148,,14045,,,BAO_0000218,CHEMBL627663,Biodistribution in mice lungs at 10 min of post injection,In vivo,N,2048.0,Lung,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14149,,14045,,,BAO_0000218,CHEMBL627664,"Percentage biodistribution in mouse lung, 30 minutes post injection",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14150,,14045,,,BAO_0000218,CHEMBL627665,"Percentage biodistribution in mousee lung, 5 minutes post injection",,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14151,,14045,,,BAO_0000218,CHEMBL627666,Biodistribution in mice lungs at 60 min of post injection,In vivo,N,2048.0,Lung,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14152,,14045,,,BAO_0000218,CHEMBL627667,Percentage biodistribution in mouse spleen,,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14153,,14045,,,BAO_0000218,CHEMBL627668,Percentage biodistribution in mouse stomach,,N,945.0,Stomach,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14154,,11745,,,BAO_0000218,CHEMBL627669,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,N,1088.0,Urine,50594,Mus musculus,Intermediate
,,,A,,0,,1,14155,,13257,,,BAO_0000218,CHEMBL627670,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,In vivo,U,1255.0,Urinary bladder,22224,,Autocuration
,,,A,,0,,1,14156,,13257,,,BAO_0000218,CHEMBL627671,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,In vivo,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,14157,,13257,,,BAO_0000218,CHEMBL627672,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,In vivo,U,1474.0,Bone element,22224,,Autocuration
,,,A,,0,,1,14158,,13257,,,BAO_0000218,CHEMBL627673,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,14159,,13257,,,BAO_0000218,CHEMBL627674,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,In vivo,U,2113.0,Kidney,22224,,Autocuration
,,,A,,0,,1,14160,,13257,,,BAO_0000218,CHEMBL627675,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,In vivo,U,2107.0,Liver,22224,,Autocuration
,,,A,,0,,1,14161,,13257,,,BAO_0000218,CHEMBL627676,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,In vivo,U,2048.0,Lung,22224,,Autocuration
,,,A,,0,,1,14162,,13257,,,BAO_0000218,CHEMBL627677,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,In vivo,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,,0,,1,14163,,8354,,,BAO_0000019,CHEMBL627678,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,14164,,7095,,,BAO_0000218,CHEMBL627679,Affinity for protein binding expressed as association constant in fresh rat serum,,N,1977.0,Serum,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,14165,,12185,,,BAO_0000019,CHEMBL627680,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,U,,,22224,,Autocuration
,,,A,,0,,1,14166,,12185,,,BAO_0000019,CHEMBL627681,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,U,,,22224,,Autocuration
,,,A,,0,,1,14167,,12185,,,BAO_0000019,CHEMBL627682,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,U,,,22224,,Autocuration
,,,A,,0,,1,14168,,12185,,,BAO_0000019,CHEMBL627683,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,U,,,22224,,Autocuration
,,,A,,0,,1,14169,,12686,,,BAO_0000019,CHEMBL627684,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,U,,,22224,,Autocuration
,,,A,,0,,1,14170,,12686,,,BAO_0000019,CHEMBL874441,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,U,,,22224,,Autocuration
,,,A,,0,,1,14171,,12686,,,BAO_0000019,CHEMBL627685,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,U,,,22224,,Autocuration
,,,A,,0,,1,14172,,12686,,,BAO_0000019,CHEMBL627686,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,U,,,22224,,Autocuration
,,,A,,0,,1,14173,,8057,,,BAO_0000019,CHEMBL627687,Apparent rate constant Koff for inactivation of dTMP synthase.,,U,,,22224,,Autocuration
,,,A,,0,,1,14174,,15778,,,BAO_0000019,CHEMBL627688,The irreversible inhibitor activity by second order rate equation.,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,14175,,12375,,,BAO_0000218,CHEMBL628038,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14176,,12375,,,BAO_0000218,CHEMBL628039,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14177,,12375,,,BAO_0000218,CHEMBL628040,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,14178,,13588,,,BAO_0000019,CHEMBL628041,Dissociation rate calculated from the first-order equation using t1/2 value,,U,,,22224,,Autocuration
,,,A,,0,,1,14179,,15039,,,BAO_0000019,CHEMBL630226,The compound was tested for Binding constant against DNA,,U,,,22224,,Autocuration
,,,A,,0,,1,14180,,9500,,,BAO_0000019,CHEMBL628042,First order rate constant for cyclization of the compound,,U,,,22224,,Autocuration
,,,A,,0,,1,14181,,10014,,,BAO_0000019,CHEMBL625232,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,U,,,22224,,Autocuration
,,,A,,0,,1,14182,,10014,,,BAO_0000019,CHEMBL625233,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,U,,,22224,,Autocuration
,,,A,,0,,1,14183,,568,,,BAO_0000019,CHEMBL625979,Hydrolysis rate constant was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,14184,,10026,,,BAO_0000019,CHEMBL625980,Observed first order rate constant,,U,,,22224,,Autocuration
,,,A,,0,,1,14185,,10281,,,BAO_0000019,CHEMBL625981,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,U,,,22224,,Autocuration
,,,A,,0,,1,14186,,10281,,,BAO_0000019,CHEMBL625982,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,U,,,22224,,Autocuration
,,,A,,0,,1,14187,,9680,,,BAO_0000019,CHEMBL625983,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,U,,,22224,,Autocuration
,,,A,,0,,1,14188,,13028,,,BAO_0000019,CHEMBL625984,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14189,,13028,,,BAO_0000019,CHEMBL625985,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14190,,13028,,,BAO_0000019,CHEMBL625986,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14191,,13028,,,BAO_0000019,CHEMBL625987,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14192,,13028,,,BAO_0000019,CHEMBL625988,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14193,,13028,,,BAO_0000019,CHEMBL625989,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14194,,13028,,,BAO_0000019,CHEMBL625990,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14195,,13028,,,BAO_0000019,CHEMBL625991,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14196,,13028,,,BAO_0000019,CHEMBL625992,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14197,,13028,,,BAO_0000019,CHEMBL625993,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14198,,13028,,,BAO_0000019,CHEMBL631973,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14199,,13028,,,BAO_0000019,CHEMBL632143,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14200,,13028,,,BAO_0000019,CHEMBL632144,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14201,,13028,,,BAO_0000019,CHEMBL632145,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14202,,13028,,,BAO_0000019,CHEMBL632146,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14203,,13028,,,BAO_0000019,CHEMBL632147,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14204,,13028,,,BAO_0000019,CHEMBL632148,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14205,,13028,,,BAO_0000019,CHEMBL632149,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14206,,13028,,,BAO_0000019,CHEMBL632150,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14207,,13028,,,BAO_0000019,CHEMBL632151,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,9606.0,1,,1,14208,,3008,,,BAO_0000218,CHEMBL632152,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,N,,,50587,Homo sapiens,Intermediate
,,,A,9606.0,1,,1,14209,,4509,,,BAO_0000218,CHEMBL632153,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,N,,,50587,Homo sapiens,Intermediate
,,,A,9606.0,1,,1,14210,,4509,,,BAO_0000218,CHEMBL632154,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,N,,,50587,Homo sapiens,Intermediate
,,,A,10298.0,1,,1,14211,,8613,,,BAO_0000218,CHEMBL632155,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,14212,,8613,,,BAO_0000218,CHEMBL632156,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,14213,,8613,,,BAO_0000218,CHEMBL632157,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,14214,,8613,,,BAO_0000218,CHEMBL632158,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,14215,,8613,,,BAO_0000218,CHEMBL632159,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,14216,,8613,,,BAO_0000218,CHEMBL626305,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,14217,,8613,,,BAO_0000218,CHEMBL626306,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,14218,,8613,,,BAO_0000218,CHEMBL626307,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,14219,,8613,,,BAO_0000218,CHEMBL626308,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,14220,,8613,,,BAO_0000218,CHEMBL626479,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,N,,,50602,Human herpesvirus 1,Intermediate
,,,A,10298.0,1,,1,14221,,8613,,,BAO_0000218,CHEMBL626480,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,N,,,50602,Human herpesvirus 1,Intermediate
,,,P,,0,,1,14222,,6021,,,BAO_0000100,CHEMBL626481,Calculated partition coefficient (clogP) (MlogP),,U,,,22229,,Autocuration
,,,A,,0,,1,14223,,9348,,,BAO_0000019,CHEMBL626482,Equipotent potent ratio relative to carbachol (nicotinic activity),,U,,,22224,,Autocuration
,,,A,9615.0,1,,1,14224,,15592,,,BAO_0000218,CHEMBL626483,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14225,,15592,,,BAO_0000218,CHEMBL626484,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,N,,,50588,Canis lupus familiaris,Intermediate
,,,P,,0,,1,14226,,15592,,,BAO_0000100,CHEMBL626485,Solubility at pH 7.4 in micro g/mL;NA denotes available,,U,,,22229,,Autocuration
,,,P,,0,,1,14227,,15592,,,BAO_0000100,CHEMBL626486,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,U,,,22229,,Autocuration
,,,P,,0,,1,14228,,15592,,,BAO_0000100,CHEMBL626487,Solubility at pH 7.4 in ug/mL;NA denotes not available,,U,,,22229,,Autocuration
,,,A,9615.0,1,,1,14229,,15592,,,BAO_0000218,CHEMBL626488,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,In vivo,N,1969.0,Plasma,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,14230,,7095,,,BAO_0000218,CHEMBL626489,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,N,1977.0,Serum,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,14231,,16618,,,BAO_0000019,CHEMBL626490,Area under the MAP curve measured over 5 min; ND means Not determined,,U,,,22224,,Autocuration
,,,P,,0,,1,14232,,16835,,,BAO_0000100,CHEMBL626491,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,U,,,22224,,Autocuration
,,,P,,0,,1,14233,,15284,,,BAO_0000100,CHEMBL626492,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,U,,,22229,,Autocuration
,,,A,,0,,1,14234,,15750,,,BAO_0000019,CHEMBL626493,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,14235,,16618,,,BAO_0000218,CHEMBL626494,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,14236,,16618,,,BAO_0000218,CHEMBL626495,Half life after oral tested,In vivo,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,14237,,15812,,,BAO_0000218,CHEMBL626496,Half life was determined in plasma of rat; NT indicates not tested,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14238,,16618,,,BAO_0000218,CHEMBL626497,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,14239,,16618,,,BAO_0000218,CHEMBL626498,Oral bioavailability after oral tested,In vivo,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,14240,,13098,,,BAO_0000218,CHEMBL626499,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14241,,13098,,,BAO_0000218,CHEMBL626500,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14242,,15812,,,BAO_0000218,CHEMBL626501,half life was determined in plasma of rat; NT indicates not tested,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14243,,15812,,,BAO_0000218,CHEMBL626502,half life was determined in plasma of rat; NT means not tested,,N,1969.0,Plasma,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14244,,11510,,,BAO_0000218,CHEMBL626503,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14245,,11510,,,BAO_0000218,CHEMBL626504,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14246,,11510,,,BAO_0000218,CHEMBL626505,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14247,,11510,,,BAO_0000218,CHEMBL626506,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14248,,11510,,,BAO_0000218,CHEMBL626507,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14249,,11510,,,BAO_0000218,CHEMBL626508,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14250,,11510,,,BAO_0000218,CHEMBL626509,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14251,,11510,,,BAO_0000218,CHEMBL875480,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14252,,11510,,,BAO_0000218,CHEMBL626510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14253,,11510,,,BAO_0000218,CHEMBL626511,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14254,,11510,,,BAO_0000218,CHEMBL626512,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14255,,11510,,,BAO_0000218,CHEMBL628208,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14256,,11510,,,BAO_0000218,CHEMBL628209,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14257,,11510,,,BAO_0000218,CHEMBL628210,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14258,,11510,,,BAO_0000218,CHEMBL628211,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14259,,11510,,,BAO_0000218,CHEMBL628212,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14260,,11510,,,BAO_0000218,CHEMBL628213,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14261,,12582,,,BAO_0000218,CHEMBL628214,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14262,,12582,,,BAO_0000218,CHEMBL628215,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14263,,12582,,,BAO_0000218,CHEMBL628216,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14264,,12582,,,BAO_0000218,CHEMBL626595,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14265,,12582,,,BAO_0000218,CHEMBL626596,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14266,,12582,,,BAO_0000218,CHEMBL626597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14267,,12582,,,BAO_0000218,CHEMBL626598,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14268,,12582,,,BAO_0000218,CHEMBL622242,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14269,,12582,,,BAO_0000218,CHEMBL622243,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14270,,12582,,,BAO_0000218,CHEMBL622244,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14271,,12582,,,BAO_0000218,CHEMBL622245,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14272,,12582,,,BAO_0000218,CHEMBL622246,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14273,,12582,,,BAO_0000218,CHEMBL622247,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14274,,12582,,,BAO_0000218,CHEMBL622248,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14275,,12582,,,BAO_0000218,CHEMBL877483,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14276,,12582,,,BAO_0000218,CHEMBL622249,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,14277,,12582,,,BAO_0000218,CHEMBL622250,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14278,,12582,,,BAO_0000218,CHEMBL622251,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14279,,12582,,,BAO_0000218,CHEMBL622252,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14280,,12582,,,BAO_0000218,CHEMBL622253,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14281,,12582,,,BAO_0000218,CHEMBL622254,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14282,,12582,,,BAO_0000218,CHEMBL622255,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14283,,12582,,,BAO_0000218,CHEMBL622256,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14284,,12582,,,BAO_0000218,CHEMBL622257,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14285,,12582,,,BAO_0000218,CHEMBL622258,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14286,,12582,,,BAO_0000218,CHEMBL622259,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14287,,12582,,,BAO_0000218,CHEMBL622927,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14288,,12582,,,BAO_0000218,CHEMBL622928,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14289,,12582,,,BAO_0000218,CHEMBL622929,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14290,,12582,,,BAO_0000218,CHEMBL623182,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14291,,12582,,,BAO_0000218,CHEMBL623183,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,14292,,12582,,,BAO_0000218,CHEMBL623184,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14293,,12582,,,BAO_0000218,CHEMBL623185,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14294,,12582,,,BAO_0000218,CHEMBL877484,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14295,,12582,,,BAO_0000218,CHEMBL627274,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14296,,12582,,,BAO_0000218,CHEMBL623186,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14297,,12582,,,BAO_0000218,CHEMBL623187,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14298,,12582,,,BAO_0000218,CHEMBL623188,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14299,,12582,,,BAO_0000218,CHEMBL628055,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14300,,12582,,,BAO_0000218,CHEMBL628056,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14301,,12582,,,BAO_0000218,CHEMBL628200,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14302,,12582,,,BAO_0000218,CHEMBL628201,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14303,,12582,,,BAO_0000218,CHEMBL628202,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14304,,12582,,,BAO_0000218,CHEMBL628203,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14305,,12582,,,BAO_0000218,CHEMBL628204,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14306,,12582,,,BAO_0000218,CHEMBL628205,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14307,,12582,,,BAO_0000218,CHEMBL628206,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,14308,,13257,,,BAO_0000218,CHEMBL628207,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),In vivo,U,2367.0,Prostate gland,22224,,Autocuration
,,,A,,0,,1,14309,,13257,,,BAO_0000218,CHEMBL627220,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,In vivo,U,2367.0,Prostate gland,22224,,Autocuration
,,,A,,0,,1,14310,,13257,,,BAO_0000218,CHEMBL627221,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,In vivo,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,,0,,1,14311,,13257,,,BAO_0000218,CHEMBL627222,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),In vivo,U,2367.0,Prostate gland,22224,,Autocuration
,,,A,,0,,1,14312,,13257,,,BAO_0000218,CHEMBL627223,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,14313,,13257,,,BAO_0000218,CHEMBL632062,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,In vivo,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,,0,,1,14314,,13257,,,BAO_0000218,CHEMBL632063,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,In vivo,U,2106.0,Spleen,22224,,Autocuration
,,,A,,0,,1,14315,,13257,,,BAO_0000218,CHEMBL632064,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,In vivo,U,1255.0,Urinary bladder,22224,,Autocuration
,,,A,,0,,1,14316,,13257,,,BAO_0000218,CHEMBL632065,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,In vivo,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,14317,,13257,,,BAO_0000218,CHEMBL632066,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,In vivo,U,1474.0,Bone element,22224,,Autocuration
,,,A,,0,,1,14318,,13257,,,BAO_0000218,CHEMBL632067,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,14319,,13257,,,BAO_0000218,CHEMBL629188,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,In vivo,U,2113.0,Kidney,22224,,Autocuration
,,,A,,0,,1,14320,,13257,,,BAO_0000218,CHEMBL629189,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,In vivo,U,2107.0,Liver,22224,,Autocuration
,,,A,,0,,1,14321,,13257,,,BAO_0000218,CHEMBL629190,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,In vivo,U,2048.0,Lung,22224,,Autocuration
,,,A,,0,,1,14322,,13257,,,BAO_0000218,CHEMBL629191,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,In vivo,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,,0,,1,14323,,13257,,,BAO_0000218,CHEMBL629192,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),In vivo,U,2367.0,Prostate gland,22224,,Autocuration
,,,A,,0,,1,14324,,13257,,,BAO_0000218,CHEMBL629193,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,In vivo,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,,0,,1,14325,,13257,,,BAO_0000218,CHEMBL629194,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),In vivo,U,2367.0,Prostate gland,22224,,Autocuration
,,,A,,0,,1,14326,,13257,,,BAO_0000218,CHEMBL629195,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,14327,,13257,,,BAO_0000218,CHEMBL629373,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,In vivo,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,,0,,1,14328,,13257,,,BAO_0000218,CHEMBL629374,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,In vivo,U,2106.0,Spleen,22224,,Autocuration
,,,A,,0,,1,14329,,13257,,,BAO_0000218,CHEMBL629375,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,In vivo,U,2367.0,Prostate gland,22224,,Autocuration
,,,A,,0,,1,14330,,13257,,,BAO_0000218,CHEMBL629376,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,In vivo,U,1255.0,Urinary bladder,22224,,Autocuration
,,,A,,0,,1,14331,,13257,,,BAO_0000218,CHEMBL629377,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,In vivo,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,14332,,13257,,,BAO_0000218,CHEMBL629378,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,In vivo,U,1474.0,Bone element,22224,,Autocuration
,,,A,,0,,1,14333,,13257,,,BAO_0000218,CHEMBL629379,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,14334,,13257,,,BAO_0000218,CHEMBL629151,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,In vivo,U,2113.0,Kidney,22224,,Autocuration
,,,A,,0,,1,14335,,13257,,,BAO_0000218,CHEMBL629152,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,In vivo,U,2107.0,Liver,22224,,Autocuration
,,,A,,0,,1,14336,,13257,,,BAO_0000218,CHEMBL629153,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,In vivo,U,2048.0,Lung,22224,,Autocuration
,,,A,,0,,1,14337,,13257,,,BAO_0000218,CHEMBL629154,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,In vivo,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,,0,,1,14338,,13257,,,BAO_0000218,CHEMBL629155,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),In vivo,U,2367.0,Prostate gland,22224,,Autocuration
,,,A,,0,,1,14339,,13257,,,BAO_0000218,CHEMBL629156,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,In vivo,U,2367.0,Prostate gland,22224,,Autocuration
,,,A,,0,,1,14340,,13257,,,BAO_0000218,CHEMBL629157,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,In vivo,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,,0,,1,14341,,13257,,,BAO_0000218,CHEMBL629158,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),In vivo,U,2367.0,Prostate gland,22224,,Autocuration
,,,A,,0,,1,14342,,13257,,,BAO_0000218,CHEMBL629159,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,14343,,13257,,,BAO_0000218,CHEMBL629160,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,In vivo,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,,0,,1,14344,,13257,,,BAO_0000218,CHEMBL629161,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,In vivo,U,2106.0,Spleen,22224,,Autocuration
,,,A,,0,,1,14345,,13257,,,BAO_0000218,CHEMBL629162,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,In vivo,U,1255.0,Urinary bladder,22224,,Autocuration
,,,A,,0,,1,14346,,13257,,,BAO_0000218,CHEMBL629163,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,In vivo,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,14347,,13257,,,BAO_0000218,CHEMBL629164,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,In vivo,U,1474.0,Bone element,22224,,Autocuration
,,,A,,0,,1,14348,,13257,,,BAO_0000218,CHEMBL629165,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,14349,,13257,,,BAO_0000218,CHEMBL629166,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,In vivo,U,2107.0,Liver,22224,,Autocuration
,,,A,,0,,1,14350,,13257,,,BAO_0000218,CHEMBL629167,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,In vivo,U,2048.0,Lung,22224,,Autocuration
,,,A,,0,,1,14351,,13257,,,BAO_0000218,CHEMBL629168,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,In vivo,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,,0,,1,14352,,2193,,,BAO_0000019,CHEMBL629169,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,U,,,22224,,Autocuration
,,,A,,0,,1,14353,,2193,,,BAO_0000019,CHEMBL629170,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,U,,,22224,,Autocuration
,,,A,,0,,1,14354,,2193,,,BAO_0000019,CHEMBL631153,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,U,,,22224,,Autocuration
,,,A,,0,,1,14355,,2193,,,BAO_0000019,CHEMBL875121,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,U,,,22224,,Autocuration
,,,A,,0,,1,14356,,2193,,,BAO_0000019,CHEMBL631154,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,U,,,22224,,Autocuration
,,,A,,0,,1,14357,,2193,,,BAO_0000019,CHEMBL631155,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,U,,,22224,,Autocuration
,,,A,,0,,1,14358,,568,,,BAO_0000019,CHEMBL631156,Hydrolysis rate constant was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,14359,,9680,,,BAO_0000019,CHEMBL631157,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,U,,,22224,,Autocuration
,,,A,,0,,1,14360,,9680,,,BAO_0000019,CHEMBL631158,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,U,,,22224,,Autocuration
,,,A,,0,,1,14361,,9680,,,BAO_0000019,CHEMBL631159,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,U,,,22224,,Autocuration
,,,A,,0,,1,14362,,10026,,,BAO_0000019,CHEMBL631160,Observed second order rate constant,,U,,,22224,,Autocuration
,,,A,,0,,1,14363,,10281,,,BAO_0000019,CHEMBL631161,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,U,,,22224,,Autocuration
,,,A,,0,,1,14364,,10014,,,BAO_0000019,CHEMBL631162,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,U,,,22224,,Autocuration
,,,A,,0,,1,14365,,10014,,,BAO_0000019,CHEMBL630313,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,U,,,22224,,Autocuration
,,,A,,0,,1,14366,,9680,,,BAO_0000019,CHEMBL630314,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,U,,,22224,,Autocuration
,,,A,,0,,1,14367,,9680,,,BAO_0000019,CHEMBL630315,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,U,,,22224,,Autocuration
,,,A,,0,,1,14368,,13028,,,BAO_0000019,CHEMBL630316,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14369,,13028,,,BAO_0000019,CHEMBL630986,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14370,,13028,,,BAO_0000019,CHEMBL630987,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14371,,13028,,,BAO_0000019,CHEMBL630988,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14372,,13028,,,BAO_0000019,CHEMBL630989,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14373,,13028,,,BAO_0000019,CHEMBL630990,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14374,,13028,,,BAO_0000019,CHEMBL630991,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14375,,13028,,,BAO_0000019,CHEMBL630992,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14376,,13028,,,BAO_0000019,CHEMBL630993,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,,0,,1,14377,,13028,,,BAO_0000019,CHEMBL630994,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,14378,,10014,,,BAO_0000218,CHEMBL630995,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,14379,,9962,,,BAO_0000019,CHEMBL629252,Association constant for compound at 31 degree C was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,14380,,12029,,,BAO_0000019,CHEMBL629253,Calculated antagonist equilibrium dissociation constant of the compound,,U,,,22224,,Autocuration
,,,A,,0,,1,14381,,12029,,,BAO_0000019,CHEMBL629944,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,U,,,22224,,Autocuration
,,,A,10141.0,1,,1,14382,,10583,,,BAO_0000218,CHEMBL629945,Dissociation constants vs LTE4 on guinea pig trachea,,N,3126.0,Trachea,50512,Cavia porcellus,Intermediate
,,,A,,0,,1,14383,,568,,,BAO_0000019,CHEMBL629946,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,U,,,22224,,Autocuration
,,,A,,0,,1,14384,,568,,,BAO_0000019,CHEMBL629947,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,U,,,22224,,Autocuration
,,,A,,0,,1,14385,,568,,,BAO_0000019,CHEMBL629948,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,U,,,22224,,Autocuration
,,,A,,0,,1,14386,,568,,,BAO_0000019,CHEMBL856024,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,U,,,22224,,Autocuration
,,,A,,0,,1,14387,,7493,,,BAO_0000019,CHEMBL629949,Affinity constant KD value was derived from TMP,,U,,,22224,,Autocuration
,,,A,,0,,1,14388,,8371,,,BAO_0000019,CHEMBL629950,Apparent dissociation (binding) rate constant was evaluated,,U,,,22224,,Autocuration
,,,P,,0,,1,14389,,13114,,,BAO_0000100,CHEMBL630127,Dissociation constant (KD) of the compound,,U,,,22224,,Autocuration
,,,P,,0,,1,14390,,15515,,,BAO_0000100,CHEMBL630128,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,U,,,22224,,Autocuration
,,,P,,0,,1,14391,,522,,,BAO_0000100,CHEMBL630129,Dissociation constant from ESR titration experiments,,U,,,22224,,Autocuration
,,,,,0,,1,14392,,13888,,,BAO_0000019,CHEMBL630130,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,U,,,22224,,Autocuration
,,,P,,0,,1,14393,,2616,,,BAO_0000100,CHEMBL875234,Dissociation constant was evaluated.,,U,,,22224,,Autocuration
,,,P,,0,,1,14394,,3798,,,BAO_0000100,CHEMBL630131,Dissociation constant was reported,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,14395,,8731,,,BAO_0000218,CHEMBL630132,Dissociation constant was determined in rat pituitary cells.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,14396,,11892,,,BAO_0000019,CHEMBL630133,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,U,,,22224,,Autocuration
,,,A,,0,,1,14397,,11892,,,BAO_0000019,CHEMBL630134,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,U,,,22224,,Autocuration
,,,A,,0,,1,14398,,2582,,,BAO_0000019,CHEMBL630135,Equilibrium dissociation constant of the compound,,U,,,22224,,Autocuration
,,,A,,0,,1,14399,,11892,,,BAO_0000019,CHEMBL630136,Equilibrium dissociation constant was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,14400,,13396,,,BAO_0000019,CHEMBL630137,Kinetic constant KD was evaluated,,U,,,22224,,Autocuration
,,,A,,0,,1,14401,,603,,,BAO_0000019,CHEMBL630138,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,U,,,22224,,Autocuration
,,,A,,0,,1,14402,,15673,,,BAO_0000019,CHEMBL630139,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,U,,,22224,,Autocuration
,,,A,,0,,1,14403,,10368,,,BAO_0000019,CHEMBL630140,Rate constant for hydrolysis in aqueous acetone.,,U,,,22224,,Autocuration
,,,A,,0,,1,14404,,14228,,,BAO_0000019,CHEMBL875235,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,14405,,11510,,,BAO_0000218,CHEMBL876439,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14406,,11510,,,BAO_0000218,CHEMBL630605,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14407,,11510,,,BAO_0000218,CHEMBL630606,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14408,,11510,,,BAO_0000218,CHEMBL630607,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14409,,11510,,,BAO_0000218,CHEMBL630608,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14410,,11510,,,BAO_0000218,CHEMBL630609,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14411,,11510,,,BAO_0000218,CHEMBL630610,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14412,,11510,,,BAO_0000218,CHEMBL630611,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14413,,11510,,,BAO_0000218,CHEMBL629552,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14414,,11510,,,BAO_0000218,CHEMBL629733,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14415,,11510,,,BAO_0000218,CHEMBL629734,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14416,,11510,,,BAO_0000218,CHEMBL629735,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14417,,11510,,,BAO_0000218,CHEMBL629736,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14418,,11510,,,BAO_0000218,CHEMBL629737,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14419,,11510,,,BAO_0000218,CHEMBL629738,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14420,,11510,,,BAO_0000218,CHEMBL629739,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14421,,11510,,,BAO_0000218,CHEMBL629740,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14422,,11510,,,BAO_0000218,CHEMBL629741,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14423,,11510,,,BAO_0000218,CHEMBL629742,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14424,,11510,,,BAO_0000218,CHEMBL629743,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14425,,11510,,,BAO_0000218,CHEMBL629744,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14426,,11510,,,BAO_0000218,CHEMBL629745,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14427,,11510,,,BAO_0000218,CHEMBL629746,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14428,,11510,,,BAO_0000218,CHEMBL629747,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14429,,11510,,,BAO_0000218,CHEMBL629748,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14430,,11510,,,BAO_0000218,CHEMBL629749,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14431,,11510,,,BAO_0000218,CHEMBL629750,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14432,,11510,,,BAO_0000218,CHEMBL629751,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14433,,11510,,,BAO_0000218,CHEMBL629752,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14434,,11510,,,BAO_0000218,CHEMBL629753,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14435,,11510,,,BAO_0000218,CHEMBL629754,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14436,,11510,,,BAO_0000218,CHEMBL629755,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14437,,11510,,,BAO_0000218,CHEMBL629756,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14438,,11510,,,BAO_0000218,CHEMBL629757,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14439,,11510,,,BAO_0000218,CHEMBL629758,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14440,,11510,,,BAO_0000218,CHEMBL629759,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14441,,11510,,,BAO_0000218,CHEMBL629760,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14442,,11510,,,BAO_0000218,CHEMBL876443,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,14443,,8310,,,BAO_0000218,CHEMBL629761,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14444,,8310,,,BAO_0000218,CHEMBL629762,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10090.0,1,,1,14445,,8310,,,BAO_0000218,CHEMBL629763,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14446,,8310,,,BAO_0000218,CHEMBL629764,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14447,,8310,,,BAO_0000218,CHEMBL629765,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14448,,8310,,,BAO_0000218,CHEMBL629766,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14449,,8310,,,BAO_0000218,CHEMBL629767,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,N,,,50594,Mus musculus,Intermediate
,,,A,9615.0,1,,1,14450,,8310,,,BAO_0000218,CHEMBL629768,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10090.0,1,,1,14451,,8310,,,BAO_0000218,CHEMBL629769,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,N,,,50594,Mus musculus,Intermediate
,,,A,9615.0,1,,1,14452,,8310,,,BAO_0000218,CHEMBL629770,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14453,,8310,,,BAO_0000218,CHEMBL629771,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,N,,,50588,Canis lupus familiaris,Intermediate
,,,A,10090.0,1,,1,14454,,8310,,,BAO_0000218,CHEMBL629772,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14455,,8310,,,BAO_0000218,CHEMBL629773,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14456,,8310,,,BAO_0000218,CHEMBL625455,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14457,,8310,,,BAO_0000218,CHEMBL625456,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14458,,8310,,,BAO_0000218,CHEMBL625457,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,14459,,12582,,,BAO_0000218,CHEMBL625458,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14460,,12582,,,BAO_0000218,CHEMBL625459,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14461,,12582,,,BAO_0000218,CHEMBL875483,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14462,,12582,,,BAO_0000218,CHEMBL634779,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14463,,12582,,,BAO_0000218,CHEMBL625460,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14464,,12582,,,BAO_0000218,CHEMBL626117,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14465,,12582,,,BAO_0000218,CHEMBL626118,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14466,,12582,,,BAO_0000218,CHEMBL628342,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14467,,12582,,,BAO_0000218,CHEMBL628343,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14468,,12582,,,BAO_0000218,CHEMBL628344,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14469,,12582,,,BAO_0000218,CHEMBL628345,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14470,,12582,,,BAO_0000218,CHEMBL628346,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14471,,12582,,,BAO_0000218,CHEMBL628347,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14472,,12582,,,BAO_0000218,CHEMBL628348,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14473,,12582,,,BAO_0000218,CHEMBL628349,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14474,,12582,,,BAO_0000218,CHEMBL875611,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14475,,12582,,,BAO_0000218,CHEMBL628350,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14476,,12582,,,BAO_0000218,CHEMBL628351,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14477,,12582,,,BAO_0000218,CHEMBL628352,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14478,,12582,,,BAO_0000218,CHEMBL628353,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14479,,12582,,,BAO_0000218,CHEMBL628354,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14480,,12582,,,BAO_0000218,CHEMBL626667,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14481,,12582,,,BAO_0000218,CHEMBL626668,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14482,,12582,,,BAO_0000218,CHEMBL626669,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14483,,12582,,,BAO_0000218,CHEMBL626670,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14484,,12582,,,BAO_0000218,CHEMBL626671,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14485,,12582,,,BAO_0000218,CHEMBL626672,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14486,,12582,,,BAO_0000218,CHEMBL626673,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14487,,12582,,,BAO_0000218,CHEMBL626674,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14488,,12582,,,BAO_0000218,CHEMBL626675,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14489,,12582,,,BAO_0000218,CHEMBL626676,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14490,,12582,,,BAO_0000218,CHEMBL626677,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14491,,12582,,,BAO_0000218,CHEMBL626678,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14492,,12582,,,BAO_0000218,CHEMBL626679,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14493,,12582,,,BAO_0000218,CHEMBL875612,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14494,,12582,,,BAO_0000218,CHEMBL626680,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14495,,12582,,,BAO_0000218,CHEMBL626681,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14496,,12582,,,BAO_0000218,CHEMBL626682,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14497,,12582,,,BAO_0000218,CHEMBL626683,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14498,,12582,,,BAO_0000218,CHEMBL626684,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14499,,12582,,,BAO_0000218,CHEMBL626685,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14500,,12582,,,BAO_0000218,CHEMBL626686,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14501,,12582,,,BAO_0000218,CHEMBL626687,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14502,,12582,,,BAO_0000218,CHEMBL624978,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14503,,12582,,,BAO_0000218,CHEMBL624979,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14504,,12582,,,BAO_0000218,CHEMBL624980,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14505,,12582,,,BAO_0000218,CHEMBL624981,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,14506,,12582,,,BAO_0000218,CHEMBL624982,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,,0,,1,14507,,13257,,,BAO_0000218,CHEMBL627564,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),In vivo,U,2367.0,Prostate gland,22224,,Autocuration
,,,A,,0,,1,14508,,13257,,,BAO_0000218,CHEMBL627565,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),In vivo,U,2367.0,Prostate gland,22224,,Autocuration
,,,A,,0,,1,14509,,13257,,,BAO_0000218,CHEMBL627566,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,14510,,13257,,,BAO_0000218,CHEMBL627567,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,In vivo,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,,0,,1,14511,,13257,,,BAO_0000218,CHEMBL627568,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,In vivo,U,2106.0,Spleen,22224,,Autocuration
,,,A,,0,,1,14512,,13257,,,BAO_0000218,CHEMBL627569,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,In vivo,U,2113.0,Kidney,22224,,Autocuration
,,,A,,0,,1,14513,,13257,,,BAO_0000218,CHEMBL627570,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,In vivo,U,1255.0,Urinary bladder,22224,,Autocuration
,,,A,,0,,1,14514,,13257,,,BAO_0000218,CHEMBL627571,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,In vivo,U,178.0,Blood,22224,,Autocuration
,,,A,,0,,1,14515,,13257,,,BAO_0000218,CHEMBL627572,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,In vivo,U,1474.0,Bone element,22224,,Autocuration
,,,A,,0,,1,14516,,13257,,,BAO_0000218,CHEMBL627573,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,14517,,13257,,,BAO_0000218,CHEMBL627574,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,In vivo,U,2113.0,Kidney,22224,,Autocuration
,,,A,,0,,1,14518,,13257,,,BAO_0000218,CHEMBL627575,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,In vivo,U,2107.0,Liver,22224,,Autocuration
,,,A,,0,,1,14519,,13257,,,BAO_0000218,CHEMBL627576,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,In vivo,U,2048.0,Lung,22224,,Autocuration
,,,A,,0,,1,14520,,13257,,,BAO_0000218,CHEMBL627577,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,In vivo,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,,0,,1,14521,,13257,,,BAO_0000218,CHEMBL627578,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),In vivo,U,2367.0,Prostate gland,22224,,Autocuration
,,,A,,0,,1,14522,,13257,,,BAO_0000218,CHEMBL627579,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,In vivo,U,2367.0,Prostate gland,22224,,Autocuration
,,,A,,0,,1,14523,,13257,,,BAO_0000218,CHEMBL627580,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,In vivo,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,,0,,1,14524,,13257,,,BAO_0000218,CHEMBL627581,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),In vivo,U,2367.0,Prostate gland,22224,,Autocuration
,,,A,,0,,1,14525,,13257,,,BAO_0000218,CHEMBL627582,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,In vivo,U,,,22224,,Autocuration
,,,A,,0,,1,14526,,13257,,,BAO_0000218,CHEMBL627583,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,In vivo,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,,0,,1,14527,,13257,,,BAO_0000218,CHEMBL627584,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,In vivo,U,2106.0,Spleen,22224,,Autocuration
,,,A,,0,,1,14528,,13257,,,BAO_0000218,CHEMBL627585,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,In vivo,U,2367.0,Prostate gland,22224,,Autocuration
,,,A,,0,,1,14529,,13257,,,BAO_0000218,CHEMBL627586,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,In vivo,U,2385.0,Muscle tissue,22224,,Autocuration
,,,A,10116.0,1,,1,14530,,15413,,,BAO_0000218,CHEMBL627587,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14531,,15413,,,BAO_0000218,CHEMBL627588,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14532,,15413,,,BAO_0000218,CHEMBL628250,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14533,,15413,,,BAO_0000218,CHEMBL628251,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14534,,15413,,,BAO_0000218,CHEMBL628252,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,In vivo,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14535,,15413,,,BAO_0000218,CHEMBL628253,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14536,,15413,,,BAO_0000218,CHEMBL628254,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,In vivo,N,1898.0,Hypothalamus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14537,,15413,,,BAO_0000218,CHEMBL877493,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,N,1898.0,Hypothalamus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14538,,15413,,,BAO_0000218,CHEMBL628255,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14539,,15413,,,BAO_0000218,CHEMBL628256,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14540,,15413,,,BAO_0000218,CHEMBL628257,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14541,,15413,,,BAO_0000218,CHEMBL628258,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,N,1898.0,Hypothalamus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14542,,15413,,,BAO_0000218,CHEMBL628259,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14543,,15413,,,BAO_0000218,CHEMBL628429,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14544,,15413,,,BAO_0000218,CHEMBL626862,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14545,,15413,,,BAO_0000218,CHEMBL626863,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,In vivo,N,1898.0,Hypothalamus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14546,,15413,,,BAO_0000218,CHEMBL625886,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,In vivo,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14547,,15413,,,BAO_0000218,CHEMBL625887,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,In vivo,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14548,,15413,,,BAO_0000218,CHEMBL625888,Biodistribution of the [11C]-radiolabeled compound in rat cortex,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14549,,15413,,,BAO_0000218,CHEMBL625889,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14550,,15413,,,BAO_0000218,CHEMBL625890,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,In vivo,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14551,,15413,,,BAO_0000218,CHEMBL625891,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,In vivo,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14552,,15413,,,BAO_0000218,CHEMBL625892,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,In vivo,N,1898.0,Hypothalamus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14553,,15413,,,BAO_0000218,CHEMBL625893,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,In vivo,N,1898.0,Hypothalamus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14554,,15413,,,BAO_0000218,CHEMBL625894,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,In vivo,N,2037.0,Cerebellum,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14555,,15413,,,BAO_0000218,CHEMBL625895,Biodistribution of the [18F]-radiolabeled compound in rat cortex,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,14556,,12404,,,BAO_0000019,CHEMBL625896,Reaction rate parameter value for phosphate with transfer with respect to ATP,,U,,,22224,,Autocuration
,,,A,,0,,1,14557,,568,,,BAO_0000019,CHEMBL625897,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,U,,,22224,,Autocuration
,,,A,,0,,1,14558,,568,,,BAO_0000019,CHEMBL625898,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,U,,,22224,,Autocuration
,,,A,,0,,1,14559,,568,,,BAO_0000019,CHEMBL625899,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,U,,,22224,,Autocuration
,,,A,,0,,1,14560,,12404,,,BAO_0000019,CHEMBL626124,Reaction rate parameter value for phosphate with transfer with respect to ATP,,U,,,22224,,Autocuration
,,,A,562.0,1,,1,14561,,7624,,,BAO_0000218,CHEMBL628500,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,N,,,50212,Escherichia coli,Intermediate
,,,A,10116.0,1,,1,14562,,7624,,,BAO_0000218,CHEMBL857856,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14563,,7624,,,BAO_0000218,CHEMBL628501,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,14564,,4643,,,BAO_0000019,CHEMBL628502,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,U,,,22224,,Autocuration
,,,A,,0,,1,14565,,11532,,,BAO_0000019,CHEMBL628503,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,U,,,22224,,Autocuration
,,,A,,0,,1,14566,,11018,,,BAO_0000019,CHEMBL628504,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,U,,,22224,,Autocuration
,,,A,,0,,1,14567,,2276,,,BAO_0000019,CHEMBL628505,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,U,,,22224,,Autocuration
,,,A,,0,,1,14568,,2276,,,BAO_0000019,CHEMBL874452,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,U,,,22224,,Autocuration
,,,A,,0,,1,14569,,2276,,,BAO_0000019,CHEMBL628506,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,U,,,22224,,Autocuration
,,,A,,0,,1,14570,,2276,,,BAO_0000019,CHEMBL628507,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,U,,,22224,,Autocuration
,,,A,,0,,1,14571,,2276,,,BAO_0000019,CHEMBL628508,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,U,,,22224,,Autocuration
,,,A,,0,,1,14572,,8949,,,BAO_0000019,CHEMBL628509,Michaelis constant (KM) was evaluated,,U,,,22224,,Autocuration
,,,A,,0,,1,14573,,12404,,,BAO_0000019,CHEMBL628510,Reaction rate parameter value for phosphate with transfer with respect to ATP,,U,,,22224,,Autocuration
,,,B,,0,,1,14574,,7625,,,BAO_0000019,CHEMBL628511,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,U,,,22224,,Autocuration
,,,B,,0,,1,14575,,7625,,,BAO_0000019,CHEMBL628512,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,U,,,22224,,Autocuration
,,,B,,0,,1,14576,,7625,,,BAO_0000019,CHEMBL628513,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,U,,,22224,,Autocuration
,,,B,,0,,1,14577,,7625,,,BAO_0000019,CHEMBL628514,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,U,,,22224,,Autocuration
,,,A,,0,,1,14578,,12908,,,BAO_0000019,CHEMBL628515,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,U,,,22224,,Autocuration
,,,A,,0,,1,14579,,10368,,,BAO_0000019,CHEMBL628516,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,U,,,22224,,Autocuration
,,,A,,0,,1,14580,,13108,,,BAO_0000019,CHEMBL628517,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,U,,,22224,,Autocuration
,,,A,,0,,1,14581,,13108,,,BAO_0000019,CHEMBL628518,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,U,,,22224,,Autocuration
,,,A,,0,,1,14582,,15217,,,BAO_0000019,CHEMBL628519,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,U,,,22224,,Autocuration
,,,A,,0,,1,14583,,15217,,,BAO_0000019,CHEMBL628520,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,U,,,22224,,Autocuration
,,,A,,0,,1,14584,,10933,,,BAO_0000019,CHEMBL628521,Binding constant was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,14585,,2363,,,BAO_0000019,CHEMBL630443,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,U,,,22224,,Autocuration
,,,A,,0,,1,14586,,2363,,,BAO_0000019,CHEMBL630444,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,U,,,22224,,Autocuration
,,,A,,0,,1,14587,,2276,,,BAO_0000019,CHEMBL857732,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,U,,,22224,,Autocuration
,,,P,,0,,1,14588,,14915,,,BAO_0000100,CHEMBL630445,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,U,,,22224,,Autocuration
,,,A,,0,,1,14589,,8847,,,BAO_0000019,CHEMBL630446,Catalytic rate constant of the compound,,U,,,22224,,Autocuration
,,,B,,0,,1,14590,,15357,,,BAO_0000019,CHEMBL630447,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,U,,,22224,,Autocuration
,,,A,,0,,1,14591,,2869,,,BAO_0000019,CHEMBL630448,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,U,,,22224,,Autocuration
,,,A,,0,,1,14592,,3484,,,BAO_0000019,CHEMBL630449,Catalytic rate constant against phospholipase A2 was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,14593,,1373,,,BAO_0000019,CHEMBL630450,"Compound was evaluated for catalytic constant, Kcat",,U,,,22224,,Autocuration
,,,A,,0,,1,14594,,8142,,,BAO_0000019,CHEMBL630451,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,14595,,14131,,,BAO_0000019,CHEMBL630452,Kcat calculated from 0.693/T1/2,,U,,,22224,,Autocuration
,,,A,,0,,1,14596,,17269,,,BAO_0000019,CHEMBL630453,Kcat was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,14597,,3485,,,BAO_0000019,CHEMBL630454,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,U,,,22224,,Autocuration
,,,A,,0,,1,14598,,3485,,,BAO_0000019,CHEMBL630455,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,U,,,22224,,Autocuration
,,,A,,0,,1,14599,,3485,,,BAO_0000019,CHEMBL631487,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,U,,,22224,,Autocuration
,,,A,,0,,1,14600,,5962,,,BAO_0000019,CHEMBL631488,Kcat value was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,14601,,3133,,,BAO_0000019,CHEMBL876440,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,U,,,22224,,Autocuration
,,,A,,0,,1,14602,,3133,,,BAO_0000019,CHEMBL631489,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,U,,,22224,,Autocuration
,,,A,,0,,1,14603,,2276,,,BAO_0000019,CHEMBL857742,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,U,,,22224,,Autocuration
,,,A,,0,,1,14604,,2276,,,BAO_0000019,CHEMBL631490,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,U,,,22224,,Autocuration
,,,A,,0,,1,14605,,2276,,,BAO_0000019,CHEMBL631491,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,U,,,22224,,Autocuration
,,,A,,0,,1,14606,,2276,,,BAO_0000019,CHEMBL631492,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,U,,,22224,,Autocuration
,,,A,,0,,1,14607,,2276,,,BAO_0000019,CHEMBL631493,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,U,,,22224,,Autocuration
,,,A,,0,,1,14608,,4892,,,BAO_0000019,CHEMBL631494,Kinetic parameter for rate of conversion to PABA was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,14609,,3133,,,BAO_0000019,CHEMBL631495,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,14610,,11488,,,BAO_0000218,CHEMBL631496,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,N,1988.0,Feces,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14611,,11488,,,BAO_0000218,CHEMBL631497,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14612,,11488,,,BAO_0000218,CHEMBL631498,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14613,,11488,,,BAO_0000218,CHEMBL629776,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14614,,11488,,,BAO_0000218,CHEMBL629777,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14615,,11488,,,BAO_0000218,CHEMBL629778,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14616,,11488,,,BAO_0000218,CHEMBL630456,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14617,,11488,,,BAO_0000218,CHEMBL630457,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14618,,11488,,,BAO_0000218,CHEMBL630458,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14619,,11488,,,BAO_0000218,CHEMBL630459,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14620,,11488,,,BAO_0000218,CHEMBL630460,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14621,,11488,,,BAO_0000218,CHEMBL876550,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14622,,11488,,,BAO_0000218,CHEMBL630461,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14623,,11488,,,BAO_0000218,CHEMBL630462,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14624,,11488,,,BAO_0000218,CHEMBL630463,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14625,,11488,,,BAO_0000218,CHEMBL630464,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14626,,11488,,,BAO_0000218,CHEMBL630465,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14627,,11488,,,BAO_0000218,CHEMBL630466,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14628,,11488,,,BAO_0000218,CHEMBL630467,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14629,,11488,,,BAO_0000218,CHEMBL630633,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14630,,11488,,,BAO_0000218,CHEMBL630634,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14631,,11488,,,BAO_0000218,CHEMBL630635,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14632,,11488,,,BAO_0000218,CHEMBL630636,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14633,,11488,,,BAO_0000218,CHEMBL630637,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,9986.0,1,,1,14634,,7132,,,BAO_0000218,CHEMBL630638,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,N,1988.0,Feces,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,14635,,7132,,,BAO_0000218,CHEMBL630639,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,N,1988.0,Feces,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,14636,,7132,,,BAO_0000218,CHEMBL630640,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,N,1988.0,Feces,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,14637,,7132,,,BAO_0000218,CHEMBL876551,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,N,1988.0,Feces,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,14638,,7132,,,BAO_0000218,CHEMBL630641,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,14639,,7132,,,BAO_0000218,CHEMBL630642,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,14640,,7132,,,BAO_0000218,CHEMBL630643,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,14641,,7132,,,BAO_0000218,CHEMBL630644,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,14642,,7132,,,BAO_0000218,CHEMBL630645,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,14643,,7132,,,BAO_0000218,CHEMBL625599,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,N,1988.0,Feces,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,14644,,7132,,,BAO_0000218,CHEMBL625600,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,N,1988.0,Feces,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,14645,,7132,,,BAO_0000218,CHEMBL625601,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,N,1988.0,Feces,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,14646,,7132,,,BAO_0000218,CHEMBL625602,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,N,1988.0,Feces,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,14647,,7132,,,BAO_0000218,CHEMBL627470,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,14648,,7132,,,BAO_0000218,CHEMBL627471,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,14649,,7132,,,BAO_0000218,CHEMBL627472,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,14650,,7132,,,BAO_0000218,CHEMBL627473,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,9986.0,1,,1,14651,,7132,,,BAO_0000218,CHEMBL627474,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,N,1088.0,Urine,50592,Oryctolagus cuniculus,Intermediate
,,,A,10116.0,1,,1,14652,,13925,,,BAO_0000218,CHEMBL627475,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14653,,13925,,,BAO_0000218,CHEMBL627476,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,9615.0,1,,1,14654,,12582,,,BAO_0000218,CHEMBL627477,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14655,,12582,,,BAO_0000218,CHEMBL627478,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14656,,12582,,,BAO_0000218,CHEMBL627479,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14657,,12582,,,BAO_0000218,CHEMBL627480,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14658,,12582,,,BAO_0000218,CHEMBL627481,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14659,,12582,,,BAO_0000218,CHEMBL627482,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14660,,12582,,,BAO_0000218,CHEMBL627483,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14661,,12582,,,BAO_0000218,CHEMBL875636,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14662,,12582,,,BAO_0000218,CHEMBL625764,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14663,,12582,,,BAO_0000218,CHEMBL625765,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14664,,12582,,,BAO_0000218,CHEMBL625766,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14665,,12582,,,BAO_0000218,CHEMBL625767,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14666,,12582,,,BAO_0000218,CHEMBL625768,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14667,,12582,,,BAO_0000218,CHEMBL625769,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14668,,12582,,,BAO_0000218,CHEMBL625770,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14669,,12582,,,BAO_0000218,CHEMBL625771,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14670,,12582,,,BAO_0000218,CHEMBL625772,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,9615.0,1,,1,14671,,12582,,,BAO_0000218,CHEMBL625773,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,N,1088.0,Urine,50588,Canis lupus familiaris,Intermediate
,,,A,10116.0,1,,1,14672,,12582,,,BAO_0000218,CHEMBL625774,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14673,,12582,,,BAO_0000218,CHEMBL625775,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14674,,12582,,,BAO_0000218,CHEMBL625776,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14675,,12582,,,BAO_0000218,CHEMBL625777,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14676,,12582,,,BAO_0000218,CHEMBL625778,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14677,,12582,,,BAO_0000218,CHEMBL625779,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14678,,12582,,,BAO_0000218,CHEMBL625780,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14679,,12582,,,BAO_0000218,CHEMBL625781,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14680,,12582,,,BAO_0000218,CHEMBL875637,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14681,,12582,,,BAO_0000218,CHEMBL626473,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14682,,12582,,,BAO_0000218,CHEMBL626474,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14683,,12582,,,BAO_0000218,CHEMBL626475,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14684,,12582,,,BAO_0000218,CHEMBL626476,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14685,,12582,,,BAO_0000218,CHEMBL634397,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14686,,12582,,,BAO_0000218,CHEMBL626477,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14687,,12582,,,BAO_0000218,CHEMBL631069,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14688,,12582,,,BAO_0000218,CHEMBL631070,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14689,,12582,,,BAO_0000218,CHEMBL631071,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14690,,12582,,,BAO_0000218,CHEMBL631072,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14691,,12582,,,BAO_0000218,CHEMBL631073,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14692,,12582,,,BAO_0000218,CHEMBL631074,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14693,,12582,,,BAO_0000218,CHEMBL631075,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14694,,12582,,,BAO_0000218,CHEMBL631725,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14695,,12582,,,BAO_0000218,CHEMBL631726,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14696,,12582,,,BAO_0000218,CHEMBL631727,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14697,,12582,,,BAO_0000218,CHEMBL631728,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14698,,12582,,,BAO_0000218,CHEMBL631729,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14699,,12582,,,BAO_0000218,CHEMBL631730,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14700,,12582,,,BAO_0000218,CHEMBL631731,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14701,,12582,,,BAO_0000218,CHEMBL631910,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14702,,15413,,,BAO_0000218,CHEMBL631911,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,In vivo,N,10000000.0,Hippocampus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14703,,15413,,,BAO_0000218,CHEMBL631912,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,In vivo,N,1898.0,Hypothalamus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14704,,15413,,,BAO_0000218,CHEMBL631913,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,In vivo,N,1898.0,Hypothalamus,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14705,,12017,,,BAO_0000218,CHEMBL631914,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14706,,12017,,,BAO_0000218,CHEMBL631915,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14707,,12017,,,BAO_0000218,CHEMBL875778,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14708,,12017,,,BAO_0000218,CHEMBL631916,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14709,,12017,,,BAO_0000218,CHEMBL631917,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14710,,12017,,,BAO_0000218,CHEMBL631918,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14711,,12017,,,BAO_0000218,CHEMBL631919,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14712,,12017,,,BAO_0000218,CHEMBL631920,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14713,,12017,,,BAO_0000218,CHEMBL631921,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14714,,12017,,,BAO_0000218,CHEMBL631922,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14715,,12017,,,BAO_0000218,CHEMBL631923,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14716,,12017,,,BAO_0000218,CHEMBL631924,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14717,,12017,,,BAO_0000218,CHEMBL630234,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14718,,12017,,,BAO_0000218,CHEMBL630235,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14719,,12017,,,BAO_0000218,CHEMBL630236,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14720,,12017,,,BAO_0000218,CHEMBL630237,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14721,,12017,,,BAO_0000218,CHEMBL630238,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14722,,12017,,,BAO_0000218,CHEMBL630239,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14723,,12017,,,BAO_0000218,CHEMBL630303,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14724,,12017,,,BAO_0000218,CHEMBL630304,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14725,,12017,,,BAO_0000218,CHEMBL630305,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14726,,12017,,,BAO_0000218,CHEMBL630306,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14727,,12017,,,BAO_0000218,CHEMBL630307,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14728,,12017,,,BAO_0000218,CHEMBL630308,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14729,,12017,,,BAO_0000218,CHEMBL630309,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14730,,12017,,,BAO_0000218,CHEMBL629309,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14731,,12017,,,BAO_0000218,CHEMBL629993,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14732,,12017,,,BAO_0000218,CHEMBL629994,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14733,,12017,,,BAO_0000218,CHEMBL629995,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14734,,12017,,,BAO_0000218,CHEMBL631993,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14735,,12017,,,BAO_0000218,CHEMBL631994,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14736,,12017,,,BAO_0000218,CHEMBL631995,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14737,,12017,,,BAO_0000218,CHEMBL631996,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14738,,12017,,,BAO_0000218,CHEMBL631997,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14739,,12017,,,BAO_0000218,CHEMBL631998,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14740,,12017,,,BAO_0000218,CHEMBL631999,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14741,,12017,,,BAO_0000218,CHEMBL632000,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14742,,12017,,,BAO_0000218,CHEMBL632001,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14743,,12017,,,BAO_0000218,CHEMBL874424,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14744,,12017,,,BAO_0000218,CHEMBL632002,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14745,,12017,,,BAO_0000218,CHEMBL632003,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,14746,,3133,,,BAO_0000019,CHEMBL632004,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,U,,,22224,,Autocuration
,,,A,,0,,1,14747,,2742,,,BAO_0000019,CHEMBL632005,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,U,,,22224,,Autocuration
,,,A,,0,,1,14748,,2742,,,BAO_0000019,CHEMBL632006,Compound was tested for amidase rate in the presence of N62C screen enzyme,,U,,,22224,,Autocuration
,,,A,,0,,1,14749,,2742,,,BAO_0000019,CHEMBL632007,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,U,,,22224,,Autocuration
,,,A,,0,,1,14750,,2742,,,BAO_0000019,CHEMBL632008,Compound was tested for amidase rate in the presence of S166C screen enzyme,,U,,,22224,,Autocuration
,,,A,,0,,1,14751,,2742,,,BAO_0000019,CHEMBL632009,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,U,,,22224,,Autocuration
,,,A,,0,,1,14752,,2742,,,BAO_0000019,CHEMBL632010,Compound was tested for esterase rate in the presence of N62C screen enzyme,,U,,,22224,,Autocuration
,,,A,,0,,1,14753,,2742,,,BAO_0000019,CHEMBL857750,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,U,,,22224,,Autocuration
,,,A,,0,,1,14754,,2742,,,BAO_0000019,CHEMBL632011,Compound was tested for esterase rate in the presence of S166C screen enzyme,,U,,,22224,,Autocuration
,,,A,,0,,1,14755,,2276,,,BAO_0000019,CHEMBL632012,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,U,,,22224,,Autocuration
,,,A,,0,,1,14756,,2276,,,BAO_0000019,CHEMBL632013,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,U,,,22224,,Autocuration
,,,A,,0,,1,14757,,2276,,,BAO_0000019,CHEMBL632014,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,U,,,22224,,Autocuration
,,,A,,0,,1,14758,,2276,,,BAO_0000019,CHEMBL629622,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,U,,,22224,,Autocuration
,,,A,,0,,1,14759,,2276,,,BAO_0000019,CHEMBL629623,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,U,,,22224,,Autocuration
,,,A,,0,,1,14760,,2276,,,BAO_0000019,CHEMBL629624,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,U,,,22224,,Autocuration
,,,A,,0,,1,14761,,17269,,,BAO_0000019,CHEMBL629625,Ratio of Kcat to that of Km was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,14762,,2276,,,BAO_0000019,CHEMBL629626,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,U,,,22224,,Autocuration
,,,A,,0,,1,14763,,2276,,,BAO_0000019,CHEMBL629627,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,U,,,22224,,Autocuration
,,,A,,0,,1,14764,,15917,,,BAO_0000019,CHEMBL629628,"Compound was evaluated for constant, Kd",,U,,,22224,,Autocuration
,,,A,,0,,1,14765,,10933,,,BAO_0000019,CHEMBL629629,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,U,,,22224,,Autocuration
,,,A,,0,,1,14766,,10933,,,BAO_0000019,CHEMBL629630,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,U,,,22224,,Autocuration
,,,A,,0,,1,14767,,14293,,,BAO_0000019,CHEMBL856030,Dissociation Constant of compound determined,,U,,,22224,,Autocuration
,,,B,,0,,1,14768,,6698,,,BAO_0000019,CHEMBL629631,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,U,,,22224,,Autocuration
,,,B,,0,,1,14769,,6698,,,BAO_0000019,CHEMBL629632,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,U,,,22224,,Autocuration
,,,P,,0,,1,14770,,4318,,,BAO_0000100,CHEMBL629633,Dissociation constant of compound with Fructose was determined,,U,,,22224,,Autocuration
,,,P,,0,,1,14771,,4318,,,BAO_0000100,CHEMBL629634,Dissociation constant of compound with Fructose was determined; Not determined,,U,,,22224,,Autocuration
,,,P,,0,,1,14772,,4318,,,BAO_0000100,CHEMBL629635,Dissociation constant of compound with Lactulose was determined,,U,,,22224,,Autocuration
,,,P,,0,,1,14773,,4318,,,BAO_0000100,CHEMBL629636,Dissociation constant of compound with Lactulose was determined; Not determined,,U,,,22224,,Autocuration
,,,P,,0,,1,14774,,14959,,,BAO_0000100,CHEMBL629637,Dissociation constant of the Compound,,U,,,22224,,Autocuration
,,,P,,0,,1,14775,,5913,,,BAO_0000100,CHEMBL629638,Dissociation constant by non-linear regression analysis,,U,,,22224,,Autocuration
,,,P,,0,,1,14776,,14218,,,BAO_0000100,CHEMBL629639,Dissociation constant was determined,,U,,,22224,,Autocuration
,,,P,,0,,1,14777,,10689,,,BAO_0000100,CHEMBL629640,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,U,,,22224,,Autocuration
,,,P,,0,,1,14778,,13925,,,BAO_0000100,CHEMBL629641,Dissociation constant was determined,,U,,,22224,,Autocuration
,,,P,,0,,1,14779,,16359,,,BAO_0000100,CHEMBL631344,Dissociation constant was determined,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,14780,,10944,,,BAO_0000218,CHEMBL631345,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,14781,,11080,,,BAO_0000019,CHEMBL631346,The dissociation constant determined by fluorescence displacement assay,,U,,,22224,,Autocuration
,,,A,,0,,1,14782,,17805,,,BAO_0000019,CHEMBL631524,kd value surface plasmon resonance (SPR) method,,U,,,22224,,Autocuration
,,,A,10116.0,1,,1,14783,,10944,,,BAO_0000218,CHEMBL631525,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,F,,0,,1,14784,,16645,,,BAO_0000019,CHEMBL631526,First dissociation constant of the binding of compound to V30M TTR,,U,,,22224,,Autocuration
,,,F,,0,,1,14785,,16645,,,BAO_0000019,CHEMBL631527,Second dissociation constant of the binding of compound to V30M TTR,,U,,,22224,,Autocuration
,,,A,,0,,1,14786,,7793,,,BAO_0000019,CHEMBL631528,"Compound was evaluated for equilibrium constant, Ke",,U,,,22224,,Autocuration
,,,A,,0,,1,14787,,12199,,,BAO_0000019,CHEMBL631529,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,U,1898.0,Hypothalamus,22224,,Autocuration
,,,A,,0,,1,14788,,12199,,,BAO_0000019,CHEMBL631530,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,U,1898.0,Hypothalamus,22224,,Autocuration
,,,A,,0,,1,14789,,9680,,,BAO_0000019,CHEMBL631531,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,U,,,22224,,Autocuration
,,,A,,0,,1,14790,,9680,,,BAO_0000019,CHEMBL631532,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,U,,,22224,,Autocuration
,,,A,,0,,1,14791,,9680,,,BAO_0000019,CHEMBL631533,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,14792,,13758,,,BAO_0000218,CHEMBL876552,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14793,,13758,,,BAO_0000218,CHEMBL631534,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14794,,13758,,,BAO_0000218,CHEMBL631535,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14795,,13758,,,BAO_0000218,CHEMBL631536,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14796,,13758,,,BAO_0000218,CHEMBL631537,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14797,,13758,,,BAO_0000218,CHEMBL631538,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14798,,13758,,,BAO_0000218,CHEMBL631539,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14799,,13758,,,BAO_0000218,CHEMBL631540,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,14800,,14393,,,BAO_0000218,CHEMBL625637,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14801,,14393,,,BAO_0000218,CHEMBL625638,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14802,,15078,,,BAO_0000218,CHEMBL625639,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14803,,13925,,,BAO_0000218,CHEMBL625640,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14804,,13925,,,BAO_0000218,CHEMBL625641,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14805,,13925,,,BAO_0000218,CHEMBL625642,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14806,,13925,,,BAO_0000218,CHEMBL625643,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14807,,13925,,,BAO_0000218,CHEMBL625644,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14808,,13925,,,BAO_0000218,CHEMBL625645,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,N,2113.0,Kidney,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14809,,13925,,,BAO_0000218,CHEMBL625646,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14810,,13925,,,BAO_0000218,CHEMBL625647,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14811,,13925,,,BAO_0000218,CHEMBL625648,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14812,,13925,,,BAO_0000218,CHEMBL625649,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14813,,13925,,,BAO_0000218,CHEMBL625650,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14814,,13925,,,BAO_0000218,CHEMBL625651,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14815,,13925,,,BAO_0000218,CHEMBL625652,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,N,14.0,Zone of skin,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14816,,13925,,,BAO_0000218,CHEMBL625653,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,N,14.0,Zone of skin,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14817,,13925,,,BAO_0000218,CHEMBL625654,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14818,,13925,,,BAO_0000218,CHEMBL625655,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14819,,9712,,,BAO_0000218,CHEMBL625656,Biodistribution of Compound in rat blood after 15 minutes of administration,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14820,,9712,,,BAO_0000218,CHEMBL625657,Biodistribution of Compound in rat blood after 2 minutes of administration,In vivo,N,178.0,Blood,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14821,,9712,,,BAO_0000218,CHEMBL625658,Biodistribution of Compound in rat brain after 15 minutes of administration,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14822,,9712,,,BAO_0000218,CHEMBL625659,Biodistribution of Compound in rat brain after 2 minutes of administration,In vivo,N,955.0,Brain,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14823,,9712,,,BAO_0000218,CHEMBL625660,Biodistribution of Compound in rat heart after 15 minutes of administration,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14824,,9712,,,BAO_0000218,CHEMBL625661,Biodistribution of Compound in rat heart after 2 minutes of administration,In vivo,N,948.0,Heart,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14825,,9712,,,BAO_0000218,CHEMBL625662,Biodistribution of Compound in rat liver after 15 minutes of administration,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14826,,9712,,,BAO_0000218,CHEMBL625663,Biodistribution of Compound in rat liver after 2 minutes of administration,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14827,,9712,,,BAO_0000218,CHEMBL875621,Biodistribution of Compound in rat lung after 15 minutes of administration,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14828,,9712,,,BAO_0000218,CHEMBL628382,Biodistribution of Compound in rat lung after 2 minutes of administration,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14829,,9712,,,BAO_0000218,CHEMBL628383,Biodistribution of Compound in rat muscle after 15 minutes of administration,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14830,,9712,,,BAO_0000218,CHEMBL628384,Biodistribution of Compound in rat muscle after 2 minutes of administration,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14831,,13925,,,BAO_0000218,CHEMBL628385,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14832,,13925,,,BAO_0000218,CHEMBL875753,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14833,,13925,,,BAO_0000218,CHEMBL628386,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14834,,6941,,,BAO_0000218,CHEMBL628387,Organ distribution in rat blood 2 minutes after intravenous injection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14835,,6941,,,BAO_0000218,CHEMBL628388,Organ distribution in rat blood 2 hr after intravenous injection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14836,,6941,,,BAO_0000218,CHEMBL628389,Organ distribution in rat blood 30 minutes after intravenous injection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14837,,6941,,,BAO_0000218,CHEMBL632756,Organ distribution in rat blood 30 min after intravenous injection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14838,,6941,,,BAO_0000218,CHEMBL628390,Organ distribution in rat brain 2 minutes after intravenous injection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14839,,6941,,,BAO_0000218,CHEMBL631811,Organ distribution in rat brain 2 hr after intravenous injection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14840,,6941,,,BAO_0000218,CHEMBL631812,Organ distribution in rat brain 30 minutes after intravenous injection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14841,,6941,,,BAO_0000218,CHEMBL631813,Organ distribution in rat heart 2 minutes after intravenous injection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14842,,6941,,,BAO_0000218,CHEMBL631814,Organ distribution in rat heart 2 hr after intravenous injection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14843,,6941,,,BAO_0000218,CHEMBL631815,Organ distribution in rat heart 30 minutes after intravenous injection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14844,,6941,,,BAO_0000218,CHEMBL631816,Organ distribution in rat kidney 2 minutes after intravenous injection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14845,,6941,,,BAO_0000218,CHEMBL875758,Organ distribution in rat kidney 2 hr after intravenous injection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14846,,6941,,,BAO_0000218,CHEMBL631817,Organ distribution in rat kidney 30 minutes after intravenous injection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14847,,6941,,,BAO_0000218,CHEMBL631818,Organ distribution in rat liver 2 minutes after intravenous injection,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14848,,6941,,,BAO_0000218,CHEMBL631819,Organ distribution in rat liver 2 hr after intravenous injection,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14849,,6941,,,BAO_0000218,CHEMBL631820,Organ distribution in rat liver 30 minutes after intravenous injection,,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14850,,6941,,,BAO_0000218,CHEMBL631821,Organ distribution in rat lung 2 minutes after intravenous injection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14851,,6941,,,BAO_0000218,CHEMBL631822,Organ distribution in rat lung 2 hr after intravenous injection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14852,,6941,,,BAO_0000218,CHEMBL631823,Organ distribution in rat lung 30 minutes after intravenous injection,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14853,,6941,,,BAO_0000218,CHEMBL631824,Organ distribution in rat muscle 2 minutes after intravenous injection,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14854,,6941,,,BAO_0000218,CHEMBL631825,Organ distribution in rat muscle 2 hr after intravenous injection,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14855,,6941,,,BAO_0000218,CHEMBL631826,Organ distribution in rat muscle 30 minutes after intravenous injection,,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,14856,,14439,,,BAO_0000218,CHEMBL631827,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14857,,14439,,,BAO_0000218,CHEMBL631828,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14858,,14439,,,BAO_0000218,CHEMBL631829,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,14859,,12582,,,BAO_0000218,CHEMBL875759,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14860,,12582,,,BAO_0000218,CHEMBL631830,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14861,,12582,,,BAO_0000218,CHEMBL631831,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14862,,12582,,,BAO_0000218,CHEMBL631832,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14863,,12582,,,BAO_0000218,CHEMBL631833,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14864,,12582,,,BAO_0000218,CHEMBL631834,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14865,,12582,,,BAO_0000218,CHEMBL631835,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14866,,12582,,,BAO_0000218,CHEMBL631836,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14867,,12582,,,BAO_0000218,CHEMBL631837,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14868,,12582,,,BAO_0000218,CHEMBL631838,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14869,,12582,,,BAO_0000218,CHEMBL631839,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14870,,12582,,,BAO_0000218,CHEMBL631840,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14871,,12582,,,BAO_0000218,CHEMBL631841,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14872,,12582,,,BAO_0000218,CHEMBL631842,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14873,,12582,,,BAO_0000218,CHEMBL631843,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14874,,12582,,,BAO_0000218,CHEMBL631844,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14875,,12582,,,BAO_0000218,CHEMBL631845,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14876,,12582,,,BAO_0000218,CHEMBL631846,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14877,,12582,,,BAO_0000218,CHEMBL875760,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14878,,12582,,,BAO_0000218,CHEMBL632199,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14879,,12582,,,BAO_0000218,CHEMBL631847,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14880,,12582,,,BAO_0000218,CHEMBL631848,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14881,,12582,,,BAO_0000218,CHEMBL628707,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14882,,12582,,,BAO_0000218,CHEMBL628708,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14883,,12582,,,BAO_0000218,CHEMBL628709,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14884,,12582,,,BAO_0000218,CHEMBL628710,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14885,,12582,,,BAO_0000218,CHEMBL628711,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14886,,12582,,,BAO_0000218,CHEMBL628712,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14887,,12582,,,BAO_0000218,CHEMBL628713,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14888,,12582,,,BAO_0000218,CHEMBL628714,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,N,1088.0,Urine,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14889,,7415,,,BAO_0000218,CHEMBL628715,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,14890,,7313,,,BAO_0000019,CHEMBL629179,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,U,,,22224,,Autocuration
,,,A,,0,,1,14891,,7313,,,BAO_0000019,CHEMBL629180,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,U,,,22224,,Autocuration
,,,A,,0,,1,14892,,7313,,,BAO_0000019,CHEMBL875108,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,U,,,22224,,Autocuration
,,,A,,0,,1,14893,,7570,,,BAO_0000019,CHEMBL629181,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,U,1235.0,Adrenal cortex,22224,,Autocuration
,,,A,,0,,1,14894,,7570,,,BAO_0000019,CHEMBL629182,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,U,1235.0,Adrenal cortex,22224,,Autocuration
,,,A,,0,,1,14895,,7570,,,BAO_0000019,CHEMBL629183,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,U,,,22224,,Autocuration
,,,A,,0,,1,14896,,7570,,,BAO_0000019,CHEMBL629184,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,U,,,22224,,Autocuration
,,,A,,0,,1,14897,,7570,,,BAO_0000019,CHEMBL629185,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,U,1235.0,Adrenal cortex,22224,,Autocuration
,,,A,,0,,1,14898,,7570,,,BAO_0000019,CHEMBL629186,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,U,1235.0,Adrenal cortex,22224,,Autocuration
,,,A,,0,,1,14899,,7570,,,BAO_0000019,CHEMBL629187,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,U,,,22224,,Autocuration
,,,A,,0,,1,14900,,7570,,,BAO_0000019,CHEMBL629887,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,U,,,22224,,Autocuration
,,,A,,0,,1,14901,,7570,,,BAO_0000019,CHEMBL629888,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,U,,,22224,,Autocuration
,,,A,,0,,1,14902,,7570,,,BAO_0000019,CHEMBL629889,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,U,,,22224,,Autocuration
,,,A,,0,,1,14903,,7570,,,BAO_0000019,CHEMBL629890,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,U,1235.0,Adrenal cortex,22224,,Autocuration
,,,A,,0,,1,14904,,7570,,,BAO_0000019,CHEMBL629891,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,U,,,22224,,Autocuration
,,,A,,0,,1,14905,,7570,,,BAO_0000019,CHEMBL629892,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,U,,,22224,,Autocuration
,,,A,,0,,1,14906,,7570,,,BAO_0000019,CHEMBL629893,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,U,1235.0,Adrenal cortex,22224,,Autocuration
,,,A,,0,,1,14907,,7570,,,BAO_0000019,CHEMBL629894,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,U,,,22224,,Autocuration
,,,A,,0,,1,14908,,7570,,,BAO_0000019,CHEMBL629895,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,U,,,22224,,Autocuration
,,,A,9615.0,0,,1,14909,,14122,,,BAO_0000218,CHEMBL875109,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",In vivo,U,,,22224,Canis lupus familiaris,Autocuration
,,,A,9541.0,0,,1,14910,,16449,,,BAO_0000218,CHEMBL629896,Absolute bioavailability in male cynomolgus monkeys,In vivo,U,,,22224,Macaca fascicularis,Autocuration
,,,A,10116.0,0,,1,14911,,16449,,,BAO_0000218,CHEMBL629897,Absolute bioavailability in maleSprague-Dawley rats,In vivo,U,,,22224,Rattus norvegicus,Autocuration
,,,A,10116.0,1,,1,14912,,12017,,,BAO_0000218,CHEMBL629898,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14913,,12017,,,BAO_0000218,CHEMBL630057,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14914,,12017,,,BAO_0000218,CHEMBL630058,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2107.0,Liver,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14915,,12017,,,BAO_0000218,CHEMBL630059,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14916,,12017,,,BAO_0000218,CHEMBL630060,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14917,,12017,,,BAO_0000218,CHEMBL630061,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14918,,12017,,,BAO_0000218,CHEMBL630062,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14919,,12017,,,BAO_0000218,CHEMBL630063,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14920,,12017,,,BAO_0000218,CHEMBL630064,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14921,,12017,,,BAO_0000218,CHEMBL630065,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14922,,12017,,,BAO_0000218,CHEMBL630066,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14923,,12017,,,BAO_0000218,CHEMBL630067,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14924,,12017,,,BAO_0000218,CHEMBL630068,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2048.0,Lung,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14925,,12017,,,BAO_0000218,CHEMBL631113,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14926,,12017,,,BAO_0000218,CHEMBL631114,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14927,,12017,,,BAO_0000218,CHEMBL631115,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14928,,12017,,,BAO_0000218,CHEMBL631116,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14929,,12017,,,BAO_0000218,CHEMBL630528,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14930,,12017,,,BAO_0000218,CHEMBL630529,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14931,,12017,,,BAO_0000218,CHEMBL630530,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14932,,12017,,,BAO_0000218,CHEMBL630531,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14933,,12017,,,BAO_0000218,CHEMBL630532,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14934,,12017,,,BAO_0000218,CHEMBL630533,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2385.0,Muscle tissue,50597,Rattus norvegicus,Intermediate
,,,A,10090.0,1,,1,14935,,15045,,,BAO_0000218,CHEMBL630534,Biodistribution in normal mice blood after 120 hr,In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14936,,15045,,,BAO_0000218,CHEMBL630535,Biodistribution in normal mice blood after 24 hr,In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14937,,15045,,,BAO_0000218,CHEMBL630536,Biodistribution in normal mice blood after 4 hr,In vivo,N,178.0,Blood,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14938,,15045,,,BAO_0000218,CHEMBL630537,Biodistribution in normal mice bone after 120 hr,In vivo,N,10000001.0,Bone,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14939,,15045,,,BAO_0000218,CHEMBL630538,Biodistribution in normal mice bone after 24 hr,In vivo,N,10000001.0,Bone,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14940,,15045,,,BAO_0000218,CHEMBL630539,Biodistribution in normal mice bone after 4 hr,In vivo,N,10000001.0,Bone,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14941,,15045,,,BAO_0000218,CHEMBL630540,Biodistribution in normal mice heart after 120 hr,In vivo,N,948.0,Heart,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14942,,15045,,,BAO_0000218,CHEMBL630541,Biodistribution in normal mice heart after 24 hr,In vivo,N,948.0,Heart,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14943,,15045,,,BAO_0000218,CHEMBL630542,Biodistribution in normal mice heart after 4 hr,In vivo,N,948.0,Heart,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14944,,15045,,,BAO_0000218,CHEMBL630543,Biodistribution in normal mice kidney after 120 hr,In vivo,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14945,,15045,,,BAO_0000218,CHEMBL630544,Biodistribution in normal mice kidney after 24 hr,In vivo,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14946,,15045,,,BAO_0000218,CHEMBL630545,Biodistribution in normal mice kidney after 4 hr,In vivo,N,2113.0,Kidney,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14947,,15045,,,BAO_0000218,CHEMBL630546,Biodistribution in normal mice liver after 120 hr,In vivo,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14948,,15045,,,BAO_0000218,CHEMBL630547,Biodistribution in normal mice liver after 24 hr,In vivo,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14949,,15045,,,BAO_0000218,CHEMBL630548,Biodistribution in normal mice liver after 4 hr,In vivo,N,2107.0,Liver,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14950,,15045,,,BAO_0000218,CHEMBL630549,Biodistribution in normal mice spleen after 120 hr,In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14951,,15045,,,BAO_0000218,CHEMBL630550,Biodistribution in normal mice spleen after 24 hr,In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,14952,,15045,,,BAO_0000218,CHEMBL876426,Biodistribution in normal mice spleen after 4 hr,In vivo,N,2106.0,Spleen,50594,Mus musculus,Intermediate
,,,A,10116.0,1,,1,14953,,12017,,,BAO_0000218,CHEMBL630551,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14954,,12017,,,BAO_0000218,CHEMBL630552,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14955,,12017,,,BAO_0000218,CHEMBL630553,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14956,,12017,,,BAO_0000218,CHEMBL630554,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14957,,12017,,,BAO_0000218,CHEMBL630555,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14958,,12017,,,BAO_0000218,CHEMBL630556,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14959,,12017,,,BAO_0000218,CHEMBL630557,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14960,,12017,,,BAO_0000218,CHEMBL630558,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14961,,12017,,,BAO_0000218,CHEMBL630559,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14962,,12017,,,BAO_0000218,CHEMBL630560,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2106.0,Spleen,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14963,,12017,,,BAO_0000218,CHEMBL876427,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,N,2046.0,Thyroid gland,50597,Rattus norvegicus,Intermediate
,,,A,10116.0,1,,1,14964,,14941,,,BAO_0000218,CHEMBL630561,The Kel values in female wistar rats.,,N,,,50597,Rattus norvegicus,Intermediate
,,,A,,0,,1,14965,,4646,,,BAO_0000019,CHEMBL630562,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,U,,,22224,,Autocuration
,,,A,,0,,1,14966,,8847,,,BAO_0000019,CHEMBL630563,Hydrolysis rate constant of the compound,,U,,,22224,,Autocuration
,,,P,,0,,1,14967,,11778,,,BAO_0000100,CHEMBL629673,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,U,,,22229,,Autocuration
,,,A,,0,,1,14968,,2363,,,BAO_0000019,CHEMBL629674,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,U,,,22224,,Autocuration
,,,A,,0,,1,14969,,2363,,,BAO_0000019,CHEMBL629675,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,U,,,22224,,Autocuration
,,,A,,0,,1,14970,,2363,,,BAO_0000019,CHEMBL629676,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,U,,,22224,,Autocuration
,,,A,,0,,1,14971,,2363,,,BAO_0000019,CHEMBL629677,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,U,,,22224,,Autocuration
,,,A,,0,,1,14972,,8371,,,BAO_0000019,CHEMBL629678,Apparent inactivation rate constant was evaluated,,U,,,22224,,Autocuration
,,,A,,0,,1,14973,,14883,,,BAO_0000019,CHEMBL629679,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,U,,,22224,,Autocuration
,,,A,,0,,1,14974,,14883,,,BAO_0000019,CHEMBL629680,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,U,,,22224,,Autocuration
,,,A,,0,,1,14975,,4643,,,BAO_0000019,CHEMBL629681,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,U,,,22224,,Autocuration
,,,A,,0,,1,14976,,3519,,,BAO_0000019,CHEMBL629682,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,U,,,22224,,Autocuration
,,,A,,0,,1,14977,,10600,,,BAO_0000019,CHEMBL629683,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,U,,,22224,,Autocuration
,,,F,,0,,1,14978,,8501,,,BAO_0000019,CHEMBL629684,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,U,,,22224,,Autocuration
,,,P,,0,,1,14979,,8505,,,BAO_0000100,CHEMBL629685,Dissociation constant was determined,,U,,,22224,,Autocuration
,,,P,,0,,1,14980,,9778,,,BAO_0000100,CHEMBL629686,Dissociation constant was determined,,U,,,22224,,Autocuration
,,,P,,0,,1,14981,,9778,,,BAO_0000100,CHEMBL872932,Dissociation constant at pH 7.4,,U,,,22224,,Autocuration
,,,P,,0,,1,14982,,9778,,,BAO_0000100,CHEMBL629687,Dissociation constant in presence of 1 mM dithiothreitol,,U,,,22224,,Autocuration
,,,A,,0,,1,14983,,13007,,,BAO_0000019,CHEMBL872931,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,U,,,22224,,Autocuration
,,,A,,0,,1,14984,,13007,,,BAO_0000019,CHEMBL628151,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,U,,,22224,,Autocuration
,,,A,,0,,1,14985,,13007,,,BAO_0000019,CHEMBL628152,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,U,,,22224,,Autocuration
,,,A,,0,,1,14986,,13007,,,BAO_0000019,CHEMBL628153,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,U,,,22224,,Autocuration
,,,A,,0,,1,14987,,11482,,,BAO_0000019,CHEMBL628154,Kinetic constant for aromatization of androstenedione,,U,,,22224,,Autocuration
,,,A,,0,,1,14988,,11482,,,BAO_0000019,CHEMBL628155,Kinetic constant for aromatization of testosterone,,U,,,22224,,Autocuration
,,,A,,0,,1,14989,,2303,,,BAO_0000019,CHEMBL628156,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,U,,,22224,,Autocuration
,,,A,,0,,1,14990,,11964,,,BAO_0000019,CHEMBL628157,Local inhibition constant was determined,,U,,,22224,,Autocuration
,,,A,4932.0,1,,1,14991,,3140,,,BAO_0000218,CHEMBL857533,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,N,,,50347,Saccharomyces cerevisiae,Intermediate
,,,P,,0,,1,14992,,10650,,,BAO_0000100,CHEMBL628158,Dissociation constant value of the compound,,U,,,22224,,Autocuration
,,,A,,0,,1,14993,,4667,,,BAO_0000019,CHEMBL628159,In vitro permeability through cornea without epithelium,,U,964.0,Cornea,22224,,Autocuration
,,,A,,0,,1,14994,,4667,,,BAO_0000019,CHEMBL875616,In vitro permeability through intact cornea,,U,964.0,Cornea,22224,,Autocuration
,,,A,9986.0,1,,1,14995,,9199,,,BAO_0000218,CHEMBL628160,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,N,964.0,Cornea,50592,Oryctolagus cuniculus,Intermediate
,,,A,,0,,1,14996,,11966,,,BAO_0000019,CHEMBL628161,Rate of enzyme inactivation for the compound was determined,,U,,,22224,,Autocuration
,,,A,,0,,1,14997,,4667,,,BAO_0000019,CHEMBL628162,In vitro permeability through cornea without epithelium,,U,964.0,Cornea,22224,,Autocuration
,,,A,,0,,1,14998,,4667,,,BAO_0000019,CHEMBL628163,In vitro permeability through intact cornea,,U,964.0,Cornea,22224,,Autocuration
,,,A,,0,,1,14999,,8354,,,BAO_0000019,CHEMBL628164,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,15000,,8354,,,BAO_0000019,CHEMBL628165,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,15001,,8354,,,BAO_0000019,CHEMBL628166,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,15002,,8354,,,BAO_0000019,CHEMBL628167,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,15003,,8354,,,BAO_0000019,CHEMBL628168,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,15004,,8354,,,BAO_0000019,CHEMBL628169,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,15005,,8354,,,BAO_0000019,CHEMBL628170,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,15006,,8354,,,BAO_0000019,CHEMBL628171,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,15007,,8354,,,BAO_0000019,CHEMBL627434,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,15008,,8354,,,BAO_0000019,CHEMBL627435,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,15009,,8354,,,BAO_0000019,CHEMBL628110,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,15010,,8354,,,BAO_0000019,CHEMBL628111,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,15011,,8354,,,BAO_0000019,CHEMBL628112,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,15012,,8354,,,BAO_0000019,CHEMBL628260,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,,0,,1,15013,,8354,,,BAO_0000019,CHEMBL628261,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,U,,,22224,,Autocuration
,,,A,10090.0,1,,1,15014,,14439,,,BAO_0000218,CHEMBL628262,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,9606.0,1,,1,15015,,14439,,,BAO_0000218,CHEMBL628263,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,In vivo,N,,,50587,Homo sapiens,Intermediate
,,,A,10090.0,1,,1,15016,,14439,,,BAO_0000218,CHEMBL628264,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,15017,,14439,,,BAO_0000218,CHEMBL628265,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,15018,,14439,,,BAO_0000218,CHEMBL628266,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,15019,,14439,,,BAO_0000218,CHEMBL628267,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,15020,,14439,,,BAO_0000218,CHEMBL628268,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,15021,,14439,,,BAO_0000218,CHEMBL628269,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,15022,,14439,,,BAO_0000218,CHEMBL628270,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,15023,,14439,,,BAO_0000218,CHEMBL628271,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),In vivo,N,,,50594,Mus musculus,Intermediate
,,,A,10090.0,1,,1,15024,,14439,,,BAO_0000218,CHEMBL628272,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),In vivo,N,,,50594,Mus musculus,Intermediate
